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Abstract 
Predicting the likelihood of non-healing: A venous leg ulcer risk assessment tool 
Background and Significance:  Chronic leg ulcers affect approximately 1-3% of the 
population (Briggs et al., 2003; Margolis, Bilker, et al., 2002) with many of these leg ulcers 
remaining unhealed for years or decades and, if healed, high rates of recurrence exist 
(Abbade & Lastória, 2005).  Three percent of the total health expenditure (Posnett et al., 
2008) in developed countries is being spent on chronic wounds, equating to $3.9 billion spent 
annually in Australia (Australian Institute of Health and Welfare., 2012).  Patients with 
chronic leg ulcers are often health service resource intensive (Graham, Harrison, Friedberg, et 
al., 2001; Walker et al., 2002) and their leg ulcers may result in serious complications, such 
as cellulitis, requiring hospitalisation (Golinko et al., 2009).  Venous leg ulcers make up 
about 70% of all chronic leg ulcers (Abbade & Lastória, 2005) and are usually debilitating, 
with evidence of pain, reduced mobility and a decreased quality of life.  An important 
challenge for health practitioners involved in venous leg ulcer management is to objectively 
identify at an early stage those patients at risk of non-healing.  At present, health practitioners 
utilise their clinical judgement, with no risk assessment tools widely utilised to assist them to 
detect venous leg ulcers at risk of non-healing in order to guide appropriate wound 
management. 
Aim:  The aim of this research was to develop a risk assessment tool for failure to heal of 
venous leg ulcers by 24 weeks, and to test the tool for inter-rater reliability and validity.  The 
development of the risk assessment tool was guided by risk factors for non-healing of venous 
leg ulcers identified from a literature review, data analysis of physiological, economic, social 
and psychological variables and advice from an expert wound advisory group.  The tool was 
then validated on the derivation database, tested for inter-rater reliability and validated on a 
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prospective sample of participants.  Feedback from health professionals was also sought in 
regards to their perceived usefulness of the risk assessment tool. 
Methods:  A secondary analysis was undertaken of a large data set of clinical, wound 
healing, health and psychosocial data from patients (n=366) with venous leg ulcers currently 
held by the School of Nursing (SON), Queensland University of Technology (QUT) wound 
healing group.  All variables significantly associated with non-healing at 24 weeks at the 
bivariate level (p<0.10), along with predictors identified from the literature, were entered into 
a Generalised Linear Mixed Model (GLMM) to determine their independent influences on 
non-healing of venous leg ulcers by 24 weeks. 
A risk assessment tool was developed utilising the results from this analysis and 
combining them with evidence from the literature and feedback from an expert wound 
advisory group (WAG).  This tool was validated on the retrospective database using Area 
Under the Receiver Operating Characteristic (ROC) curve (AUC) analysis. 
Inter-rater reliability of the tool was determined using Intra-Class Correlation (ICC) 
analysis, and further validity of the risk assessment tool was tested on a prospective sample of 
participants across ten clinical sites in Queensland and Victoria, using AUC analysis.  
Descriptive analysis was undertaken of questionnaires completed by health professionals’ on 
ease of use and usefulness of the risk assessment tool. 
Results:  Bivariate analysis of data from 318 ulcers identified thirty-three potential predictors 
(p<0.10) of non-healing in venous leg ulcers by 24 weeks.  A significant multivariate GLMM 
(p<0.001) identified four independent predictors of failure to heal after 24 weeks; living alone 
(OR 10.7 95% CI 4.60-22.19, p=0.03); compression level <30mmHg (OR 4.18 95% CI 1.95-
8.97, p=0.002); Pressure Ulcer Scale for Healing (PUSH) score ≥ 10 (OR 5.1 95% CI 2.33-
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11.88, p=0.001) and ulcer area reduction of <25% in 2 weeks (OR 2.3 95% CI 1.13-4.61, 
p<0.001). 
A simple, 10–item tool using plain language with binary yes/no responses was 
developed and included socio-demographic, venous history, mobility, compression, ulcer and 
lower limb characteristic items.  The tool had very good discrimination and goodness-of-fit in 
analysis of the retrospective database with an AUC of 0.80 (95% CI, 0.68-0.93, p<0.001), for 
the total risk assessment score.  Validation results from a sample of 141 ulcers in a 
prospective study across ten clinical sites indicated good discrimination and goodness-of-fit 
with an AUC of 0.78 (95% CI, 0.70-0.87, p<0.001) and good inter-rater reliability with ICC 
results of 0.86 (95% CI, 0.69-0.95, p<0.001). 
Conclusions:  Health professionals may reject prognostic models due to lack of clinical 
credibility and lack of evidence that the prognostic model can support decisions about patient 
care.  This risk assessment tool was developed with clinical credibility in mind, using 
evidence based data and content endorsed by an expert wound advisory group.  Validation 
results reveal that the risk assessment tool met the recommendations for a useful, predictive 
tool, providing a real-time prediction of the risk of non-healing by 24 weeks.  The 
identification of risk factors for delayed healing will provide health professionals with 
information on the need to implement adjuvant interventions in addition to routine care at an 
early stage and/or specialist referral, saving time and resources.  It will also be able to 
determine realistic outcomes for patients and guide decisions on alternative, tailored 
interventions to address the specific risk factors and thus promote early healing. 
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Chapter One: Introduction 
1.1 Background  
Chronic wounds are costly, with three percent of the total health expenditure in 
developed countries spent on their care (Posnett, et al., 2008), equating to $3.9 billion spent 
annually in Australia (Australian Institute of Health and Welfare., 2012).  Leg ulcers have 
been a serious health problem for thousands of years and continue to pose a considerable 
burden today for both patients and carers in many countries around the world, exemplified by 
the establishment of health professional wound healing groups worldwide.  This condition 
affects approximately 1-3% of the population (Briggs, et al., 2003; Margolis, et al., 2002) and 
can result in serious complications requiring hospitalisation, such as cellulitis or sepsis 
(Golinko, et al., 2009). 
This study was undertaken as part of a larger study within the Wound Management and 
Innovation - Cooperative Research Centre (WMI-CRC) project 3-05 titled “Development and 
validation of risk assessment tools to guide management and prevention of venous leg 
ulcers”.  The WMI-CRC project team is led by Queensland University of Technology (QUT) 
along with principal and co-investigators from Blue Care and Royal Brisbane & Women’s 
Hospital (RB&WH) in Queensland; and the Royal District Nursing Service (RDNS) in 
Victoria.  The project team is described in Appendix One.  The larger WMI-CRC project 
investigated the broader development of risk assessment tools for healing and recurrence of 
leg ulcers, while this PhD study focused on a risk assessment tool for delayed or non-healing 
of venous leg ulcers. 
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1.2 Research problem and significance 
The incidence of chronic leg ulcers increases with age (Callam et al., 1985), and with 
ageing populations this will remain a significant healthcare issue in the future.  Venous leg 
ulcers make up about 70% of all chronic leg ulcers (Abbade & Lastória, 2005) and are the 
result of chronic venous insufficiency or venous disease in the lower leg.  These ulcers can be 
debilitating, having a major impact on a patient’s life, with evidence of pain, decreased 
physical functioning, immobility, sleep disturbance, lack of energy, limitations in work and 
leisure activities, worries and frustrations, lack of self esteem and a decreased quality of life 
(Chase et al., 2000; Persoon et al., 2004).  Chronic leg ulcers can often take months or years 
to heal and frequently recur (Finlayson et al., 2009). 
At present, clinicians utilise their own expert judgement and previous experience 
when predicting whether a venous leg ulcer will be difficult to heal.  In this field screening 
tools are rarely utilised to assist clinicians to detect leg ulcers at-risk of not healing within an 
expected time period, in order to guide appropriate wound management.  Most of the 
screening tools found in the literature, utilise variables that are difficult to determine for the 
majority of wound care health professionals and also rely on mostly clinically derived ulcer 
variables with no consideration as to psychosocial variables.  Deciding whether a leg ulcer 
will respond to routine treatment remains an important challenge for all practitioners involved 
in venous leg ulcer management and the lack of risk assessment tools may contribute to the 
current high level of health service use for leg ulcers and poor rates of wound healing 
(O'Meara, Cullum, et al., 2009).  Venous leg ulcers often take long periods of time to heal, 
with about 70% healing within a 24 week period, leaving 30% unhealed within this time 
(Gohel, Taylor, et al., 2005; Guest et al., 1999), often despite evidence based care.  Current 
Australian guidelines indicate that clinicians should review a venous leg ulcer after four 
weeks and if it is not healing at an optimal rate (25% improvement in four weeks) then 
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further review of alternative therapies or referral is necessary (The Australian Wound 
Management Association Inc and the New Zealand Wound Care Society Inc, 2011). 
This research identified early predictors of venous leg ulcers which remained 
unhealed after 24 weeks of treatment, and developed and tested the inter-rater reliability and 
validity of a newly developed risk assessment tool, which will identify those at risk of non-
healing venous leg ulcers within two weeks of commencement of treatment, earlier than the 
four weeks currently recommended.  The tool developed drew upon evidence based risk 
factors to provide an innovative multidisciplinary tool for early detection of those at risk of 
non-healing by 24 weeks.  Importantly, such a tool will be able to guide management of 
venous leg ulcers, particularly early interventions and referrals, to prevent a venous leg ulcer 
remaining unhealed at 24 weeks and possible complications. 
The identification of risk factors and the development of a venous leg ulcer risk 
assessment tool for non-healing by 24 weeks offers an opportunity for health professionals to 
be able to implement adjuvant interventions in addition to routine care at an early stage, and 
to be able to determine realistic outcomes for their patients.  This could be linked to decisions 
in relation to alternative interventions when standard care may be insufficient to achieve 
healing (Moffatt et al., 2010).  A risk factor profile for patients would offer benefits to 
healthcare professionals who are under increasing pressure to justify their actions in terms of 
cost-effectiveness and clinical outcomes (European Wound Management Association, 2008).  
There are also benefits to the healthcare system, which requires information on the burden of 
care in order to make decisions on the needs of the population and the allocation of 
appropriate resources (Moffatt, et al., 2010). 
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1.3 Aims and research questions 
The specific aims of this research were to: 
 Identify evidence in the literature on risk factors for non-healing of venous leg 
ulcers 
 Identify and evaluate any previously developed risk assessment tools for non-
healing of venous leg ulcers 
 Analyse a large database of information collected from patients with venous leg 
ulcers to identify significant relationships between physiological, economic, 
social and psychological factors and healing outcomes after 24 weeks of 
treatment 
 Use the identified venous leg ulcer risk factors for non-healing and advice from 
an expert Wound Advisory Group (WAG), to develop a risk assessment tool for 
non-healing venous leg ulcers by 24 weeks 
 Test the newly developed venous leg ulcer risk assessment tool for inter-rater 
reliability and validity 
 
The following research questions were developed for this study: 
1. What physiological, economic, social and psychological factors were significantly 
associated with the non-healing of venous leg ulcers at 24 weeks? 
2. Controlling for potential confounders and all independent variables in a 
multivariable Generalised Linear Mixed Model (GLMM), what factors remained 
independent predictors of non-healing by 24 weeks in venous leg ulcers to guide 
the development of a risk assessment tool? 
3. Which risk factors identified from data analysis, a review of the literature and 
agreed upon by an expert WAG were able to be incorporated into a risk 
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assessment tool that could be easily used by health professionals across all 
settings? 
4. Is the venous leg ulcer risk assessment tool a reliable measure between different 
health professional users for predicting whether patients with venous leg ulcers 
are at risk of non-healing by 24 weeks? 
5. Does the venous leg ulcer risk assessment tool accurately predict patients with 
venous leg ulcers who are at high risk of non-healing by 24 weeks? 
6. What are end users’ views on the ease of use and usefulness of the risk assessment 
tool? 
 
1.4  Thesis outline 
Chapter Two describes the wound healing process, chronic leg ulcers and specifically 
the underlying anatomy, aetiology, treatment and impact of venous leg ulcers.  Chapter Three 
includes a literature review of current knowledge of risk factors for non-healing of venous leg 
ulcers.  Chapter Four follows with a review of five risk assessment tools for venous leg ulcers 
that have previously been developed and evaluated in the literature.  The research for this 
thesis was conducted across three studies and these studies are outlined in Figure 1.1.  
Chapter Four will also describe the conceptual framework upon which this research was 
based. 
Chapter Five outlines the methods and results of Study One (Identification of risk 
factors for non-healing of venous leg ulcers by 24 weeks).  Study One involved a pooled 
analysis of a database of information on 318 ulcers from previous studies to examine 
physiological and psychosocial factors associated with non-healing by 24 weeks and this 
study addressed research questions 1 and 2: What are the significant associations between 
physiological, economic, social and psychological factors and non-healing of venous leg 
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ulcers by 24 weeks; and what are the independent predictors of non-healing of venous leg 
ulcers by 24 weeks utilising a GLMM? 
Chapter Six outlines the methods and results of Study Two (Development and 
retrospective validation of the venous leg ulcer risk assessment tool).  Study Two involved 
the development of a Risk Assessment Tool in consultation with an expert WAG.  The expert 
WAG included twenty multidisciplinary clinicians from different clinical settings and 
researchers with particular knowledge and expertise in wound healing and instrument 
development.  Study Two also included validation of the risk assessment tool, 
retrospectively, on the Study One derivation database.  This study addressed research 
questions 3 and 5: Which risk factors identified in research questions one and two and agreed 
upon by an expert WAG could be incorporated into a risk assessment tool; and can the 
venous leg ulcer risk assessment tool accurately predict venous leg ulcer patients that are at 
risk of non-healing by 24 weeks? 
Chapter Seven outlines the methods and results for Study Three which consisted of 
three parts (Inter-rater reliability testing, prospective validation and end users’ evaluation of 
the risk assessment tool).  Study Three determined inter-rater reliability of the newly 
developed risk assessment tool in a sample of 16 participants using 3 raters.  It also included 
prospective validation of the risk assessment tool in a sample of 148 ulcers on 141 
participants recruited across ten clinical sites.  Finally, this study utilised a feedback sheet 
completed by health professionals and student health professionals who had used the risk 
assessment tool within QUT’s Wound Healing Community Outreach Service to determine 
their perceptions of the risk assessment tool.  Study Three answered research questions 4, 5 
and 6: Is the venous leg ulcer risk assessment tool a reliable measure between raters of 
predicting venous leg ulcer patients who are at high risk of non-healing by 24 weeks, can the 
venous leg ulcer risk assessment tool accurately predict venous leg ulcer patients who are at 
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high risk of non-healing by 24 weeks and what are end users’ perceptions of the risk 
assessment tool? 
Chapter Eight provides an overview of the results from all three studies and a 
discussion of how these results contribute to the conceptual framework and to improved 
knowledge of the risk factors contributing to the non-healing of venous leg ulcers, while also 
discussing implications of the overall study. 
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Figure 1.1: Outline of studies 
Study One 
Aim: To determine independent physiological, economic, social and/or  
psychological predictors of non-healing in venous leg ulcers 
Design/Methods: Pooled analysis of data from observational studies of 318 venous  
leg ulcers  
utilising GLMM analysis 
 
Study Two 
Aim: 2a) To develop a risk assessment tool for venous leg ulcers 
          2b) To retrospectively validate the tool on the derivation database 
Design/Methods: 2a) Development of the risk assessment tool utilising results  
from Study One, evidence from the literature review and advice 
from an expert WAG 
2b) Validity of the tool on the retrospective database (n=119) 
utilising Area Under the Receiver Operating Characteristic (ROC) 
curve (AUC) analysis 
Study Three 
Aim: 3a) To evaluate inter-rater reliability of the risk assessment tool 
          3b) To prospectively validate the risk assessment tool 
          3c) To describe end users’ perceptions of ease of use and usefulness of the risk  
              assessment tool 
Design/Methods: 3a) Validity of the tool on a prospective sample of patients with  
             venous leg ulcers (n=141) utilising AUC analysis 
               3b) Inter-rater reliability of the tool utilising Intra –Class  
         Correlation (n=16) 
      3c) A convenience sample of end users’ perceptions      
      utilising descriptive analysis of a feedback sheet (n=20) 
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Chapter Two: Background literature on leg ulcers 
2.1 Introduction 
Chronic leg ulcers have been a health care problem throughout history.  The ancient 
Egyptians were masters in applying and arranging bandages and recognising the signs of 
infection and inflammation (Sipos et al., 2004), while Sweden in the 1700s appointed a 
special saint for chronic leg ulcers: St. Peregrinus (Bergqvist et al., 1999).  However, despite 
the long history and the fact that a great deal has been learnt about the pathogenesis and 
treatment of chronic leg ulcers, their healing remains a difficult problem worldwide today. 
Chronic leg ulcers have been noted to affect approximately 1-3% of the population 
(Briggs, et al., 2003; Graham et al., 2003; Margolis, et al., 2002) with hospitalisation 
occurring as a result of serious complications in some cases (Golinko, et al., 2009).  Venous 
leg ulcers make up about 70% of all chronic leg ulcers (Abbade & Lastória, 2005) and are the 
result of venous disease in the leg, or inadequacies in the superficial or deep venous system 
of the legs where venous return is impaired.  Chronic venous insufficiency (CVI) is a severe 
manifestation, or an advanced stage, of venous disease (Abbade & Lastória, 2005; Coghlan, 
2004).  Chronic leg ulcers can result in reduced mobility, pain, a decreased quality of life and 
have a significant economic impact, taking long periods of time to heal (Abbade & Lastória, 
2005).  Evidence on healing times in the literature varies, however overall 70% of venous leg 
ulcers will be expected to heal within a 24 week period (Gohel, Taylor, et al., 2005; Guest, et 
al., 1999).  Despite evidence based care, 30% will remain unhealed (Gohel, Taylor, et al., 
2005; Guest, et al., 1999) and it is important to identify those who will not respond to routine 
care and remain unhealed, early on in treatment, to determine appropriate courses of action. 
This chapter will provide an overview of wound healing and the significance and 
impact of chronic leg ulcers and specifically, venous leg ulcers.  This will be followed by a 
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discussion of the pathophysiology of venous disease and venous leg ulcers.  Chapter Three 
will outline a narrative literature review on identified physiological, economic, social and 
psychological risk factors for non-healing of venous leg ulcers.  This will be followed in 
Chapter Four by a discussion of five risk assessment tools that have previously been 
developed specifically for venous leg ulcers and a conceptual framework used to guide 
investigation into risk factors related to non-healing of venous leg ulcers by 24 weeks. 
 
2.2 Wound healing 
A wound has been defined as a breach of the epidermis of the skin (Schultz et al., 
2003) or a disruption of normal anatomic structure and function (Lazarus et al., 1994).  An 
overview of the usual wound healing process is necessary before abnormal wound healing 
can be investigated.  Wound healing is a complex series of interactions between different cell 
types, cytokine mediators, and the extracellular matrix (Hampton, 2012).  The normal wound 
healing trajectory generally follows four phases (coagulation or haemostasis phase, 
inflammatory phase, cell proliferation and matrix repair phase and epithelialisation and 
remodelling phase), often with overlap among the phases. 
The coagulation or haemostasis phase occurs immediately after injury and involves 
platelets sticking together to form a plug (Thompson et al., 2007).  This aggregation of 
platelets triggers the release of a number of soluble mediators which rapidly diffuse from the 
wound resulting in inflammatory cells being drawn to the area of the injury and initiating 
subsequent stages of the healing process (Hampton, 2012; Schultz, et al., 2003).  The release 
of soluble mediators initially results in the vasoconstriction of the affected blood vessels 
reducing blood flow (Thompson, et al., 2007).  Bradykinin and histamine are then released 
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which cause the capillary blood vessels to vasodilate, resulting in increased blood flow and 
redness around the wound (Thompson, et al., 2007). 
The inflammatory phase is initiated within hours, can last up to three days and 
involves a blood clotting and platelet degranulation process (Clark, 2002).  At the same time 
significant vasodilation, increased capillary permeability, complement activation, and 
migration of polymorphonuclear leukocytes and neutrophils to the site of the wound occurs.  
These cells release enzymes that break down bacteria and other foreign material in the wound 
and phagocytose the resulting debris into the surrounding tissue (Harding et al., 2002; 
Schultz, et al., 2003).  This process forms the first line of defence against infection and clears 
the wound bed to allow healing (Hampton, 2012).  The vasodilation results in redness, 
swelling and increased temperature in the surrounding skin, often associated with pain 
(Hampton, 2012).  Macrophages are then drawn to the area and secrete a variety of 
chemotactic and growth factors to direct the next phase (Hampton, 2012). 
The cell proliferation and matrix repair phase occurs as the number of inflammatory 
cells in the wound decreases and the fibroblasts, endothelial cells and keratinocytes take over.  
This phase predominantly involves the synthesis of growth factors promoting cell migration, 
proliferation, new capillary formation (Schultz, et al., 2003), replacement of dermal or sub-
dermal tissue and wound contraction (Hampton, 2012).  This process usually begins within 
three days of injury, providing there is sufficient blood circulation, and can continue for two 
to three weeks (Clark, 2002). 
The epithelialisation and remodelling of scar tissue phase continues for several weeks, 
or more often months and years after initial wound closure, with a reduction of both cell 
content and blood flow in the scar tissue (Clark, 2002; Harding, et al., 2002; Schultz, et al., 
2003).  During this stage, the initial extracellular matrix is restructured, and tensile strength 
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improves, although the injured site will always remain weaker than the surrounding skin 
(Wyffels et al., 2011). 
The phases of healing overlap, with duration of the phases and overall wound healing 
depending on many factors.  There are a multitude of reports on what time frame constitutes a 
chronic wound, however, the generally accepted definition of a chronic, non-healing wound 
is a wound remaining unhealed after four to six weeks (Centers for Medicare & Medicaid 
Services., 2005).  Acute wounds normally proceed through an orderly and timely reparative 
process without complication, and result in sustained restoration of anatomic and functional 
integrity (Lazarus, et al., 1994).  However, a chronic wound does not proceed through this 
timely, orderly sequence of healing; instead chronic wounds have a delayed, arrested or a 
repetitive cycle of the late inflammatory and early proliferative phases of wound healing, 
with progress continuing slowly, if at all (Casey, 2011; Harvey, 2006; Wyffels, et al., 2011). 
 
2.3 Chronic leg ulcers 
A chronic leg ulcer has been defined as a leg ulcer which fails to proceed through an 
orderly process to produce anatomic and functional integrity (Lazarus, et al., 1994).  It occurs 
below the knee and does not heal within a four to six week period (Baker et al., 1991; 
Bergqvist, et al., 1999; Cromwell, 2002; Mekkes et al., 2003), often taking months or years 
to heal (Ebbeskog et al., 1999; Seiler et al., 1994).  People with chronic leg ulcers represent a 
complex group of patients who often have co-morbid conditions and are therefore health 
service resource intensive, primarily receiving community care for their wounds from 
registered nurses (Graham, et al., 2001; Walker, et al., 2002).  Due to the advanced age and 
multiple co-morbidities of many patients with chronic leg ulcers, they tend to be cared for by 
a multitude of health professionals, leading to problems with continuity of evaluation of 
wounds, availability of wound care supplies and variations in consistency of care (Coyer et 
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al., 2005; Lazarus, et al., 1994).  It is also well known that many patients treat their ulcers 
themselves at home, often with assistance from families and carers (Edwards, et al., 2013).  
Therefore, in addition to being a significant burden for the patient, chronic leg ulcers are also 
a significant burden for their families and carers (Graham, et al., 2001). 
2.3.1 Prevalence 
Chronic leg ulcers affect approximately 1-3% of the population (Briggs, et al., 2003; 
Margolis, et al., 2002); with data suggesting that the prevalence increases with increasing age 
(Briggs, et al., 2003; Graham, et al., 2001; Graham, et al., 2003; Moffatt, et al., 2010; 
Salaman et al., 1995).  Studies have shown that 0.1% - 0.2% of the population are likely to 
have an open ulcer at any one time (Briggs, et al., 2003; Graham, et al., 2003; Gross et al., 
1993).  With an ageing population, chronic leg ulcers are, and will continue to be, a 
significant local, national and international healthcare issue.  It is also likely that these figures 
are understated as patients often do not recognise the ulcer as a problem, seek medical help, 
or may conceal it due to social stigma, fear, embarrassment, or potential cost to consult a 
health professional (Jones et al., 2008; Margolis, et al., 2002; Ruckley, 1997).  Chronic leg 
ulcers can occur in young people, however, the prevalence of the disease is greater in the 
older population (Callam et al., 1987).  One third of patients indicate having their first leg 
ulcer before they were 50, and more than two thirds before the age of 65 (Callam, et al., 
1987).  Graham et al. (2001) found that 40% of patients had their lower limb leg ulceration 
for one year or longer while others have found that between 20% and 35% of participants had 
had their leg ulcers for longer than 5 years (Baker et al., 1994; Price et al., 2004).  Many 
patients have also had more than one episode of leg ulceration, with 20% having had more 
than 10 episodes of leg ulceration (Baker, et al., 1994).  Females are noted to have a higher 
prevalence of chronic leg ulcers than males, with a further female predominance after the 
eighth decade; possibly related to a greater frequency of venous disorders in women, 
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particularly deep vein thrombosis (DVT), believed to be related to pregnancy (Baker, et al., 
1994; Callam, et al., 1987; Graham, et al., 2003). 
2.3.2 Cost 
Chronic wounds cost around 3% of the total health care expenditure (Posnett, et al., 
2008), in developed countries, with indirect costs such as loss of productivity adding to these 
costs.  Total health expenditure in Australia for 2010-2011 was released by the Australian 
Institute of Health and Welfare as $130.3 billion, therefore equating to $3.9 billion spent 
annually in Australia on chronic wounds (Australian Institute of Health and Welfare., 2012).  
Chronic leg ulcers are estimated to cost between 1.5 and 3.5 billion US dollars annually with 
a further estimated two million work days lost each year (Ongenae et al., 1993).  Costs in 
Europe account for 2 to 4 percent of the health budget, with the average episode of care for a 
leg ulcer ranging from 6,500 to 10,000 Euro (Casey, 2011).  Other than medical costs, there 
are likely to be non-medical costs related to loss of productivity and psychosocial and 
emotional costs including stress, pain and anxiety (Harvey, 2006).  Chronic leg ulcers have a 
significant socioeconomic impact in relation to medical care, days off work, job loss in some 
cases, expenses for dressings, medication, transportation and reduced quality of life (Abbade 
& Lastória, 2005; Phillips et al., 1994).  Large amounts of time are spent on ulcer care with 
studies showing 50-60% of patients need family and/or carer assistance with their leg ulcer 
wound care (Edwards, et al., 2013; Phillips, et al., 1994). 
There are multiple aetiologies for chronic leg ulcers, with venous aetiology the 
underlying factor in about 70% of all chronic leg ulcers (Abbade & Lastória, 2005).  Other 
common aetiologies include arterial, mixed (arterial and venous), diabetes related or pressure.  
A small number of ulcers have rarer aetiologies which may include malignancy, infection or 
lymphoedema. 
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2.4 Venous anatomy and venous disease of the leg 
A brief overview of the venous anatomy of the leg will be discussed and related to the 
abnormalities associated with venous disease.  The venous system of the leg is made up of 
deep, femoral and popliteal veins, superficial, greater and shorter saphenous veins and their 
branches (Casey, 2011), with perforator or communicating veins connecting the superficial 
and deep vein systems (Etufugh et al., 2007).  It is also composed of flaps of connective 
tissue, called valves, arising from the vein walls that close to prevent backflow when the 
blood is not being moved along the vein (Casey, 2011).  During movement, such as 
dorsiflexion of the ankle, the compression of the deep veins by the calf muscle, pumps 
venous blood up towards the heart (Casey, 2011).  Venous disease is caused by inadequacies 
in the superficial or deep venous system of the legs where venous return is impaired by 
reflux, obstruction or failure of the calf muscle pump, resulting in an accumulation of blood 
in the legs (Coghlan, 2004; O'Meara, Cullum, et al., 2009).  Any condition that interferes 
with the functioning of these veins, valves or calf muscle pump leads to venous hypertension 
(Casey, 2011), oedema and the cessation of normal venous blood flow within the lower limb 
(Gatt, 2011).  This increases the normal venous capillary pressure in the legs (25mmHg) to 
pressures over 90mmHg (Kerstein, 1996; Williams, 2000). 
Half the adult population, greater than 15 years of age, have been noted to have 
venous disease in the lower limbs with the prevalence ranging from 40 to 50% in men and 
from 50 to 55% in women (Abbade & Lastória, 2005).  The normal venous system may be 
affected by a DVT or injury to legs such as fractures or trauma which may result in 
permanent damage to valves in the venous system (Casey, 2011).  Occlusion of the venous 
system may occur due to DVT, obesity or during pregnancy where increased pressure on 
abdominal veins reduces venous outflow from the legs (Casey, 2011).  Congestive heart 
failure can also impact on the venous flow, while decreased ankle function affects the 
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activation of the calf-muscle pump which can also impair blood flow back to the heart (Allen, 
2008). 
Symptoms of venous disease may include: varicose veins, oedema and venous skin 
changes such as lipodermatosclerosis and/or haemosiderin staining (Fowkes et al., 2001).  
Lipodermatosclerosis is a painful induration, which, if severe, gives the lower leg an inverted 
shape with enlargement of the calf and narrowing at the ankle (Beers et al., 2006).  
Haemosiderin pigmentation is characterised by a brown staining of the leg resulting from iron 
in haemoglobin being deposited in the tissues (Casey, 2011). 
CVI is an extreme form of venous disease (Coghlan, 2004) leading to extravasation of 
red blood cells and large protein molecules that leak out from capillaries resulting in 
oedematous skin, thereby inhibiting oxygen diffusion (Coghlan, 2004; Cromwell, 2002) and 
damaging the lymphatic system (Kerstein, 1996).  The prevalence of CVI ranges from 2-7% 
in men and 3-7% in women (Abbade & Lastória, 2005) although one study reported a higher 
incidence in men (Scott et al., 1995).  Prevalence data may be underestimated due to the 
differing definitions that exist for venous disease and CVI, as well as the presence of 
asymptomatic disease (Abbade & Lastória, 2005). 
Symptoms may include mild to severe swelling, aching legs, leg heaviness and skin 
changes (Black, 1995).  Swelling usually worsens with prolonged standing or sitting and 
improves with elevation (Black, 1995).  It has been estimated that six million work days per 
year are lost in the United States of America (USA) due to CVI complications, and in Europe 
estimations determined that 11,000 work days were lost per year per 100,000 population 
(Weiss et al., 1992). 
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2.5 Aetiology of venous leg ulcers 
There are differing hypotheses regarding the relationship between venous disease, 
venous hypertension and venous leg ulcers throughout the literature, with no current 
consensus on a confirmed hypothesis.  The fibrin cuff theory was hypothesised by Browse et 
al. (1982), who proposed that high ambulatory pressure within the calf-muscle pump led to 
distension of the local capillary beds and widening of the endothelial pores, thus allowing 
fluid, including fibrinogen which converts to fibrin, to deposit around the capillaries.  This 
forms a barrier to the passage of oxygen and other nutrients which sustain the cells of the 
epidermis, thus leading to cell death and ulceration (Browse et al., 1982).  However, others 
have disputed the idea that pure fibrin would act as a barrier to diffusion of oxygen to such 
critical levels (Michel, 1990).  Observations of others have noted fibrin cuffs to be 
discontinuous around the capillaries and that some venous ulcers healed despite the presence 
of fibrin cuffs (Falanga et al., 1992). 
In 1988, an alternative hypothesis was presented, suggesting that increased pressure in 
the venous system led to pressure decrease of capillary perfusion causing leukocyte trapping 
(Coleridge Smith et al., 1988).  These trapped cells were hypothesised to release toxic 
oxygen metabolites and proteolytic enzymes, resulting in damage to the capillaries and 
resulting in areas of ischaemia (Coleridge Smith, et al., 1988).  This theory has been 
criticised because the studies were performed with patients whose cutaneous alterations were 
secondary to chronic venous hypertension and therefore difficult to determine whether the 
trapped leukocytes were caused from a local inflammatory process, or were secondary to it 
(Abbade & Lastória, 2005). 
In 1991, it was further proposed that activation of leukocytes released free radicals 
and proteolytic enzymes, increasing elastase activity, causing epithelial injury and increasing 
vessel permeability, resulting in deposition of pericapillary fibrin (Claudy et al., 1991).  Thus, 
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it was believed that difficulties with ulcer healing could be explained by both fibrin and toxic 
metabolites released by leukocytes (Abbade & Lastória, 2005). 
There was further evidence to support a proposal put forward in 1993 of capillary 
distension, or injury, of endothelial cells due to venous hypertension, leading to 
macromolecules causing a functional inhibition of endogenous growth factors, making them 
unable to maintain tissue integrity and healing (Falanga et al., 1993).  Although this proposal 
provides an explanation for unsuccessful single growth factor therapy, it has been unable to 
explain how these events would cause inflammation and tissue death (Abbade & Lastória, 
2005). 
In 1999, an association was demonstrated between CVI and increased platelet and 
monocyte activation and aggregation throughout the circulation (Powell et al., 1999) and it 
has been suggested that these aggregates would be able to injure the venous endothelium and 
valves, leading to the development of valvular dysfunction (Abbade & Lastória, 2005).  
However, the stimuli of activation and roles of circulating aggregates are still unknown 
(Abbade & Lastória, 2005).  Smith (1999) hypothesised that cell activation may play an 
important role in venous insufficiency and venous leg ulcers.  This was studied further, with 
reports indicating that white blood cells were greater in limbs of a patient with chronic 
venous disease than controls, suggesting that patients with CVI might have trapped 
neutrophils in the peripheral circulation leading to plugging of the dermal capillaries (Smith, 
1999; Takase et al., 1999; Word, 2010).  Further findings led to the hypotheses of white cell 
trapping; where veins become distended and tortuous secondary to hypertension, decreasing 
the velocity of blood (Word, 2010).  This reduction in flow allows neutrophils to separate 
from the plasma and adhere to vessel walls, essentially plugging the dermal capillaries 
(Rudolph, 2001; Word, 2010).  The subsequent sluggish capillary blood flow leads to 
hypoxia and neutrophil activation, producing an inflammatory response and migration of the 
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neutrophils out of the vessels into the tissue where they release proteolytic enzymes causing 
endothelial and tissue damage (Rudolph, 2001; Word, 2010). 
Despite these various hypotheses we still have a limited understanding of the 
relationship between venous disease, venous hypertension and venous leg ulcers, although it 
is believed that many of the mechanisms described above are important and therefore studies 
continue to be conducted to determine relevant links (Abbade & Lastória, 2005). 
 
2.6 Venous leg ulcers 
Interchangeably named in the literature varicose ulcers, gravitational ulcers, stasis 
ulcers and hypostatic ulcers, venous leg ulcers generally occur in the distal portion of the 
lower limbs, are shallow and moist, irregular in shape with well-defined borders; often with 
eczema, haemosiderin pigmentation, leg oedema, ankle flare, atrophie blanche and 
lipodermatosclerosis (Abbade & Lastória, 2005; Anand et al., 2003; Gross, et al., 1993).  
Atrophie blanche describes areas of pale, depigmented skin on the legs that are covered with 
red dots from dilated capillaries and venules, and have low blood flow (Casey, 2011; Grey, 
2006).  Venous leg ulcers can vary in size, ranging from small and single to multiple and 
encompassing the full circumference of the leg (Abbade et al., 2011). 
2.6.1 Prevalence 
An estimate of the prevalence of unhealed or open venous leg ulcers at any one time 
is approximately 0.3% or about 1 in 350 adults (Abbade & Lastória, 2005; Fowkes, et al., 
2001).  A study in the USA noted a prevalence rate of the history of open or healed venous 
ulceration as 1-2% in the older population and an annual prevalence of venous leg ulcers 
among older people of 1.69% (Walters et al., 1999), while the United Kingdom (UK) 
acknowledged that they have about 70,000 to 190,000 individuals with a venous leg ulcer at 
any one time (Posnett, et al., 2008).  In Australia, the latest prevalence data found on venous 
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leg ulcers in the published literature was conducted by Stacey et al. (1997) which indicated 
that 57% of patients with a chronic leg ulcer had a venous abnormality and the prevalence of 
chronic venous ulceration in the study population in Western Australia was 0.62 per 1000 
people (Baker, et al., 1991).  Prevalence of venous leg ulcers increases with age (Heit et al., 
2001), with Australian prevalence figures in the over 60 year age group indicated to be 3.3 
per 1000 people (Baker, et al., 1991).  The Australian data are quite dated and therefore these 
prevalence figures are likely to now be higher.  Chronic venous leg ulcers also appear to have 
a slightly higher prevalence in females in comparison to males (Abbade, et al., 2011; Baker, 
et al., 1994; Graham, et al., 2003; Margolis, et al., 2002; Posnett, et al., 2008). 
2.6.2 Treatment 
The main treatment for venous leg ulcers is dressings and compression bandages.  
Dressings are used as an adjuvant therapy to compression therapy (Etufugh, et al., 2007).  No 
specific dressing product has been found to be superior for venous leg ulcers but dressings 
should be chosen based on their ability to absorb exudate, debride the wound and promote 
healthy granulation tissue (Etufugh, et al., 2007; The Australian Wound Management 
Association Inc and the New Zealand Wound Care Society Inc, 2011).  Selection of dressings 
will also be based on cost, access and patient / health professional preferences (Palfreyman, 
2007; The Australian Wound Management Association Inc and the New Zealand Wound 
Care Society Inc, 2011).  Compression therapy is usually the mainstay of therapy aiming to 
counteract venous hypertension by facilitating venous return toward the heart, improving 
venous hypertension, venous pump function, lymphatic drainage and preventing venous stasis 
and oedema (Allen, 2008; Etufugh, et al., 2007).  Application of graduated compression 
bandaging, hosiery, or intermittent compression systems aim to force blood in the interstitial 
spaces back into the blood stream and hence, back to the heart (Allen, 2008).  Other 
interventions that may be used as treatments in venous leg ulcers, often in combination with 
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compression therapy include skin grafting, pharmacological treatments such as pentixifylline 
or micronized purified flavanoid fraction and leg elevation to reduce oedema and enhance 
flow in the microcirculation (Simon et al., 2004). 
2.6.3 Cost 
The costs associated with treating venous leg ulcers vary greatly.  A study in the USA 
estimated a conservative figure of at least $US150 million annually, however, this figure also 
included the health problem of venous stasis syndrome (Heit, et al., 2001).  The costs of 
treating venous ulceration in the UK are 168 to 198 million pounds per year, primarily in 
primary care and community services (Gatt, 2011; Posnett, et al., 2008).  The costs of venous 
ulcer treatment have been reported to represent about 2.5% of the total health budgets in 
France and Belgium (Abbade & Lastória, 2005; Van den Oever et al., 1998) and have a 
significant socioeconomic impact in terms of medical care, days off work and reduced quality 
of life (Abbade & Lastória, 2005).  In a retrospective cohort study conducted in the USA, the 
average total medical cost per patient with a venous leg ulcer was $US9685 (median 
$US3036) (Olin et al., 1999), with a further study indicating that the total cost for a healed 
venous ulcer was between $US1873 and $US15053 (Kerstein et al., 2001).  This study also 
noted that the costs of a healed venous leg ulcer far exceeded the estimated costs for a healed 
pressure injury (Kerstein, et al., 2001).  Home health care, hospitalisations and home dressing 
changes accounted for 48%, 25% and 21% of total costs, respectively (Olin, et al., 1999).  
One study in Australia indicated that patients spent on average $A114 per month (range $A29 
to $A376) on treating and managing their venous leg ulcer (Smith et al., 2010).  Wound 
dressings counted for the majority of the expenses incurred, followed by consultation fees, 
medication, transport and other expenses (Smith, et al., 2010).  Considering a weekly aged 
pension of $AUD206, this equates to 14% of pensioner patients’ weekly income being spent 
on their leg ulcers with the possibility of being exposed to these costs for lengthy periods of 
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time and on multiple occasions (Smith, et al., 2010).  These figures are likely to be an 
underestimate since indirect costs such as time absent from work, forced early retirement, 
loss of functional independence and unquantifiable suffering may be additional factors 
contributing to the overall burden (Olin, et al., 1999). 
2.6.4 Pain 
A literature review of venous leg ulcers and their impact on daily life reported pain as 
the first and most dominant experience related to having a venous leg ulcer (Maddox, 2012).  
In one study, 65% were noted to have severe pain (Phillips, et al., 1994) while other studies 
have reported approximately 80% of patients having some form of pain (Buchanan, 2010; 
Persoon, et al., 2004).  Continuous pain and difficulties treating that pain have been noted as 
particular issues for patients suffering with venous leg ulcers (Herberger et al., 2011).  
Patients have reported that pain serves as a constant reminder of their leg ulceration, with 
treatment therapies often exacerbating the pain, while standing or walking aggravated the 
pain and therefore was often avoided (Walshe, 1995).  Pain with venous leg ulcers has been 
described as sharp, burning, or a feeling of pressure, while others report aching or tired leg 
muscles after standing for long periods (Ryan et al., 2003; Sieggreen et al., 2004).  Greater 
wound duration has been found to be significantly related to greater pain (Merkle, 2011).  
Fluid build-up in the legs from venous hypertension may also cause the muscular cells to 
distend and depolarize, resulting in twitching-like contractions of muscle groups leading to 
nocturnal leg cramps (Sieggreen, et al., 2004). 
In a systematic review of the impact of venous leg ulcers on daily life, impaired 
mobility was an issue in most studies, often being pain related (Persoon, et al., 2004).  In 
many instances, the primary concern is the ability to walk, be able to maintain mobility and 
be able to accomplish everyday tasks (Phillips, et al., 1994).  Walshe (1995) reported major 
restrictions to patient’s mobility, often complicated by leakage of exudate causing the patient 
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to be housebound.  The limitation of mobility and the challenges faced in order to complete 
daily activities pose a significant problem for venous leg ulcer sufferers (Green et al., 2010).  
Younger patients have reported more negative emotions and difficulties with mobility 
(Phillips, et al., 1994). 
2.6.5 Psychosocial impact 
In one study, 68% of patients reported that their leg ulcer had a negative emotional 
impact on their lives, including feelings of fear, social isolation, anger, depression and 
negative self-image (Phillips, et al., 1994).  Major life changes, such as retirement, are 
necessary for some people because their ulcer does not heal (European Wound Management 
Association, 2008).  The impact of pain, limited mobility, time needed and discomfort from 
wound dressings and compression therapy on venous leg ulcer patients have reportedly 
resulted in sleep disturbances and social isolation (Walshe, 1995).  A high prevalence of 
depression and anxiety has also been reported in patients with venous leg ulcers (Nogueira et 
al., 2009).  A study including 190 patients with venous leg ulcers reported 27% were 
categorised as depressed, as determined by the Hospital and Anxiety Depression scale, while 
26% were categorised as anxious (Jones et al., 2006).  Interestingly, only three of these 
patients had been clinically diagnosed with depression (Jones, et al., 2006).  Other studies 
noted 44.4% of patients felt low or had depressive symptoms, with figures as high as 65% in 
one study (Palfreyman et al., 2010).  It is clear that anxiety and depression are major factors 
impacting on venous leg ulcer patient’s quality of life and most notably associated with pain 
and odour, however, many patients are not even aware that they have depression (Jones, et 
al., 2006). 
Quality of life instruments have been designed to look at the impact of a given 
disorder on everyday living and compare any given group of patients with age and sex 
matched norms established for the health population (European Wound Management 
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Association, 2008).  The venous leg ulcer population have lower quality of life scores on 
quality of life instruments than the normative population indicating a decreased quality of life 
(Gonzalez-Consuegra et al., 2011; Palfreyman, et al., 2010).  Reports from analysis of the 
short form-36 (SF-36), indicated that categories of physical functioning, role-emotional, role-
physical, vitality, social functioning and mental health scores in patients with venous leg 
ulcers  are lower than the age equivalent norms (Charles, 2004).  Hareendran et al. (2005) 
reported that 97.2% reported restriction to functioning, 47.2% indicated that they were unable 
to pursue enjoyable activities and 33% were frustrated that they could not see an end to the 
problem.  Unsuccessful and long-term treatment may often lead to anger and resentment 
(Labropoulos et al., 2012). 
Studies have demonstrated how inconsistencies in treatment, odour and excessive 
exudate leading to leakage and difficulties with personal hygiene have an adverse effect on a 
person’s psychological state, leading to feelings of disgust, self-loathing, powerlessness and 
low self-esteem (Jones, et al., 2008; Walshe, 1995).  Further, 50% of patients had difficulty 
bathing due to their venous leg ulcer (Hareendran et al., 2005) and this inability to maintain 
personal hygiene often led to social isolation (Green et al., 2009). 
 
2.7  Summary of background literature on leg ulcers 
Chronic leg ulcers remain a difficult problem worldwide.  They affect large numbers 
of people with high costs associated with their care.  70% of all chronic leg ulcers are venous 
in aetiology.  While a large proportion of the population suffer from venous disease, it 
remains unclear as to the relationship between venous disease and venous ulceration.  Pain 
has been noted to have a dominant impact on daily life with psychosocial issues also 
impacting significantly on patients’ lives.  Chapter Two has summarised the literature on 
chronic leg ulcers and specifically venous leg ulcers.  Chapter Three will further investigate 
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venous leg ulcers in relation to physiological, social, economical and psychological risk 
factors associated with non-healing. 
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Chapter Three: Literature review of risk factors for non-healing 
3.1  Introduction 
There have been multiple studies that have investigated risk factors for non-healing 
and delayed healing in all types of chronic wounds.  Many have included venous leg ulcers 
within a mixed chronic leg ulcer sample; however this literature review concentrates on the 
studies that investigated risk factors for non-healing and delayed healing specifically of 
venous leg ulcers.  This is a narrative literature review, as a meta-analysis was unable to be 
undertaken due to differences in study designs, measures, bias, and sample inclusion and 
exclusion criteria.  Fifty-one studies were found that addressed single or multiple risk factors 
for non-healing of venous leg ulcers and these will be discussed in more detail in this chapter.  
Chapter Four will examine five risk assessment tools that have previously been developed for 
predicting non-healing of venous leg ulcers. 
 
3.2 Search strategy 
The material for this review has been compiled up to December 2013 from an 
extensive search of the online databases Medline; Academic Search Elite; EJS-E Journals; 
Information, Science and Technology abstracts; PsycINFO; Cinahl; Health and Medical 
Complete; Nursing and Allied Health; The Cochrane Library databases; Sciencedirect; Web 
of Science; PubMed; Australian Digital Theses database; Networked Digital Library of 
Theses and Wiley On-Line library, as well as Google Scholar.  These databases were 
searched for journal articles, books, dissertations, theses, conference papers and proceedings.  
Professional wound management association websites were also searched for relevant 
information, including: European Wound Management Association; Australian Wound 
Management Association; Wound Healing Society; Association for Advances in Wound 
Care; Canadian Association of Wound Care; European Tissue Repair Society and World 
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Union of Wound Healing Societies.  These searches were undertaken using the keywords 
“Venous” OR “Varicose” OR Stasis” AND “Ulcer*” AND “Non Healing” OR “Delayed 
Healing” AND/OR “Risk factor*” with further resources sourced as cited in relevant articles. 
 
3.3 Levels of evidence 
Findings from research studies identifying factors significantly associated with non-
healing in venous leg ulcers have been rated according to the National Health and Medical 
Research Council Levels of Evidence (National Health and Medical Research Council, 2007) 
as follows: 
 Level I  Evidence from a systematic review of level II studies 
Level II Evidence from a randomised controlled trial or prospective cohort 
study 
Level III-1 Evidence from a pseudo randomised controlled study (i.e. alternate 
allocation or some other method) 
Level III-2 Evidence from a comparative study with concurrent controls (i.e. non-
randomised experimental trial, cohort study, case control study, 
interrupted time series with a control group) 
Level III-3 A comparative study without concurrent controls (i.e. historical control 
study, two or more single arm study and interrupted time series without 
a parallel control group) 
Level IV Evidence from studies with no control or comparison group (i.e. case 
series or cohort study with either post-test or pre-test/post-test 
outcomes) 
 Page | 29  
 
Three reviewers independently assessed the articles for levels of evidence and all 
disagreements were resolved by discussion. 
 
3.4  Risk factors associated with non-healing of venous leg ulcers 
The methods of assessment and treatment of venous leg ulcers has changed in the last 
twenty years, thus some of the early studies may not continue to be as relevant, however there 
has long been interest in the identification of risk factors for delayed healing and value seen 
in prognostic indicators (Gelfand et al., 2002; Margolis et al., 1999; Skene et al., 1992). 
A number of factors have been identified in the literature as affecting wound healing 
in venous leg ulcers.  The literature search revealed fifty-one studies investigating a variety of 
risk factors for non-healing of venous leg ulcers conducted from the early 1990s to 2012.  
These studies ranged from 13 to 1506 participants and looked at single or multiple risk 
factors for non-healing in these ulcers.  Many were secondary analyses of data from previous 
studies which had a range of differing inclusion criteria.  The studies were conducted mostly 
in the United Kingdom (UK), however other studies also occurred in the United States of 
America (USA), France, Ireland, Serbia, Austria, Netherlands, Germany, Poland, Spain, 
Australia, Finland and Brazil.  They were undertaken in a variety of settings including 
vascular and dermatology clinics and hospital and community leg ulcer clinics, with follow 
up periods between 6 and 104 weeks.  The level of evidence for most studies in relation to 
risk factors was low (Level III or IV), with few risk factors investigated by well-designed 
cohort studies, randomised controlled trials and/or systematic reviews (Levels I or II 
evidence).  The significant risk factors identified from these studies are discussed below, 
along with their levels of evidence.  They have been grouped according to the conceptual 
framework categories of: physiological, economic, social or psychological.  In each 
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framework category, risk factors identified consistently across multiple studies are discussed 
first, followed by risk factors found less consistently and finally risk factors with limited 
evidence.  The studies that identified significant risk factors associated with non-healing and 
their levels of evidence are documented in Appendix Two.  This chapter will conclude with 
identification of those risk factors that could be considered for inclusion in a risk assessment 
tool.   
3.4.1 Physiological factors 
The literature review identified a number of consistent physiological predictors of 
non-healing in venous leg ulcers: lack of high level compression therapy; larger wound area; 
longer ulcer duration and venous abnormalities.  The levels of evidence ranged from Level I 
(a meta-analysis of compression therapy) to mostly Level III and IV evidence (studies of 
wound area, ulcer duration and venous abnormalities). 
Level I evidence supports the lack of high level graduated compression therapy being 
significantly associated with non-healing in venous leg ulcers.  This has led to high level 
compression therapy being identified as the cornerstone of evidence based management for 
venous leg ulcers (European Wound Management Association, 2003).  The aim of graduated 
compression is to provide greater pressure at the ankle (approximately 40 mmHg) than the 
knee (approximately 17 mmHg), to reverse venous hypertension in the superficial venous 
system by forcing the blood to the deeper vessels, aiding the venous return of blood to the 
heart (Coull et al., 2006; Williams, 2000).  This also lessens oedema by reducing the pressure 
difference between the capillaries and tissue (Coull, et al., 2006; Williams, 2000).  A 
systematic review of 48 Randomised Control Trials (RCT) up until May 2012 reported 59 
comparisons of different types of compression and included 4321 participants (O'Meara et 
al., 2012) [I].  Many forms of compression were compared with no compression and the 
review examined the clinical effectiveness of compression bandage or compression stocking 
 Page | 31  
 
systems in the treatment of venous leg ulceration (O'Meara, et al., 2012) [I].  This review 
concluded that compression increased healing rates compared with no compression, and that 
multi-component systems were more effective than single-component systems, especially 
when the multi-component systems, contained an elastic bandage (O'Meara, et al., 2012) [I].  
Due to difficulties with compression in regards to ease of applicability and comfort, 
compliance is an ongoing issue with compression systems.  A study of 165 participants in the 
USA investigated the compliance of wearing compression in relation to non-healing, and 
although failing to mention how compliance was measured, determined that lack of 
compression compliance was significantly related to non-healing (Phillips et al., 2000) [IV].  
Another study measured adherence as, keeping compression bandages in place for greater 
than 5 days per week and applying them less than an hour after getting up (Chaby et al., 
2013) [III-3].  This study concluded a relationship between lack of adherence to compression 
therapy and non-healing with lower adherence to compression therapy in the non-healed 
group possibly explained by a loss of motivation in this group. 
Wound area has been examined in twenty-three studies and found to be a significant 
consistent risk factor for non-healing, with a larger wound area significantly related to non-
healing in twelve of these studies.  These were predominantly Level IV evidence studies, 
with no investigation in any Level I or II evidenced studies.  Of the twelve studies that found 
a significant relationship with non-healing in venous leg ulcers, one was a Level III 
comparative study of wound duration above and below six months, without a concurrent 
control (Labropoulos, et al., 2012) [III-3], while all other studies were Level IV evidence 
(Cardinal et al., 2009; Franks, Moffatt, et al., 1995; Guest, et al., 1999; Margolis, et al., 1999; 
Milic et al., 2009; O'Meara, Tierney, et al., 2009; Phillips, et al., 2000; Skene, et al., 1992; 
Sola et al., 2012; Stacey et al., 1997; Taylor et al., 2002).  These studies were conducted over 
a variety of timeframes (12, 16, 24 and 52 weeks) and in a range of different settings. 
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An ulcer larger than 10cm
2
 was noted to define an ulcer unlikely to be healed in two 
years (Chaby et al., 2006) [III-2] and greater than 5cm
2 
and 20cm
2 
was found to be 
significantly related with non-healing at 12 and 52 weeks (Milic, et al., 2009; Phillips, et al., 
2000) [IV].  Ulcers with areas of <5cm
2
, had a mean time to healing of 7.5 weeks as 
compared to ulcers with areas >5cm
2
, that had a mean time to healing of 9.8 weeks (Phillips, 
et al., 2000) [IV].  Margolis et al. (2004) reported that ulcers >10cm
2
 in size and lasting over 
twelve months had a 78% chance of not healing after 24 weeks of treatment [IV].  In another 
study, a longer length of a venous leg ulcer wound was an indicator of a non-favourable 
outcome for healing, where the study outcome measured reduction in wound length (Meaume 
et al., 2005) [IV].  This study indicated that a length ≥ 10cm was significantly associated with 
a reduction in wound length of 40% or more at three to six weeks and this was seen as a 
favourable measurement due to possible difficulties associated with surface area measures 
during routine visits (Meaume, et al., 2005) [IV].  Therefore the simple measurement of 
wound length was proposed as an easier indicator to collect in a clinical setting (Meaume, et 
al., 2005) [IV]. 
Eleven studies failed to find wound area significantly associated with non-healing 
(Chaby, et al., 2006; Clarke-Moloney et al., 2007) [III-2]; (Chaby, et al., 2013) [III-3]; 
(Abbade, et al., 2011; Arnold et al., 1994; Barwell, Taylor, et al., 2000; Franks, Bosanquet, et 
al., 1995; Hjerppe et al., 2010; Jones, 2009; Lantis et al., 2013; Layton et al., 1994) [IV].  
This was possibly due to differences in the classification of wound area used in some studies, 
where patients with more than one ulcer in one study had the individual areas of ulceration 
added together (Chaby, et al., 2006) [III-2], whereas most studies stipulated that if a 
participant had more than one wound, either one ulcer was targeted or the largest ulcer was 
targeted.  The failure to find a significant relationship with non-healing may also have been 
due to grouping of wound areas, e.g. in one study the areas of the ulcers were classified as 
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small (<30cm
2
), medium (30-60cm
2
), large (60-90cm
2
) or very large (>90cm
2
) (Abbade, et 
al., 2011) [IV].  In another study, how the wounds were measured was unable to be 
determined (Barwell, Taylor, et al., 2000) [IV], one study had a small sample size of only 20 
participants (Layton, et al., 1994) [IV], and one study only included ulcer areas of 2-12cm
2
 
due to the maximal area that could be covered by the treatment being tested (Lantis, et al., 
2013) [IV]. 
The wound characteristic of duration has been examined extensively in the literature 
in twenty-one studies, with a longer wound duration found to be a consistent significant risk 
factor for non-healing in eleven of those studies.  The majority of studies provided Level IV 
evidence from secondary analyses of other studies with no control or comparison group.  The 
studies occurred in the USA, UK, France, Serbia, Austria, Netherlands, Germany and Ireland 
and had follow up periods ranging from 6 to 52 weeks with participant numbers from 32 to 
1324 (Barwell, Ghauri, et al., 2000; Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; 
Gohel, Taylor, et al., 2005; Lantis, et al., 2013; Margolis, et al., 1999; Meaume, et al., 2005; 
Milic, et al., 2009; O'Meara, Tierney, et al., 2009; Phillips, et al., 2000; Skene, et al., 1992) 
[IV].  An ulceration greater than three months (Meaume, et al., 2005) [IV], six months 
(Franks, Moffatt, et al., 1995) [IV] and twelve months (Milic, et al., 2009) [IV] were found to 
be significantly related with non-healing, although one smaller study indicated conflicting 
results, not finding an ulceration of greater than six months significantly associated with non-
healing (Chaby, et al., 2006) [III-2].  However, in this study they were specifically looking at 
refractory ulcers or ulcers they considered had little chance of healing (Chaby, et al., 2006) 
[III-2].  Ten studies found a longer wound duration was not significantly related with non-
healing (Chaby, et al., 2006; Clarke-Moloney, et al., 2007) [III-2]; (Chaby, et al., 2013) [III-
3]; (Franks, Bosanquet, et al., 1995; Hjerppe, et al., 2010; Kulkarni et al., 2007; Layton, et 
al., 1994; Sola, et al., 2012; Stacey, et al., 1997; Taylor, et al., 2002) [IV].  Most of these 
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studies acknowledged that it was in contrast with previous studies, and in two cases indicated 
that this may have been due to a longer study duration of nine months (Stacey, et al., 1997) 
[IV] or small sample size of 20 participants (Layton, et al., 1994) [IV]. 
Venous abnormalities have been investigated with mixed results, depending on the 
type of venous abnormality investigated.  Studies have reviewed: superficial venous reflux, 
with and without surgery (Barwell, Taylor, et al., 2000; Gohel, Taylor, et al., 2005; Skene, et 
al., 1992) [IV]; mixed venous reflux (Barwell, Taylor, et al., 2000) [IV]; varicosities 
(Cardinal, et al., 2009) [IV]; previous history of deep vein thrombosis (DVT) (Chaby, et al., 
2006) [III-2]; (Chaby, et al., 2013; Labropoulos, et al., 2012) [III-3]; (Abbade, et al., 2011; 
Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; Guest, et al., 1999; Kulkarni, et al., 2007; 
Layton, et al., 1994; Margolis, et al., 1999; Meaume, et al., 2005; Milic, et al., 2009; 
O'Meara, Tierney, et al., 2009; Taylor, et al., 2002) [IV]; superficial, total deep reflux, 
segmental deep reflux, deep venous system incompetence, and presence of incompetent calf 
perforating veins (Gohel, Taylor, et al., 2005; Sola, et al., 2012; Stacey, et al., 1997; 
Szewczyk et al., 2009) [IV].  Twenty-four studies with participant numbers ranging from 32 
to 669, have investigated some form of venous abnormality.  In relation to non-healing, seven 
studies with Level III and IV evidence found a significant relationship with non-healing in 
venous leg ulcers and the venous abnormalities including deep vein abnormalities or 
insufficiency (Labropoulos, et al., 2012) [III-3]; (Skene, et al., 1992; Szewczyk, et al., 2009) 
[IV]; popliteal reflux (Barwell, Taylor, et al., 2000) [IV], although Guest et al. (1999) found 
no relationship between popliteal reflux and non-healing [IV]; and venous refill time (VRT) 
≤ 20 seconds (Kulkarni, et al., 2007) [IV].  In contrast, six deep vein studies that utilised 
duplex scanning did not find deep vein or superficial venous involvement to be related with 
non-healing (Abbade, et al., 2011; Barwell, Taylor, et al., 2000; Gohel, Taylor, et al., 2005; 
Kulkarni, et al., 2007; Sola, et al., 2012; Stacey, et al., 1997) [IV]; surgical correction of 
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superficial venous reflux in addition to compression bandaging did not improve ulcer healing 
(Barwell et al., 2004) [II]; and two studies found no relationship between incompetent calf 
perforating veins and non-healing (Gohel, Taylor, et al., 2005; Kulkarni, et al., 2007) [IV]. 
In addition, there have been documented associations between DVTs, post-thrombotic 
syndrome and venous leg ulcer healing.  DVTs can often result from venous abnormalities 
(Kyrle et al., 2005), and themselves result in post-thrombotic syndrome, a syndrome that can 
affect up to one-third of people following a DVT (Anthony, 2013), and resulting in ongoing 
valve damage (Ettridge, 2011).  A study in Perth, Western Australia found that in 36% of 
patients with a venous abnormality, there was at least one other aetiological factor 
contributing to their chronic ulceration of the leg, with 96% having either a history of DVT or 
a condition known to predispose to a DVT – major limb injury, general anaesthesia or 
pregnancy (Baker, et al., 1991) [IV].  In relation to ulcer non-healing, two studies of Level III 
evidence, found that a previous history of a DVT was significantly related to non-healing by 
24 weeks and 2 years (Chaby, et al., 2006) [III-2]; (Labropoulos, et al., 2012) [III-3].  
However, previous DVTs were shown to have no relationship with venous leg ulcer non-
healing in twelve other studies (Chaby, et al., 2013) [III-3]; (Abbade, et al., 2011; Cardinal, 
et al., 2009; Franks, Moffatt, et al., 1995; Guest, et al., 1999; Kulkarni, et al., 2007; Layton, 
et al., 1994; Margolis, et al., 1999; Meaume, et al., 2005; Milic, et al., 2009; O'Meara, 
Tierney, et al., 2009; Taylor, et al., 2002) [IV].  The presence of a DVT was a subjective 
measure in all studies with the participant indicating that they remembered having a DVT, 
however it is known that there is a portion of the population who have ‘silent’ DVTs, 
meaning they remain undiagnosed and unrecognised (Meetoo, 2013). 
Location of leg ulcers has been theorised to be related to particular venous 
insufficiencies and therefore has been investigated in relation to non-healing.  One study with 
a follow up period of nine months and 113 participants indicated a significant relationship 
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with non-healing when the ulcer was on the right leg (Stacey, et al., 1997) [IV], however 
subsequent studies with larger participant numbers have not found this to be replicated 
(Gohel, Taylor, et al., 2005; Kulkarni, et al., 2007; Taylor, et al., 2002) [IV].  Position of 
ulcers on the leg have been examined in six studies (Cardinal, et al., 2009; Lantis, et al., 
2013; Margolis, et al., 1999; Phillips, et al., 2000; Szewczyk, et al., 2009; Taylor, et al., 
2002) [IV], with one finding a significant relationship between ankle position and non-
healing at 12 weeks (Cardinal, et al., 2009) [IV].  A further study indicated that superficial 
venous insufficiency and posterior localisation of venous pathology was associated with non-
healing venous leg ulcers located on the posterior leg, possibly related to popliteal vein 
insufficiency (Szewczyk, et al., 2009) [IV].  However, due to small numbers with this 
atypical ulcer site in this study, no conclusive decisions could be made (Szewczyk, et al., 
2009) [IV].  Another study found that position of ulcer, although not related to non-healing 
played an important part in predicting time to healing based on Artificial Neural Network 
(ANN) analysis, a processing model that uses a series of mathematical processes to produce a 
correct output response or prediction for a known outcome (Taylor, et al., 2002) [IV].  
Number of limbs involved (Cardinal, et al., 2009; Franks, Bosanquet, et al., 1995) [IV] and 
number of ulcers present (Abbade, et al., 2011; Margolis, et al., 1999; Meaume, et al., 2005; 
Sola, et al., 2012) [IV] have also been investigated, however neither have been found to be 
significantly related to non-healing.  Venous filling index, as measured by air 
plethysmography, was also not found significantly related to non-healing in a sample of 433 
participants (Margolis, et al., 1999) [IV].  Overall, there is reasonable evidence, as shown by 
significant findings from a range of studies, that some venous abnormalities are significantly 
related to non-healing in venous leg ulcers, although the level of evidence was varied and 
comparisons difficult due to the different types of venous abnormalities investigated. 
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The literature review identified a range of other potential but inconsistent 
physiological risk factors for non-healing of venous leg ulcers, including: history of ulcer 
recurrence, decreased mobility, previous limb surgery and age.  While the levels of evidence 
ranged from Level II to Level IV, the majority of studies were Level IV evidence. 
Longstanding venous disease may result in scar tissue and subcutaneous fibrosis 
causing tissue to lose its elasticity and become inflexible and to have a woody appearance 
and texture (Sieggreen, et al., 2004).  This tissue will not stretch in the presence of oedema 
and further ulceration may develop at the site of old scars (Sieggreen, et al., 2004).  The final 
stage of wound healing can take up to two years and never achieve the same level of tissue 
strength, only reaching 80% of tissue strength in the long-term (Wyffels, et al., 2011; Young 
et al., 2011).  Scar tissue does not have blood vessels, which then further compromises ulcer 
healing (Sieggreen, et al., 2004).  The number of recurrence ulcer episodes has for this reason 
been examined with mixed results.  Comparison of studies is difficult due to a lack of 
information in regards to how recurrence has been defined.  Overall, of the ten studies that 
examined previous ulcer recurrence, four have shown a history of a previous leg ulcer to be 
significantly associated with non-healing in venous leg ulcers, with Level III and IV evidence 
(Chaby, et al., 2006) [III-2]; (Abbade, et al., 2011; O'Meara, Tierney, et al., 2009; Taylor, et 
al., 2002) [IV].  Taylor et al. (2002) used the variable of history of previous leg ulcer to 
calculate a prognostic index for healing and this will be discussed further in Chapter Four.  
Recurrence was not significantly related to non-healing in seven venous leg ulcer studies  
(Chaby, et al., 2013) [III-3]; (Cardinal, et al., 2009; Guest, et al., 1999; Meaume, et al., 2005; 
Milic, et al., 2009; Skene, et al., 1992; Stacey, et al., 1997) [IV].  Longest time of unhealed 
ulceration and time since first ulcer have also been investigated and not found to be 
significantly related to non-healing (Stacey, et al., 1997; Taylor, et al., 2002) [IV]. 
 Page | 38 
 
Lack of general mobility, a fixed ankle joint and use of walking aids have been shown 
to be significant risk factors for non-healing in venous leg ulcers or significantly associated 
with a venous leg ulcer considered unlikely to heal (Meagher et al., 2012) [II]; (Chaby, et al., 
2006; Clarke-Moloney, et al., 2007) [III-2]; (Barwell et al., 2001; Franks, Bosanquet, et al., 
1995; Milic, et al., 2009) [IV].  However, it is difficult to compare studies, due to the 
variation in measurement of mobility in different studies.  The levels of evidence varied from 
two Level II studies to mostly Level IV evidenced studies.  Overall, eighteen studies 
evaluated a variety of measures of mobility, with eight comparisons finding a significant 
association with non-healing.  In two studies where mobility was categorised as: walks freely 
/ walks with aid / is chair or bed bound, mobility was found to be significantly related with 
non-healing or found to be associated with a refractory ulcer (Chaby, et al., 2006) [III-2]; 
(Franks, Moffatt, et al., 1995) [IV].  Fixed ankle joint or ankylosis of the ankle was found to 
be significantly related to non-healing in two studies at 24 and 26 weeks (Franks, Moffatt, et 
al., 1995; Milic, et al., 2009) [IV].  Milic et al. (2009) determined that a range of movement 
of <20 degrees was indicative of a fixed ankle [IV].  A study by Barwell et al. (2001) also 
found a fixed ankle joint to be an independent risk factor for venous leg ulcer non-healing by 
24 weeks by measuring ankle range of movement with a standard goniometer [IV].  Four 
studies however, found ankylosis or a fixed ankle joint not to be significantly related to non-
healing (Chaby, et al., 2006) [III-2]; (Chaby, et al., 2013) [III-3]; (O'Meara, Tierney, et al., 
2009; Skene, et al., 1992) [IV], however none of these studies indicated how a fixed ankle 
was measured making it difficult to compare studies. 
Milic et al. (2009) demonstrated that participants who walked less than 200m a day 
were significantly more likely to be non-healed by 26 weeks in a 189 participant single centre 
venous leg ulcer study [IV].  In one study, it was noted that leg ulcer participants took fewer 
steps than a control group, indicating that the calf muscle pump may not be functioning at a 
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level to assist ulcer healing (Clarke-Moloney, et al., 2007) [III-2].  A compromised calf 
muscle pump as determined by air plethysmography was associated with an increased risk of 
delayed healing in venous leg ulcers (Simka, 2007) [IV].  A small pilot study of twelve 
participants noted that those who received a home-based progressive resistance exercise 
program in addition to usual care demonstrated a trend toward healing at a faster rate 
compared to participants involved in usual care (O’Brien, et al., 2012) [II].  The findings of 
another study found significant improvements in healing rates of venous leg ulcers when 
participants took more steps per day, however the target of 10,000 steps per day may be 
unachievable for the majority of patients with venous leg ulcers  (Meagher, et al., 2012) [II]. 
In studies where mobility was measured using categories of: walks easily; walks with 
difficulty; house-bound; the ability to walk one block; full mobility or not; total, slightly 
limited, very limited or motionless; mobile or immobile; or utilising a mobility monitor and 
recording number of steps, time spent walking, standing and sitting or lying over a one week 
period, no significant relationship was found with non-healing (Clarke-Moloney, et al., 2007) 
[III-2]; (Barwell, Taylor, et al., 2000; Cardinal, et al., 2009; Franks, Bosanquet, et al., 1995; 
Margolis, et al., 1999; O'Meara, Tierney, et al., 2009; Taylor, et al., 2002) [IV].  Hjerppe et 
al. (2010) chose not to measure any specific ankle function, however using clinical 
observation, concluded that the use of a walking aid reflected a reduction in calf muscle 
pump function, shorter walking distances, reduced ankle movements and reduced venous 
flow, however this was not found to be significantly related to non-healing by 12 weeks [IV].  
Chaby et al. (2013) chose to assess mobility utilising Katz’s basic Activities of Daily Living 
(ADL) score, which measures independence in basic activities, however also failed to find 
any significant relationship with non-healing [III-3].  Interestingly, Taylor et al. (2002) noted 
that despite not finding mobility to be a significant risk factor for non-healing, measured as 
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full, or not, they concluded that poor mobility played an important part in predicting 
outcome, utilising ANN analysis [IV]. 
Only two out of seven studies, found a significant relationship between previous 
venous surgery in the leg and non-healing in venous leg ulcers (Margolis, et al., 1999; Sufian 
et al., 2011) [IV], and one of three studies determined that a history of knee or hip surgery 
had a significant relationship with non-healing (Margolis, et al., 1999) [IV].  Two RCTs 
investigated venous surgery and non-healing in venous leg ulcers, however neither of these 
studies concluded a significant relationship with non-healing (Barwell, et al., 2004; Robson 
et al., 2006) [II] and all other investigations were Level IV evidence.  History of venous 
ligation or venous stripping has been concluded to be significantly associated with failure of a 
venous leg ulcer to heal by 24 weeks (Margolis, et al., 1999) [IV], while another study 
suggested that Subfascial Endoscopic Perforator Surgery (SEPS) combined with superficial 
venous surgery or endovenous ablation of incompetent superficial veins improved healing 
rates with a low recurrence rate (Sufian, et al., 2011) [IV].  This procedure involves the use 
of a small incision whereby an endoscopic camera and tools are used to ligate the perforator 
veins (Etufugh, et al., 2007).  The procedure aims to address the underlying venous 
abnormalities preventing backflow from the deep to the superficial venous system, however 
has not been found to be as effective if the patient has severe deep venous disease (Robson, et 
al., 2006) [II], and was not found to be significantly related with non-healing in a study over 
52 weeks investigating any previous operations including SEPS and stripping (Milic, et al., 
2009) [IV].  Following SEPS, venous ulcer healing rates have demonstrated improved wound 
healing rates over 24 weeks (>95% versus 65%) with a decreased incidence of recurrence 
over 12 months (13% versus 28%) (Barwell, et al., 2004; Chong et al., 2005) [IV].  However, 
surgery is not always seen as an attractive treatment option, with the possibility of 
complications.  One RCT  indicated that 41% of participants who were eligible for superficial 
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venous surgery, refused the surgery (Barwell, et al., 2004) [II].  Further studies of 229, 330 
and 94 participants in the UK and France found that venous surgery or history of venous 
surgery was not significantly related to non-healing (Barwell, et al., 2004) [II]; (Kulkarni, et 
al., 2007; Meaume, et al., 2005) [IV].  One study concluded that for their cohort of long 
standing, large venous leg ulcers, healing was independently associated with ablation of the 
incompetent superficial vein, which can rapidly lower venous hypertension, during the follow 
up period of 24 weeks (Chaby, et al., 2013) [III-3].  Although it has not been stipulated as to 
what represented treatment for varicose veins, a large study of 345 ulcers found that any 
treatment for varicose veins was not significantly related with non-healing (Taylor, et al., 
2002) [IV].  A history of knee replacement surgery has been found to be significantly 
associated with failure of a venous leg ulcer to heal by 24 weeks (Margolis, et al., 1999) [IV]. 
Age has also been widely investigated over twenty-five studies of varying sizes, with 
Level III and IV evidence and over multiple sites.  Older people have a thinner epidermal 
layer, slower inflammatory, migratory and proliferation responses and are likely to have 
chronic diseases, combining to potentially put them at higher risk of wound complications 
(Young, et al., 2011).  Increased age was found to be significantly related with non-healing in 
only six of the twenty-five studies in which it has been examined, with the majority of those 
studies having Level IV evidence (Labropoulos, et al., 2012) [III-3]; (Barwell, Taylor, et al., 
2000; Gohel, Taylor, et al., 2005; Kulkarni, et al., 2007; Skene, et al., 1992; Taylor, et al., 
2002) [IV].  Interestingly, five of the studies where age was found significantly related with 
non-healing were conducted in UK leg ulcer clinics and vascular units, with only one of these 
studies occurring outside the UK, in an USA vascular surgery unit [III-3] (Labropoulos, et 
al., 2012). 
Additional potential physiological risk factors for non-healing in venous leg ulcers, 
with limited evidence available include: nutrition, ulcer area percent reduction, wound tissue 
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and exudate, calf circumference reduction, calf/ankle circumference ratio reduction, 
debridement, surrounding skin characteristics, chronic venous disease duration, medications, 
infection, pain, dressings, race and co-morbid conditions.  More studies are required to 
examine these risk factors due to a lack of current data and/or high quality studies. 
Tissue repair requires adequate nutrition in the form of protein, calories, vitamins and 
minerals (Tobón et al., 2008; Wipke-Tevis et al., 1996).  There has been very little research 
into the effect of vitamins and minerals on wound healing, although it has generally been 
reported that levels of Vitamin A, Vitamin D, Iron, Zinc and Selenium levels are often lower 
in patients with chronic wounds  (Heinen et al., 2004).  Therefore it has been deemed that 
they may have a role in wound healing and may influence the non-healing of wounds.  
However, many of the studies on nutrition were done a long time ago and are of poor quality 
or were conducted on animal models (Rojas et al., 1999) and despite a systematic review 
(Wilkinson, 2012) [I] the sample sizes were small and no significant relationships with non-
healing were determined.  A literature review found that many patients with leg ulcers have 
low levels of Vitamin A, C, Zinc and Carotenes (Heinen, et al., 2004) [II].  The review also 
showed that there is a little evidence that zinc may have a beneficial effect on healing of 
venous ulcers in people with a low baseline serum zinc level (Heinen, et al., 2004) [II].  A 
Cochrane systematic review containing six RCTs, involving 183 participants, was conducted 
to determine if oral zinc was effective in increasing wound healing (Wilkinson, 2012) [I].  
Four of these studies involved small sample sizes of venous leg ulcers and a meta-analysis 
indicated that there was no statistically significant benefit in healing in the intervention 
groups of oral zinc sulphate compared with controls (Wilkinson, 2012) [I]. 
Obesity is likely to contribute to venous ulceration by causing musculoskeletal calf 
pump dysfunction (Gross, et al., 1993).  Nutritional status has been examined in the form of 
Body Mass Index (BMI) in ten studies; with eight finding no significant relationship with 
 Page | 43  
 
non-healing at 6, 12, 16 and 24 weeks (Clarke-Moloney, et al., 2007) [III-2]; (Chaby, et al., 
2013) [III-3]; (Abbade, et al., 2011; Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; 
Hjerppe, et al., 2010; Meaume, et al., 2005; Skene, et al., 1992) [IV]; although one study 
excluded anyone with a BMI greater than 35 (Clarke-Moloney, et al., 2007) [III-2].  Only 
two determined a significant relationship with non-healing (Labropoulos, et al., 2012) [III-3]; 
(Milic, et al., 2009) [IV].  The individual variables of height and weight were also not found 
to be significantly associated with non-healing (Cardinal, et al., 2009) [IV].  A study with 
larger numbers of participants and using ANN analysis found that a high BMI was 
significantly associated with non-healing at 24 weeks and was considered the third most 
important risk factor (Taylor, et al., 2002) [IV].  This result, however, was not repeated in a 
validation study using a Cox regression analysis and was therefore not included in a 
developed prognostic index that will be discussed in Chapter Four (Taylor, et al., 2002).  A 
BMI >33kg/m
2 
and >25kg/m
2 
were found to be significantly associated with prolonged 
healing in two studies (Labropoulos, et al., 2012) [III-3]; (Milic, et al., 2009) [IV].  A further 
study investigating the presence of more than one risk factor (obesity, smoking, malnutrition, 
drug/alcohol use) also failed to find a statistical significant relationship with failure to heal in 
venous leg ulcers (Jones, 2009) [IV]. 
Ulcer area percent reduction and depth of wound have also been investigated.  One 
study found percentage area reduction in the first four weeks to be a significant indicator of 
wound healing potential (Kantor et al., 2000) [IV] and a further study indicated it was a good 
predictor of wound healing prediction at three weeks, although there was no indication of 
significance level (Phillips, et al., 2000) [IV].  A dated study found a thirty percent reduction 
at two weeks was significantly related to time to healing, however, this was not found to be 
replicated in any further studies (Arnold, et al., 1994) [IV].  A study that investigated initial 
healing rates, defined as the linear advance or retreat of wound margin in cm/week over four 
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weeks, as a predictor for healing by 24 weeks found poor predictive ability (Hill et al., 2004) 
[IV].  Depth of wound has been investigated in a study with 433 participants in the USA but 
was not found to be significantly related to non-healing (Margolis, et al., 1999) [IV]; whereas 
Milic et al. (2009) reported wound depth of greater than 2cm as being significantly related to 
non-healing at 52 weeks [IV]. 
Patients with venous leg ulcers  often accept that exudate and odour are part of having 
a leg ulcer, frequently leading to embarrassment and difficulties with personal hygiene, 
general appearance, maintaining dignity and outward appearance (Walshe, 1995).  Venous 
ulcers tend to be moist with moderate to heavy exudate (Sieggreen, et al., 2004).  The level of 
exudate has been found to be significantly related to non-healing in one study, with the 
heavier the exudate the more likely a wound not to heal (Taylor, et al., 2002) [IV].  Taylor et 
al. (2002) measured this as dry, almost dry, quite wet and very wet.  However, Jones et al. 
(2009) found no significant relationship between exudate levels and non-healing, when 
exudate levels were measured as none, scant, moderate and heavy; and Cardinal et al. (2009) 
did not find levels of exudate significantly related to non-healing at twelve weeks, when 
exudate was classified as being ‘more or less’, without reporting what more or less exudate 
constituted [IV]. 
A wound which is over 50% covered with fibrin at commencement of a study has 
been found to be significantly related with non-healing of venous leg ulcers by 24 weeks in a 
sample of 433 participants (Margolis, et al., 1999) [IV]; however not in a sample of 189 
participants over 52 weeks (Milic, et al., 2009) [IV].  Presence or amounts of epithelialisation 
tissue, necrotic tissue, granulation tissue or slough were not found to be significantly related 
with non-healing at 12, 24 or 52 weeks in venous leg ulcer studies with large numbers of 
participants (Chaby, et al., 2013) [III-3]; (Cardinal, et al., 2009; Margolis, et al., 1999; 
O'Meara, Tierney, et al., 2009; Sola, et al., 2012; Taylor, et al., 2002) [IV].  Emergence of 
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skin islets on <10% of the wound surface in 50 days was however noted to be a significant 
risk factor for non-healing at 52 weeks (Milic, et al., 2009) [IV].  Jones et al. (2009) 
developed a wound severity score which consisted of calculating the scores for the wound 
characteristics of area, exudate type, exudate amount, and type of necrotic tissue with a rating 
of 0 to 3 for each variable and a final score rated from 0 (least severe) to 12 (most severe) 
[IV].  This wound severity score was not found to be significantly related to non-healing in a 
study of 183 participants (Jones, 2009) [IV]. 
Milic et al. (2009) examined the variables of calf circumference reduction of less than 
3cm in 50 days, and a calf / ankle circumference ratio of <1.3, and found these to be 
significantly related with non-healing [IV].  A study investigating ankle circumference only, 
without any measure of calf circumference, did not find a significant relationship with non-
healing (O'Meara, Tierney, et al., 2009) [IV]. 
Cardinal et al. (2009) examined change in the shape of a venous leg ulcer and found 
that a change in shape, other than from concave to convex, was significantly related with 
non-healing at 24 weeks, however was unable to determine a significant relationship with 
non-healing in regards to initial wound shape [IV].  Sola et al. (2012) found no significant 
relationship in regards to shape and non-healing [IV]. 
History of wound debridement was examined in 183 participants by Jones (2009) and 
was measured as ‘yes or no’ to the following types of debridement: mechanical, autolytic, 
sharp/surgical or enzymatic.  When yellow or grey slough was not debrided, the participant 
was less likely to achieve healing, and enzymatic debridement was indicated to be the least 
effective form of debridement (Jones, 2009) [IV].  One retrospective cohort study of 433 
participants studied over 24 weeks found no significant relationship between surgical wound 
debridement and non-healing (Margolis, et al., 1999) [IV].  However a more recent open 
prospective study of 189 participants studied over 52 weeks indicated that previous surgical 
 Page | 46 
 
debridement was an influencing risk factor on prolonged time to healing (Milic, et al., 2009) 
[IV].  The reason for this they proposed was that the complete destruction of skin structures 
and lack of growth factors subsequently present in the dermis made the healing process more 
difficult (Milic, et al., 2009) [IV]. 
The surrounding skin characteristics of swelling and lipodermatosclerosis have been 
investigated in a few studies with mixed results.  The presence of leg swelling was 
significantly associated with non-healing at 24 weeks in a study of 338 participants (Cardinal, 
et al., 2009) [IV], however, in one much earlier study over 24 weeks and 433 participants, 
oedema was not found to be significantly associated with non-healing (Margolis, et al., 1999) 
[IV].  Lipodermatosclerosis was not found significantly associated with non-healing in five 
studies of between 32 and 338 participants in Serbia, France and USA (Chaby, et al., 2006) 
[III-2]; (Chaby, et al., 2013) [III-3]; (Cardinal, et al., 2009; Margolis, et al., 1999; Milic, et 
al., 2009) [IV], although was significantly associated with non-healing in one study of 90 
participants (Abbade, et al., 2011) [IV].  Other surrounding skin characteristics investigated 
included general skin condition, inflammation, induration, hyperpigmentation, dry/flaky, 
maceration and dermatitis which have all failed to show significant relationships with non-
healing (Cardinal, et al., 2009; Margolis, et al., 1999; Phillips, et al., 2000; Sola, et al., 2012; 
Taylor, et al., 2002) [IV]. 
A study that investigated chronic venous disease duration rather than ulcer duration 
showed a prolonged duration of chronic venous disease was also associated with ulcer non-
healing (Labropoulos, et al., 2012) [III-3].  The authors attributed this to a worsening of 
valvular damage with increasing length of venous disease allowing for hemodynamic damage 
at the microcirculatory level, possibly compromising healing ability (Labropoulos, et al., 
2012) [III-3]. 
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Few medications have been investigated in relation to their possible effect on venous 
leg ulcer non-healing.  Two RCTs found a significant relationship with Aspirin and non-
healing, however, they had small sample sizes (Layton, et al., 1994; Sola, et al., 2012) [II].  
Any medications that suppress the immune system, such as steroids and chemotherapy 
agents, leave a patient immunosuppressed, at higher risk of infection, with an impaired 
inflammatory process, therefore are hypothesised to affect healing (Clark, 2002; Min et al., 
1991).  Assuming that the leukocyte trapping hypothesis is correct in the perpetuation of 
venous leg ulcers, drugs inhibiting leukocyte activation and platelet function should be 
considered (Sola, et al., 2012) [II].  Two RCTs involving 300mg daily of enteric coated 
Aspirin have been studied in small samples of 20 and 51 participants with reduction in ulcer 
surface area significantly better in the Aspirin-treated group as compared to a placebo 
(Layton, et al., 1994) [II]; and a significant 46% reduction in healing time for the participants 
receiving Aspirin versus the control subjects (Sola, et al., 2012) [II].  In one study of 
hormone replacement therapy (HRT), users older than 65 were found to be 30 to 40% less 
likely to develop a venous leg ulcer, however the study did not directly observe whether HRT 
was significantly related to non-healing of a venous leg ulcer (Margolis, Knauss, et al., 2002) 
[III-3].  Two small studies of 51 and 90 participants investigating the types and numbers of 
medications taken found no significant relationship with non-healing (Hjerppe, et al., 2010; 
Sola, et al., 2012) [IV].  Interestingly, one study indicated that more than half of the 
participants were taking more than five types of medications (Hjerppe, et al., 2010) [IV] and 
the other study excluded participants on Aspirin, oral anticoagulants or non-steroidal anti-
inflammatory drugs (Sola, et al., 2012) [IV].  Alcohol consumption has also been 
investigated in one study, finding no significant relationship with non-healing (Cardinal, et 
al., 2009) [IV].  No significant relationship between smoking and non-healing has been found 
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(Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; Hjerppe, et al., 2010; Meaume, et al., 
2005; Taylor, et al., 2002) [IV]. 
Assuming that the theory of pericapillary cuffs in venous leg ulceration is correct, 
fibrinolytic therapeutic modalities should be considered (Van de Scheur et al., 1997).  
Pentoxifylline decreases tissue elastases and fibrin deposition while down regulating 
leukocyte activation, reducing leukocyte adhesion and providing fibrinolytic effects 
(Dormandy, 1995).  A good quality systematic review of RCTs that compared the use of 
Pentoxifylline in the treatment of venous leg ulcers with a placebo, in the years up to 2001 
identified eight trials involving 547 participants (Jull et al., 2002) [I], with results suggesting 
that Pentoxifylline with compression and without compression was more effective than a 
placebo in venous leg ulcer healing (Jull, et al., 2002) [I].  Pentoxifylline is a 
haemorrheological agent which reduces the viscosity of blood by increasing the flexibility of 
erythrocytes and encourages the migration of white cells, inhibiting the aggregation of 
platelets and lowering the viscosity of plasma which is thought to have actions that could 
possibly correct microcirculatory disorders (Jull, et al., 2002).  Results also suggest that 
Daflon, which is a micronized purified flavonoid fraction that acts on the inflammatory 
mediators by inhibiting synthesis of free radicals and prostaglandins; and decreasing 
bradykinin and leukocyte activation and trapping (Bergan et al., 2001) may also be useful.  
Two Level II evidence studies have been conducted and shown to be safe and be of benefit in 
healing venous ulcers (Glinski et al., 2000; Guilhou et al., 1997) [II].  A two month double-
blind, randomised controlled, placebo-controlled trial of 105 participants and a six month 
open multicentre RCT of 140 participants concluded that a daily dose of 1000mg of Daflon, 
in addition to conventional treatment, was of benefit in participants with venous leg ulcers 
(Glinski, et al., 2000; Guilhou, et al., 1997) [II].  Thirty-two per cent of ulcers in one study 
group completely healed as compared to 13% in the placebo group, almost reaching statistical 
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significance (Guilhou, et al., 1997) [II], while the other study also showed improved healing 
compared to the placebo group (46.5% Vs 27.5%, p<0.05) (Glinski, et al., 2000) [II]. 
Infection is known to prolong the inflammatory stage of wound healing by destroying 
surrounding tissue, increasing protease activity, retarding epithelialisation and collagen 
deposition, therefore impeding normal wound healing (Clark, 2002).  It is accepted that 
venous leg ulcers are colonised with multiple species of bacteria (Gilchrist et al., 1989; 
Gjødsbøl et al., 2006; Hansson et al., 1995) and it is noted that the bacteria present in wounds 
change from month to month (Skene, et al., 1992).  Pseudomonas aeruginosa is capable of 
altering the wound-healing response, causing enlargement or delayed healing in chronic 
wounds, and once established may persist (Gjødsbøl, et al., 2006) [IV].  Venous leg ulcer 
studies have measured infection by way of number of species of bacteria present, and/or signs 
of infection present, including purulent exudation, wound erythema, regional adenopathies, 
fever and high leukocyte count (Meaume, et al., 2005; Moore et al., 2010; Phillips, et al., 
2000; Skene, et al., 1992; Sola, et al., 2012) [IV].  However no study has found any 
significant relationship between non-healing and numbers or types of bacteria (Meaume, et 
al., 2005; Moore, et al., 2010; Phillips, et al., 2000; Skene, et al., 1992; Sola, et al., 2012) 
[IV]. 
Pain is notably the most significant issue in patients with venous leg ulcers , followed 
by physical symptoms often suffered as a result of pain – reduced mobility, limitations to 
daily functioning and a lack of vitality, sleep disturbance, limitations in work and leisure 
activities, worries, frustrations, social isolation and detriments to psychological wellbeing, 
such as lack of self-esteem (Persoon, et al., 2004).  The SF-36 has indicated that patients with 
chronic venous leg ulcers score worse in the category of bodily pain than the age equivalent 
norms, with significant improvements when the ulcer has healed [IV] (Charles, 2004; 
Walters, et al., 1999).  However, the majority of studies have indicated no significant 
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relationship between pain and non-healing (Arnold, et al., 1994; Taylor, et al., 2002) [IV].  
Although no significant relationship with non-healing was determined, Taylor et al. (2002) 
used ANN analysis and indicated that level of ulcer pain played an important part in 
predicting non-healing [IV].  One small study found pain to be significantly different between 
participants with ulcers that healed in under two years, to those that remained unhealed at two 
years, in a retrospective study of 32 participants (Chaby, et al., 2006) [III-2].  The more 
severe pain was present in participants who took longer to heal, although, there was no 
indication as to how pain was measured (Chaby, et al., 2006) [III-2].  A systematic review 
conducted up until May 2012 identified six RCTs including 343 participants comparing a 
eutectic mixture of local anaesthetic (EMLA) cream with a placebo for pain during 
debridement (Briggs M et al., 2012) [I], however only one of these studies reported healing 
outcomes (Hansson et al., 1993).  While this trial favoured the EMLA group, this did not 
reach statistical significance (Hansson, et al., 1993). 
Level I and II evidence systematic reviews and RCTs have examined the relationships 
between types of wound dressings and venous leg ulcer healing.  Guidelines developed for 
wound dressings recommend a moist wound environment which physiologically favours cell 
migration and matrix formation, production of growth factors and promotion of cellular 
proliferation, while accelerating healing of wounds by promoting autolytic debridement and 
reducing pain (Robson, et al., 2006; Zenilman et al., 2013).  Dry dressings over open wounds 
are considered injurious, and can cause desiccation of the wound (Robson, 2006).  Periwound 
maceration and continuous contact with wound exudate can enlarge the wound and therefore 
impede healing, so any dressing product must be considered for its exudate management 
ability (Robson, 2006).  Therefore, the ideal wound dressing should protect the wound, keep 
it warm and moist, remove exudate and reduce the risk of infection (Jones, 2009).  A 
Cochrane review of 42 prospective RCTs found that there were a number of limitations to 
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most of the studies, and due to insufficient evidence, they were unable to recommend one 
type of dressing over another (Lopez et al., 2007) [I].  Another systematic review of 31 
studies, 16 of those specifically investigating venous leg ulcers, examined a variety of 
dressings and revealed no statistically significant differences in healing rates (Bouza et al., 
2005) [I].  The use of topical antiseptics has also been investigated; neomycin, bacitracin, 
mupirocin, clotrimazole cream or silver sulfadiazine all had significant bivariate relationships 
with non-healing, with their use more likely to heal wounds, however, after adjustment for 
other known risk factors, failed to achieve statistical significance (Jones, 2009) [IV]. 
Race and ethnicity have been examined as risk factors for non-healing in venous leg 
ulcers in five studies in the USA.  Jones (2009) found that being Caucasian improved the 
chances of healing whereas the other studies indicated that race was not significantly related 
to wound healing over three months and six months (Lantis, et al., 2013; Margolis, et al., 
1999; Phillips, et al., 2000) [IV]. 
The influence of gender on healing in venous leg ulcers has been examined in 
nineteen studies, in a range of countries and across variable time frames, with only one study 
finding a significant relationship with non-healing (Taylor, et al., 2002) [IV], thus there is 
little evidence to support any relationship with non-healing (Chaby, et al., 2006) [III-2]; 
(Chaby, et al., 2013; Labropoulos, et al., 2012) [III-3]; (Abbade, et al., 2011; Barwell, 
Taylor, et al., 2000; Cardinal, et al., 2009; Franks, Bosanquet, et al., 1995; Franks, Moffatt, 
et al., 1995; Gohel, Barwell, et al., 2005; Kulkarni, et al., 2007; Lantis, et al., 2013; 
Margolis, et al., 1999; Meaume, et al., 2005; Milic, et al., 2009; O'Meara, Tierney, et al., 
2009; Phillips, et al., 2000; Sola, et al., 2012; Stacey, et al., 1997) [IV].  The only study 
reporting gender as having a significant relationship with non-healing, was a Level IV study 
where the authors found males were more likely to remain unhealed but indicated that it was 
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an unexpected finding, however related it to a possible increased prevalence of deep-vein 
incompetence in men (Taylor, et al., 2002) [IV]. 
Other variables that have been studied, however have shown no significant 
relationship with non-healing include: ankle brachial pressure index (ABPI) (O'Meara, 
Tierney, et al., 2009) [I]; (Cardinal, et al., 2009; Hjerppe, et al., 2010; Skene, et al., 1992; 
Taylor, et al., 2002) [IV], co-morbid conditions such as diabetes (Chaby, et al., 2013) [III-3]; 
(Abbade, et al., 2011; Barwell, Taylor, et al., 2000; Cardinal, et al., 2009; Franks, Moffatt, et 
al., 1995; Gohel, Barwell, et al., 2005; Kulkarni, et al., 2007; Margolis, et al., 1999; 
Meaume, et al., 2005; Taylor, et al., 2002) [IV], heart disease (Chaby, et al., 2013) [III-3]; 
(Cardinal, et al., 2009; Margolis, et al., 1999) [IV], cerebral vascular accident (CVA) 
(Cardinal, et al., 2009; Margolis, et al., 1999) [IV]; dyslipidaemia (Meaume, et al., 2005) 
[IV]; hypoalbuminaemia (Chaby, et al., 2013) [III-3]; Alzheimer’s disease or dementia (Sola, 
et al., 2012) [IV]; chronic obstructive pulmonary disease (Sola, et al., 2012) [IV]; chronic 
renal insufficiency (Chaby, et al., 2013) [III-3]; (Sola, et al., 2012) [IV]; hypertension 
(Chaby, et al., 2013) [III-3]; (Abbade, et al., 2011; Cardinal, et al., 2009; Franks, Moffatt, et 
al., 1995; Meaume, et al., 2005; Skene, et al., 1992; Sola, et al., 2012; Taylor, et al., 2002) 
[IV]; and anaemia (Chaby, et al., 2013) [III-3]; (Cardinal, et al., 2009) [IV].  It has also been 
suggested that it is likely that arthritis contributes to venous ulceration by causing 
musculoskeletal calf pump dysfunction (Gross, et al., 1993).  Although osteoarthritis has 
been investigated in one study (Cardinal, et al., 2009) [IV] and rheumatoid arthritis in six 
studies over 24 weeks (Chaby, et al., 2013) [III-3]; (Barwell, Taylor, et al., 2000; Cardinal, et 
al., 2009; Gohel, Barwell, et al., 2005; Kulkarni, et al., 2007; Taylor, et al., 2002) [IV]; no 
significant relationships were found with non-healing.  Although, rheumatoid 
arthritis/rheumatoid vasculitis have been used as an exclusion criteria in multiple studies 
(Franks, Moffatt, et al., 1995; Guest, et al., 1999; Hjerppe, et al., 2010; Milic, et al., 2009; 
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Skene, et al., 1992; Sola, et al., 2012; Stacey, et al., 1997) [IV]; while cancer or active cancer 
treatment have been exclusion criteria in others (Franks, Bosanquet, et al., 1995; Jones, 2009; 
Margolis et al., 2000) [IV] and therefore may affect the analyses in relation to these diseases. 
3.4.2 Economic factors 
Patients with chronic leg ulcers have been found to have significantly lower average 
incomes than control patients without leg ulcers (Bergqvist, et al., 1999; Moffatt et al., 2006).  
Few studies have investigated economic factors in relation to non-healing in patients with 
venous leg ulcers.  The studies found were Level III and IV studies, including comparative 
methods without concurrent controls or no control or comparison group.  Socioeconomic 
status was measured by Franks et al. (1995), who reported that low social class (determined 
by occupation and lack of central heating) was significantly related with non-healing at 12 
weeks in a sample of 168 patients [IV].  However, employment status, educational level, 
income, insurance status and receiving social security benefits have been examined in four 
studies of 94, 168, 183 and 433 participants over 12 and 24 weeks with no significant 
relationship with non-healing determined (Chaby, et al., 2013) [III-3]; (Franks, Bosanquet, et 
al., 1995; Jones, 2009; Margolis, et al., 1999) [IV]. 
3.4.3 Social factors 
Social support can be defined as the interactive process by which emotional, 
instrumental, or financial aid is obtained from one’s social network, and research has shown 
that health and supportive relationships can improve overall health and enhance a sense of 
wellbeing (Charles, 2010).  Few studies have investigated social circumstances in relation to 
non-healing in venous leg ulcer patients with one RCT (Edwards et al., 2005) [II] and one 
Level IV evidenced study (Franks, Moffatt, et al., 1995) finding a significant relationship 
with non-healing.  A study in 1995 indicated that patients treated at home were significantly 
more likely to remain unhealed at 24 weeks (Franks, Moffatt, et al., 1995) [IV].  Another 
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study showed that significant improvements in pain and ulcer healing were demonstrated in 
patient groups receiving a social model of care, as opposed to the conventional model of 
individual home visits for treatment in healthcare delivery for venous leg ulcers (Edwards, et 
al., 2005) [II].  The Lindsay Leg Club social model of care has been extremely successful 
in removing the stigma of leg ulceration for sufferers and its approach has resulted in many 
encouraging benefits, including improved concordance and positive healing outcomes 
(Lindsay, 2004).  No significant relationships with non-healing venous leg ulcers has been 
found with marital status (Chaby, et al., 2013) [III-3]; (Franks, Bosanquet, et al., 1995) [IV]; 
or social isolation, as measured by frequency of contact with relatives and friends (Franks, 
Bosanquet, et al., 1995) [IV].  It has been reported that patients who live alone are more 
likely to have a higher incidence of leg ulceration (Moffatt, et al., 2006) [IV], however, a 
study with 325 participants in the UK did not find living alone to be significantly associated 
with non-healing (Taylor, et al., 2002) [IV]. 
3.4.4 Psychological factors 
Relatively few studies have investigated psychological or quality of life factors as 
risks associated with non-healing in patients with venous leg ulcers.  However, it is known 
that patients with venous leg ulcers  are profoundly affected by the ulceration in their 
everyday lives, their feelings and emotions and in health related quality of life (Gonzalez-
Consuegra, et al., 2011; Herberger, et al., 2011; Nogueira et al., 2012; Walshe, 1995) [IV].  
Although anxiety and depression have been suggested to have an association with delayed 
healing, little research has been undertaken to examine whether these factors may not only be 
a consequence of delayed healing, but may also have a role in delayed healing (European 
Wound Management Association, 2008).  One high quality Level II evidenced study of 103 
participants found that higher depressive symptom scores on the geriatric depression scale, 
were significantly related to non-healing in venous leg ulcers (Finlayson, et al., 2012) [IV].  
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In a cohort study of 94 participants with venous leg ulcers, the use of well-validated 
psychometric instruments indicated that almost half of the participants showed a high number 
of depressive symptoms which is an indication of possible depression, and one-third had low 
self-esteem; however this study was unable to provide any evidence supporting a relationship 
with non-healing (Chaby, et al., 2013) [III-3].  Although not well studied, there is evidence 
that psychological stress adversely affects the immune system, and therefore has an adverse 
effect on wound healing (Kiecolt-Glaser et al., 1995; Marucha et al., 1998).  It is 
hypothesised that stress delays the appearance of proinflammatory cytokines early in the 
wound repair cascade (Glaser et al., 1999).  Stress and depression have been linked to 
changes in immune function and therefore may adversely influence wound healing (European 
Wound Management Association, 2008). 
3.5  Summary of literature on risk factors for non-healing of venous leg ulcers 
Chapter Three has reviewed risk factors for non-healing in venous leg ulcers.  Some 
of the research on risk factors is dated and it has been well noted that review of the evidence 
in relation to wound care research can be difficult due to the variability of wound assessment 
methods, definitions and data collection methods.  Such issues can make it difficult to 
compare results and extrapolate findings (Van Rijswijk et al., 1994).  Overall, the level of 
evidence in regards to significant risk factors is low, predominantly Level IV evidence, 
although there are some good quality Level I and II evidence studies providing valuable 
information. 
Despite these difficulties, many physiological factors have been examined in a range 
of studies in relation to non-healing in venous leg ulcers.  This literature review has identified 
reasonable and consistent evidence for the following risk factors: lack of high compression; 
larger wound area; longer ulcer duration; and venous abnormalities.  Predictors with potential 
but inconsistent evidence to support their influence on non-healing of venous leg ulcers 
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include: decreased mobility; history of ulcer recurrence; previous venous, knee or hip 
surgery; and increased age.  Predictors of non-healing in venous leg ulcers requiring more 
studies to confirm any relationship include: nutrition, ulcer area percent reduction, wound 
tissue and exudate, calf circumference reduction, calf/ankle circumference ratio, debridement, 
surrounding skin characteristics, chronic venous disease duration, medications, infection, 
pain, dressings, race and co-morbid conditions. 
There have been few studies investigating economic, social and/or psychological 
factors influencing non-healing of venous leg ulcers.  There is one good quality RCT in 
relation to social support, however the majority of studies are Level IV evidence.  The 
conclusion of many reviews is that venous leg ulcers have a major impact on these areas of a 
patient’s life (Persoon, et al., 2004).  Chase et al. (2000) reported large deficits in 
psychosocial abilities for sufferers of chronic venous leg ulcers even when compared with 
other chronic conditions such as type II diabetes and cardiovascular disease.  It is therefore 
important that economic, social and psychological factors are taken into consideration and 
investigated when looking to identify early risk factors of non-healing venous leg ulcers. 
This literature review has determined physiological, social, economic and 
psychological predictors of non-healing in venous leg ulcers.  The development of a risk 
assessment tool in Chapter Six will consider these predictors of non-healing in venous leg 
ulcers along with analysis of a large data set of information and advice from an expert Wound 
Advisory Group.  Five risk assessment tools have been documented in the literature and 
Chapter Four will examine the design and appropriateness of these tools in clinical practice.  
This will be followed by the conceptual framework to guide the studies of this research. 
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Chapter Four: Literature review of risk assessment tools and conceptual 
framework 
4.1 Introduction 
Risk assessment tools for screening people for the risk of developing wound types 
have proved successful in practice (Hess, 2005).  These include the Braden Scale and the 
Norton Scale which assess the risk of developing a pressure injury (Hess, 2005).  Risk 
assessment tools for diabetes related foot ulcers, nutritional risk assessment tools and other 
risk assessment tools have also been successfully used in preventing various disease states 
(Hess, 2005).  However prognostic tools are less utilised and even though five tools have 
been found in the literature for detecting difficult to heal venous leg ulcers, most use 
measurements that are unavailable to the general wound care health professional (e.g. venous 
refill time), and thus are currently not well utilised.  These risk assessment tools will be 
discussed in detail within this chapter and followed by a conceptual framework guiding the 
research. 
4.2 Search strategy 
The material for the review of risk assessment tools has been compiled up to December 
2013 from an extensive search of the online databases Medline; Academic Search Elite; EJS-
E Journals; Information, Science and Technology abstracts; PsycINFO; Cinahl; Health and 
Medical Complete; Nursing and Allied Health; The Cochrane Library databases; 
Sciencedirect; Web of Science; PubMed; Australian Digital Theses database; Networked 
Digital Library of Theses and Wiley On-Line library, as well as Google Scholar.  These 
databases were searched for journal articles, books, dissertations, theses, conference papers 
and proceedings.  Professional wound management association websites were also searched 
for relevant information, including: European Wound Management Association; Australian 
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Wound Management Association; Wound Healing Society; Association for Advances in 
Wound Care; Canadian Association of Wound Care; European Tissue Repair Society and 
World Union of Wound Healing Societies.  These searches were undertaken using the 
keywords “Venous” OR “Varicose” OR Stasis” AND “Ulcer*” AND “Non Healing” OR 
“Delayed Healing” AND/OR “Risk factor*” with further resources sourced as cited in 
relevant articles. 
4.3 Risk assessment tools for the non-healing of venous leg ulcers 
A search of the literature revealed five studies that had developed prognostic tools to 
assess the risk of non-healing in venous leg ulcers.  These studies devised scoring systems 
associated with significant risk factors that had either been identified from their own research 
or had been shown to be significant predictors in the literature.  The scoring systems were 
devised to indicate the likelihood of venous leg ulcers not healing within certain time frames. 
The first study by Skene et al. (1992) identified prognostic factors in venous leg ulcer 
non-healing and then used these factors to determine a simple scoring system to predict time 
to healing.  The secondary analysis in this study was based on 200 participants, with data 
collected during a randomised parallel group controlled trial comparing different dressings 
(Skene, et al., 1992).  The study included four months of follow up data, with inclusion 
criteria requiring that a wound be >2cm in diameter and be diagnosed as a venous ulcer, with 
the outcome measure being healing by four months (Skene, et al., 1992).  Participant data 
were excluded if they had been diagnosed with diabetes, rheumatoid arthritis, arterial disease, 
Ankle Brachial Pressure Index (ABPI) <0.75, intolerance to iodine, neurological disease 
causing trophic impairment and/or infected wounds which precluded a dressing being left in 
place for a week (Skene, et al., 1992).  Risk factors of age; diastolic blood pressure; Body 
Mass Index (BMI); venous circulation assessed with photoplethysmography; ABPI; fixed 
ankle joint; previous venous leg ulceration; ulcer area; duration of ulceration and bacterial 
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examination of a swab were investigated (Skene, et al., 1992).  A cox proportional hazards 
model identified significant independent predictors of non-healing to be a larger ulcer area, 
longer duration of ulceration, increased age and deep vein involvement on 
photoplethysmography, with deep vein involvement showing the greatest significant 
relationship with non-healing (Skene, et al., 1992).  Participants with deep vein involvement 
were 1.8 (95% CI 1.19-2.78) times more likely to not heal by four months (Skene, et al., 
1992).  A scoring system or prognostic index was devised utilising the regression co-efficient 
to determine the scoring and the cut off points, with an overall total score calculated as shown 
in Table 4.1. 
From this scoring system a prognostic index was calculated up to 10.5, with the 
higher the value the more likely an ulcer not to heal by four months (Skene, et al., 1992).  A 
prognostic index of 1 to 4 was deemed to indicate a low risk of non-healing by four months 
and patients in this group had a median time to healing of 40 days (Skene, et al., 1992).  A 
prognostic index of 4.5 to 5.5 was deemed to indicate a medium risk of non-healing by four 
months, and such patients had a median time to healing of 70 days; and finally a ≥ 6 
prognostic index was deemed to indicate a high risk of non-healing and these patients had a 
median time to healing of 92.5 days (Skene, et al., 1992). 
This scoring system is based on data collected twenty years ago; with no further 
studies identified in the literature utilising this prognostic index; or any studies testing 
prospective validity or reliability.  Photoplethysmography is not commonly available in most 
wound care settings; therefore the tool would not be generalisable to the majority of wound 
care environments.  There were also multiple exclusion criteria in this study, which may 
reduce the numbers of patients with venous leg ulcers for whom this tool could be relevant.  
All participants were recruited from one vascular clinic in the United Kingdom (UK), which 
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may mean that the data are not relevant to other populations of patients with venous leg 
ulcers. 
Table 4.1: Scoring system for Skene’s et al. (1992) prognostic indicators 
Ulcer area (cm
2
) Score 
<1.7 0 
1.7 - 4.89 1 
4.9 - 14.19 2 
         14.2 - 40.89 3 
40.9 - 118.3 4 
>118.3 5 
Duration of ulcer (years) Score 
<2 0 
2 - 31          1 
>31 2 
Age Score 
<52 1 
52 - 86 2 
>86 3 
Deep vein involvement on 
Photoplethysmography 
Score 
No 0 
Yes 0.5 
 
 (Skene, et al., 1992, p.1120) 
 
A second study by Margolis et al. (2000) developed a simple prediction rule to 
identify whether patients with a venous leg ulcer, being treated with compression bandaging 
would heal by 24 weeks.  A retrospective cohort study of 260 participants being treated 
between 1993 and 1995 were analysed.  Participants were included if they were classified as 
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having a venous ulcer located in the gaiter area of the leg (i.e. an area extending from mid-
calf to approximately one inch below the malleolus), had a past or current history of lower 
leg oedema that improved with leg elevation, and had other cutaneous signs of venous 
disease, such as, venous blush or flare, varicose veins or venous valvular incompetence 
(Margolis, et al., 2000).  Participants also needed to have an ABPI ≥ 0.7, no recent use of 
immunosuppressive medications and no history of cutaneous vasculitis or neutrophilic 
dermatoses (Margolis, et al., 2000).  An additional sample of 219 participants was used to 
validate the prediction rule developed from the retrospective study (Margolis, et al., 2000).  
The validation sample consisted of participants from two Randomised Control Trials (RCTs), 
with recruited participants from more than twenty clinical sites (Margolis, et al., 2000).  
Eligibility in these studies included wounds that had at least a four week duration and an area 
of between 0.5 and 200cm
2
 (Margolis, et al., 2000).  All participants received multilayered 
compression bandaging that was changed weekly, with the outcome of interest being healing 
by 24 weeks (Margolis, et al., 2000).  If a patient had more than one ulcer, one was randomly 
selected.  A limitation of this project was that participants who discontinued care or switched 
to another therapy were considered ‘not healed’ for the purposes of analysis (Margolis, et al., 
2000).  Prognostic factors of race (white/all others); wound area; duration of wound; ABPI; 
number of wounds; inability to walk one block; history of wound debridement; >50% of the 
wound covered in fibrin; lipodermatosclerosis and undermined wound margin were 
considered as risk factors, as these had previously been found to be significant risk factors 
related to non-healing in bivariate analysis of a larger dataset (p ≤ 0.10) (Margolis, et al., 
2000).  Multivariate logistic regression was utilised and, while several models of varying 
complexity were examined, a simple counting model based on dichotomous factors was 
produced with cut off points selected to maximise differences between those who healed and 
those who did not heal (Margolis, et al., 2000).  The study reported that the likelihood that a 
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venous leg ulcer would not heal could be estimated simply by using the variables of wound 
area and duration of wound before treatment, and a scoring system was devised with 
allocated points for these variables, with the points then summed as described in Table 4.2 
(Margolis, et al., 2000). 
Model discrimination was estimated using the area under the Receiver Operating 
Characteristic (ROC) curve (AUC) and indicated good results of 0.87 in the development set, 
and 0.77 in the validation dataset (Margolis, et al., 2000).  In the developmental data set, 7% 
of participants with a score of 0 did not heal within 24 weeks and 87% of those with a score 
of 2 did not heal within 24 weeks.  In the validation study, 5% of participants with a score of 
0 did not heal within 24 weeks and 63% of those with a score of 2 did not heal within 24 
weeks (Margolis, et al., 2000). 
This tool was designed using data collected nearly twenty years ago.  No further 
studies relating to this tool or reliability testing were located in the literature.  While the 
advantage of this model is that it was developed and validated in two different databases with 
the two assessment variables readily available as part of routine initial assessment, only a few 
prognostic factors were considered in the initial analyses.  The addition of a broader range of 
variables may be of greater clinical use to improve accuracy of the tool.  The study indicated 
that multilayered, high level compression bandages were used on all participants (Margolis, 
et al., 2000), therefore excluding participants who were unable to tolerate high compression.  
Data for development of this tool were collected in a specialty clinic and validation data in 
RCTs with strict protocols, therefore data may not be relevant to other populations of patients 
with venous leg ulcers. 
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Table 4.2: Prognostic scoring system developed by Margolis et al. (2000) 
Wound area Score 
>5cm
2
 1 
<=5cm
2
 0 
Wound duration  
>6 months 1 
<=6 months 0 
 
(Margolis, et al., 2000) 
 
Taylor et al. (2002) conducted a retrospective cohort study of 325 participants with 
345 ulcers of venous aetiology from 1997 to 1999 at the Salford Primary Care Trust leg ulcer 
clinic in the UK.  This study aimed to identify risk factors that influenced healing of venous 
leg ulcers treated with compression therapy and was conducted over 24 weeks (Taylor, et al., 
2002).  Of the 345 ulcers assessed, 275 were included with 175 randomly assigned to the 
developmental data set and 100 randomly assigned to the validation dataset (Taylor, et al., 
2002).  Risk factors were determined from the developmental data set and a prognostic index 
developed, with the validation data set used to validate the prognostic index.  The authors did 
not indicate any inclusion or exclusion criteria although the ulcers did need to be diagnosed 
as venous and it appears that those with an ABPI <0.8 and/or an inability to tolerate four 
layers of compression bandaging were excluded.  Interestingly, this study chose to add the 
total area of ulcers if more than one ulcer was present, using a computerised planimetry 
program (Taylor, et al., 2002).  Healing was only judged to be complete when all ulcers had 
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healed (Taylor, et al., 2002).  This is in contrast to the majority of other studies where one 
ulcer was targeted or the largest ulcer was targeted and healing related to that ulcer.  An 
Artificial Neural Network (ANN) processing model was utilised for analysis and included 45 
study parameters that were used as input nodes, including the variables of age; gender; lives 
alone; smoker; previous leg ulcer; co-morbid conditions; treatments; mobility; ulcer duration; 
ulcer location; pain; exudate; surrounding skin; tissue type; BMI; ABPI; blood pressure; and 
area; however there was no rationale given as to why these particular variables were chosen 
(Taylor, et al., 2002).  The risk stratification identified the key variables predicting non-
healing as history of previous leg ulceration, ‘quite wet’ ulcer exudate, high BMI, large initial 
total ulcer area, increasing age and male gender (Taylor, et al., 2002).  Multivariate survival 
analysis using a Cox proportional hazards model confirmed four independent risk factors and 
using regression coefficients, the values for age, ulcer area, gender and history of a previous 
leg ulcer were used to create the following prognostic index to determine healing time 
(Taylor, et al., 2002): 
 
Prognostic Index = regression co-efficient of ulcer area (0.6471) x log10 (1 + ulcer 
area) + regression co-efficient of age (0.0207) x age + regression coefficient of gender 
(0.3959) x gender + regression coefficient previous ulceration status (0.4541) x previous 
ulceration status 
(Taylor, et al., 2002) 
 
The probability of ulcer healing was plotted against the prognostic index for healing 
times and the higher the prognostic index, the longer the ulcer took to heal (Taylor, et al., 
2002).  The use of the ANN for analysis is complex and the authors noted that the finding of 
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males being harder to heal than females was unexpected.  This was the only study in the 
literature review to conclude that a significant relationship between gender and non-healing 
existed, with eighteen other studies finding no significant relationship with non-healing.  
Therefore the use of this variable in a prognostic tool is questionable.  The prognostic index 
equation is difficult to calculate and would not be easy to utilise for the majority of wound 
care nurses.  This tool was not found to be utilised in any further studies investigating wound 
healing in venous leg ulcers and no reliability testing data appeared in the literature.  A 
further limitation of this study included the assumptions of a proportional hazards model not 
always being satisfied across all risk factors considered.  However the author points out these 
results were only included to confirm the less used analysis of ANN. 
A fourth study by Falanga et al. (2006) developed and tested a new classification 
system for wound bed status that has predictive value for non-healing of venous leg ulcers.  
In 2000, a wound bed preparation classification score was proposed for all chronic wounds, 
based on wound bed appearance and wound exudate, from which a wound total score was 
determined (Falanga, 2000).  The wound bed score (WBS) was useful for assessing wounds, 
however provided no predictive value for ultimate wound closure (Falanga, 2000).  In further 
work by Falanga et al. (2006), data was used from a prospective RCT conducted prior to 
1998 of 177 participants aged between 15 and 85 years in 15 outpatient settings in the United 
States of America (USA).  The classification system was applied to venous leg ulcers and a 
further revised WBS was devised reflecting previous work and clinical experience.  The 
WBS was used with participants who were then prospectively randomised to either 
conventional therapy (compression alone) or compression with a living bilayered skin 
construct over a 24 week period.  Inclusion criteria were that a wound must have been present 
for greater than four weeks and the ulcer must have been extending through the epidermis 
into dermal tissue, without exposed bone or tendon.  Exclusion criteria included any area of 
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<1cm
2
 or more than 10 x 20cm, ABPI<0.65 and medical conditions known to impair healing, 
however the medical conditions considered in this study to impair healing were not stipulated 
(Falanga et al., 1998).  Logistic regression was used to model WBS as a predictor for healing 
status.  This revised wound bed score included wound bed appearance, wound exudate, 
wound duration and surrounding skin as shown in Table 4.3. 
A total score was calculated with a maximum of 16 being the best possible score and 
0 being the worst possible score (Falanga et al., 2006).  Results showed statistical 
significance (p=0.001) in predicting whether wound closure would occur (Falanga, et al., 
2006), with a higher WBS for wounds that achieved full closure than those that did not heal.  
Although all parameters were important in improving the probability of healing, the three 
parameters of wound edge, peri-wound callus / fibrosis and wound duration prior to initiation 
of treatment showed the strongest predictive power (Falanga, et al., 2006). 
No further studies were found that utilised this scoring system or reported on validity 
or reliability.  It also relies entirely on ulcer specific variables without incorporating a holistic 
view of other factors that may influence healing. 
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Table 4.3: Wound bed score for healing developed by Falanga et al. (2006) 
Wound bed score 
characteristics 
0 1 2 
Healing edges None 25-75% >75% 
Black eschar >25% of wound 
surface area 
0-25% None 
Greatest wound 
depth/granulation tissue 
Severely depressed or 
raised when compared 
to peri-wound skin 
Moderate Flushed or 
almost even 
Exudate amount Severe Moderate None/mild 
Oedema Severe Moderate None/mild 
Peri-wound dermatitis Severe Moderate None or 
minimal 
Peri-wound callus/fibrosis Severe Moderate None or 
minimal 
Pink wound bed None 50-75% >75% 
Wound duration prior to 
treatment 
≥ 1 year  < 1 year 
 
(Falanga et al., 2006, p.385) 
 
The fifth risk assessment tool was developed by Kulkarni et al. (2007) from a cohort 
study of 229 participants who had participated in the Effect of Surgery and Compression on 
Healing Recurrence (ESCHAR) study that recruited participants from 1999 to 2001.  The 
scoring system developed was validated in a further cohort study of 86 participants during 
2004 and 2005 in an open-access nurse-led specialist resource leg ulcer service in 
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Gloucestershire.  The validation study involved all venous leg ulcer participants who were 
treated with conventional four layer compression (Kulkarni, et al., 2007).  The study included 
all open leg ulcerations of more than 4 weeks duration, ABPI ≥  0.85 and were shown to have 
superficial venous reflux alone, or mixed superficial and deep venous reflux on duplex 
imaging (Kulkarni, et al., 2007).  The study was limited in that patients that had deep reflux 
alone or occluded deep veins and those in whom photoplethysmography was not possible 
were excluded from this study (Kulkarni, et al., 2007).  This study evaluated twelve risk 
factors including, age; gender; right or left leg; history of Deep Vein Thrombosis (DVT); 
diabetes; rheumatoid arthritis; duration of wound; segmental deep reflux; total deep reflux; 
incompetent perforators; superficial venous surgery; and a Venous Refill Time (VRT) of ≤  
20 seconds (Kulkarni, et al., 2007).  A Cox regression model was used to identify 
independent predictors, with older participants and a VRT of ≤ 20 seconds identified as 
significant predictors of wound healing, with a VRT ≤  20 showing the greatest influence on 
non-healing (Kulkarni, et al., 2007).  This study did not identify ulcer chronicity as an 
independent significant risk factor but the authors included it in their scoring due to evidence 
from previous studies (Barwell, Ghauri, et al., 2000; Gohel, Taylor, et al., 2005).  The 
Ulcerated Leg Severity Assessment (ULSA) score was then calculated using the VRT results 
of a patient, utilising hazard ratios from the Cox regression analysis: 
If venous refill time >20 seconds 
ULSA Score = age (years) + ulcer chronicity (months) - 50 
 
If venous refill time ≤ 20 seconds 
ULSA Score = age (years) + ulcer chronicity (months)     
 (Kulkarni, et al., 2007) 
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The differences in the equations allowed for the differences in VRT, however it was 
unclear from this study as to why the figure of 50 was utilised in the first equation.  The 
author was contacted and stated that weighting of the log of the hazard ratios for the three 
identified risk factors provided the prognostic indices for the score of 50.  In this study, 9% of 
participants in the development study with ULSA scores ≤ 50 had not healed at 24 weeks 
(validation cohort 23%); 30% of participants with ULSA scores of 51 to 90 (validation cohort 
45%) had not healed at 24 weeks; and 55% with ULSA score of ≥  91 (validation cohort 
77%) had not healed by 24 weeks (Kulkarni, et al., 2007).  Kulkarni et al. (2007) 
acknowledged that while patient age and duration of ulcer had been found to be significantly 
related to non-healing in many other studies and are simple and easy to use, VRT is not used 
in many leg ulcer units.  VRT is not commonly available in practice, and 24% of potential 
participants were excluded in this study as VRT was unable to be measured, indicating the 
limitation of the applicability of the tool in routine clinical practice (Gibson, 2007).  
However, the authors suggest that it could be used in clinical practice if shown to be 
important, and they suggest a case could be made for the purchase of equipment (Kulkarni, et 
al., 2007).  Even so, this would not be an option for many wound care clinics and community 
and home care organisations.  They also acknowledged that inclusion of other factors they 
have not measured may produce a more reliable scoring system (Kulkarni, et al., 2007).  A 
response to this study was submitted by Gibson (2007) who suggested that as the data were 
derived and validated in a specialised leg ulcer service; this may not be valid for patients 
receiving standard community-based care. 
All of the five tools described in this chapter utilised variables that had been found to 
be significantly related with non-healing either in their own studies, or from the literature.  
The authors all indicated that scoring systems needed to be short and relatively easy to use, 
with all of the tools using a minimum amount of variables; however none of the tools appear 
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to have been utilised in any other published studies or used more widely.  Wound duration 
has been used in four of the five tools, while age and area have been used in three of the five 
tools, suggesting strong evidence for their use.  Two tools, however, have used measures of 
deep vein involvement or VRT using photoplethysmography which are not readily available 
in the majority of wound care services, therefore limiting the use of these tools.  Another two 
tools utilised variables and equations that would be difficult for wound care nurses to use 
without a greater understanding of wound specific variables and time to complete.  Most 
tools have also only utilised ulcer specific variables without consideration of other holistic 
factors that may influence healing.  Most studies did not examine a broad range of factors 
influencing healing and the addition of the covariates of social, economic and psychological 
variables to identify factors associated with non-healing may provide more accurate 
predictors of non-healing.  Margolis et al. (2002)’s tool appears simple and useful, although it 
would be of interest to determine if there are other variables that may be of assistance in 
adding to the tool, and therefore developed for use by all clinicians and in all settings to 
improve predictive ability. 
 
4.4 Conceptual framework 
Findings from the literature review in Chapter Three indicated that a combination of 
physiological, economic, social and psychological variables may influence the healing of 
venous leg ulcers, and thus should be used to guide research; therefore a conceptual 
framework to explore the impact and interactions of factors from multiple domains is 
necessary.  A broad framework is required to guide investigation into both the direct 
influences on venous leg ulcer healing, for example, physiological factors such as area of the 
wound; and indirect influences such as depressive symptoms and income status. 
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Previous conceptual models of wound management have been developed primarily 
based on physiological or biological principles of wound healing (Flanagan, 1996; Schultz, et 
al., 2003).  Wound assessment and management has tended to be subjective and biologically 
based on assessment of the ulcer (Flanagan, 1996).  However, significant progress has been 
made in understanding the biological correlates of stress, anxiety and depression as well the 
social support and economic contributions that may be relevant to wound assessment and 
management, providing substantive insights and therefore the need to include in a conceptual 
approach for future studies (Miller et al., 2009).  There have been a small number of 
conceptual frameworks published to guide the assessment of wounds, reflecting the values 
and theoretical beliefs of particular authors (Morison et al., 2007).  Some of these 
frameworks have been designed for generic wound types (European Wound Management 
Association, 2008; Morison, et al., 2007; Popoola, 2003), while others have been created for 
specific wound types (Gorecki et al., 2010).  Currently no conceptual framework exists that is 
concerned specifically with risk factors for chronic non-healing or delayed healing in venous 
leg ulcers, however the models previously developed utilise similar variables and 
relationships to the proposed research into risk factors and are thus suitable to guide a 
framework for identification of risk factors for non-healing venous leg ulcers.  Three 
conceptual frameworks relating specifically to chronic wounds using the necessary holistic 
approach were reviewed and relevant aspects have been incorporated from each to design a 
final framework to guide this research. 
Poopoola (2003) developed a holistic framework to address multiple influencing 
factors on healing; including physiological (healing/reparative, nutrition/trauma, pressure, 
illness); psychosocial (caring/attitude, education, culture/values, dedication/motivation); 
economic (knowledge, insurance/cost, lifestyle, access to care); political (policies, 
lawsuit/fear, legislatures/governmental, ethical) and spiritual factors (god/prayer, healers, 
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belief/values, hope/biofeedback) to guide care of all chronic wounds.  This framework 
utilises the concept of holism which is an approach to care based on the premise that the 
whole is greater than the sum of its parts and allows clinicians to do more than ‘fix’ an 
isolated problem, or focus on the wound itself, and to consider the whole person, whilst 
involving other care provider disciplines in the process (Popoola, 2003).  This framework is 
informed by theories from holistic, caring and systems nursing theorists (Meleis, 2005; 
Whitney, 1999).  Holism encourages health professionals to address multiple factors that can 
hinder healing, therefore maximising patients potential for healing (Popoola, 2003).  It entails 
a paradign shift from a mechanistic ‘curing’ perspective to one that is broad, flexible and 
dynamic and takes into consideration caregivers’ motivation and skills and maximises 
patients’ potential for self-healing by utilising complementary therapies (Popoola, 2003).  It 
is also intended to open the debate with policymakers, care management organisations and 
wound care product manufacturers (Popoola, 2000, 2003) and is described in Figure 4.1.  
This model utilises more variables than it is feasible to measure in the current study, such as 
political and spiritual environment, however the physiological, economic and psychosocial 
categories will be incorporated into a final model to guide the current research, discussed 
later in this chapter. 
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Access to Care
Economic Environment
 
Figure 4.1: Holistic reparative model for chronic wound management. 
Note: This figure is reproduced from Advances in Skin & Wound Care, Vol 13, Popoola, 
M.M., ‘Paradign shift: A clarion call for a holistic approach to chronic wound management’, 
p. 47-48, 2000, with permission from Lippincott Williams & Wilkins. 
 
Morison et al. (2007) proposed a model for factors that can adversely affect wound 
healing utilising multidimensional aspects to wound healing.  This conceptual framework 
stresses the importance of removing the immediate cause of the wound, treating any 
underlying pathology, optimising the local wound environment and preventing any further 
tissue breakdown (Morison, et al., 2007).  This conceptual model was designed as a 
framework for patient assessment and care planning and involves a variety of factors 
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providing a holistic approach with a multidimensional construct that includes physical, social, 
emotional and spiritual dimensions (Morison, et al., 2007).  It takes into consideration 
pathophysiological factors, local conditions at the wound site, age, psychosocial factors, 
inappropriate wound management and adverse effects of therapies.  It considers the 
consequences of the wound for the individual’s quality of life, the patient’s beliefs about their 
wound and their perception of the likelihood of a successful outcome to treatment, both 
currently and in the longer term (Morison, et al., 2007).  This framework also highlights the 
multiplicity and complexity of factors that can affect the individual’s desire to engage in 
behaviours that will assist their wounds to heal and encourages clinicians to consider factors 
beyond the wound (Morison, et al., 2007) (See Figure 4.2). 
The third model reviewed to guide this research was published by the European 
Wound Management Association (EWMA) (2008) in the position document ‘Hard-to-heal 
wounds: a holistic approach’ and utilises the concept of wound complexity.  This framework 
encompasses both biological and psychosocial factors that are thought to influence delayed 
healing of chronic wounds (European Wound Management Association, 2008).  It is 
acknowledged in this document that early recognition of a wound that is slow to heal is of 
importance and it is necessary to recognise the complex combination of factors, both within 
and outside the wound, that are involved in the process of healing (European Wound 
Management Association, 2008).  Wound complexity has a major impact on wound healing 
progression and only by appreciating and understanding the interaction of these factors and 
their impact on non-healing can health professionals develop effective and appropriate 
strategies to improve wound healing (European Wound Management Association, 2008).  
The influences are broadly categorised into patient-related factors, wound-related factors, 
skill and knowledge of the healthcare professionals, resources and treatment related factors 
(European Wound Management Association, 2008).  The challenge for healthcare 
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professionals is to initiate strategies in timely and cost-effective ways so as to reduce wound 
complexity, thereby managing patient’s symptoms and expectations and, where possible 
achieve healing (European Wound Management Association, 2008).  The concepts within the 
model indicated within the broken lines in Figure 4.3 will be utilised to assist in the design of 
a framework to guide this research project. 
factors
Negative psychosocial factors
Altered body image resulting
in actual or perceived problems
with social relationships and roles
Additional recent life stresses,
e.g. loss of employment,
bereavement
Living alone
Patient’s lack of belief in treatment
Negative attitudes of staff
to treatment and healing
factors
Inappropriate wound
management
Failure to identify, and
where possible, correct the
underlying cause of the wound
Application of inappropriate
topical agents and primary
wound dressings
Poor wound dressing
technique
factors
Adverse effects of
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factors
Increasing age
Direct epidermal cell replacement
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Increased susceptibility to trauma
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Necrotic tissue
Excess metabolic waste products
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Figure 4.2: Factors adversely affecting wound healing. 
Note: This figure is reprinted with permission from Leg ulcers: A problem-based learning 
approach, Morison MJ, Moffatt CJ, Franks PJ, A framework for patient assessment and care 
planning, p.127. Copyright Elsevier (2007). 
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Figure 4.3: Factors that may affect complexity and hard-to-heal status. 
Note: Reprinted from Position Document: Hard-to-heal wounds: A holistic approach, 
European Wound Management Association, London: MEP Ltd; p.3, 2008, with permission 
from European Wound Management Association. 
 
Progress in healing of venous leg ulcers is influenced by a variety of factors and a 
systematic and holistic approach is essential with the adoption of a client-centred approach 
(Morison, et al., 2007).  Psychological theories of disease include complex models 
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considering factors at multiple social levels (e.g. individual, peer, community and culture) 
and therefore factors such as the role of health services have the potential to be important in 
this process due to the fact that the majority of venous leg ulcer patients are being cared for 
through a mixture of acute, general, specialist and community health care services requiring 
complex communication and organisation to achieve continuity of care (Graham, Harrison, 
Moffat, et al., 2001).  However, the investigation of these multiple social levels is outside the 
scope of this project and will not be included in the final conceptual model. 
An adaptation of the three conceptual frameworks discussed in this chapter has been 
developed to guide this research looking specifically at identifying the early risk factors 
associated with the non-healing of venous leg ulcers by 24 weeks.  Based on the literature, 
the proposed framework (see Figure 4.4), displays the hypothesised relationships, which will 
be investigated in this research and indicated by the block arrows, between physiological, 
economic environment, social and psychological risk factors and non-healing of venous leg 
ulcers.  The broken lined arrows indicate relationships that have been discussed in the 
literature as likely to occur between the four categories however these relationships are 
outside the scope of this project and will not be investigated within this study. 
There are also likely to be relationships between variables within the categories.  For 
example, in the category of social, there is some research available, although mostly dated, on 
the relationship between living alone and social support.  Literature has supported living 
alone and social support as having an important and inter-related role in the health of the 
ageing population although it is noted to be a complex interaction (Shu-Chuan et al., 2004; 
Tomaka et al., 2006).  Varying measurements of social support and lack of high quality 
studies mean results have been difficult to confirm (Victor et al., 2000).  Although, Shu-
Chuan et al.  (2004) concluded that living alone was significantly related to levels of 
perceived social supports, it was difficult to determine whether it was a cause or an effect.  
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Wenger et al. (1996) concluded that living alone was not significantly related to decreased 
social support, however determined that not all who live alone lack social support, whereas 
nearly all who lack social support live alone.  Further complexities are associated with 
comparing types of isolation, for example, emotional isolation (lack of close intimate 
attachment to another person), social isolation (lack of a network of social relationships) 
(Shu-Chuan, et al., 2004) or a further view that it is not the size of the social support but the 
quality of that support that is important (Victor, et al., 2000).  In the psychological category 
there is literature to support a relationship between clinical depression and depressive 
symptoms, although again this is a complex relationship.  Depression is a syndrome of 
episodic, psychological and physiological signs and symptoms that is diagnosed by a health 
professional based on characteristics such as depressed mood, insomnia, weight loss, fatigue 
and feelings of worthlessness (Solnek et al., 2002).  Diagnosing depression often incorporates 
the use of a screening questionnaire of depressive symptoms (Solnek, et al., 2002).  A 
questionnaire evaluates the presence of and severity of depressive symptoms which do not 
necessarily correspond to the physical symptoms of depression (Zuidersma et al., 2013), 
although can sometimes be an indication of possible depression.  Self-reported depressive 
symptoms have been noted to be a more accurate predictor than clinical depression of cardiac 
morbidity and mortality (Zuidersma, et al., 2013).  These relationships are complex and 
outside the scope of this project to investigate but are important considerations for future 
research.  
The final framework incorporates physiological factors (gender, age, medications, co-
morbid conditions, surgical/trauma history, BMI, wound characteristics, pain, DVT, 
cramps/claudication, aching legs, rest pain, surrounding tissue, fixed ankle joint, walking aid, 
previous ulcers, ABPI, dressings, varicose veins, history of venous injections and 
compression); economic environment (socioeconomic status); social (carer status, live alone, 
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marital status, activities of daily living, social support) and psychological factors (depression, 
depressive symptoms, anxiety and quality of life).  While there is strong evidence in the 
literature to support some of these factors, this research study will seek to validate those 
factors while also investigating other factors that have little or no evidence in the literature. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4:  Conceptual Framework - Risk factors for non-healing of venous leg ulcers by 24  
weeks 
While there is currently no framework specifically for venous leg ulcers or the 
investigation of risk factors associated with the non-healing of these ulcers, concepts from 
three conceptual frameworks for chronic wounds have been incorporated into a final 
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framework to guide the research investigating early risk factors significantly associated with 
non-healing at 24 weeks in chronic venous leg ulcers. 
 
4.5 Conclusion 
Current knowledge on chronic leg ulcers indicates the significant impact of the 
disease on health and quality of life for individuals, families and communities.  Delayed 
wound healing impacts on patients’ health and well-being and increases cost of care with up 
to 30% of venous leg ulcers not healing in a timely manner (Gohel, Taylor, et al., 2005; 
Guest, et al., 1999).  Therefore it would be helpful to have a prognostic tool that could be 
used in a clinical setting to provide appropriate information at an early stage regarding ability 
of a wound to heal in order to promote implementation of appropriate strategies as early as 
possible (Ogrin et al., 2011).  Currently there is no risk assessment tool that is being regularly 
utilised for venous leg ulcers; although accurate and timely assessment is essential, and 
engagement crucial.  While five studies have developed risk assessment tools for healing of 
venous leg ulcers, most have included variables that are unavailable or difficult to use in the 
majority of wound care settings.  These authors acknowledged that to be useful, any tool 
must be short and relatively simple to use, therefore a tool based on more readily available 
measurements will have a greater practical application (Gibson, 2007).  These tools have also 
been developed based on predictors which have in the majority, been medical and 
physiological factors.  Mounting evidence that psychosocial factors have important 
implications for health (Miller, et al., 2009), mean that it is important to include the 
categories of social, economic and psychological factors to provide more accurate predictors 
of non-healing.  Predictive models could then assist with predictive ability to target more 
effective interventions.  The methods and results of Study One, ‘Identification of risk factors 
for non-healing of venous leg ulcers by 24 weeks’, which aims to identify a broad range of 
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risk factors for non-healing from the categories of physiological, social, economical and 
psychological will be presented in Chapter Five. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page | 82 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Page | 83  
 
Chapter Five: Study One 
Identification of risk factors for non-healing of venous leg ulcers by 24 weeks 
 
5.1 Introduction 
A review of the literature in Chapter Three found that a large number of studies had 
investigated risk factors for non-healing of venous leg ulcers.  The literature review identified 
a consistent body of evidence for physiological predictors for non-healing, i.e. lack of high 
compression; larger wound area; longer ulcer duration; and venous abnormalities.  
Inconsistently found physiological predictors of non-healing also included: decreased 
mobility; history of ulcer recurrence; previous lower limb surgery; and increased age.  Other 
potential predictors, with limited evidence, requiring additional or more consistent studies to 
improve the level of evidence to support these relationships included: wound tissue and 
exudate; ulcer area percentage reduction; calf circumference reduction; calf/ankle 
circumference ratio; debridement; surrounding skin and tissue characteristics; infection; 
dressings; pain; nutrition; medications and race. 
Despite few studies investigating the economic, social and/or psychological impact on 
venous leg ulcer healing, and even fewer studies combining all factors to determine 
independent predictors, findings from the literature review indicated that it was important to 
include these categories when looking to identify early risk factors.  This is important as 
healing requires a holistic approach and is affected by multiple factors (European Wound 
Management Association, 2008).   
A review of risk assessment tools previously developed for use with venous leg ulcers 
found five tools or prognostic indexes had been developed, however most had used items that 
were unavailable or unable to be tested in the majority of wound care settings, or the tool did 
not consider all categories of risk factors.  Subsequently, there remains no risk assessment 
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tool for venous ulcers being widely utilised, despite the potential for assistance to wound care 
health providers and patients with venous leg ulcers. 
The aim of Study One was to: 
 Analyse a large database of information collected from patients with venous leg 
ulcers to identify significant relationships between physiological, economic, 
social and psychological factors and healing outcomes after 24 weeks of 
treatment 
 
Study One, addressed the following research questions: 
 What physiological, economic, social and psychological factors were 
significantly associated with the non-healing of venous leg ulcers at 24 weeks? 
 
 Controlling for potential confounders and all independent variables in a 
multivariable Generalised Linear Mixed Model (GLMM), what factors 
remained independent predictors of non-healing by 24 weeks in venous leg 
ulcers to guide the development of a risk assessment tool? 
 
5.2 Design 
A secondary analysis of a combined database from a series of longitudinal prospective 
studies of participants with venous leg ulcers, followed for 24 weeks, was undertaken.  
Predictors of non-healing venous leg ulcers were identified from the large data set of clinical, 
healing, health and psychosocial data from participants with venous leg ulcers currently held 
by the School of Nursing, Queensland University of Technology (QUT), Wound Healing 
Group.  This data set was made up of data collected from seven previous studies. 
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5.3 Sample 
The potential sample for analysis consisted of 399 chronic leg ulcers drawn from 
studies detailed later in this chapter.  Of these 399 chronic leg ulcers, 33 were excluded as 
they did not meet the inclusion criteria for this study (17 did not have 4 weeks of data 
including healing data available from baseline, 1 was diagnosed as a skin cancer, 5 appeared 
to be possibly repeats of ulcers in more than one study, and 10 had an Ankle Brachial 
Pressure Index (ABPI) outside the inclusion criteria range).  The final sample therefore 
included 366 venous leg ulcers in 247 community living patients who had been recruited 
from hospital outpatient clinics and community settings, and had participated in at least one 
of the outlined studies between 2004 and 2012. 
The seven studies from which the study database was constructed are described 
below, including the respective inclusion and exclusion criteria: 
 A Queensland Nursing Council funded project titled “Randomised 
Controlled Trial (RCT) of a community nursing intervention for managing 
patients with chronic leg ulcers”.  This study included participants recruited 
from a community nursing service in the Brisbane and Gold Coast regions.  
This was a RCT that aimed to determine the effectiveness of a new 
community nursing model of care on quality of life, healing, pain and 
functional ability of clients with chronic venous leg ulcers.  The inclusion 
criteria were: patients with an ulcer below the knee of primarily venous 
aetiology; and who had an ABPI ≥  0.8 and <1.3.  The exclusion criteria 
were: patients who did not speak or understand English and patients with a 
cognitive impairment.  All participants in both study groups received the 
same leg ulcer treatment protocol, based on evidence based guidelines, 
including high level compression (Edwards, et al., 2009).  Seventy-three 
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cases from this study were eligible for inclusion in the combined venous leg 
ulcer database, constituting 20.0% of the final database. 
 A QUT Strategic Collaborative Project Grant titled “Wound Healing 
Dynamics” included patients from a community nursing service 
organisation and a tertiary metropolitan hospital outpatient vascular clinic 
with data collected between December 2004 and August 2006.  This project 
aimed to identify the relationship between biochemical markers in wound 
fluid and wound healing in chronic venous leg ulcers being treated with 
compression therapy.  An observational longitudinal study was utilised to 
determine the effect of differing types and levels of compression on wound 
fluid composition and wound healing.  The overall aim was to gain a better 
understanding of the wound healing process and to utilise this knowledge to 
develop improved techniques to increase healing rates of chronic venous leg 
ulcers.  Inclusion criteria were: patients with leg ulcers of primarily venous 
aetiology as confirmed by the clinician; and an ABPI ≥  0.8 and < 1.3.  The 
exclusion criteria were: patients with a leg ulcer of non-venous aetiology; 
patients unable to mobilise at all i.e. completely bed bound; ABPI <0.8 or ≥ 
1.3; and presence of clinical signs of infection on admission.  Forty-three 
cases from this study database were eligible for inclusion in the final venous 
leg ulcer database, constituting 12.0% of the final database. 
 A National Health and Medical Research Council project titled “Identifying 
the relationship between biochemical markers and wound healing in chronic 
venous leg ulcers treated with compression therapy” included patients from 
three community nursing wound clinics, two tertiary metropolitan 
outpatients’ chronic wound clinics and QUT’s Wound Healing Community 
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Outreach Service with data collected between September 2006 and January 
2009.  This was a RCT that aimed to compare the effectiveness of a four-
layer compression system with Class 3 (30-35mmHg) compression hosiery 
on healing and quality of life in patients with venous leg ulcers.  The 
inclusion criteria were: patients with leg ulcers of primarily venous 
aetiology as confirmed by clinicians; and an ABPI ≥  0.8 and < 1.3.  The 
exclusion criteria were: patients with a leg ulcer of non-venous origin; 
patients unable to mobilise at all i.e. completely bed bound; ABPI <0.8 or ≥ 
1.3; and the presence of clinical signs of infection on admission.  Eighty-
seven cases from this study were eligible for inclusion in the final venous 
leg ulcer database, constituting 24.0% of the final database. 
 A project titled “A home based progressive resistance exercise program for 
participants with venous leg ulcers” included patients from a tertiary 
metropolitan hospital vascular clinic, with data collected between April 
2008 and September 2008.  This RCT assessed the feasibility of a home 
based exercise programme and examined the effects on the healing rates of 
venous leg ulcers.  The inclusion criteria were: any break in the skin on the 
lower leg that had been present for six weeks or more; appearing clinically 
venous with no other causative aetiology being present; an ABPI ≥  0.8 and 
< 1.3; 18 years of age or older; and able to give informed consent.  The 
exclusion criteria were: clinical signs of cellulitis. Ten cases from this study 
were eligible for inclusion in the final venous leg ulcer database, 
constituting 3.0% of the final database.  Of these ten cases, 6 were in the 
intervention group and four were in the control group, however both groups 
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received evidence based care with no significant differences in healing rates 
between the control and the intervention groups. 
 An Australian Research Council project titled “Pathways to healing: 
Determining effective care pathways for chronic wounds for timely healing, 
prevention and cost effectiveness” included patients from a tertiary 
outpatients’ chronic wound clinic (Royal Brisbane and Women’s Hospital) 
and QUT’s Wound Healing Community Outreach Service.  The data was 
collected between April 2009 and September 2010.  This observational 
study aimed to identify effective health service pathways of care which 
facilitated evidence-based management of chronic leg ulcers.  The inclusion 
criteria were: patients with a chronic wound (>4 weeks duration) of the 
lower leg, venous, arterial, mixed or diabetic in origin; and they must have 
been a community patient able to attend an outpatient clinic.  The exclusion 
criteria were: patients unable to communicate in English; and persons, who 
in the previous 12 months had been a patient of either of the participatory 
recruitment clinics.  Only participants with venous leg ulcers from this study 
were eligible for inclusion in the combined database with thirty-three cases 
included, constituting 9.0% of the final database. 
 A Wound Management Innovation-Cooperative Research Centre (WMI-
CRC) project titled “Biochemical and Microbiological Analysis of the 
Wound Environment” included participants recruited from QUT’s Wound 
Healing Community Outreach Service between April 2011 and December 
2011. This was an observational study that aimed to investigate the 
biochemical and microbiological changes occurring during chronic wound 
healing.  Inclusion criteria were: patients with a chronic wound of longer 
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than four weeks duration.  Exclusion criteria were: patients with cognitive 
impairment; presence of clinical signs of infection; and diabetes related foot 
ulcers.  Only participants with venous leg ulcers from this study were 
eligible for inclusion in the combined database and seventeen cases were 
eligible, constituting 5.0% of the final database. 
 One hundred and three ulcers were eligible for inclusion in the final venous 
leg ulcer database from QUT’s Wound Healing Community Outreach 
Service database of patients attending this service, constituting 27.0% of the 
final database. 
A flow chart of these studies is provided in Appendix Three.  For all studies a venous 
leg ulcer was defined as a loss of skin on the leg or foot that had been diagnosed as 
predominantly venous in nature by the clinician in charge of care.  All participants had been 
followed up for 24 weeks from recruitment or until healing was achieved.  Healing for all 
these studies was defined as: 100% epithelialisation maintained for at least two weeks, which 
was evaluated by the clinician in charge of care and supported with photos. 
Consistent with the above studies for venous leg ulcers, eligibility to be included in 
the current study’s venous leg ulcer database included: 
Inclusion criteria 
o Ulcers of primarily venous aetiology, as diagnosed clinically by the clinician 
in charge 
o ABPI ≥  0.8 and < 1.3 in the affected leg 
Exclusion criteria  
o Participants with non-venous aetiology ulcers as clinically diagnosed by the 
clinician in charge of care based on medical history and clinical assessment of 
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the ulcer e.g. arterial, mixed, diabetes related or pressure injuries.  This 
included ulcers with malignancy present.  The possibility of malignancy was 
assessed by the clinician in charge, biopsied and referred as appropriate 
o Participants who had withdrawn from a study within the first 4 weeks and did 
not have healing status recorded 
o Participants with cognitive impairment, as diagnosed by the clinician assessing 
the patient. 
 
5.4 Data measures and collection 
The data set for the current study consisted of baseline and follow up data which are 
detailed below. 
5.4.1 Baseline (at recruitment) data 
Data collected at baseline included: 
 Sociodemographic factors, including gender; age; source of income; possession 
of a health care card; marital status; suburb of residence; Australian Socio-
Economic Index for Areas (SEIFA) code and living arrangements – including 
whether a patient lived alone, whether they were a carer for someone else and 
whether they lived in a residential home 
The Australian SEIFA code used was the Index of Relative Socio-economic 
Advantage and Disadvantage and is derived by the Australian Bureau of Statistics, which 
draws from census variables related to both advantage and disadvantage (Australian Bureau 
of Statistics, 2006).  This draws on information such as, a household with low income and/or 
people with tertiary education and occurs on a continuum of advantage (high values) to 
disadvantage (low values) (Australian Bureau of Statistics, 2006).  The Australian Bureau of 
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Statistics (2006) broadly defines relative socio-economic advantage and disadvantage in 
terms of people’s access to material and social resources, and their ability to participate in 
society. 
 Medical history, including the following information: 
o Co-morbid conditions, i.e. whether participants had a history of diabetes; 
osteoarthritis; rheumatoid arthritis; hypertension; heart disease; Cerebral 
Vascular Accident (CVA); autoimmune disease; respiratory problems; gout; 
depression; hypercholesterolemia; hyperthyroidism; cancer and peripheral 
vascular disease (PVD) 
o Current medications – including anticoagulants; antihypertensives; diuretics; 
thyroxine; steroids; analgesics; salbutamol; antidepressants; non-steroidal anti-
inflammatories; zinc; allopurinol; statins; antibiotics; immunosuppressants; 
hyperglycemic medications; reflux medications; benzodiazepines; nitrates and 
hormone replacement therapy (HRT) 
o Height, weight and Body Mass Index (BMI) (weight/height2 (kg/m2)) 
o ABPI – Calculated by determining the ratio of the blood pressure at the ankle 
to the blood pressure in the arm (Hess, 2005).  The ABPI is a reproducible, 
non-invasive test that requires a hand-held Doppler probe to reproduce arterial 
pulse wave-forms of the dorsalis pedis and/or posterior tibial arteries with 
normal healthy individuals recording ABPIs of about 1.0 (Kunimoto, 2001).  
This is an important method to substantiate the presence or absence of 
significant peripheral arterial disease (Scottish Intercollegiated Guidelines 
Network., 2010), however requires a patient to be in a supine position and 
should be restricted to those practitioners who have been trained (Kunimoto, 
2001) 
 Page | 92 
 
o Ankle and calf circumference, which is measured around the smallest part of 
the ankle and the largest part of the calf 
o Fixed ankle joints as determined by the clinician 
o Whether the participant uses a walking aid 
o Whether the patient sleeps in a bed or a chair 
o Number of pregnancies 
o Smoking status 
o Venous history, including presence of varicose veins or history of venous 
surgery or other leg surgery or trauma; Deep Vein Thrombosis (DVT); venous 
injections; swelling; rest pain; aching legs; cramps/claudication (pain in the 
calf muscle) and any previous ulcer information 
 Ulcer characteristics 
o Area – ulcer area was calculated from acetate tracings and measured by 
Visitrak
TM
, Smith and Nephew (device to calculate digital planimetry from an 
acetate tracing).  Wound area using Visitrak
TM
 has been compared with other 
forms of wound measurement (linear, digital photography and counting 
squares) and has been found to be an accurate, valid and reliable measure of 
wound area (Haghpanah et al., 2006; Majeske, 1992; Moore, 2005) 
o Anatomic Location – extremity involved and location as noted by clinician as 
predominantly either lateral, medial, posterior, anterior, gaiter or over the 
malleolus 
o Duration of the ulcer on recruitment as indicated by the patient or medical 
records in weeks 
o Percentage of wound bed tissue type, where tissue type is described as 
epithelial, granulation, slough or necrotic in nature as noted by the clinician 
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o Exudate amount - measured as none, light, moderate or heavy 
o  Pressure Ulcer Scale for Healing (PUSH) Score (National Pressure Ulcer 
Advisory Panel, 2013; Stotts, Rodeheaver, Thomas, Frantz, & al, 2001).  
Details of this scoring system are discussed later in this chapter in section 5.4.3 
– Instruments 
 Ulcer treatment 
o Wound dressings 
o Compression bandage systems 
 Infection – caused by a multiplication of bacteria and characterised by signs and 
symptoms of pain, heat, swelling and redness (WUWHS, 2008) and diagnosed as 
infected or not by the clinician in charge of care 
 Surrounding skin and tissue condition assessed and classified by the clinician as: 
o Healthy 
o Oedematous – swelling between the ankles and the knees 
o Dry, scaly 
o Maceratered – a white discolouration due to surface keratocytes becoming 
over-hydrated (Thompson, et al., 2007) 
o Blistered – a collection of serous fluid within the epidermis or between the 
epidermis and dermis, due to short-term friction (Tortora et al., 2012) 
o Erythema – a reddening of the skin caused by dilation of the cutaneous 
vasculature; that is often accompanied by increased skin temperature (LeBlond 
et al., 2009) 
o Induration – a hardening of the skin and subcutaneous tissues around a wound 
due to inflammation (WUWHS, 2008) 
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o Lymphoedema – an accumulation of lymph in the lymphatic vessels, causing 
swelling of a limb (Tortora, et al., 2012) 
o Haemosiderosis – characterised by a brown staining of the leg resulting from 
iron in haemoglobin being deposited in the tissues of the leg (Casey, 2011) 
o Bruising – an area of haemorrhage that may be palpable (Beers, et al., 2006) 
o Hyperkeratosis – keratotic cells that do not separate and slough normally, thus 
piling up to produce elevated thick skin (LeBlond, et al., 2009) 
o Eczema – an inflammation of the skin characterised by patches of red, 
blistering, dry, extremely itchy skin (Tortora, et al., 2012) 
o Excoriation – a linear erosion caused by scratching, rubbing or picking (Beers, 
et al., 2006) 
o Cellulitis – an infection of the dermis spreading radially within the skin and 
subcutaneous structures which is characterised by warm, raised and tender 
lesions and may involve fever (LeBlond, et al., 2009) 
o Atrophie Blanche – areas of pale, depigmented skin on the leg that are covered 
with red dots from dilated capillaries and venules and have low blood flow 
(Casey, 2011; Grey, 2006) 
o Callus – an area of hardened and thickened skin due to persistent pressure and 
friction (Tortora, et al., 2012) 
 Pain – participants were asked to indicate their level of pain on a scale of 1 to 10.  
Additional pain measures were collected using The Medical Outcomes Study 
(MOS) Pain Measures questionnaire (Stewart et al., 1988).  Details of this 
questionnaire are discussed later in this chapter in section 5.4.3 - Instruments 
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 Functional ability, social support, depression, and quality of life information were 
collected using instruments described later in this chapter in section 5.4.3 - 
Instruments 
Three quality of life measures have been used due to differing instruments used in 
different studies and all are discussed later in this chapter. 
5.4.2 Follow up data  
Data were collected and entered in the databases weekly or fortnightly for 24 weeks 
from recruitment for the majority of studies.  However, due to variation in the length of 
follow-up between studies and missing data due to participant loss to follow-up or short 
absences from the clinics, participants did not all have the same number of completed data 
points.  Where data allowed, the following information was entered into the database for 24 
weeks from baseline or until completely healed: 
 Wound tracings by way of Visitrak
TM
 to determine ulcer area and weekly percent 
reduction in ulcer area (from baseline and from the previous measurement); time to 
healing (weeks); and healing rates 
Percentage reduction in ulcer area from baseline and the most recent previous 
measurement was documented following the formulas: 
% area reduction from baseline = 100 x (baseline area (cm
2
)-current area (cm
2
)) / 
baseline area (cm
2
); and 
% area reduction from previous measurement = 100 x (previous measurement of 
area (cm
2
)-current area (cm
2
)) / previous measurement of area (cm
2
) 
 PUSH Score (Stotts, Rodeheaver, Thomas, Frantz, Bartolucci, et al., 2001).  
Details of this scoring system are discussed later in this chapter in section 5.4.3 - 
Instruments 
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 Clinical data related to healing progress (e.g. oedema, eczema, inflammation, 
dressings, compression) 
 Pain – assessed at each visit with participants asked to indicate their level of pain 
on a scale of 1 to 10 while pain measures were also collected at week 12 and week 
24 by way of the MOS Pain Measures questionnaire (Stewart, et al., 1988).  Details 
of this questionnaire are discussed later in this chapter in section 5.4.3 - 
Instruments 
5.4.3 Instruments 
Copies of all instruments are provided in Appendix Four. 
The PUSH tool for ulcer healing considers ulcer area, amount of exudate and wound 
bed tissue type / surface appearance (Stotts, et al., 2001).  Wound area is categorised from 0 
to >24cm
2
 and scored 0 to 10 according to the category of the area.  Exudate amount is 
classified as 0 (none), 1 (light), 2 (moderate) or 3 (heavy), and tissue type is defined as 0 
(closed wound), 1 (epithelial tissue), 2 (granulation tissue), 3 (slough) or 4 (necrotic tissue) 
(Santos et al., 2007).  When totalled the scores range from 0 to 17 with higher scores 
indicating worse ulcer conditions and diminishing scores indicating improvement in the 
wound healing process (Santos, et al., 2007).  The PUSH instrument has demonstrated 
reliability in patients with chronic leg ulcers (Santos, et al., 2007).  Studies have assessed this 
scale with a range of leg ulcer types and found it to be responsive for all types of ulcers (Hon 
et al., 2010; Ratliff et al., 2005).  Inter-rater reliability has been assessed as 0.97-1.00 for all 
three sub scores of area, exudate amount and tissue type as well as the total score (Santos, 
2007). 
The MOS Pain Measures questionnaire covers the intensity, frequency, and duration 
of pain and records the impact of pain on daily living (Stewart et al., 1992).  The intention of 
this scale was to develop pain measures that were not specific to a condition or disease 
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(Sherbourne et al., 1991).  Three subscales are determined from this survey - ‘effects of 
pain’, ‘pain severity’ and ‘days pain interfered’ (McDowell et al., 1996).  This scale includes 
12 self-reported items covering severity of pain over the past four weeks with higher scores 
indicating more pain (McDowell, et al., 1996).  Good internal consistency has been reported 
ranging from 0.86-0.91 for each of the subscales (McDowell, et al., 1996). 
Functional ability was assessed using the Katz Activities of Daily Living (ADL) 
Survey: this is a six-point scale designed to assess the physical functioning of elderly and 
chronically ill patients assessing independence in basic everyday functional competence with 
consideration to feeding, continence, transferring, toileting, dressing and bathing (Graf, 2008; 
McDowell, et al., 1996).  Each activity is rated on a three point scale of independence and 
this survey has been widely used in adults in the community.  A small number of studies have 
tested reliability and validity with inter-rater reliability reported at 0.74-0.88 and studies 
predicting mortality have shown good reliability and high sensitivity (73%) and specificity 
(80%) (McDowell, et al., 1996). 
Functional ability was also assessed with the Lawton Independent Activities of Daily 
Living (IADL) survey: an eight-point scale designed to assess a patient’s everyday functional 
competence with consideration to telephoning, shopping, food preparation, housekeeping, 
laundering, use of transportation, use of medicine and financial behaviour (Lawton et al., 
1969).  This scale has been tested in acute care, rehabilitation and outpatient settings and 
extends the ADL theme to cover tasks that require a finer level of motor coordination 
assessing the more complex activities of daily living in the community (Graf, 2008; Lawton, 
et al., 1969).  It has been found to have practical utility in widely diverse settings, with a 
range of ages in population groups, and for a variety of goals (Graf, 2008; Lawton, et al., 
1969).  The questionnaire answers are rated with 1 indicating that a patient is unable to 
complete the function to 3 indicating that the patient is totally independent with the function.  
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A summary score of the eight responses then indicates patient’s abilities with ranges from 0 
(low function, dependent) to 8 (high function, independent) with the functional behaviours 
(Graf, 2008).  Validity was tested using 180 subjects and the correlation was measured 
against four additional tests that measured different domains of functional status: self-care 
activities, physical health and mental health and behavioural and social adjustment and these 
correlations were significant with ranges between 0.40 and 0.61 (Graf, 2008).  Inter-rater 
reliability has been established at 0.85 with reproducibility coefficients between 0.93-0.96 
(Graf, 2008). 
Social support was measured by the Medical Outcomes Study Social Support Survey 
(MOSSSS); a 20-item survey examining the perceived social support available to patients and 
represents the multiple dimensions of support including emotional/informational, tangible, 
affectionate, and positive social interaction (Sherbourne, et al., 1991).  The instrument uses 
self-reported five-point answer scales and subscale totals which are calculated with high 
scores indicating more support (McDowell, et al., 1996).  Although designed for use in 
chronically ill patients, items have been shown to be universally applicable (McDowell, et 
al., 1996).  Good evidence exists for its reliability and validity with internal consistency for 
the overall scale high (α 0.97) and values for the subscales ranging from α 0.91-0.96 
(McDowell, et al., 1996) with the item scale correlations all exceeding 0.72 (Sherbourne, et 
al., 1991). 
Depressive symptoms were assessed with the shortened 15 question version of the 
Geriatric Depression Scale (GDS) (Brink et al., 1982): an abbreviated version of a larger 30 
question depression scale.  The shortened version was proposed to reduce problems of fatigue 
and lack of focus, especially among physically ill or cognitively impaired patients 
(McDowell, et al., 1996).  As the GDS has been recommended for initial screening of 
depressive symptoms for depression in older medical patients it was a relevant scale in this 
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population.  It has been shown to be easy to administer and readily accepted by older patients 
as well as being a sensitive and specific screening tool for depression (Brink et al., 1982).  
One point is counted for each depressive symptom answer and points are added to form a 
total score (McDowell, et al., 1996).  Scores between 0 and 4 are considered normal; 5 to 9 
are an indication of mild depression; and 10 to 15 are an indication of moderate to severe 
depression (McDowell, et al., 1996).  It has been tested in community and patient samples 
and achieved good reliability, alpha coefficient 0.90-0.94 and sensitivity (84%) and 
specificity (95%) has been high (McDowell, et al., 1996).  The inter-rater reliability has been 
reported at 0.85 and test-retest reliability of the GDS has also been shown to be high (0.85-
0.98) (McDowell, et al., 1996). 
Quality of life was measured utilising the Short Form -12 (SF-12) survey, a 12 item 
survey designed to measure physical and mental components of health related quality of life 
(Ware et al., 1996).  This survey evaluates and provides a health profile and has been 
extensively tested.  It is a shortened form of the Short Form-36 (SF-36) which is the most 
studied, validated and widely used health survey in the world due to its simplicity and proven 
usefulness in measuring health status (Ware, et al., 1996).  Results of the SF-12 closely 
mirrored those of the SF-36 (Ware, et al., 1996).  This survey includes the subscales of 
physical functioning, role physical, bodily pain, general health, vitality, social functioning, 
role emotional and mental health with a total physical score and mental score also calculated 
(Ware, et al., 1996).  The SF-36 and SF-12 have both been used in populations of leg ulcer 
patients and been found to be useful to detect changes in condition in this group, including 
changes in pain, mental health, physical role, emotional role and vitality (Franks et al., 2003; 
Iglesias et al., 2005; Walters, et al., 1999).  Estimates of reliability for the physical and 
mental summary scores were 0.89 and 0.86 respectively with internal consistency reliability 
for both scores ranging from 0.80-0.90 across the subgroups (Ware et al., 2002).  The test-
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retest reliability for the physical score is reported to have coefficients between 0.86-0.89, 
with mental health coefficients between 0.76-0.77 (Ware, et al., 1996). 
Quality of Life was also assessed using Spitzer’s index which was initially designed 
to measure the general well-being of patients terminally ill with cancer or other chronic 
diseases, and measures the effects of treatment (McDowell, et al., 1996).  However, it has 
been subsequently used more broadly (McDowell, et al., 1996).  It is designed to measure 
activity, daily living, health, support and outlook with scores noted as 0, 1 or 2 for each 
category reflecting increasing well-being and are summed to give a total score range of 0 to 
10 (McDowell, et al., 1996).  Internal consistency has been reported as co-efficient α = 0.77 
and inter-rater reliability reported as 0.74-0.84 (Spitzer et al., 1981). 
The Cardiff Wound Impact Schedule (CWIS) (Price, et al., 2004) is a condition 
specific tool designed to assess the quality of life of patients suffering from chronic wounds 
(leg ulcers and diabetic foot ulcers) (Anand, et al., 2003; Price, et al., 2004).  This tool is 
divided into four sections: physical symptoms and daily living, social, wellbeing and overall 
quality of life.  Only the physical symptoms scale, concentrating on the impact of symptoms 
on daily functioning and comfort, was utilised in two of our studies, involving 12 self-
reported items rated on the extent of the problem and associated stress, each on a five point 
Likert scale.  These were then transformed into a 0-100 profile score for each of the domains 
within the tool, with a high score representing a good health related quality of life and a low 
score representing a poor health related quality of life (Palfreyman, et al., 2010; Price, et al., 
2004).  It has been shown to be appropriate for individuals with chronic wounds with high 
internal consistency and the ability to discriminate between health states and good 
reproducibility with alpha value greater than 0.7 (Price, et al., 2004).  It has been suggested 
that the CWIS is the best health related quality of life measurement instrument for chronic 
wounds (Gonzalez-Consuegra, et al., 2011).  The test-retest reproducibility indicated 
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correlation coefficients over 0.9 for each of the domains and the discriminative ability of the 
instrument was calculated for healed and unhealed leg ulcers with consistently higher scores 
for healed ulcers (Price, et al., 2004).  Strong correlations have been shown between the 
CWIS and respective SF-36 domains (Price, et al., 2004).  Internal consistency was good (α = 
0.77-0.96), and the tool has been validated in United States of America (USA) and United 
Kingdom (UK) in English, German, French (Acquadro et al., 2005) and Portuguese 
languages (Ferreira et al., 2007; Gonzalez-Consuegra, et al., 2011). 
All of these instruments were in the public domain, with the exception of the SF-12, 
for which a licence agreement was obtained for all studies that utilised the instrument.  
Permission was also sought and granted for use of the CWIS. 
 
5.5 Procedure and data management 
Ethical approval for this study was obtained through QUT Human Research Ethics 
Committee (HREC).  The human ethics approval certificate is shown in Appendix Five. 
Due to variation in measures across the studies, full sets of data were not available for 
all patients.  Nevertheless, it was possible to extract an average of 250 - 300 sets of data at 
baseline and in follow up.  These data then formed the common data set for the current study. 
Due to the combination of data from a range of studies it was necessary to check, 
recode and regroup certain variables.  The following section details how these processes were 
carried out.  Mixed venous/arterial ulcer data were included in the study if their ABPI results 
fitted the inclusion criteria and they were determined to be a mixed ulcer with a 
predominantly venous component.  Patient data were also removed from the database if it 
could not be ascertained whether it was a different ulcer to one in another study’s database. 
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The following variables were grouped into categories for analysis, due to small 
numbers in some of the variable responses: 
 Sociodemographic factors: 
 Income – grouped as Department of Veteran Affairs payments, pensions 
(Aged/Disability), Self-funded retiree/Employed or ‘other’ categories 
 Marital status – categorised as married/defacto, divorced, single, separated or 
widowed 
Ulcer characteristics: 
 Area of wound was analysed as a continuous variable as well as a grouped variable 
of greater than or equal to 10cm, as identified as a significant cut-off point in 
previous studies (Chaby, et al., 2006; Tennvall et al., 2005) 
 Ulcer location was grouped into the common areas of the lower leg and foot and 
categorised as being predominantly gaiter, malleolus, or other (foot, achilles, 
circumferential or knee) 
 Duration of wound was analysed as a continuous variable as well as a grouped 
variable of greater than 24 weeks or less on recruitment to the respective study, as 
identified as a significant cut-off point in a previous study (Margolis, et al., 2000) 
Tissue type was grouped into epithelial/granulation or slough/necrotic  
Ulcer treatment: 
 Classes of dressings were grouped as per the generic type of dressing, i.e. zinc paste 
bandages, paraffin gauze medicated/unmedicated, hydrocolloid, low adherent, 
alginates, hydrofibre, hydrogel, silver, foam, iodine, silicone or other 
 Compression bandage types were grouped into levels of compression bandaging 
and then further grouped into the categories of none, low (<20mmHg), medium (20-
30mmHg), or high (30+mmHg) compression (as per manufacturers’ indications) 
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The following variables were included as additional variables to the database: 
Medical history: 
 Polypharmacy, categorised as four or more medications 
 Medical conditions grouped as participants with three or more medical conditions 
  BMI was grouped into <22, 22 to 27 and >27 as per the recommended cut-off 
points for public health action (World Health Organization., 2014) 
 Calf/ankle ratios were calculated by calf measurement divided by ankle 
measurement and analysed both as a continuous variable as well as grouped as 
calf/ankle ratio 1.3 or below as reported as a significant cut-off point in a previous 
study (Milic, et al., 2009). 
All data were entered into a Statistical package for the Social Science (SPSS 19.0) 
software.  Original databases were kept in password protected areas while hard copies of 
original data were kept in locked filing cabinets.  All database entries were checked against 
the original hard copies for accuracy.  A second person verified accuracy of all dates, ulcer 
area percent reductions, PUSH scores, co-morbid condition variables, SEIFA codes and 
medication sub-headings. 
If data were missing from the database, all efforts were made to follow up original 
documented data collection forms and update as necessary.  The responses to the instruments 
in the questionnaires had been coded; these responses were then summated and transformed 
as per the relevant guidelines for each instrument.  Not all questionnaire items had been 
completed by all participants.  Any missing scale item data were managed as per the 
instruments’ authors suggested methods for scoring when missing data was present and when 
at least half of the items had been answered in a multi-item scale.  If less than half of the 
items were answered in a multi-item scale the data were classified as missing. 
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Descriptive analyses were undertaken for all variables.  Frequencies were run on 
categorical variables along with frequency histograms, central tendencies, dispersion and 
distribution statistics on all continuous variables.  Bivariate relationships were then analysed 
to identify possible explanatory factors contributing to non-healing of venous leg ulcers by 24 
weeks.  Chi-square analysis was used to test relationships between categorical independent 
variables and non-healing at 24 weeks.  So as not to violate the assumption of a chi-square 
test that, expected cell sizes must be five or greater, a Fishers exact test was used when the 
expected value in any of the cells of any of the variables was < 5 (Labropoulos, et al., 2012; 
Pallant, 2011).  T-tests were used for normally distributed continuous variables, and Mann-
Whitney U tests used to test non-normally distributed continuous variables to determine 
statistical significance.  A p value of below 0.05 was used for statistical significance. 
Multivariable analysis utilised GLMM.  Different terms have been used to describe 
this method of analysis in the literature, including hierarchical, sequential or multi-level 
modelling (Pallant, 2011).  This method of analysis was performed to control for potential 
confounders and determine the independent influence of each variable on failure of venous 
leg ulcers to heal by 24 weeks.  GLMM has the capability to handle correlated data and is 
appropriate for studying the relationships of variables in data sets with some form of 
dependency introduced by a hierarchical study design (West, 2009).  GLMM analyses 
contains both fixed effects and random effects (Tabachnick et al., 2007).  The fixed effects 
that were tested for in the model included both categorical and continuous independent 
variables where all levels of the variables are included in the study design (i.e. all 
compression levels, all ages and both genders) (West, 2009).  The random effects were those 
variables that may randomly vary across study replications and included the variables of 
study, patient number and ulcer identification.  This method thus alleviated a need to run 
analysis by person and by ulcer, controlling for more than one ulcer case per participant over 
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the different studies, to avoid overvaluing the contribution of variables to the outcome, taking 
into account that there were 318 ulcers in 247 participants. In performing GLMM a binomial 
distribution was used and the dependent outcome variable was whether the ulcer remained 
unhealed after 24 weeks from baseline.  The first model included simultaneous entry of all 
the variables found to be significantly related, or close to significantly related to non-healing, 
p <0.10 (Katz, 2011) in the bivariate analyses.  In addition, other variables which have been 
consistently reported in the literature as having an influence on delayed healing were also 
included.  These were age (Barwell, Taylor, et al., 2000; Gohel, Barwell, et al., 2005; 
Kulkarni, et al., 2007; Labropoulos, et al., 2012; Skene, et al., 1992; Taylor, et al., 2002) and 
mobility (Barwell, et al., 2001; Chaby, et al., 2006; Franks, Moffatt, et al., 1995; Hjerppe, et 
al., 2010; Milic, et al., 2009).  A parsimonious model was then derived through removal of 
non-significant variables and analysing differences between models using the log likelihood 
test.  If there were no significant differences between models, the smaller parsimonious 
model was retained.  Odds ratios (OR) were calculated for predictor variables to determine 
the degree of influence each predictor had on non-healing at 24 weeks. 
 
5.6 Bivariate results 
Univariate and bivariate results are reported according to the conceptual framework 
categories of: physiological, economic, social and psychological factors.  A brief description 
of these sample characteristics is provided first followed by a discussion of the results of the 
bivariate analyses related to non-healing status.  The sample size for the bivariate analyses 
was 318 ulcers in 247 participants of the total sample of 366 ulcers, due to healing status at 
24 weeks being missing for n=48 (13.1%) of the sample.  Of these, 18 participants were 
hospitalised and lost to follow-up during their study times, 3 participants moved away from 
the area or to another clinic, 4 participants were withdrawn from their study due to change in 
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ulcer status that rendered them ineligible for their study and 23 were lost to follow up for 
unknown reasons.  Demographic, medical, social and venous characteristics of the initial 
sample and those who were lost to follow up were not significantly different.  However, ulcer 
duration of > 24weeks, ulcer area >10cm
2
 and those treated with ≥ 30mmHg were 
significantly different between samples.  Those with a longer ulcer duration (p=0.014), larger 
ulcer area (p=0.007) and those in lower levels of compression (p=0.023) were significantly 
more likely to have missing data on healing status at 24 weeks.  These differences suggest 
that participants with more complex ulcers (i.e. larger ulcer area and/or longer ulcer duration) 
or who were unable to tolerate high compression were more likely to have been hospitalised 
or lost to follow up.  Of the remaining sample of 318, 221 (69.5%) had healed within 24 
weeks, while 97 (30.5%) had not, which is consistent with the literature of 62%-76% healing 
rates within 24 weeks (Gohel, Barwell, et al., 2005; Guest, et al., 1999; Margolis et al., 
2004).  Based on the findings from the bivariate analyses, a multivariable GLMM analysis 
was undertaken.  After a summary of the bivariate results this chapter will conclude with a 
discussion of the GLMM analysis and how this informed the development of a Risk 
Assessment Tool. 
5.6.1 Physiological Characteristics 
The demographic data for the total ulcer sample are summarised in Table 5.1.  The 
age and gender distributions were consistent with other studies of venous leg ulcer 
populations.  Neither of these variables were significantly related with non-healing of venous 
leg ulcers by 24 weeks in the study sample. 
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Table 5.1: Demographic characteristics for the total ulcer sample  
(n=318 ulcers / 247 participants)  
  Healed 
n (%) 
Unhealed 
n (%) 
    Total 
n (%) 
  
      Frequencies 2 p 
Gender Male 
Female 
107 (48.4%) 
114 (51.6%) 
55 (56.7%) 
42 (43.3%) 
162 (50.9%) 
156 (49.1%) 
1
1.85 
 
0.174 
  Mean (SD) t  
Age  67.97 (14.62) 70.19 (14.54) 69.45 (14.49) 1.24 0.215 
 
 
The medical conditions reported by the participants in the total ulcer sample are 
summarised in Appendix Six.  The medical conditions significantly related to non-
healing are reported in Table 5.2.  Many conditions were reported by participants, with 
about half of the participants reporting that they suffered from hypertension and a third 
reporting that they had some form of heart disease.  Thirty percent reported having 
osteoarthritis and 16% reported having diabetes.  Only two of the medical conditions 
were significantly related with non-healing status at 24 weeks at the bivariate level: 
rheumatoid arthritis and gout.  In this study, participants with rheumatoid arthritis and 
gout were more likely to remain unhealed at 24 weeks than those participants not 
reporting those conditions. 
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Table 5.2: Medical Conditions for the total ulcer sample (n=318ulcers / 247 participants) 
  Healed 
 n (%) 
Unhealed 
  n (%) 
Total 
 n (%) 
  
                           Frequencies 2 p 
Rheumatoid Arthritis Yes 
No 
12 (5.6%) 
203 (94.4%) 
12 (12.6%) 
83 (87.4%) 
24 (7.7%) 
286 (92.3%) 
 
4.59 
 
0.032 
Gout Yes 
No 
5 (2.4%) 
202 (97.6%) 
7 (7.8%) 
83 (92.2%) 
12 (3.8%) 
285 (96.0%) 
 
4.65 
 
0.031 
 
The total list of medications reported by the participants in the total ulcer sample are 
summarised in Appendix Six.  The medications significantly related to non-healing are 
reported in Table 5.3.  The most frequent type of medications reported by participants 
included, almost 50% of participants taking antihypertensives and/or analgesics and 40% 
taking anticoagulants.  Three of the medication categories were significantly related with 
non-healing status: salbutamol, antidepressants and allopurinol.  Participants not taking 
salbutamol were more likely to remain unhealed; whereas participants taking allopurinol or 
antidepressants were significantly less likely to heal by 24 weeks. Clark (2002) proposed that 
any condition that suppressed the immune system would likely affect wound healing because 
the inflammatory process was impaired, however, no studies found in the literature reported 
autoimmune disorders or rheumatoid arthritis to be significantly related with non-healing.  
No studies were found in the literature review that had examined the impact of salbutamol 
and/or allopurinol on healing. 
Specific aspects of venous disease are summarised in Appendix Six.  The venous 
disease characteristics significantly related to non-healing are reported in Table 5.4.  Seventy-
five percent of participants reported a history of swollen legs in the study leg, while 60% had 
varicose veins, and 40% experienced aching in their study leg or had had some form of 
surgery or trauma to their study leg.  In bivariate testing, three of the variables were 
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significantly related to non-healing by 24 weeks: history of DVT in the study leg, previous 
venous surgery in the study leg and aching in the study leg.  Participants with a history of 
DVT and previous venous surgery were less likely to be healed at 24 weeks, which is 
consistent with the literature (Labropoulos, et al., 2012; Margolis, et al., 1999), while a 
history of aching legs in the study leg was also associated with non-healing at 24 weeks. 
 
Table 5.3: Medications for the total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
   Total 
n (%) 
  
               Frequencies 2 p 
Salbutamol* Yes 
No 
21 (10.1%) 
186 (89.9%) 
2 (2.4%) 
82 (97.6%) 
23 (7.9%) 
268 (92.1%) 
 
 
 
0.029 
Antidepressants Yes 
No 
27 (13%) 
180 (87.0%) 
19 (22.9%) 
64 (77.1%) 
46 (15.9%) 
244 (84.1%) 
 
4.31 
 
0.038 
Allopurinol Yes 
No 
8 (4.2%) 
182 (95.8%) 
8 (10.7%) 
67 (89.3%) 
16 (6.0%) 
249 (94.0%) 
 
3.95 
 
0.047 
*Fishers exact test used due to the value in at least one cell being < 5                      
 
Table 5.4: Venous history for the total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
   Total 
n (%) 
  
            Frequencies 2 p 
DVT study leg Yes 
No 
27 (13.6%) 
185 (86.4%) 
22 (23.7%) 
71 (76.3%) 
49 (16.6%) 
256 (83.4%) 
 
5.72 
 
0.017 
Venous surgery in 
study leg 
Yes 
No 
37 (17.4%) 
176 (82.6%) 
27 (29.0%) 
66 (71.0%) 
64 (20.9%) 
242 (79.1%) 
 
5.32 
 
0.021 
Aching in study leg Yes 
No 
41 (40.2%) 
61 (59.8%) 
34 (58.6%) 
24 (41.4%) 
75 (46.9%) 
85 (53.1%) 
 
6.27 
 
0.012 
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Clinical data characteristics recorded from participants’ baseline visit and calf size 
reduction between baseline and two weeks are summarised in Appendix Six.  Clinical data 
significantly related to non-healing are reported in Table 5.5.  Thirty percent of participants 
relied on a walking aid, 30% had their calf circumference reduced by 2cm or more at week 
two, while a quarter of participants had a fixed ankle joint.  There were a large range of pain 
scores which is consistent with the literature (Buchanan, 2010; Persoon, et al., 2004).  The 
physical component score (PCS) of the SF-12 quality of life score was lower for all groups of 
participants in this study, than what would normally be expected in adults in the over 65 year 
age group, with mean normal scores usually ranging from 40.83 to 43.87 (Ware, et al., 2002).  
Five of the clinical data parameters were significantly related with non-healing status: fixed 
ankle joint, needing a walking aid, PCS, pain when scored out of ten and the physical 
symptoms sub scale of the CWIS.  A fixed ankle joint, the use of a walking aid, a higher pain 
score, a lower PCS (indicating a lower level of health) and a lower CWIS (indicating lower   
quality of life) were all indictors for remaining non-healed at 24 weeks.  The need for a 
walking aid (Hjerppe, et al., 2010) and a fixed ankle joint (Hjerppe, et al., 2010) have been 
reported in the literature to have a significant relationship with non-healing venous ulcers. 
Wound characteristics recorded from participants ulcers’ are summarised in Appendix 
Six.  Wound characteristics significantly related to non-healing are reported in Table 5.6.  
Seventy five percent of participants reported a previous ulcer which is consistent with the 
literature findings (Abbade & Lastória, 2005; Moffatt et al., 1995).  Interestingly, only thirty 
five percent of these ulcers were reported as being in the same site as a previous ulcer.  The 
duration of the ulcer prior to recruitment into studies and the area of ulcers on recruitment 
into the studies involved in this research had large ranges, consistent with other reported 
studies.  Many of these variables were significantly related with non-healing at 24 weeks, 
including ulcer duration (specifically ulcer duration >24 weeks), ulcer area (specifically ulcer 
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area ≥ 10cm2), exudate levels, wound bed tissue type, wound size that had not reduced by 
25% and/or 40% at two weeks and/or four weeks, PUSH total and compression treatment.  
Consistent with the literature, a longer ulcer duration and larger ulcer area were significantly 
associated at the bivariate level with non-healing at 24 weeks (Cardinal, et al., 2009; Franks, 
Moffatt, et al., 1995; Guest, et al., 1999; Labropoulos, et al., 2012; Margolis, et al., 1999; 
Milic, et al., 2009; O'Meara, Tierney, et al., 2009; Phillips, et al., 2000; Skene, et al., 1992; 
Sola, et al., 2012; Stacey, et al., 1997; Taylor, et al., 2002).  A higher PUSH score (including 
the individual variable of exudate level) was significantly related with non-healing at 24 
weeks, with increased exudate level also identified as a risk factor in the literature (Milic, et 
al., 2009; Taylor, et al., 2002).  Wounds not treated with high compression (>30mmHg) is 
consistent with a systematic review of all types of compression (O'Meara, et al., 2012) and 
wounds that had not reduced in size by 25% or 40% at two weeks or four weeks were also 
more likely to remain unhealed at 24 weeks.  This is also consistent with literature findings 
which indicated that a >30 percent ulcer reduction at two weeks (Arnold, et al., 1994) and a 
four week percent ulcer area reduction (Kantor, et al., 2000) were significant indicators of 
wound healing potential (Kantor, et al., 2000). 
Surrounding tissue characteristics of participants are summarised in Appendix Six and 
those significantly related to non-healing are reported in Table 5.7.  Seventy percent of 
participants were noted to have dry/scaly skin and/or oedematous surrounding tissue.  Fifty 
percent had signs of erythema, haemosiderosis or atrophie blanche.  Three of these 
characteristics were significantly related to non-healing status: presence of lymphoedema and 
absence of haemosiderosis and oedema.  Participants with lymphoedema, lack of 
haemosiderosis and lack of oedema were more likely to be non-healed at 24 weeks, although 
due to small numbers this analysis should be viewed with caution.  Oedema has been 
examined in a few previous studies however has only been found to be a significant predictor 
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for non-healing in one (Cardinal, et al., 2009) with this studies results contradicting those 
found in Cardinal et al.’s (2009) study. 
 
Table 5.5: Clinical data for the total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
      Total 
n (%) 
  
              Frequencies 2 p 
Fixed ankle joint Yes 
No 
14 (15.2%) 
79 (84.8%) 
17 (50.0%) 
17 (50.0%) 
31 (24.6%) 
96 (75.4%) 
 
16.48 
 
<0.001 
Walking aid 
 
Yes 
No 
59 (27.8%) 
153 (72.2%) 
41 (42.3%) 
55 (57.7%) 
100 (32.4%) 
208 (67.6%) 
 
6.67 
 
0.010 
            Median (Range) Mann 
Whitney 
U 
p 
Pain/10  2.5 (0-10) 4 (0-10) 3 (0-10) 3104.00 0.032 
  Mean (SD)    t p 
PCS1  36.7 (10.7) 28.30 (7.34) 34.40 (10.40) -2.51 0.016 
CWIS2  63.14(18.3) 49.31 (23.38) 59.81 (19.57) -2.14 0.037 
 
1 PCS: Physical Component Summary Scale of the SF-12 survey, a health related quality of life measure (Ware, 
et al., 1996).  This scale is designed to have a mean of 50 and SD 10 where 0 indicates the lowest level of health 
and 100 indicates the highest level of health 
2 CWIS (Physical symptoms scale) with scores ranging from 24 to 120, a high score representing a good wound 
specific health related quality of life and a low score representing a poor wound specific health related quality of 
life (Price, et al., 2004). 
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Table 5.6: Wound characteristics for the total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
  Total 
n (%) 
  
  Frequencies 2 p 
Area ≥ 10cm2  Yes 
No 
33 (15.3%) 
182 (84.7%) 
34 (37.0%) 
58 (63.0%) 
67 (21.8%) 
240 (78.2%) 
 
17.63 
 
<0.001 
Tissue type Epithelial 
Granulation 
Slough 
Necrotic 
9 (4.2%) 
105 (48.6%) 
99 (45.8%) 
3 (1.4%) 
3 (3.1%) 
31 (32.0%) 
60 (61.9%) 
3 (3.1%) 
12 (3.8%) 
136 (43.5%) 
159 (50.8%) 
6 (1.9%) 
 
 
 
8.87 
 
 
 
0.031 
Wound percent 
area reduction 
>40% at 4 
weeks 
 
 
Yes 
No 
 
 
110 (75.2%) 
36 (24.8%) 
 
 
11 (26.2%) 
31 (73.8%) 
 
 
121 (64.2%) 
67 (35.8%) 
 
 
 
34.35 
 
 
 
<0.001 
Wound percent 
area reduction 
>25% at 4 
weeks 
 
 
Yes 
No 
 
 
117 (80.0%) 
29 (20.0%) 
 
 
14 (33.3%) 
28 (66.7%) 
 
 
131 (69.5%) 
57 (30.5%) 
 
 
 
33.82 
 
 
 
<0.001 
Wound percent 
area reduction 
>25% at 2 
weeks 
 
 
Yes 
No 
 
 
87 (65.9%) 
45 (34.1%) 
 
 
9 (25.0%) 
27 (75.0%) 
 
 
96 (57.1%) 
72 (42.9%) 
 
 
 
19.33 
 
 
 
<0.001 
Wound percent 
area reduction 
>40% at 2 
weeks 
 
 
Yes 
No 
 
 
59 (44.7%) 
73 (55.3%) 
 
 
5 (13.9%) 
31 (86.1%) 
 
 
64 (38.1%) 
104 (61.9%) 
 
 
 
11.38 
 
 
 
0.001 
Treated with ≥ 
30mmHg 
Compression 
 
Yes 
No 
 
164 (74.9%) 
55 (25.1%) 
 
50 (51.5%) 
47 (48.5%) 
 
214 (67.7%) 
102 (32.3%) 
 
 
16.75 
 
 
<0.001 
  Median (Range) Mann 
Whitney 
U 
p 
Duration 
(weeks) 
 20.5 
(0-1040) 
28 
(0-1040) 
24 
(0-1040) 
 
7825.0 
 
0.004 
Ulcer Area 
(cm
2
) 
 2.2 
(0.1-105) 
6.5 
(0.2-174.4) 
2.6 
(0.1-174.4) 
 
6203.5 
 
<0.001 
  Mean (SD) t p 
PUSH Total  9.22 (2.9) 11.11 (3.09) 9.97 (3.17) 5.08 <0.001 
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Table 5.7: Surrounding tissue characteristics for the total ulcer sample 
     (n=318 ulcers / 247 participants) 
 Healed 
n (%) 
Unhealed 
n (%) 
 Total 
n (%) 
  
 Frequencies 2 p 
Lymphoedema* Yes 
No 
0 (0%) 
92 (100.0%) 
4 (11.4%) 
31 (88.6%) 
4 (3.1%) 
123 (96.9%) 
 
 
 
0.005 
Haemosiderosis Yes 
No 
60 (56.1%) 
47 (43.9%) 
14 (32.6%) 
29 (67.4%) 
74 (49.3%) 
76 (50.7%) 
 
6.79 
 
0.009 
Oedema Yes 
No 
149 (73.4%) 
54 (26.6%) 
42 (60.0%) 
28 (40.0%) 
191 (70.0%) 
82 (30.0%) 
 
4.45 
 
0.035 
*Fishers exact test used due to the value in at least one cell being < 5 
 
5.6.2 Economic / Social / Psychological Characteristics 
The economic characteristics of participants are summarised in Appendix Six.  The 
majority of the participants (84%) were reliant on pensions for income, with 83% of 
participants having access to a health care card.  No economic factors were found to be 
significantly related with non-healing at 24 weeks in this sample. 
Social characteristics of participants are summarised in Appendix Six and the 
characteristics significantly related to non-healing are reported in Table 5.8.   Forty-six per 
cent of participants lived alone.  This was the only variable that was significantly related to 
non-healing status, with those living by themselves less likely to heal by 24 weeks. 
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Table 5.8: Social characteristics for the total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
   Total 
n (%) 
  
      Frequencies 2 p 
Lives 
alone 
Yes 
No 
85 (39.7%) 
129 (60.3%) 
59 (61.5%) 
37 (38.5%) 
144 (46.5%) 
166 (53.5%) 
 
12.60 
 
<0.001 
 
 
Psychological data are summarised in Appendix Six and those characteristics 
significantly related to non-healing are reported in Table 5.9.  Thirty-six per cent of 
participants were noted to be at risk of depression with a GDS score of depressive symptoms 
> 4.  This was significantly related with non-healing with those scoring GDS>4 being 
significantly more likely to remain unhealed.  
 
Table 5.9: Psychological profile for the total ulcer sample  
     (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
    Total 
n (%) 
  
                                         Frequencies 2 p 
GDS>41
 
Yes 
No 
48 (31.8%) 
103 (68.2%) 
33 (45.8%) 
39 (54.2%) 
81 (36.3%) 
142 (63.7%) 
 
4.16 
 
0.041 
 
1 GDS with scores ranging between 0 and 15.  Scores between 0 and 4 are considered normal; 5 to 9 indicate 
mild depression; and 10 to 15 indicate moderate to severe depression (Brink, et al., 1982; McDowell, et al., 
1996). 
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5.7 Multivariable results 
As this study had a binary outcome (healed or not healed at 24 weeks), a mixture of 
continuous and categorical predictor variables, and some participants with more than one 
ulcer used for analysis, a multivariable GLMM was used. The random effects, multi-levels or 
hierarchical levels included the variables of study, patient number and ulcer identification. To 
control for all variables, including potential confounders, all variables were entered into the 
GLMM to determine their independent influence on non-healing at 24 weeks.  Residuals 
from the model were checked for outliers and outliers with standardised residuals higher than 
3 (four cases) were removed from the analysis.  All variables significantly associated with 
non-healing at 24 weeks (p<0.10 level) were simultaneously entered into a multivariable 
GLMM.  These were living alone; duration of ulcer; ulcer area; rheumatoid arthritis; 
autoimmune disease; gout; taking salbutamol/antidepressants/allopurinol; DVT in study leg; 
venous surgery in study leg; aching in study leg; fixed ankle joint; walking aid; exudate 
levels; tissue type; level of pain; lymphoedema; haemosiderosis; oedema; GDS>4; wound 
size reduced at 2 weeks by < 25%; PUSH score; compression category < 30mmHg; calf size 
reduced by 2cm or more at two weeks; PCS and CWIS.  In addition, age and mobility were 
included as they had been identified as predictors of non-healing in the literature.  Log 
likelihood tests were used to eliminate unnecessary variables and determine a parsimonious 
final regression model that retained a strong prediction.  Significance tests, odds ratios were 
calculated for the predictor variables to determine the degree of influence each variable had 
on non-healing by 24 weeks. 
Overall the final model (Table 5.10) was significant (p<0.001) and after controlling 
for all variables, four variables made a statistically significant contribution to the model (lives 
alone, level of compression therapy less than 30mmHg, PUSH score greater than or equal to 
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10, and reduction of less than 25% in wound area at two weeks).  The model correctly 
classified 81.1% in relation to wound non-healing at 24 weeks. 
 
Table 5.10: Generalised Linear Mixed Modelling: Factors influencing non-healing at 
24 weeks of venous leg ulcers  
 Coefficient SE t p Odds 
Ratios 
95% CI 
FF       
Lives Alone 0.83 0.32 2.60 0.025 2.3 1.13 - 4.61 
Compression 
(<30mmHg) 
 
1.43 
 
0.35 
 
4.13 
 
0.002 
 
4.18 
 
1.95 - 8.97 
PUSH score ≥10 1.63 0.36 4.58 0.001 5.10 2.33 - 11.18 
Ulcer area reduction of  
< 25% in 2 weeks 
 
2.31 
 
0.36 
 
6.47 
 
<0.001 
 
10.07 
 
4.60 - 22.19 
 
SE:Standard Error; 95% CI: Confidence Interval; FF: Fixed Factors  
 
The strongest predictor of ulcer non-healing was whether the wound had reduced in area by 
less than 25% at 2 weeks from baseline, recording an odds ratio of 10.07 (95% CI 4.60 to 
22.19).  This indicated that the odds of non-healing in participants who had an ulcer area 
reduction of less than 25% in 2 weeks were over 10 times higher than those who achieved an 
ulcer reduction of 25% or more in 2 weeks.  The odds of failure to heal by 24 weeks for 
participants with a PUSH score greater than or equal to 10 was over 5 times higher than those 
with a PUSH score less than 10, (OR 5.10, 95% CI 2.33 to 11.18). The odds of non-healing 
for participants treated with moderate / low compression (<30mmHg) were over 4 times 
higher (OR 4.18, 95% CI 1.95 to 8.97) than those who had high compression applied at 
baseline (≥  30mmHg).  Participants who lived alone had odds of non-healing twice as high 
as those who did not live alone (OR 2.3, 95% CI 1.13 to 4.61).  
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5.8  Discussion and conclusion 
The final model contained four independent variables which made a unique and 
statistically significant contribution to the model: less than 25% reduction in ulcer area at two 
weeks from admission; higher ulcer severity scores on admission as defined by a PUSH score 
≥ 10; participants who were not treated with high level compression therapy (i.e. <30mmHg) 
at the time of recruitment; and participants who lived alone. 
Three previous studies have shown ulcer area percent reduction at two, three and four 
weeks of between 30% and 40% to be a predictor of wound healing (Arnold, et al., 1994; 
Kantor, et al., 2000; Phillips, et al., 2000), and the current study further demonstrates that the 
rate of area reduction can be a good indicator of prognosis at the earliest stage – within two 
weeks.  With today’s technology for wound area measurement, this is an easy measure for 
clinicians to check. 
The PUSH score, comprising ulcer area, ulcer exudate amount and ulcer predominant 
tissue type, was found to be significantly related to failure to heal in this study.  Although the 
PUSH score has not been reported as a risk factor for non-healing in the literature, its 
individual components of area, exudate and tissue type have been investigated, with varying 
results.  Larger ulcer area has been found to be significantly related to failure to heal in 
venous leg ulcers in many studies (Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; Guest, 
et al., 1999; Labropoulos, et al., 2012; Margolis, et al., 1999; Milic, et al., 2009; O'Meara, 
Tierney, et al., 2009; Phillips, et al., 2000; Skene, et al., 1992; Sola, et al., 2012; Stacey, et 
al., 1997; Taylor, et al., 2002), while larger amounts of exudate have been shown to be 
significantly related to failure to heal of venous leg ulcers in a smaller number of studies 
(Jones, 2009; Taylor, et al., 2002).  Tissue type, although only investigated in a few studies, 
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has not previously been found to be significantly related to failure to heal in venous leg ulcers 
(Cardinal, et al., 2009; Taylor, et al., 2002). 
While there is no consensus in the literature on what type or specific level of 
compression is the most likely to promote healing, a systematic review on compression 
therapy for venous leg ulcers concluded that treatment with compression improves healing 
compared with no compression (O'Meara S et al., 2012).  In this study, all high level 
compression systems >30mmHg (i.e. Profore, Class III Hosiery, Proguide, Coban II and 
Short Stretch bandages) were associated with a greater likelihood of healing than systems 
providing <30mmHg. 
This is the first known study to find a significant direct association between living 
alone and failure to heal of a venous leg ulcer by 24 weeks, although Moffat et al. (2006) 
found an association between patients who live alone and the increased likelihood of the 
incidence of ulceration (Moffatt, et al., 2006).  A possible relationship exists between living 
alone and social isolation, which has been found to have a significant association with 
increased mortality in older men and women in studies with other adult populations 
(Brummett et al., 2001; Steptoe et al., 2013).  The effect of social isolation and living alone 
on the failure to heal of venous leg ulcers may possibly be related to a lack of assistance with 
daily activities or psychological support; however these require further investigation to 
determine contributing factors. 
In comparison with previous studies, this study confirms some previously known 
predictors of delayed healing in venous leg ulcers, and has examined a range of additional 
potential factors.  Importantly, the study has shown that psychosocial factors are also 
significantly related to non-healing by 24 weeks and are important to consider when 
assessing patients with a venous leg ulcer. 
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This chapter has discussed the research methods and results from Study One and 
identified significant predictors for non-healing in venous leg ulcers. These are important 
results to take into consideration when developing a venous leg ulcer risk assessment tool. 
Chapter Six will discuss the research methods and results for Study Two, the development of 
a risk assessment tool based on findings from this study (One), evidence from the literature 
and an expert Wound Advisory Group, followed by retrospective validation of the risk 
assessment tool utilising the Study One database. 
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Chapter Six: Study Two 
Development and retrospective validation of the venous leg ulcer risk assessment tool 
6.1 Introduction 
A large obstacle in the treatment of chronic venous leg ulcers is the uncertainty in 
predicting individual long-term clinical outcomes, or time to healing.  About 70% of venous 
leg ulcers will heal within a 24 week period (Gohel, Taylor, et al., 2005; Guest, et al., 1999).  
The remaining 30% remain unhealed after 24 weeks (Gohel, Taylor, et al., 2005; Guest, et 
al., 1999), often despite evidence based care.  Therefore the challenge is to identify who these 
patients are likely to be as early as possible.  While there have been many tools developed 
specifically for assessment of wounds (e.g. the Pressure Sore Status Tool (Harris et al., 
2010), the Pressure Ulcer Scale for Healing (PUSH) tool (Thomas et al., 1997), the Sussman 
Wound Healing Tool (Sussman et al., 1997), the Sessing Scale (Ferrell et al., 1995), the 
Wound Healing Scale (Krasner, 1997) and the Photographic Wound Assessment Tool 
(Houghton et al., 2000), these tools monitor progress of wound healing and do not address 
risk assessment for predicting specific patient healing outcomes in wounds or specifically 
venous leg ulcers. 
At present, clinicians utilise their own expert judgement and previous experience in 
relation to whether they consider a wound will be difficult to heal, with no screening tools 
used widely to assist the detection of leg ulcers at-risk of delayed healing.  It is an important 
challenge for all practitioners involved in venous leg ulcer management, with the lack of such 
tools possibly contributing to the current high level of health service use for leg ulcers and 
poor rates of wound healing (O'Meara, Cullum, et al., 2009). 
A risk assessment tool weighs the value of factors that increase the risk of non-healing 
and then combines the values for an individual’s risk score (Koopman et al., 2008).  Many 
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authors have discussed the potential usefulness of such prognostic tools.  Discussion includes 
the requirement for tools to include clinically relevant patient data that has been tested for 
inclusion in the tool.  The tool also needs to include patient data that is simple, reliable and 
quick to obtain, while not expending undue resources for the clinician or the patient and 
generating the prediction in time to guide decisions (Wyatt et al., 1995).  It is also important 
that any tool should be simple to calculate, with a small number of items, and not require 
specialist assessment technology or skills (El Miedany et al., 2011).  The predictions of any 
risk assessment tool should also make sense to the clinicians who will rely on it (Wyatt, et al., 
1995). 
A search of the literature found four risk assessment tools (Falanga, et al., 2006; 
Kulkarni, et al., 2007; Margolis, et al., 2000; Skene, et al., 1992) and one prognostic index 
(Taylor, et al., 2002), that were all devised specifically to indicate the risk of venous leg 
ulcers not healing.  These five forms of risk assessment were discussed in Chapter Four and 
appear to have limited use, as the majority of the tools use measures based on investigations 
which are not readily available in most wound care services, and/or contain prognostic index 
equations which are mathematically challenging.  Margolis et al. (2002)’s tool includes only 
two variables and is easy to use, although it has only been developed and validated with those 
patients able to tolerate multilayered compression.  It may be enhanced by the inclusion of a 
broader range of variables to increase predictive ability, and therefore become more 
acceptable for use to all clinicians and in all settings. 
This chapter describes the research methods and results for Study Two which 
involved two parts: firstly the development of a risk assessment tool based on Study One 
results, predictors of failure to heal by 24 weeks from the literature, and advice from an 
expert Wound Advisory Group (WAG); secondly the evaluation of the validity of the tool on 
the retrospective database described in Study One. 
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The aims of Study Two were to: 
 Develop a risk assessment tool for venous leg ulcers based on the results from 
Study One, the evidence in the literature, and advice from an expert WAG 
 Devise a scoring system that could easily be measured by health professionals 
across all settings to determine the risk of venous leg ulcers not healing by 24 
weeks 
 Incorporate the scoring system into a risk assessment tool that could assess the 
probability of whether a venous leg ulcer would remain unhealed after 24 weeks 
 Validate retrospectively the risk assessment tool for non-healing of venous leg 
ulcers by 24 weeks 
 
Study Two addressed the following research questions: 
 Which risk factors identified from data analysis, a review of the literature and 
agreed upon by an expert WAG were able to be incorporated into a risk assessment 
tool that could be easily used by health professionals across all settings? 
 Does the venous leg ulcer risk assessment tool accurately predict venous leg ulcer 
patients who are at high risk of non-healing by 24 weeks? 
 
The methods and results for the development of the risk assessment tool will be 
discussed first in this chapter, followed by the methods and results for the second part of 
Study Two, the retrospective validation of the risk assessment tool. 
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6.2 Development of the risk assessment tool and scoring system 
6.2.1 Method 
Development of the risk assessment tool encompassed considering predictors of non-
healing identified from the literature review, predictors identified in Study One and advice 
from an expert WAG which ensured content validity of the risk assessment tool by consensus 
of the group.  The regression coefficients (β) of the variables found in Study One to be 
significantly associated with non-healing were used as the basis of the scoring of items for 
the risk assessment tool.  The utilisation of the regression co-efficient (β) of the covariates is 
a commonly used method of developing a weighted risk score in risk assessment tools 
(Lindström et al., 2003; Papaioannou et al., 2004; Wand, 2011) and indicates an estimate of 
the relative magnitude of the prognostic power of a specific variable (El Miedany, et al., 
2011).  For ease of use, many developers of risk scores round into whole numbers (Koopman, 
et al., 2008).  To obtain a simplified prediction rule and whole number point scores, this 
study assigned points to each variable on the basis of the regression co-efficient (β) of the 
covariates in the final model and the coefficient was multiplied by two.  This allowed for a 
greater variation in scores, maximisation of differences and an increase in sensitivity between 
those that remained unhealed and those that healed after 24 weeks.  The result was rounded to 
the nearest integer resulting in a weighted score (El Miedany, et al., 2011). 
Additional variables not found in Study One, however were indicated from evidence 
in the literature and included in the final risk assessment tool, were allocated one point. The 
exception was the calf circumference reduction variable, where the expert WAG agreed that 
based on the literature (Milic, et al., 2009), results from Study One and their clinical 
experience a higher score should be applied.  Grouped categories for the continuous variables 
of age and ulcer duration were created based on percentile analysis of these variables from 
the database in Study One, and it was confirmed with the expert WAG that they were 
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clinically applicable cut-off levels.  These scores were then summed for an overall risk 
assessment score. 
The expert WAG included twenty national and international multi-disciplinary 
clinicians, from different clinical settings, and researchers with particular knowledge and 
expertise in wound healing and instrument development.  This provided significant clinician 
input into the tool to ensure that it was feasible to be used across a range of clinical settings.  
Expert WAG participants were invited to be in the group on the basis of their expertise in 
relation to wound healing as well as having the ability to commit time to the project and 
attend teleconferences.  The group consisted of one dietician, two general practitioners, three 
community nursing managers, two nurse practitioners in wound care, two podiatrists, four 
research nurse specialists, the president of the Australian Wound Management Association, 
one Clinical Nurse Consultant, one Clinical Nurse, four Professors / Associate Professors in 
nursing, exercise or nutrition sciences, and a community care advisor, with many years of 
combined wound care experience.  The list of experts, titles and organisations they were 
employed in can be found in Appendix Seven.  Terms of reference for this group were 
formulated and have been included in Appendix Eight. 
6.2.2 Procedure and data management - Consensus process 
Ethical approval for analysis of the Study One database had been obtained through 
Queensland University of Technology (QUT) Human Research Ethics Committee (HREC) as 
previously discussed in Chapter Five.   
Three teleconferences with the WAG were organised to discuss the formation of the 
risk assessment tool and email correspondence provided all relevant information in advance 
of the teleconferences so that those who could not attend the teleconference could provide 
feedback by email.  The first teleconference held on 22
nd
 November, 2011 provided 
information to the expert WAG on definitions and findings in regards to risk factors from the 
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literature review, including variables identified as predictors for non-healing: longer ulcer 
duration; larger wound area; percentage area reduction at 3 and 4 weeks; lack of high 
compression; venous abnormalities; recurrence; increased age; and a history of Deep Vein 
Thrombosis (DVT).  Study One results were also discussed, which included the significant 
independent predictors of non-healing: lives alone; compression<30mmHg; higher Pressure 
Ulcer Scale for Healing (PUSH) score and wound area reduction <25% at 2 weeks.  
Definitions of mobility and venous abnormalities were discussed due to varying 
interpretations of these variables in the literature.  Potential scoring systems were also 
discussed, including those found in the literature review of previously developed risk 
assessment tools.  Thirteen people attended this first teleconference, with some of those 
unable to attend opting to provide feedback by email. 
The second teleconference was held on 6
th
 March, 2012.  Eleven people attended this 
teleconference and a draft two page tool (version one) was provided to the group for 
discussion, while also discussing the potential scoring system for the tool utilising the 
regression co-efficients (β) of the covariates.  The group determined that any risk assessment 
tool should be one page, simple and easy to use by a wide range of practitioners in a variety 
of settings, with no more than ten variables.  It was also decided by the expert WAG that it 
was not appropriate to have a tool within a tool; and therefore scales such as the PUSH score 
or Geriatric Depression Scale (GDS) score were not considered appropriate items for the risk 
assessment tool; however the items that made up these tools were considered.  The initial two 
page draft risk assessment tool was reduced to one page with the inclusion of all items on the 
one page, following the teleconference.  The expert WAG suggested that the items chosen be 
compatible with ‘The Australian and New Zealand Clinical Practice Guideline for Prevention 
and Management of Venous Leg Ulcers (The Australian Wound Management Association 
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Inc and the New Zealand Wound Care Society Inc, 2011).  The items on the risk assessment 
tool were checked and were found to be compatible with these guidelines. 
Many other potential variables were discussed within the expert WAG as possibilities 
for inclusion in a risk assessment tool, based on the literature review, Study One results and 
clinical experience.  Arterial competence or involvement was discussed however, a decision 
was taken that this was difficult to measure, as an Ankle Brachial Pressure Index (ABPI) was 
not always indicative of arterial involvement.  Co-morbidities, specifically diabetes, and 
medications were considered and it was suggested that four or more medications may be an 
appropriate variable to measure polypharmacy.  Results from Study One analysis of co-
morbidities and medications (including a polypharmacy variable of four medications or 
more) were then discussed; however no significant relationships with non-healing had been 
concluded.  Body Mass Index (BMI) or waist measurements were also considered, however it 
was determined that community nurses may find these variables difficult to measure.  Venous 
disease symptoms were also explored as possible predictors, however due to many different 
predictors associated with venous disease, it was decided this would be difficult to include.  
As the expert WAG did not feel it was appropriate to include a tool within a tool, a two item 
depression scale and a one question self-efficacy scale were examined to allow for inclusion 
of depression and self-efficacy items.  However, in the interests of having a one page, simple 
and easy to use tool which had considered evidence from the literature and Study One results, 
it was agreed with the expert WAG that none of the variables mentioned above would be 
included in the final tool.  Two further versions of the tool were developed within the project 
group prior to the third teleconference. 
The third teleconference, held on 21
st
 August, 2012 was attended by eleven people 
and version four of the risk assessment tool was discussed.  The expert WAG discussed 
detailed, specific information required for the study in regards to content validity.  This 
 Page | 128 
 
included questions about format, content and the response categories for each item 
(Woodbury et al., 2004).  The expert WAG discussed the proposed risk assessment tool and 
changes were made based on comments from these specialists, with a further three versions 
being developed prior to the final tool being adapted.  A majority consensus was reached by 
the expert WAG that the final risk assessment tool (version seven) included all important 
variables and response options were appropriate.  The responses of the wound care expert 
advisory group were not quantified; their consensus ensured content validity (Woodbury, et 
al., 2004). 
The final risk assessment tool consisted of ten items and a copy can be found in 
Figure 6.1.  These included the variables of age; ulcer duration; history of previous DVT; 
living alone; mobility aid; tissue type; ulcer area; compression level; 25% ulcer reduction in 
two weeks; and 2cm or more decrease in calf circumference. 
Although age was not found to be statistically significantly related with non-healing 
in Study One, and was inconsistently found in the literature review, a number of studies did 
identify higher age as being significantly related to non-healing (Barwell, Taylor, et al., 2000; 
Gohel, Barwell, et al., 2005; Kulkarni, et al., 2007; Labropoulos, et al., 2012; Skene, et al., 
1992; Taylor, et al., 2002).  Three of the previous five developed risk assessment tools also 
utilised age deeming it to be a necessary inclusion in any tool, all determining higher age to 
be a significant independent risk factor for non-healing (Kulkarni, et al., 2007; Skene, et al., 
1992; Taylor, et al., 2002).  The expert WAG agreed that based on the number of studies in 
the literature that had found age to be significantly related to non-healing and from their 
clinical experience, age would be a necessary inclusion as a risk factor in any scoring system. 
Ulcer duration was identified in Study One of this research as having a significant 
bivariate relationship with non-healing of venous leg ulcers at 24 weeks (p=0.004), and while 
this did not retain a significant relationship in our analysis at the multivariate level, several 
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studies in the literature review had confirmed ulcer chronicity as a consistent independent 
risk factor for non-healing (Barwell, Ghauri, et al., 2000; Cardinal, et al., 2009; Franks, 
Moffatt, et al., 1995; Gohel, Taylor, et al., 2005; Lantis, et al., 2013; Margolis, et al., 1999; 
Meaume, et al., 2005; Milic, et al., 2009; O'Meara, Tierney, et al., 2009; Phillips, et al., 
2000; Skene, et al., 1992). 
Figure 6.1: Venous leg ulcer risk assessment tool 
 
Risk Assessment Tool  
Venous Leg Ulcers 
Participant Code No.: 
Date: 
At First Visit or Assessment 
Health, medical & social history Score 
1. Age (years) < 70 = 0 70 - 79 = 1 ≥ 80 = 2  
2. Ulcer Duration (weeks) < 24 = 0 24 – 51 = 1 ≥ 52 = 2  
3. History of previous Deep Vein Thrombosis in    
     ulcer leg  
No = 0 Unknown = 0 Yes = 1 
 
4. Client lives alone? No = 0 Yes = 2  
On clinical examination 
5. Uses an aid to mobilise? No = 0 Yes = 1  
6. Wound bed mainly slough and/or necrotic tissue? No = 0 Yes = 1  
 7. Ulcer area ≥  5cm2? No = 0 Yes = 3  
 8. Treatment at present time with no, low or moderate level 
compression systems (<30mmHg) 
No = 0 Yes = 3 
 
                                                                               Baseline score after initial assessment   
2 weeks after admission or first assessment   
 9. 25% ulcer area reduction in 2 weeks Achieved = 0 Not achieved = 6  
 10. 2cm or more decrease in calf circumference in 2 
weeks 
Achieved = 0 Not achieved = 4 
 
2 week score after initial assessment   
OVERALL RISK ASSESSMENT SCORE   
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Four of the previous five developed risk assessment tools also utilised wound 
duration, deeming it to be a necessary inclusion in any tool after finding it a significant 
independent predictor for non-healing (Falanga, et al., 2006; Margolis, et al., 2000; Skene, et 
al., 1992); or determining from previous studies it was an important predictor of non-healing 
(Kulkarni, et al., 2007).  The expert WAG agreed that based on the consistent literature 
results and their own clinical experience it was a necessary inclusion in the tool. 
Venous abnormalities have been investigated over a variety of studies with varying 
classifications of abnormalities.  The assessment of venous abnormalities is mostly outside 
the scope of a routine wound clinic visit and therefore the inclusion of deep vein involvement 
on photoplethysmography and Venous Refill Time (VRT) in two previous risk assessment 
tools (Kulkarni, et al., 2007; Skene, et al., 1992) would be of limited value to any clinically 
useful risk assessment tool.  A study of venous leg ulcers concluded that 36% of patients with 
a venous abnormality had a least one other aetiological factor contributing to the ulceration, 
the large majority of which were a DVT or a condition known to predispose to a DVT 
(Baker, et al., 1994).  DVTs often result because of venous abnormalities (Kyrle, et al., 2005) 
and may also result in valve damage (Ettridge, 2011).  Findings from the literature review 
indicated that two studies had shown a previous history of DVT was significantly related to 
non-healing (Chaby, et al., 2006; Labropoulos, et al., 2012) and a further two studies 
indicated a significant relationship between non-healing and deep vein abnormality or 
insufficiency, without specifically testing for a previous DVT (Skene, et al., 1992; Szewczyk, 
et al., 2009).  There is a possibility that these may indicate a history of a previous DVT, as 
DVTs are more frequent in people with deep venous incompetence.  Study One results found 
a significant relationship with a previous DVT in the ulcer leg and non-healing of venous leg 
ulcers at 24 weeks (p=0.017) at the bivariate level, however this did not retain significance in 
multivariate analysis.  Discussion occurred between the expert WAG about the issues noted 
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in the literature review in regards to ‘silent’ DVTs and undiagnosed DVTs (Meetoo, 2013).  
Venous abnormalities have been a frequent predictor in the literature, albeit inconsistent, due 
to varying measures of venous abnormalities.  As clinical diagnosis of DVTs is generally 
improving, it was decided that venous abnormalities were an important part of the risk 
assessment tool.  The question on whether a person had previously had a DVT in the ulcer leg 
would be an appropriate venous abnormality question and a simple item in the tool as 
compared to measures of venous abnormality that would be difficult to measure and interpret. 
Living alone was included in the risk assessment tool as it was a significant risk factor 
for non-healing in Study One.  Relatively few studies have concentrated on psychosocial or 
quality of life factors and the risks associated with non-healing in patients with a venous leg 
ulcer , however, patients who live alone have a higher incidence of leg ulceration (Moffatt, et 
al., 2006).  One study demonstrated significant benefits for ulcer healing in patient groups 
receiving a social model of care (Edwards, et al., 2005).  Study One of this research, is the 
first study to conclude that living alone was independently significantly associated with 
failure to heal by 24 weeks (p<0.001).  It is undeterminable as to what may contribute to 
living alone being a significant predictor for non-healing in venous leg ulcers, with possible 
relationships between living alone, social support, financial constraints and loneliness (Shu-
Chuan, et al., 2004; Victor, et al., 2000).  Social support was measured in Study One by way 
of the Medical Outcomes Social Support Survey and not found to be significantly associated 
with non-healing.  Based on significant results in Study One of living alone being a risk 
factor for non-healing and it being a simple, one question variable, the expert WAG agreed 
that it was an important addition to the risk assessment tool. 
Mobility was a significant predictor for non-healing in venous leg ulcers from the 
literature review, although there were difficulties in comparing studies due to a lack of 
consistency in the measurements of mobility.  Lack of general mobility (Chaby, et al., 2006; 
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Franks, Moffatt, et al., 1995; Milic, et al., 2009), a fixed ankle joint (Barwell, et al., 2001; 
Franks, Moffatt, et al., 1995; Milic, et al., 2009) and use of a walking aid (Hjerppe, et al., 
2010) have all been investigated in the literature and found to be significant predictors of 
non-healing in venous leg ulcers.  Study One results concluded that a fixed ankle joint and 
use of a walking aid were significantly related to non-healing on bivariate analysis (p<0.001 
and p=0.01).  However possibly due to small sample sizes with data of these variables, they 
did not retain a significant relationship in a multivariate analysis.  While the expert WAG 
considered mobility an important variable to be included in the tool, the measurement of this 
item was problematic due to the lack of consensus in the literature.  Discussion on mobility 
concluded that the ‘use of a walking aid’ was the optimal measurement of mobility for the 
purpose of this risk assessment tool as it was a quick, simple item to include that would not 
involve a subjective measure of activity by the patient, or the need for equipment and/or time 
in determining ankle range of motion. 
Study One identified the PUSH score as being independently significantly associated 
with failure to heal by 24 weeks (p=0.001).  The PUSH score for ulcer healing includes 
scores for ulcer area, amount of exudate and wound bed tissue type/surface appearance.  As 
the expert WAG concluded that it would be inappropriate to include a tool within a tool, the 
individual items were considered for potential inclusion in the risk assessment tool.  Ulcer 
area was found to be a consistent significant predictor of non-healing of venous leg ulcers in 
the literature review (Cardinal, et al., 2009; Franks, Moffatt, et al., 1995; Guest, et al., 1999; 
Labropoulos, et al., 2012; Margolis, et al., 1999; Milic, et al., 2009; O'Meara, Tierney, et al., 
2009; Phillips, et al., 2000; Skene, et al., 1992; Sola, et al., 2012; Stacey, et al., 1997; Taylor, 
et al., 2002).  Studies related to wound tissue type and exudate were limited in the literature.  
However, one study indicated larger amounts of exudate were a significant predictor for non-
healing (Taylor, et al., 2002) and two studies indicated that a wound greater than 50% 
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covered with fibrin (Margolis, et al., 1999) or type of slough (Jones, 2009) had a significant 
relationship with non-healing.  Study One results concluded that increased exudate was not 
significantly related to non-healing by 24 weeks in venous leg ulcers (p=0.085), however 
predominant tissue type (slough and/or necrotic tissue) was significantly related to non-
healing on bivariate analysis (p=0.031).  Tissue type was not tested in a multivariate model in 
Study One due to it being incorporated in the PUSH tool.  Based on expert clinical 
experience and the results from Study One, the expert WAG agreed to include the variables 
of wound area and predominant wound bed tissue type in the risk assessment tool.  To ensure 
simplicity of the tool the area item was grouped into a dichotomous variable to indicate if the 
area of the ulcer was ≥ 5cm2 or not, based on percentile analysis from Study One, while the 
wound bed tissue type simply asked if it was mainly slough and/or necrotic tissue (compared 
to granulation/epithelial tissue) based on literature conclusions and bivariate analysis in Study 
One. 
A systematic review of compression concluded that compression increased healing 
rates and high compression has been acknowledged as the cornerstone of management for 
venous leg ulcers (European Wound Management Association, 2003).  Study One concurred 
that no, low or moderate (<30mmHg) compression was independently significantly 
associated with failure to heal by 24 weeks (p=0.002) in venous leg ulcers.  It was agreed by 
the expert WAG that this was an essential component of the tool.  Previously developed tools 
only included participants in high compression which is the gold standard of treatment, 
however, there are many reasons why a patient may not tolerate this level of compression 
including cost; compliance and lack of training and knowledge in clinical staff (Fife et al., 
2010; Phillips, et al., 2000; Woodward, 2002).  Therefore, it is necessary to incorporate level 
of compression into a risk assessment tool to cover all patients with venous leg ulcers. 
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The literature review identified ulcer area percent reduction at two, three and four 
weeks to be indicators of non-healing (Arnold, et al., 1994; Kantor, et al., 2000; Phillips, et 
al., 2000).  Study One concluded that a failure to achieve 25% and 40% ulcer size reduction 
at both two weeks and four weeks (p<0.001) were significant risk factors for non-healing by 
24 weeks.  As only one variable could be included, it was determined that a 25% reduction at 
two weeks be included as it had the largest effect size, and a two week time frame was the 
most relevant for a risk assessment tool.  The variable retained an independent significant 
relationship with non-healing in a multivariate model.  The expert WAG agreed that the 
percentage ulcer area reduction and the time frame were the most applicable for a risk 
assessment tool. 
Very little research has investigated the variables of ankle and calf circumference; 
however, Milic et al. (2009) found that a calf circumference reduction of less than 3cm in 50 
days was significantly related to non-healing, while also finding that a calf/ankle 
circumference ratio of <1.3 was significantly related to non-healing.  Results from Study One 
concluded that a calf circumference reduction of less than 2cm at two weeks was significantly 
related to non-healing at the bivariate level (p<0.10).  Study One also concluded that lack of 
oedema was a significant predictor of non-healing at the bivariate level (p=0.03) indicating 
that a decrease in oedema and subsequently calf measurement could possibly add value to 
any risk assessment tool.  These results did not retain significance in a multivariate model, 
possibly due to the small sample size of those participants where a reduction of calf size at 
two weeks was measured.  The expert WAG saw this as an important variable, specifically 
applicable to venous leg ulcers, based on the aetiology of venous disease and their own 
clinical experience.  Based on the literature and results from Study One, the group concurred 
that this was a relevant variable to include that could provide valuable information. 
In summary baseline variables selected for the risk assessment score were defined as: 
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o Age in years at time of assessment 
o Ulcer duration in weeks 
o History of previous DVT in ulcer leg 
o Did the participant live alone? 
o Use of any aid for mobilisation 
o Wound bed determined to be mainly slough and/or necrotic tissue or not 
o Ulcer area – determined to be greater than or equal to 5cm2 
o Compression system level which was categorised as below 30mmHg or not (level 
measured as per compression system manufacturers’ indications) 
Two week variables were defined as: 
o 25% ulcer area reduction in two weeks as calculated by: 
% reduction from baseline = 100 x (baseline-current size) / baseline 
o Change in calf circumference.  A calf circumference is measured around the 
largest part of the calf.  This measurement was taken at baseline and at two weeks 
to determine if there was a 2cm or more decrease in calf circumference at 2 
weeks. 
The risk assessment scores range from 0 to 15 for the baseline score and 0 to 10 for 
the two week score, culminating in an overall risk assessment score, calculated by summing 
the baseline and two week scores, with scores ranging from 0 to 25 where a higher value 
indicates an increased risk for non-healing by 24 weeks. 
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6.3 Retrospective validation of risk assessment tool 
6.3.1 Method 
            After the expert WAG reached consensus on variables to be included in the risk 
assessment tool, the retrospective database from Study One (previously described in Chapter 
Five), was used to test the predictive accuracy of the tool by way of discrimination and 
calibration.  Model performance was evaluated in terms of discrimination (area under the 
Receiver Operating Characteristic (ROC) curve (AUC)) and calibration (Hosmer-Lemeshow 
statistic).  The AUC values provide a measure of the overall discriminative ability of a model 
and is a fundamental tool for diagnostic test evaluation (Fawcett, 2006).  The ROC curve is 
generated by plotting sensitivity (the proportion of true positives that are correctly identified 
by the test, or the total number of patients who were correctly identified as not healed) 
against specificity, which is the extent to which the absence of a characteristic is correctly 
classified (the proportion of true negatives that are correctly identified by the test, or the total 
number of patients correctly defined as healed) (Altman et al., 1994; Defloor et al., 2005).  
Accuracy is measured by the AUC which indicates how well a parameter can distinguish 
between two groups (Metz, 1978) (e.g. those venous leg ulcers that did not heal and those 
that did heal by 24 weeks).  Values range between 1.0 (perfect assessment of whether the 
venous leg ulcer will heal or not) and 0.5 (no indication as to whether the venous leg ulcer 
will heal or not).  This means that the nearer the AUC to 1, the better the model’s ability to 
detect the non-healing of venous leg ulcers by 24 weeks. 
 The Hosmer-Lemeshow Goodness of Fit Test is a reliable tool for model fit (Pallant, 
2011), testing whether the predicted probabilities agree with the observed probabilities 
(Sbidian et al., 2010).  It is widely used for the evaluation of risk-scoring models in medicine 
that are developed using a wide range of sample sizes (Paul et al., 2013).  The Hosmer-
Lemeshow Goodness of Fit Test indicates a poor fit with a significance level of less than 
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0.05, so to support a model we require a significance value of larger than 0.05, thereby 
indicating support for the model (Pallant, 2011).  The dependent variable in all analyses was 
the non-healing of a venous leg ulcer by 24 weeks.  A p value of below 0.05 was used for 
statistical significance.  There is no gold standard tool available for venous leg ulcer healing 
to compare with the AUC results obtained in this study. 
6.3.2 Data management 
All data were statistically analysed using the software package Statistical package for 
the Social Sciences (SPSS 19.0).  Original databases were kept in password protected secure 
access university hard drives, while hard copies of original data were kept in locked filing 
cabinets. 
Validation of the risk assessment tool was conducted using the combined database 
from Study One to determine how accurately the tool could identify participants who did not 
heal by 24 weeks.  This database of venous leg ulcers contained clinical, healing, health and 
psychosocial data from participants followed for 24 weeks.  This data set was made up of 
data collected from seven previous prospective longitudinal studies conducted by QUT and 
has been previously described in detail in Chapter Five. 
6.3.3 Results 
          Due to differences in protocols for data collection from the studies contributing to the 
Study One database, of the 318 ulcers, a baseline risk assessment score was available on 280 
ulcers, however, only 119 ulcers had data for an overall risk assessment score after two 
weeks, due mostly to the majority of retrospective studies not measuring calf circumference 
at two weeks from baseline. 
Table 6.1 shows the sample characteristics of participants, both in the 280 ulcer 
sample (who had data for a baseline score) and the 119 ulcer sample (who had data for a two 
week score and therefore a total risk assessment score).  The two groups were tested for any 
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significant differences.  Participants with only baseline data available were found to have 
significantly lower healing rates, larger ulcer area, longer duration, were less likely to be 
treated with high level compression and more likely to live alone.  This group was 
predominantly from studies which did not have a protocol requiring weekly data collection, 
and these studies were recruited primarily from community nursing services rather than walk-
in clinics.  The differences are thus likely to be associated with the fact that community 
nursing services tend to care for older and frailer patients who are unable to easily access 
walk-in clinics.  It is also possibly due to the ability of participants to attend appointments or 
those participants with more complex ulcers (i.e. larger ulcer area and/or longer ulcer 
duration) being more likely to have been hospitalised or lost to follow up. 
In the validation database an ROC curve was calculated for the baseline risk 
assessment score (n=280) and the total risk assessment score (n=119).  The AUC results 
indicated good discrimination and goodness-of-fit in predicting non-healing of venous leg 
ulcers by 24 weeks with an AUC of 0.74 (95% CI 0.68-0.80, p<0.001).  Thus the model 
correctly discriminated between ulcers that did not heal as compared to those that did, based 
on the baseline score 74% of the time.  The two week score model had good discrimination 
and goodness-of-fit in predicting non-healing of venous leg ulcers by 24 weeks with an AUC 
of 0.84 (95% CI 0.73-0.93).  Thus the model correctly discriminated between ulcers that did 
not heal as compared to those that did, based on the two week score, 84% of the time.  The 
total risk assessment score model had good discrimination and goodness-of-fit in predicting 
non-healing of venous leg ulcers by 24 weeks with an AUC of 0.80 (95% CI 0.68-0.93).  
Thus the model correctly discriminated between ulcers that did not heal as compared to those 
that did, based on the overall risk assessment score, 80% of the time. 
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Table 6.1: Retrospective validation of risk assessment tool sample characteristics 
  Validation Sample  
Baseline score 
(n=280) 
Validation Sample   
Total risk assessment 
score (n=119) 
 
 
p 
Gender Male 
Female 
84 (52.2%) 
77 (47.8%) 
58 (48.7%) 
61 (51.3%) 
 
0.66 
Wound not healed Yes 66 (41.0%) 18 (15.1%) <0.001 
History of previous DVT 
(study leg) 
 
Yes 
 
26 (16.5%) 
 
20 (16.9%) 
 
1.00 
Lives alone Yes 91 (56.5%) 36 (30.3%) <0.001 
Aid to mobilise Yes 57 (35.4%) 32 (26.9%) 0.17 
Wound bed mainly 
slough/necrotic tissue 
 
Yes 
 
95 (59.0%) 
 
56 (47.1%) 
 
0.06 
Ulcer area ≥ 5cm2 Yes 70 (43.5%) 30 (25.2%) 0.02 
Treatment with no, low or 
moderate level compression 
system (<30mmHg) on 
baseline 
 
 
 
Yes 
 
 
 
63 (39.1%) 
 
 
 
24 (20.2%) 
 
 
 
0.001 
 Mean (SD)  
Age  68.9 (14.88) 67.99 (12.67) 0.07 
 Median (range)  
Ulcer duration  26 (0-1040) 20 (0-624) 0.003 
 
The number of participants whose wound did not heal by 24 weeks reported by their 
risk assessment scores - grouped into three equal groups according to the range of possible 
scores (i.e., low risk: less than 9, moderate risk: 9 to 16 and high risk: 17 to 25), are shown in 
Table 6.2, indicating that the higher the score the more likely a venous leg ulcer is to remain 
unhealed at 24 weeks.  In this study, 52.9% of participants scored < 9.  Of this group, only 
3.2% of participants remained unhealed after 24 weeks.  A risk assessment score of 9 to 16 
occurred in 40.3% of the sample and of this group 20.8% of participants remained unhealed 
after 24 weeks.  A risk assessment score of 17 and above occurred in 6.7% of the sample and 
of this group 75% of participants remained unhealed after 24 weeks.  The Hosmer-Lemeshow 
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Goodness of Fit Test also showed the total risk assessment tool score to be an acceptable 
measure 2 (8) = 11.952, p=0.15.  AUC results for the total risk assessment score are shown 
in Figure 6.2 with the sensitivity and specificity results reported in Appendix Nine. 
 
Table 6.2: Wound non-healing at 24 weeks by total risk assessment score:  
Retrospective validation sample (n=119) 
Total risk assessment score n, % not healed n, % healed 
< 9 (low risk) 2 (3.2%) 61 (96.8%) 
9-16 (moderate risk) 10 (20.8%) 38 (79.2%) 
≥ 17 (high risk) 6 (75.0%) 2 (25.0%) 
 
Figure 6.2: Retrospective Sample – AUC Results for total risk assessment score 
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6.4 Conclusion 
 Healing of venous leg ulcers is a priority for all health professionals working in 
wound care and an important aspect of venous leg ulcer management involves the assessment 
of the risk of delayed healing, in order to be able to appropriately recommend continued or 
modified management.  Simple risk scores comprising basic information are the most useful 
for health practitioners who care for venous leg ulcer patients in a range of settings.  
Instruments to assess the risk for delayed healing could help to enhance communication 
among clinicians by defining a common language and standardising assessment of risk 
characteristics (Mullins et al., 2005).  The risk assessment tool developed in this study is 
unique in that the total risk assessment score consists of the sum of a baseline score and a two 
week score.  Good discrimination and calibration results, distinguishing those venous leg 
ulcers that will not heal by 24 weeks, have been demonstrated in the total risk assessment 
score and for the baseline score and two week scores individually.  Results for these 
individual scores are important, as in the clinical situation it is not always possible to 
determine a score at both baseline and two weeks.  These results indicate that even with only 
a baseline score, a degree of assurance in the predictive ability of the risk assessment tool is 
provided to the clinician.  This chapter has discussed the research methods and results of 
Study Two where a clinically relevant and user friendly risk assessment tool was developed 
to determine the risk of venous leg ulcers remaining unhealed at 24 weeks.  These results 
indicate that the two week score on its own is a better predictor of non-healing in venous leg 
ulcers by 24 weeks than the baseline score, or the total risk assessment score.  This result will 
be investigated further in Chapter Seven which will discuss research methods and results of 
Study Three, testing the risk assessment tool for inter-rater reliability and validation in a 
prospective sample of participants. 
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Chapter Seven: Study Three 
Inter-rater reliability testing, prospective validation and end users’ evaluation of the 
venous leg ulcer risk assessment tool 
7.1 Introduction 
The risk assessment tool developed and discussed in Chapter Six, was designed to be 
easy and simple to use and included 10-items covering socio-demographic, venous history, 
mobility, compression, ulcer and lower limb characteristics items.  It was also designed to 
broaden the range of risk factors from previously developed venous leg ulcer risk assessment 
tools.  Variables were only included if they were easy to obtain and measure, and part of 
normal routine patient assessment and management, to ensure the tool would be useful for all 
wound care health professionals.  Simple measures ensured quick and easy scoring, without 
needing specialist assessment technology or skills. 
To develop and conduct evidence based practice, clinical data must be collected using 
reliable and valid instruments (Flahr et al., 2005).  The main reasons reported for health 
professionals’ rejection of prognostic models are lack of clinical credibility and lack of 
evidence that a prognostic model can support decisions about patient care; that is, evidence of 
accuracy, generality and effectiveness (Wyatt, et al., 1995).  It is therefore important to assess 
the reliability and validity of any risk assessment tool in order to know the extent that a tool is 
measuring what the tool was designed to measure; and provide the evidence to facilitate 
uptake of the tool in clinical decision making. 
Study Three assessed the inter-rater reliability and prospective validation testing of 
the risk assessment tool in a sample of participants with venous leg ulcers.  It also 
investigated health professionals’ perceptions of the usefulness and ease of use of the tool. 
The aims of Study Three were to: 
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 Evaluate the inter-rater reliability of the risk assessment tool 
 Validate the risk assessment tool, in a prospective sample of participants, for non-
healing of venous leg ulcers by 24 weeks 
 Evaluate a sample of end users’ perceptions of the tool 
 
Study Three addressed the following research questions: 
  Is the venous leg ulcer risk assessment tool a reliable measure between different 
health professional users, of predicting whether patients with venous leg ulcers are 
at risk of non-healing by 24 weeks? 
 Does the venous leg ulcer risk assessment tool accurately predict patients with 
venous leg ulcers who are at high risk of non-healing by 24 weeks? 
 What are end users’ views on the ease of use and usefulness of the risk assessment 
tool? 
 
This chapter will first discuss the methods and results of the inter-rater reliability 
testing of the risk assessment tool.  This will be followed by the methods and results of the 
prospective testing of the risk assessment tool and finally the methods and results of feedback 
from health professionals’ on their perceptions of the risk assessment tool will be discussed. 
 
7.2 Inter-rater reliability of the risk assessment tool 
7.2.1 Method 
Inter-rater reliability of a measurement is the degree to which the measurement can be 
reproduced and an evaluation of the reproducibility of a measurement between different 
observers (Margolis et al., 1996).  Inter-rater reliability was tested using Intra-Class 
Correlation (ICC) analysis to compare between the ratings of one nurse practitioner and two 
 Page | 145  
 
registered nurses for all items in the risk assessment tool, including the baseline score, two 
week score and overall risk assessment score.  The same three raters were utilised for all 
inter-rater reliability measurements.  This required the three raters to initially see a participant 
and complete a baseline score, while also attending two weeks later to complete a two week 
score and calculate an overall risk assessment score.  In this study, inter-rater reliability was 
confirmed by comparing risk assessment tool ratings made by each of the raters when using 
the risk assessment tool independently (without observation of each other), at the same 
clinical consultation visit.  These individuals had between five and fifteen years of clinical 
and/or research experience with chronic wounds.  ICC provides a measure of reliability, 
indicating whether the assessment tool could be used effectively by a variety of health 
professionals (Shrout et al., 1979) by analysing the degree of concordance or the consistency 
of the performance of two or more observers in recording the same responses of the risk 
assessment tool at the same visit (Santos, et al., 2007).  ICC is the standard statistical method 
for assessing the agreement between two or more raters (Shrout, et al., 1979) and is a 
measure of the proportion of variance that is attributable to the objects of measurement 
(McGraw et al., 1996), indicating the degree of agreement between raters.  ICC coefficients 
are categorised between 0 and 1, with 1 indicating total agreement, between 0.41 to 0.60 
indicating fair to moderate strength of agreement, 0.61 to 0.80 indicating good strength of 
agreement and 0.81 to 0.99 indicating very good agreement (Bower et al., 2009; Santos, et 
al., 2007).  A one-way random effect analysis of variance model was used where raters were 
considered random, the risk assessment variables fixed and confidence intervals were 
calculated.  ICCs were calculated as average measures since the variables used were average 
observations of several single observations.  Due to possible inaccuracies in tracing wound 
areas and to avoid unnecessary physical and mental trauma to the participants, only one rater 
carried out the ulcer area tracing on each participant utilising an acetate tracing, using the 
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same rater each time.  This tracing was then measured and the area was calculated by 
Visitrak
TM
, Smith and Nephew, by the three raters independently.  Assessment of the 
reliability of raters in regards to area tracing utilising an acetate grid was carried out by the 
same three raters on seven ulcers on a training model and ICCs were calculated for these 
assessments.  A p value below 0.05 was used to identify statistical significance. 
7.2.2 Sample  
The target sample was 30 participants to be assessed by three raters.  Sample size 
calculation was based on 80% power to detect an ICC of 0.8 when the ICC under the null 
hypothesis is 0.6 using an F-test, with a significance level of 0.05. 
7.2.3 Procedure and data management  
Ethical approval for the prospective validation of the risk assessment tool was 
obtained through Queensland University of Technology’s (QUT’s) Human Research Ethics 
Committee (HREC).  The ethics approval certificate is presented in Appendix Five.  
Participants who had consented to be involved in the prospective validation study of the risk 
assessment tool, discussed later in this chapter, and where the three raters were available to 
attend a baseline and two week visit, were approached for inclusion in the inter-rater 
reliability testing of the risk assessment tool.  The participants were all recruited from QUT’s 
Wound Healing Community Outreach Service (WHCOS) where the three raters were all 
available.  Due to difficulties in organising the three raters availability at the same time as 
wound clinic appointments for participants at both baseline and two weeks, only 16 
participants of the expected sample of 30 participants were able to be approached and have 
full data collected for both the baseline and the total risk assessment score.  Of the 16 
participants approached, all agreed to be involved.  Baseline and two week data were 
collected during a participant’s wound treatment clinic visit, from clinical records in the first 
instance, or if not able to be determined from clinical records, then directly from the 
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participant by each of the raters.  The clinician in the clinic removed the participant’s 
dressings and washed the affected area, after which each risk assessment was performed, 
independently, at the same clinical consultation visit by one nurse practitioner and two 
registered nurses as the raters.  Due to clinic activities and the ability of the raters to attend 
the clinic at certain times there was no consistent or specific order that the raters completed 
their assessments.  The risk assessment tool was completed during or immediately following 
each visit, generating three baseline scores, three two week scores and three total risk 
assessment scores for each venous leg ulcer.  If physical or mental pain was evident at any 
point in the study process, the data collection was ceased. 
All data on participants and raters were coded and de-identified.  The original 
database was kept in a password protected area of the university’s hard drive while all hard 
copies of data were kept in locked filing cabinets.  All data were entered into Statistical 
package for the Social Sciences (SPSS) 19.0 software after a total risk assessment score had 
been determined.  Database entries were checked against the original hard copies for 
accuracy by another independent person and descriptive statistics were analysed.  The three 
raters had all been involved in the development of the tool and therefore no further training 
was provided to these raters prior to use of the tool.  The raters were requested not to 
exchange information on the variables associated with the risk assessment tool. 
7.2.4 Results  
Nine participants (56.3%) were male and 7 (43.8%) were female.  The mean age of 
participants was 68.25 years (SD=20.16) and the median duration of participants’ ulcers at 
baseline was 18 weeks (range 4-79 weeks).  The median area of the ulcers was 2.1cm
2
 (range 
0.1-23.6cm
2
).  The average total risk assessment scores of the three raters were 12.31 
(SD=4.42), 11.56 (SD=5.18) and 12.75 (SD=4.70) with an ICC value of 0.86 (95% CI 0.68-
0.95, <0.001), confirming very good inter-rater reliability for the total risk assessment score.  
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There was statistically significant agreement among all raters for all individual item 
variables, baseline score, two week score and the total risk assessment score.  These results 
are presented in Table 7.1. 
Table 7.1: Inter-rater reliability results of the Risk Assessment Tool 
Items ICC CI p Strength of 
agreement* 
Health, medical & social history     
Age (years) 1.000 1.000-1.000 <0.001 Very good 
Ulcer duration (weeks) 0.784 0.509-0.918 <0.001 Good 
History of previous deep vein thrombosis in 
study ulcer leg 
 
0.905 
 
0.784-0.964 
 
<0.001 
 
Very good 
Poor social support – lives alone? 0.941 0.866-0.978 <0.001 Very good 
Clinical examination 
 
    
Uses an aid to mobilise? 0.824 0.598-0.933 <0.001 Very good 
Wound bed mainly slough and/or necrotic 
tissue? 
 
0.901 
 
0.775-0.962 
 
<0.001 
 
Very good 
Ulcer area ≥5cm2? 0.957 0.902-0.984 <0.001 Very good 
Treatment at present time with no, low or 
moderate level compression systems 
(<30mmHg) 
 
 
0.620 
 
 
0.136-0.856 
 
 
0.011 
 
 
Good 
Baseline Score 0.956 0.900-0.983 <0.001 Very good 
Two weeks after first assessment     
25% ulcer area reduction in 2 weeks 0.818 0.586-0.931 <0.001 Very Good 
2cm or more decrease in calf circumference 
in 2 weeks 
 
0.607 
 
0.107-0.851 
 
0.013 
 
Fair 
Two Week Score 0.664 0.236-0.872 0.005 Good 
Total risk assessment score 
(Baseline Score + Two Week Score)  
 
0.863 
 
0.687-0.948 
 
<0.001 
 
Very good 
 
*Strength of agreement determined as 0.41 to 0.60 - fair, 0.61 to 0.80 – good, 0.81 to 0.99 - very good 
agreement (Bower, et al., 2009; Santos, et al., 2007) 
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Statistically significant (p<0.001) agreement among all raters’ assessment of the ulcer 
area tracing utilising acetate grids by the same three raters of seven ulcers on a training model 
achieved an ICC value of 1.0 (95% CI 0.999-1.00, p<0.001).  This indicated very good inter-
rater reliability of these three raters in regards to the measurement of wounds utilising 
tracings with acetate grids. 
7.2.5 Discussion and conclusion  
Good inter-rater reliability of a risk assessment tool is an essential requirement for the 
validity of a tool.  Inter-rater reliability results on this venous leg ulcer risk assessment tool 
indicate good agreement between raters.  The majority of the ICC indices (0.8-0.9) obtained 
for the comparison between raters for items in the risk assessment tool, confirmed the 
reliability of the tool, with statistical significance (p<0.05).  This confirms that more than one 
rater can use the risk assessment tool and obtain consistent results.  Three variables on the 
risk assessment tool were less reproducible, scoring ICC <0.8.  These items require further 
evaluation, modification and clarification to improve reliability for these items.  These were 
ulcer duration, treatment compression level and calf circumference reduction.  The 
differences in ratings could have resulted from a misunderstanding of the compression 
question, with the ‘less than’ (i.e. ‘<’) symbol often being misunderstood and mistakenly 
answered as <30mmHg although the compression type had been documented as a type which 
is higher than 30mmHg.  The ulcer duration item may have been less reliable due to the 
possible misunderstanding by the participant of the need to answer in relation to that one 
particular ulcer.  Measurement of the calf was also less reliable between the three raters, due 
to slightly differing measurements between raters and the measurement reduction often being 
very close to the 2cm cut-off mark. 
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It is important to test not only inter-rater reliability but also further validation of the 
risk assessment tool to ensure that the results are consistent with those found based on the 
retrospective developmental database.  Prospective validation is important to test whether the 
risk assessment tool is valid in a new sample of patients, in addition to the derivation sample. 
 
7.3 Prospective validation of the risk assessment tool 
7.3.1 Method  
The prospective validation was conducted through a longitudinal study to determine 
how accurately the risk assessment tool could identify newly recruited participants with 
venous leg ulcers who would not heal by 24 weeks.  Model discrimination was evaluated 
identically to the retrospective validation in Study Two.  This was previously described in 
Chapter Six, with analyses investigating the prediction of the risk assessment tool in terms of 
discrimination (Area Under the Receiver Operating Characteristic (ROC) Curve (AUC)) and 
calibration (Hosmer-Lemeshow statistic).  The dependent variable in the analyses was non-
healing of a venous leg ulcer by 24 weeks.  A p value of below 0.05 was used for statistical 
significance. 
7.3.2 Sample  
The sample in this study was a sub-sample of a larger prospective multi-site Wound 
Management Innovation Cooperative Research Centre (WMI-CRC) project 3.05, which 
aimed to undertake the broader development and validation of risk assessment tools for 
healing and recurrence of venous leg ulcers.  The WMI-CRC project team is led by QUT 
along with principal and co-investigators from Blue Care and Royal Brisbane & Women’s 
Hospital (RB&WH) in Queensland; and the Royal District Nursing Service (RDNS) in 
Victoria.  The project team is described in Appendix One.  The data available for analysis in 
this study to determine the prospective validity of the risk assessment tool consisted of 
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participants diagnosed with a venous leg ulcer presenting at ten clinical sites – QUT’s 
WHCOS, Qld Health (RB&WH), Blue Care (Caloundra and Redcliffe) and RDNS (six sites 
in Victoria). 
Sample size calculations for the larger prospective study found a total sample of 360 
participants was required for AUC curve analysis based on the following parameters: 90% 
power; 95% significance level; a minimum of 20% expected non-healing ulcers, null 
hypothesis of AUC 0.5, alternative hypothesis of AUC 0.75, and allowing for a 20% dropout. 
The final prospective sub-sample cohort analysed for Study Three of this research 
consisted of 164 ulcers on 156 participants recruited from the ten clinical sites.  The larger 
prospective multi-site WMI-CRC study will continue to recruit and increase sample size.  Of 
this sample of 164 ulcers, sixteen participants did not have a total risk assessment score 
and/or non-healing status at 24 weeks was undeterminable due to: 6 participants either 
healing at week one and/or not returning to the clinic after week one; 6 participants who had 
no calf measurements attended at baseline and/or in the weeks following, 3 participants who 
withdrew from the study before week two; and 1 ulcer that was reclassified as a skin cancer 
and was therefore withdrawn from the study.  This resulted in a database of 148 ulcers on 141 
participants with non-healing status at 24 weeks and total risk assessment scores.  Validation 
results were only calculated on the first ulcer for each participant so as not to over represent 
any variable, therefore utilising a sample of 141 ulcers in 141 participants.  A venous leg 
ulcer for these studies was defined as a loss of skin on the leg or foot that was diagnosed as 
predominantly venous in nature by the clinician in charge of care. 
Inclusion Criteria 
o Participants with leg or foot ulcers of primarily venous aetiology 
o Ankle Brachial Pressure Index (ABPI) ≥  0.8 and < 1.3 
 Page | 152 
 
Exclusion Criteria 
o Participants with leg ulcers of non-venous aetiology (e.g. arterial, diabetes 
related foot ulcers) 
o Participants with cognitive impairment  
o Participants unable to attend a data collection site for assessment at selected 
time points (e.g. too far to travel) 
 QUT’s WHCOS is a nurse practitioner led wound healing service providing 
comprehensive assessments, cost-effective and evidence-based wound treatment in a 
specialised environment.  Thirty-three ulcers were included from this site, constituting 23.4% 
of the final sub-sample analysed for this study. 
 RB&WH is a 929-bed quaternary and tertiary referral teaching hospital located in 
Brisbane within the Metropolitan North Health Service District.  It is a key provider of health 
care services for Queensland Health and includes a medically led specialist wound healing 
outpatient service.  Eleven ulcers were included from this site, constituting 7.8% of the final 
sub-sample analysed for this study. 
 Blue Care is a not-for-profit organisation providing healthcare as part of Uniting Care 
Queensland.  They are one of Australia’s leading providers of community health which 
includes the clinical management of acute and chronic wounds.  Eighteen ulcers were 
included from this site, constituting 12.8% of the sub-sample analysed for this study. 
 RDNS is an independent not-for-profit organisation and is Australia’s oldest and 
largest provider of home nursing and healthcare services.  They offer a comprehensive range 
of wound care services supported by a specialist team of Clinical Nurse Consultants in wound 
care.  Seventy-nine ulcers were included from this site, constituting 56.0% of the sub-sample 
analysed for this study. 
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7.3.3 Measures  
Data collected at baseline included: 
  
o age in years 
o ulcer duration in weeks 
o whether there is a history of previous Deep Vein Thrombosis (DVT) in study 
ulcer leg 
o whether the participant lived alone? 
o whether the participant used any aid to mobilise 
o % tissue type as mainly slough and/or necrotic tissue 
o area – ulcer area was calculated from acetate tracings as measured by VistitrakTM , 
Smith and Nephew (device to calculate digital planimetry from an acetate tracing) 
and documented as greater than or equal to 5cm
2
 
o level of compression system categorised as below 30mmHg or not as per 
manufacturers’ indications 
o calf circumference measured around the largest part of the calf 
Data at two weeks included: 
o area – ulcer area was calculated from acetate tracings as measured by VistitrakTM, 
Smith and Nephew, and a determination was made as to whether there had been a 
25% ulcer area reduction in two weeks as calculated by: 
% reduction from baseline = 100 x (baseline-current size) / baseline 
o calf circumference measured around the largest part of the calf and a calculation 
made as to whether there had been a decrease in the calf circumference of 2cm or 
more in 2 weeks 
 
The baseline and two week scores were then summed to produce an overall risk 
assessment score ranging from 0 to 25.  In the case of participants with more than one ulcer 
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on one leg, the largest ulcer was identified as the study ulcer.  Follow up data were collected 
for 24 weeks on healing status and this was used to validate the risk assessment tool. 
7.3.4 Procedure and data management  
Ethical approval for this study was obtained through QUT’s HREC and the ethics 
committee of the individual organisations’ HREC’s involved.  The ethical approval 
certificates are presented in Appendix Five.  All participants received a patient information 
and consent package in relation to the study, and written consent was obtained.  The 
information and consent form are presented in Appendix Ten.  Participants were assured that 
they could withdraw from the study at any time.  If physical or mental pain was evident at 
any point in the study process, the collection of data was ceased. 
All data were entered into SPSS 19.0 software.  All data on participants were coded 
and de-identified.  Data from the different study sites were combined into one database for 
analysis.  Original databases were kept in password protected areas of the universities or 
partner organisations’ hard drives while all hard copies of data were kept in locked filing 
cabinets.  If data were missing from the database, all efforts were used to locate the original 
documented data collection forms and updated as necessary.  In some cases (n=18) where 
week two data was unavailable, week three or four data was used as an estimate to determine 
the week 2 calf circumference and ulcer size measures by calculating the average weekly 
difference, according to baseline and week three or four measures.  A random sample of ten 
per cent of all database entries were checked against the original hard copies for accuracy by 
a second person. 
7.3.5 Results  
The mean age of participants in this study was 72.69 (SD 14.49).  There were 61 
males (43.3%) and 80 (56.7%) females.  Other demographic, ulcer and wound treatment 
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characteristics of participants in the prospective validation sample of 141 ulcers are shown in 
Table 7.2. 
 
Table 7.2: Prospective validation of risk assessment tool sample characteristics  
  Prospective Validation Sample 
(n=141) 
Wound not healed at 24 weeks Yes 39 (27.7%) 
History of previous DVT (study leg) Yes 23 (16.4%) 
Lives alone Yes 52 (36.9%) 
Uses an aid to mobilise Yes 72 (51.1%) 
Wound bed mainly slough / necrotic tissue Yes 64 (45.4%) 
Ulcer area ≥ 5cm2 Yes 48 (34.3%) 
Treatment with no, low or moderate level 
compression system (<30mmHg) at baseline visit 
 
Yes 
 
49 (34.8%) 
25% ulcer area reduction in 2 weeks Yes 74 (52.5%) 
2cm or more decrease in calf circumference in 2 
weeks 
 
Yes 
 
23 (16.3%) 
 Median (Range) 
Ulcer Duration (weeks)  16.0 (1-1040) 
 
The model had good discrimination and goodness-of-fit in predicting non-healing of 
venous leg ulcers at 24 weeks with an AUC of 0.78 (95% CI 0.70-0.87, p<0.001) for the total 
risk assessment score.  Thus the model correctly discriminated between ulcers that did not 
heal as compared to those that did, based on the total risk assessment score, 78% of the time.  
Wound non-healing of participants who did not heal by 24 weeks as reported by their total 
risk assessment scores – grouped into three equal groups according to the range of possible 
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scores (i.e. low risk: less than 9, moderate risk: 9 to 16 and high risk: 17 to 25), are shown in 
Table 7.3, indicating that the higher the score the more likely a venous leg ulcer is to remain 
unhealed at 24 weeks. 
 
Table 7.3: Wound non-healing at 24 weeks by total risk assessment score: Prospective  
validation sample (n=141) 
Total risk assessment score n, % not healed n, % healed 
< 9 (low risk) 3 (8.3%) 33 (91.7%) 
9-16 (moderate risk) 17 (23.3%) 56 (76.7%) 
≥ 17 (high risk) 19 (59.4%) 13 (40.6%) 
 
 
In this study 5.5% of participants scored < 9 and of this group, only 8.3% of 
participants remained unhealed after 24 weeks.  A risk assessment score of 9 to 16 occurred 
in 51.8% of this sample and of this group 23.3% of participants remained unhealed after 24 
weeks.  A risk assessment score of 17 and above occurred in 22.7% of this sample and of this 
group 59.4% of participants remained unhealed after 24 weeks.  The Hosmer-Lemeshow 
Goodness of Fit Test also showed the total risk assessment tool score to be an acceptable 
measure of non-healing by 24 weeks (2 (7) = 11.13, p=0.19).  AUC results for baseline, two 
week and total risk assessment scores can be found in Table 7.4 and Figure 7.1 with the 
sensitivity and specificity results reported in Appendix Nine. 
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Table 7.4: Prospective Validation: AUC Results (n=141) 
Non-healed venous leg ulcer at 24 weeks AUC SE p 95% CI 
Baseline Score 0.78 0.05 <0.001 0.69-0.87 
Week Two score 0.74 0.04 0.001 0.59-0.79 
Total risk assessment score 
(Baseline Score + Two Week Score) 
 
0.78 
 
0.04 
 
<0.001 
 
0.70-0.87 
 
 
 
Figure 7.1: Prospective Sample – AUC Results for the sub-scores and total risk  
assessment score 
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7.3.6 Conclusion 
Validation of the risk assessment tool in a prospective multi-site study produced good 
results with total risk assessment scores showing good discrimination and calibration, 
distinguishing those venous leg ulcers that will not heal by 24 weeks, ensuring a valid tool.  
This provides evidence of accuracy of the risk assessment tool, a necessary requirement to 
support the use of the tool in clinical decision making. 
 
7.4  End users’ evaluation of the risk assessment tool 
7.4.1 Method  
 A feedback sheet was designed to collect information from health professionals and 
student health professionals who utilised the risk assessment tool within QUT’s WHCOS to 
determine their perceptions of the usefulness of the tool.  These questions included items on 
ease of use of the tool, the time taken to complete the tool and the perceived usefulness and 
relevance of the tool in clinical practice.  A copy of the feedback sheet is shown in Appendix 
Eleven.  Descriptive analysis was undertaken to assess the information collected from these 
feedback sheets. 
7.4.2 Sample 
A convenience sample of twenty nurse practitioners, registered nurses and student 
nurses were invited to participate in feedback on the risk assessment tool and all agreed to 
participate.  They had all utilised the tool within the clinic on more than one patient during 
their time in the clinic and had not been involved in the development of the tool.  The use of 
student nurses was important to determine the ease of use and understanding of the questions 
of health professionals with limited experience, as compared to those with more experience in 
wound care. 
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7.4.3 Procedure and data management 
An amendment to the initial ethical approval from Study One and Two was obtained 
through QUT’s HREC to survey all health professionals and student health professionals 
who utilised the Risk Assessment Tool within WHCOS, QUT (Approval number: 
1100001368).  The participant information form is documented in Appendix Ten. 
All data were entered into the Statistical package SPSS 19.0 software.  The original 
database was kept in a password protected secure access university hard drive, while all hard 
copies of data were kept in locked filing cabinets.  All database entries were checked against 
the original hard copies for accuracy by two independent persons and descriptive statistics 
run on all variables. 
The feedback sheets were completed anonymously and participant information forms 
were provided to all health professionals and student health professionals who were 
approached to fill in the feedback form.  The return of the completed form was accepted as an 
indication of their consent to participate. 
7.4.4 Results  
The majority of feedback forms were completed in full.  Descriptive statistics indicated 
that 19 (95%) of respondents were female with 7 (35%) aged 21-30 years, 6 (30%) aged 31-
40 years, 5 (25%) aged 41-50 years, 1 (5%) aged 51- 60 years and 1 (5%) aged greater than 
60 years.  Respondents were predominantly student nurses (n=8, 40%), 7 (35%) registered 
nurses, 2 (10%) nurse practitioners, one clinical consultant (5%), one clinical nurse (5%) and 
one endorsed enrolled nurse (5%).  Nine (53%) of the respondents worked mostly in a 
community wound clinic or were students within a community wound clinic, with 1 (5.9%) 
working in a community nursing service, 2 (11.8%) working in residential aged care 
facilities, 3 (17.6%) working in a hospital, 1 (5.9%) working in working in both community 
and hospital facilities and 1 (5.9%) working in private practice.  Some of the students also 
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had health professional employment outside of their studies.  The self-reported professional 
years of experience in wound care of the respondents ranged between 9 (45%) with one year 
or less, to 5 (25%) with 10 years or greater experience in wound care. 
Respondents found the risk assessment tool easy to use with 14 (73.7%) finding no 
questions difficult to answer.  Of those who found some questions difficult to answer the 
main concern was a perception that the wording of the compression question was confusing.  
Students indicated that without extra information, determination of the level of compression 
was not achievable.  The majority of respondents (n=11, 55%) indicated that it took 1-3 
minutes to complete the risk assessment tool, 5 (25%) indicated that it took 3-5 minutes and 4 
(20%) indicated that it took 5-10 minutes.  It is important to note that 6 of the 9 (66.7%) 
respondents who indicated that it took greater than 3 minutes to complete the risk assessment 
tool were students.  Respondents (n=18) indicated that patients were happy to be involved 
with the use of the risk assessment tool and that they would find the tool useful in a 
workplace. 
 
7.5 Conclusion 
Results from the feedback sheets completed by health professionals have indicated the 
tool took a minimal amount of time to complete, however as expected, those with less wound 
care experience took longer to complete the tool.  Clarification of questions, particularly in 
regards to the question asking about the level of compression, or a training manual to go with 
the tool may assist in the completion of timely and accurate completion of the risk assessment 
tool.  All patients were happy for the health professionals to use the risk assessment tool, 
ensuring patient acceptance of the tool, in their care.  To ensure transferability of the risk 
assessment tool across all wound care environments, it was important to have a variety of 
health professional’s feedback.  The convenience sample of nurse practitioners, registered 
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nurses and student registered nurses ensured feedback was able to be incorporated by all 
health professionals from beginning to advanced health practitioners ensuring the tool was 
appropriate, not only for specialist wound care health professionals, but to all wound care 
health professionals. 
This chapter has discussed the research methods and results of Study Three, testing of 
inter-rater reliability, prospective validation of the newly developed risk assessment tool and 
end-users’ evaluation of the risk assessment tool.  The results of Study Three have shown the 
risk assessment tool to have good inter-rater reliability for use in patients with venous leg 
ulcers.  Good prospective validity results have been obtained and a sample of health 
professionals has provided positive responses to the usefulness of the tool, contributing to the 
development of a clinically relevant risk assessment tool.  However, only nurses and student 
nurses were available to complete the feedback tool.  Further exploration of other health 
professionals involved in wound care, i.e. GPs, occupational therapists and podiatrists who 
may also find the tool useful, would be beneficial.  Chapter Eight will provide an overview of 
all three studies and discuss implications of the studies. 
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Chapter Eight: Discussion and Conclusion 
This final chapter overviews the main findings of the three studies conducted within 
this research.  Each study was guided by specific aims and research questions and all 
contributed to the overall aim: to be able to predict the likelihood of non-healing of venous 
leg ulcers within 24 weeks by developing a reliable and valid risk assessment tool.  The risk 
assessment tool developed used evidence based, clinically relevant variables that had the 
content confirmed with an expert Wound Advisory Group (WAG).  Inter-rater reliability 
results were good and validity was confirmed in a retrospective and prospective sample of 
participants.  This chapter will discuss the studies’ contribution to current knowledge and the 
adapted conceptual framework to guide research into failure to heal of venous leg ulcers.  The 
strengths and limitations of the research will also be examined, recommendations provided 
for the use of the risk assessment tool in clinical practice and implications for research and 
further development of the risk assessment tool. 
 
8.1 Contribution to knowledge 
Findings from a literature review indicated that a combination of factors 
(physiological, economic, social and psychological) influence non-healing in venous leg 
ulcers and a conceptual framework was designed to incorporate these categories and guide 
the research of this study.  The conceptual framework described in Chapter Four (Figure 4.4, 
pg.80) discussed the small number of frameworks that have been published to guide the 
assessment of wounds.  While no conceptual framework has been devised specifically for 
venous leg ulcers, current generic models of assessment for chronic wounds were adapted 
and used to develop the conceptual framework for this study on venous leg ulcers.  All the 
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frameworks acknowledge the complex combinations of factors both within and external to 
the wound that are involved in the process of healing.  It is therefore important to address the 
need for a holistic approach to hard-to-heal wounds with the need to look at factors beyond 
the wound itself.  Relationships are proposed to occur within and between the four predictor 
categories (i.e. physiological, social, economic environment and psychological factors); 
however these relationships were outside the scope of this research. 
Based on the conceptual framework categories, Study One, reported in chapter five 
examined significant physiological, economic, social and psychological factors associated 
with the non-healing of venous leg ulcers by 24 weeks.  The results from Study One 
confirmed some of these conceptual framework variable relationships with non-healing, 
although did not confirm others (i.e. economic factors) and identified other relationships with 
non-healing within the categories that will require further investigation.  Many physiological 
factors were noted, with few proposed relationships between social and psychological factors 
identified and/or confirmed.  Therefore an adapted conceptual framework reflects these 
findings and has included the economic category with a broken line association, indicating a 
hypothesised relationship not supported in this study.  This framework is documented in 
Figure 8.1.  It is important to note that there were fewer variables investigated in the social, 
economic and psychological categories than the physiological category and these were often 
complex to measure, with smaller amounts of data available for some variables, which may 
explain a lack of association.  This is a limitation of the study.  Use of the framework has 
demonstrated that in addition to the physiological variables that are well documented and 
researched, risk factors for non-healing in the social and psychological categories are also of 
importance and require further confirmation.  This will be a useful framework for further 
research into the area of non-healing in venous leg ulcers. 
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Figure 8.1: Framework for non-healing of venous leg ulcers by 24 weeks 
 
Study One utilised Generalised Linear Mixed Modelling (GLMM) analysis to adjust 
for all independent variables and potential confounders and identified four predictors that 
were independently and significantly associated with failure to heal of a venous leg ulcer by 
24 weeks.  These were: less than 25% reduction in ulcer area within two weeks; higher ulcer 
severity scores on admission as determined by a Pressure Ulcer Scale for Healing (PUSH) 
score ≥ 10; absence of treatment with high level compression therapy (i.e.<30mmHg) at the 
time of recruitment; and patients who lived alone.  These are important findings and valuable 
indicators for wound care clinicians to be aware of when assessing patients with venous leg 
ulcers.  These results confirm previous systematic reviews in relation to lack of high level 
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compression and non-healing (O'Meara S, et al., 2012; O'Meara, Cullum, et al., 2009) and 
also confirm that percentage area reduction is a significant risk factor for non-healing 
(Kantor, et al., 2000; Phillips, et al., 2000), although it is the first study to confirm a previous 
study’s finding that percentage area reduction at the earliest time of two weeks is 
significantly related to non-healing (Arnold, et al., 1994).  However, this study by Arnold et 
al. (1994) was done quite some time ago and indicated that a 30% area reduction was 
significantly related to non-healing as compared to this study’s findings of a 25% area 
reduction.  This is an important finding as indicators of non-healing as early as possible are 
important in clinical assessment and management. 
This was the first documented study to find a PUSH score independently significantly 
related to non-healing, although the individual variables of area, exudate and tissue type have 
previously been examined with mixed results.  This is an important finding as the PUSH 
score has already been shown to be a valid, responsive, evaluative tool to monitor and 
document progress of venous leg ulcers (Hon, et al., 2010), however predictive ability of the 
PUSH score in venous leg ulcers has not previously been determined.  The use of the PUSH 
score is already widely used with three easy to measure variables and the potential use of this 
tool in assisting to predict failure to heal of venous leg ulcers is an important finding that will 
require further investigation. 
This is also the first study to find an independent significant relationship with living 
alone and non-healing in venous leg ulcers.  Living alone is an important predictor and one 
that will require further investigation to determine contributing factors.  The impact of living 
alone on non-healing venous leg ulcers is complex and multifactorial.  Living alone has been 
significantly related to decreased levels of perceived social support (Shu-Chuan, et al., 2004) 
and is more common in older people (Shu-Chuan, et al., 2004).  Older adults who have no 
income or who receive governmental assistance have been shown to be over represented in 
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the living alone group with an increased risk of falls, dehydration, hypothermia, infection and 
physical injuries (Shu-Chuan, et al., 2004).  This population may be unable to afford 
healthcare, assistive devices, nutritious diet or lack sufficient income to pay for household 
help or travel to visit relatives and friends (Shu-Chuan, et al., 2004).  This is of importance in 
the venous leg ulcer patient population where the healthcare costs of dressings and 
compression therapy are often high.  Living alone is simply a measure of the type of 
household in which an individual lives and is not necessarily representative of ‘being alone’ 
which represents the amount of time individuals spend alone (Victor, et al., 2000). 
The inter-relationships are complex, with isolation, loneliness, being alone, living 
alone and social support clearly related (Victor, et al., 2000).  Living alone has been 
associated with levels of perceived social support and emotional and social isolation (Shu-
Chuan, et al., 2004), with a lack of social support, social isolation and loneliness related to 
negative health outcomes (Barret et al., 1999).  Pain, exudate, odour and the psychological 
impact of unsightly wounds and bandages often result in social isolation (Edwards, et al., 
2005; Persoon, et al., 2004), that could have more of an impact on those who live alone.  
While living alone has been an important finding in this research, we need to consider the 
circumstances that may be contributing to living alone that may be affecting the patient’s 
well-being.  Franks et al. (1994) reported that those with less than one social contact per 
week suffered prolonged healing; however this study did not indicate whether those people 
lived alone.  Psychological theories of disease indicate the importance of the social context of 
disease and indicate the necessary consideration of factors at multiple social levels (e.g. 
individual, peer, community, culture) with the challenge to gain a richer understanding of the 
broader social forces that contribute to these individual factors (Miller, et al., 2009).  It is 
important to determine the implications in this target group of people and further research is 
needed into the effects of these inter-relationships on individuals who live alone. 
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Considering a holistic approach to non-healing in venous leg ulcers, psychological 
considerations are important to consider.  While a geriatric depression score (GDS) did not 
retain a significant relationship with non-healing in GLMM analysis, it is an important 
psychological variable that should be investigated further.  A GDS > 4 was found to be 
significantly related to non-healing of venous leg ulcers at the bivariate level; however a 
clinical diagnosis of depression was not significant for non-healing.  Interestingly, 36% of the 
sample scored the GDS>4, indicating depressive symptoms that may indicate some form of 
depression (McDowell, et al., 1996), however only 15% of the sample had a documented 
diagnosis of depression.  This confirms a previous study by Jones et al. (2006) where 27% of 
people scored highly on depressive symptoms with the Hospital Anxiety and Depression 
Scale, however only 6% had been diagnosed as depressed by a medical practitioner (Jones, et 
al., 2006).  There is an absence of research on the relationship between poor mental health 
and healing in chronic leg ulcers but should be considered due to the profound impact that 
venous leg ulcers can have on a patient’s quality of life (Nogueira, et al., 2012).  Research 
has documented that psychological influences are related to the development and progression 
of several major medical illnesses and it is believed that depression, in particular, influences 
vulnerability to certain diseases (Glaser, et al., 1999).  Pain is notably the most significant 
issue in patients with venous leg ulcers (Persoon, et al., 2004), with depression recognised as 
a major outcome of pain (Jones, et al., 2006).  It has been hypothesised that more than half of 
patients with chronic pain suffer from depression and this has been shown to be 
independently associated with a decreased quality of life (Kroenke et al., 1994).  Studies have 
linked depressive symptoms with morbidity and mortality from cardiovascular disease 
(Miller, et al., 2009).  Many people may not even be aware that they have depression; 
therefore the importance of the identification of depressive symptoms is crucial.  Screening 
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tools of depressive symptoms provide enough information to decide whether further 
assessment of a patient’s mental status is required (Jones, et al., 2006). 
Wound healing is dependent on a range of factors and it is evident that a holistic 
approach to wound healing is necessary.  The inclusion of depressive symptoms and/or 
depression are important in the holistic care of the patient (Jones, et al., 2006).  Only one 
previous study has investigated the role of depressive symptoms in relation to non-healing in 
venous leg ulcers and reported a significant independent association with depressive 
symptoms and non-healing as scored by the GDS (Finlayson, et al., 2012).  While some 
psychological variables have been examined in the literature (i.e., depression and anxiety) 
and have been suggested to have an association with non-healing in venous leg ulcers (Jones, 
et al., 2006; Nogueira, et al., 2009; Palfreyman, et al., 2010), little research has been 
undertaken to determine any association with non-healing.  The results of the current study 
provide evidence that this area could provide important predictive information and should be 
examined further. 
This study also identified other previously unrecognised predictors of non-healing of 
venous leg ulcers at the bivariate level that did not retain significance after controlling for 
other factors but may be of interest to examine in further studies.  These included a history of 
gout, use of salbutamol as a medication, aching in the ulcerated leg, the presence of 
lymphoedema and/or haemosiderosis and health related quality of life.  While some of the 
sample numbers for these variables were small, and therefore results should be considered 
with caution, there is an indication for further exploration of these variables to confirm if they 
are significant predictors of non-healing in venous leg ulcers in larger samples of participants. 
Study Two, reported in chapter six utilised the information from the literature review, 
analysis of results from Study One in relation to non-healing of venous leg ulcers and an 
expert group to develop a risk assessment tool for non-healing in venous leg ulcers by 24 
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weeks.  The risk assessment tool was a one page, easy to use, clinically relevant tool designed 
in conjunction with an expert group.  The tool addressed the limitations of the previous tools, 
expanding the scope, simplifying items and validating the tool in a retrospective database and 
further in a prospective study.  Although it would be ideal to run a comparison of this tool 
against previously developed tools, the inclusion of variables in some of these earlier tools 
that are not routinely measured in wound clinics makes this a difficult proposition. 
The developed risk assessment tool in this study is innovative in that it includes items 
considering change over time which were strong predictors of non-healing, with a baseline 
score, a two week score and then a summed overall risk assessment score.  Early 
identification of patients at the two week mark who are at high risk of non-healing will enable 
prompt referral of this high risk group to specialist wound service providers.  This is in 
contrast to the common practice of waiting weeks or months to determine a response to 
treatment and progress in healing.  The Royal College of Nursing’s clinical practice 
guidelines (2006) recommend that if a wound has not improved in three months then a patient 
should be referred to a specialist (RCN Institute Centre for Evidence Based Nursing, 2006).  
The Australian and New Zealand Clinical Practice Guidelines for the Prevention and 
Management of venous leg ulcers (2011) recommends that if an ulcer has not reduced in size 
by 25% in four weeks, or if a venous leg ulcer fails to heal in twelve weeks, then that patient 
should be referred to a specialist (The Australian Wound Management Association Inc and 
the New Zealand Wound Care Society Inc, 2011).  The United States Agency for Healthcare 
Research and Quality’s guideline for management of wounds in patients with lower-
extremity venous disease (2012) also indicates that ulcers unresponsive to treatment after four 
weeks require referral of the patient for further evaluation or consideration of adjunctive 
therapies (Kelechi et al., 2012), although it is not clear what is considered unresponsive.  The 
findings of this study indicate earlier identification of patients at risk (i.e. two weeks), 
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facilitates earlier evaluation of response to treatment, earlier referrals, determination of 
realistic outcomes and, early implementation of adjunctive interventions or emerging 
treatments as appropriate, when standard care may be insufficient to achieve healing by 24 
weeks. 
Inter-rater reliability of the risk assessment tool was tested in Study Three and 
reported in chapter seven.  Low inter-rater reliability would be a serious drawback, because in 
clinical practice risk assessment tools are used by many different members of the health care 
team at different points of time – therefore high degrees of error would mean these scores 
were valueless (Kottner et al., 2009).  Data should be obtainable with high reliability, 
particularly in those patients for which the model’s predictions are most likely to be needed 
(Wyatt et al, 1995).  The risk assessment tool developed in this study appears to be the only 
tool that has documented testing for inter-rater reliability.  Study Three achieved statistically 
significant agreement among three raters across the majority of risk assessment tool variables 
and the total risk assessment scores, with three items being less reproducible.  In particular 
the questions about level of compression and ulcer duration were misinterpreted on some 
occasions due to the possible wording of the questions.  These items will be adapted and 
clarified in further versions of the risk assessment tool and a training tool designed to address 
the specifics of the questions being asked.  As there are a range of compression types and 
levels of compression, a training manual or the ability of a computer program (i.e. 
Information Technology or eHealth application) to determine the level of compression for a 
particular compression type will be of value for use with the risk assessment tool. 
Validity of the developed risk assessment tool was tested in a retrospective sample 
and reported in chapter six and a prospective sample of participants and reported in chapter 
seven.  The validity of any tool is an essential requirement in ensuring the clinical relevance 
of that tool.  Although a loss of predictive ability in the validation set would have been an 
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expected finding (Justice et al., 1999) and has occurred in other validation studies of venous 
leg ulcer risk assessment tools (Kulkarni, et al., 2007; Margolis, et al., 2000), this did not 
occur in this study.  While the risk assessment score in this study is unique with a baseline 
and two week score, retrospective validation indicated good discrimination and goodness-of-
fit in distinguishing those venous leg ulcers that will not heal by 24 weeks.  Even if a two 
week score was unable to be achieved, a degree of assurance in the predictive ability of the 
risk assessment score is provided to the clinician, based solely on the baseline score (AUC 
0.74, CI 0.59-0.79, p<0.001).  The prospective sample included a sample of participants from 
multiple clinical sites, including home care, specialist private, public and community 
services, therefore good validation results ensure validity in a range of settings.  Validation 
was reported in only three of the previous tools (Kulkarni, et al., 2007; Margolis, et al., 2000; 
Taylor, et al., 2002), and all occurred in participants presenting to specialised leg ulcer 
clinics.  The results indicate that the risk assessment tool developed met the recommendations 
for a reliable useful, predictive tool, providing a real-time prediction of the risk of non-
healing by 24 weeks. 
Study Three, reported in chapter seven also investigated health professionals’ 
perceptions of the risk assessment tool.  Participants reported that most items in the risk 
assessment tool were easy to understand and had simple response choices that could be 
completed without difficulty in a variety of clinical settings, taking a short period of time to 
complete.  For any tool to be effective and be utilised it must be integrated into daily activity, 
as a standalone initiative it is unlikely to have a significant impact (Sud et al., 2008).  
According to the health professionals who participated in the current study, the tool was not 
resource intensive and provided a quick and easy way to identify those at high risk of non-
healing, with easy questions that are a part of everyday clinical practice.  The sample of 
health professionals reported a range of wound care experience, from students to experienced 
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health professionals, with the inclusion of student health professionals important to gain the 
views of novices in wound care.  The health professionals’ feedback indicated that a few of 
the questions on the tool require further refinement and clarification, particularly for those 
health professionals with minimal wound care experience.  For those with limited experience 
it was suggested that the question regarding the level of compression would be difficult to 
answer without extra training or knowledge, and therefore a training manual with reference 
information to assist completion of the risk assessment tool will be a future requirement. 
Overall, the results of this study indicate that a risk assessment tool for non-healing of 
venous leg ulcers in 24 weeks was developed that met the recommendations for an evidence 
based, valid and reliable tool that would benefit clinicians, clients and the healthcare system.  
Currently, health professionals utilise their own judgement and previous experience in 
relation to whether they consider a wound will be difficult to heal.  This risk assessment tool 
will assist in early identification of determining hard-to-heal venous leg ulcers that may not 
have been otherwise recognised. 
 
8.2 Strengths and limitations 
This research has a number of strengths.  Wyatt et al. (1995) indicated that the main 
reasons doctors reject prognostic models are lack of clinical credibility and lack of evidence 
that the model could support decisions about patient care.  Ideally, a risk assessment tool 
should be conceptually straight forward and easily used by clinicians in their daily practice 
with resources available at the point of care when time is often limited (Koopman, et al., 
2008).  Factors supporting clinical credibility of this tool are the use of evidence from multi-
site studies to identify items for inclusion, clinically relevant tool items that do not require the 
need for undue resources and the use of a highly experienced and qualified expert group to 
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confirm validity.  The utilisation of easy to measure variables that are part of routine wound 
care visits used in our current study and tested across hospital and community sites for both 
tool design and validation ensured the tool’s relevance to the majority of wound care settings.  
It is also based on data obtained from patients on admission and in the first two weeks, thus 
the score is generated in time to predict and guide decisions. 
A further strength of the research was the use of GLMM to control for multiple ulcers 
and therefore increasing the sample of ulcers.  Therefore, the lack of independence of data 
that would violate most regression analyses was able to be controlled for in the utilisation of a 
GLMM regression model, ensuring accuracy of the analyses.  This type of analysis is 
relatively new and no further studies were located in the literature looking at risk factors in 
venous leg ulcers that had utilised this type of regression analysis, therefore strengthening our 
analysis results. 
As previously discussed, most of the previous risk assessment tools found in the 
literature were of limited use to many wound care clinicians due to the use of specialist 
measures or resource intensive items.  Margolis et al.’s (2000) risk assessment tool included 
only two quick and easy variables with good validation results.  Results of the evaluation of 
the developed risk assessment tool, as reported in chapter seven, were similar to Margolis’ et 
al (2000) tool.  However, Margolis et al (2000)’s risk assessment tool was developed and 
validated in participants who were treated with high compression.  It was therefore difficult 
to directly compare Margolis’ et al (2000) risk assessment tool, with the risk assessment tool 
developed in this study, which was tested on all patients with venous leg ulcers, regardless of 
compression level applied.  In the current study, 68% of participants in the retrospective 
database and 60% in the prospective database had high compression applied; therefore 30-
40% of these participants would have been inappropriate for the use of Margolis’ et al. 
(2000) tool. 
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There are many reasons that a patient may not be able to tolerate high compression or 
may not want to wear high compression.  Costs, lack of patient compliance and lack of 
training and knowledge, particularly in regards to the skills in applying compression therapy 
are noted to hinder this evidence based practice (Fife, et al., 2010; Phillips, et al., 2000; 
Woodward, 2002).  Previous research indicates that despite compression therapy being the 
gold standard for treatment of venous leg ulcers, only 6.3% of participants on admission to a 
specialty clinic had been treated with compression at any time in the last twelve months 
(Edwards, et al., 2013).  Margolis’ et al. (2000) modelling data set consisted only of patients 
evaluated in a speciality clinic and the validation set consisted of patients evaluated in a 
randomised clinical trial.  These participants may potentially have different characteristics 
than those in the general community (Margolis, et al., 2000). 
Patients are more likely to accept difficult treatment regimens on a short-term basis 
when healing is shown to be within reach (Herber et al., 2007).  The knowledge of risk 
factors associated with non-healing will be important to include in the education of patients 
on the important benefits of this risk assessment tool and the provision of information to 
patients on their likelihood of timely healing in order to make an informed decision based on 
evidence. 
There are a number of limitations in this research that also need to be acknowledged.  
Due to the variations between study data collection protocols within the combined data set 
and missing data due to participant loss to follow-up or short absences from treatment sites, 
all participants did not have the same number of data points.  Small numbers in some variable 
categories (e.g. some co-morbidities, medications) limit the reliability of results for those 
variables.  It is important to also note that previous studies have indicated that participants are 
more likely to be hospitalised and/or lost to follow up if they have larger ulcers or those with 
longer ulcer durations.  Therefore these participants may not be well captured in studies. 
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There may also have been a loss of information with some self-reported data, for 
example, participants remembering if they had ever had a DVT, although all attempts were 
made to confirm data obtained with medical records whenever possible.  Many measures and 
questionnaires containing psychosocial tools were also collected by participants’ self-
reporting and therefore may have included the possibility of self-reported bias. 
There would also potentially be some variance in the actual levels of compression 
applied, depending on clinician technique.  However, as there is a lack of an appropriate 
measurement of the levels applied, the manufacturer’s recommendations were used.  If health 
care professionals who are experienced in the use of compression bandages are applying the 
compression, it can be reasonably certain that these levels would be accurate (Margolis, et al., 
2000). 
The use of two time points in a risk assessment tool, while showing the best 
discriminatory results in relation to non-healing, may not be realistic in some clinical 
situations where reviewing a patient at two weeks may not be appropriate.  Good results were 
also achieved by simply using the baseline score (AUC 0.78, 95% CI 0.69-0.87, p<0.001) or 
the two week score (AUC 0.74, 95% CI 0.59-0.79, p=0.001).  This may also provide a degree 
of guidance in the clinical setting for those unable to achieve an overall risk assessment score.  
However, it is important to note that a two week score cannot be calculated without at least 
the two variables of area and calf circumference being collected at baseline. 
Rater characteristics (e.g. professional background, expertise and training) can have a 
major impact on the degree of reliability and agreement.  It is considered important that raters 
are representative of the population of interest (Kottner, et al., 2009).  The three raters used in 
this study were experienced/trained registered nurses who had been involved in the 
development of the risk assessment tool.  One specialist leg ulcer clinic was used to collect 
the reliability data and this may not be considered a representative sample of participants, 
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raters or clinics.  Due to difficulties in organising raters because of staff rotations and small 
staff numbers, these were the only three raters available and only one site that could provide 
the staff to achieve the information required.  Community nursing organisations only send 
one nurse out to each patient’s home for individual visits.  Therefore, only 16 participants of 
the 30 expected, based on our sample size calculations, were recruited for inter-rater 
reliability and had full risk assessment scores calculated by all three raters for the study 
reported as part of this PhD.  A larger study will continue until the sample of 30 has been 
recruited. 
The risk factors considered were chosen from the literature and previous wound 
healing research studies and were therefore evidence based.  The risk factors considered in 
the analysis of variables were limited to those assessed in Study One, relevant literature and 
expert opinion.  There may be other factors that have not been thoroughly investigated, such 
as nutritional status, calf muscle function, ankle range of motion, and wound diagnostics 
(biochemical indicators).  These factors may be identified and examined in future studies and 
provide an even more reliable scoring system.  Margolis (2000) suggested, however, that to 
be of benefit as a clinically meaningful and simple prognostic tool – any factors added must 
do so without increasing model complexity. 
 
8.3 Recommendations 
The use of this risk assessment tool in clinical practice offers the potential to guide 
management strategies and facilitate decisions for on-going care of the patient.  Results from 
this study provide important information for health professionals about significant risk factors 
for non-healing of venous leg ulcers.  This new risk assessment tool provides a valuable 
prognostic tool for anticipating the probability of non-healing by 24 weeks, utilising ten items 
 Page | 178 
 
over two weeks.  Using this risk assessment tool to guide early decision making on adjuvant 
treatment and interventions is most likely to improve healing and improve health and quality 
of life for those at risk of non-healing venous leg ulcers.  This is likely to decrease costs to 
the health care system while also assisting in the estimation of health care costs.  Tennvall et 
al. (2005) noted that identifying patients who are least likely to heal with standard therapy in 
the first four weeks may reduce total treatment costs.  This research has tested a risk 
assessment tool that will identify hard-to-heal ulcers in half this time.  A risk assessment 
score in patients may also provide valid data on which to base resource allocation and early 
specialist referral in particular settings, such as community nursing, if patients are identified 
as high risk. 
Providing a valid and reliable tool for measuring the risk for non-healing of venous 
leg ulcers will enable clinicians to intervene early in patients at high risk of not healing.  The 
risk assessment tool will assist health professionals to be more confident in recognising the 
necessity for interventions in patients with venous leg ulcers.  Instruments to assess the risk 
of non-healing wounds could help to enhance communication among clinicians by defining a 
common language and standardising assessment characteristics (Mullins, et al., 2005).  Data 
collected in clinical practice using reliable and valid instruments also have credibility and 
usefulness for developing and conducting evidence based practice (Flahr, 2005). 
Early identification of patients at high risk of delayed healing would enable prompt 
referral of this high risk group to specialist wound service providers, rather than the common 
practice of waiting weeks or months to determine response to treatment and progress in 
healing.  When paired with adequate instruction, clear documentation and guidelines for use, 
such an instrument will enable even an inexperienced wound care health professional to 
complete an accurate assessment. 
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Education for health professionals and patients should include information on 
significant predictors for non-healing in venous leg ulcers found in the risk assessment tool.  
Modification of these known variables may then be beneficial in improving outcomes.  As an 
example, while ulcer size is unable to be modified, factors such as level of compression can 
be.  Hence, the risk assessment score can be used to influence clinical decisions and 
ultimately healing.  Education should also be incorporated with any training tool developed to 
assist in the use of the risk assessment tool.  The possible incorporation of a risk assessment 
tool within a pathway of care will also require education for its use in clinical practice. 
 
8.4 Ongoing development of the risk assessment tool 
In response to the validity and inter-rater reliability study findings, further 
modification of the tool will be undertaken.  Future work will include ongoing analyses of the 
risk assessment variables and the refinement of the risk assessment tool.  The risk assessment 
tool will also benefit from being incorporated into an integrated care pathway for venous leg 
ulcers.  Integrated care pathways detail essential steps in the care of patients with a specific 
clinical problem and encourage translation of guidelines and application into clinical practice 
(Campbell et al., 1998). 
The development of a training manual will assist in the use of the risk assessment 
tool.  Each item of the risk assessment tool needs to be clearly defined using definitions that 
reflect widespread use.  Even obvious items like age need clarification.  For example, it was 
queried whether this was meant to be a patient’s age at the start of symptoms, at diagnosis or 
assessment date.  A training manual would improve consistency and interpretation of the 
questions and provide confidence to the assessor.  It would also provide information on levels 
of compression and tissue type examples that may not be well known to health professionals 
who are less experienced in wound care. 
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Analysis of the data from the sample in the prospective study has shown good validity 
results for the risk assessment tool, however, the larger Wound Management Innovation-
Cooperative Research Centre study will continue and greater confidence will be attained 
based on larger numbers of participants.  Further research on the risk assessment tool should 
also focus on reliability and validity with a broader sample of patients with venous leg ulcers, 
and with a variety of healthcare professionals in various settings.  Validity of the tool would 
benefit from testing in general practice with medical professionals and practice nurses as well 
as in international settings.  Reliability of the tool would benefit from further testing with 
other health professional disciplines and other clinics involved in venous leg ulcer care, such 
as occupational therapists and podiatrists, as well as health professionals with a wider range 
of experience and community and general practice clinical situations.  The generalisability of 
a risk assessment tool is established by testing across increasingly diverse settings in which a 
tool is tested and found to be accurate (Justice, et al., 1999). 
The adaptation of the tool into an Information Technology or eHealth application will 
be of benefit in addressing the documentation errors found in the reliability study.  By 
allowing the Information Technology application to determine the levels of compression, 
percentage wound area reduction and calf size reduction, time could be saved and reliability 
enhanced. 
Concurrent Wound Management Innovation-Cooperative Research Centre studies are 
collecting data on nutrition, wound temperature and biomarkers that may prove to be useful 
and could possibly be incorporated in a future version of the tool.  Many biochemical 
indicators are also being investigated as indicators of healing status.  Protease levels and their 
inhibitors, cytokines, senescence markers, oxidative stress markers and microbiological status 
defined by culture, for example, may be potential markers for non-healing (Moore et al., 
2007).  The connection between this PhD study, the larger WMI-CRC project 3.05 and other 
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concurrent WMI-CRC projects is outlined in Appendix 12.  Research has indicated that it is 
most likely that a combination of factors, rather than single factors, will be required to predict 
outcomes in individual patients (Moore, et al., 2007).  Some have suggested that gene 
expression profiling may also have a role in predicting wound non-healing (EWMA, 2008).  
While the risk assessment tool that has been developed is appropriate at present, analysis of 
further predictors and adaptation of the risk assessment tool, in the future, may allow more 
accurate assessment of non-healing and potential treatment targeting (EWMA, 2008). 
 
8.5 Conclusion 
The aim of this research was to identify factors associated with non-healing venous 
leg ulcers and to develop a risk assessment tool that was reliable and valid.  The lack of 
previous investigation of social, economic and psychological factors highlighted a need for 
further examination of these areas.  The development of an easy to use risk assessment tool 
combining evidence based data and consensus from an expert group contributed important 
new information in the area of assessment of venous leg ulcers. 
In conclusion, this study has identified a conceptual framework to guide research of 
risks for non-healing of venous leg ulcers.  Data from this study confirmed that the tool, with 
the components of age, ulcer duration, history of DVT, living alone, aid to mobilise, wound 
bed status, ulcer area, compression, 25% area reduction in 2 weeks and 2cm or more decrease 
in calf circumference in 2 weeks, is a valid and sensitive measure of venous leg ulcer healing.  
It is a practical approach that provides clinically valid data regarding risk assessment of 
venous leg ulcer healing.  It is recommended that this risk assessment tool be investigated 
further in regard to the current items used, other potential factors, and the potential for 
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transitioning it into an Information Technology, eHealth application and a pathway of care 
for patients with venous leg ulcers to inform clinician decisions.
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Appendix One: Project team 
 
Wound Management Innovation CRC – Project 3.05 
Relationship to the project Title First 
Name 
Surname Position 
Project Lead Chief 
Investigator 
Prof Helen Edwards Head, School of Nursing, QUT 
Program Leader, Wound Management Innovation CRC 
 
RDNS Principal Investigator Ms Charne Miller Research Fellow, RDNS Institute* 
 
RDNS Co-investigator Dr Rajna Ogrin Research Fellow, RDNS Institute* 
 
RDNS Co-investigator Ms Suzanne Kapp Clinical Nurse Consultant Wound Management & Research, RDNS Institute* 
 
QUT Co-Investigator Dr Kathy Finlayson Research Fellow, SON, Institute of Health and Biomedical Innovation (IHBI) 
 
QUT Co-Investigator Ms Michelle Gibb Nurse Practitioner (Wound Management), QUT Wound Healing Service, SON 
 
 Senior Research Assistant Dr Winnie  Wu SRA, SON, Institute of Health and Biomedical Innovation 
 
HDR student Ms  Christina  Parker HDR student, SON, IHBI 
 
Blue Care Chief Investigator Ms Kerrie Storey Community Care Advisor 
 
Blue Care Co-investigator Mr Paul Burrows Podiatrist-  Blue Care Redcliffe Community Care 
 
RB&WH Chief Investigator Dr Dianne Smith 
RB&WH chronic wound clinic 
RB&WH Chief Investigator Ms Kerrie  Coleman 
Nurse Practitioner (Wound Management), RB&WH chronic wound clinic 
* RDNS Institute: Royal District Nursing Service Helen Macpherson Smith Institute of Community Health 
    ^ Royal District Nursing Service 
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Appendix Two: Studies of significant risk factors for non-healing venous leg ulcers 
 
Risk factor Study Year Evidence level 
Physiological    
Lack of high level 
graduated 
compression therapy 
 
O'Meara S, Cullum N, Nelson EA, et al. 
 
2012 
 
I 
 
Larger ulcer area Labropoulos, N., Wang, E. D., Lanier, et al. 
 
Sola, M. L., Antonio, J., Fajardo, G., et al. 
 
Cardinal, M., Eisenbud, D. E., & Armstrong, D. G. 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al.  
 
O'Meara, S., Tierney, J., Cullum, et al. 
 
Taylor, R. J., Taylor, A. D., & Smyth, J. V. 
 
Phillips, T. J., Machado, F., Trout, et al. 
 
Guest, M., Smith, J. J., Sira, et al. 
 
Margolis, D. J., Berlin, J. A., & Strom, B. L. 
 
Franks, P. J., Moffatt, C. J., Connolly, et al. 
 
Stacey, M. C., Jopp Mckay, A. G., Rashid, et al. 
 
Skene, A. I., Smith, J. M., Dore, C. J., et al. 
 
2012 
 
2012 
 
2009 
 
2009 
 
2009 
 
2002 
 
2000 
 
1999 
 
1999 
 
1995 
 
1997 
 
1992 
III-3 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
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Longer ulcer duration Lantis, J. C., Marston, W. A., Farber, et al. 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al.  
 
O'Meara, S., Tierney, J., Cullum, et al. 
 
Barwell, J. R., Ghauri, A. S. K., Taylor, et al. 
 
Cardinal, M., Eisenbud, D. E., & Armstrong, D. G. 
 
Gohel, M. S., Taylor, M., Earnshaw, J. J., et al. 
 
Meaume, S., Couilliet, D., & Vin, F. 
 
Franks, P. J., Moffatt, C. J., Connolly, et al. 
 
Margolis, D. J., Berlin, J. A., & Strom, B. L. 
 
Phillips, T. J., Machado, F., Trout, R., et al. 
 
Skene, A. I., Smith, J. M., Dore, et al. 
 
2013 
 
2009 
 
2009 
 
2000 
 
2009 
 
2005 
 
2005 
 
1995 
 
1999 
 
2000 
 
1992 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
 
Venous abnormalities Labropoulos, N., Wang, E. D., Lanier, et al. (Deep vein 
abnormality/insufficiency and DVT) 
 
Chaby, G., Viseux, V., Ramelet, et al. (DVT) 
 
Szewczyk, M. T., Jawien, A., Migdalski, A., et al. (Deep 
vein abnormality/insufficiency) 
 
Cardinal, M., Eisenbud, D. E., & Armstrong, D. G. (Ulcer 
location) 
 
2012 
 
2006 
 
 
2009 
 
 
2009 
 
III-3 
 
III-2 
 
 
IV 
 
 
IV 
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Stacey, M. C., Jopp Mckay, A. G., Rashid, et al. (Right leg) 
 
Skene, A. I., Smith, J. M., Dore, et al. (Deep vein 
abnormality/insufficiency) 
 
1997 
 
 
1992 
 
IV 
 
 
IV 
Recurrence of leg 
ulceration 
Chaby, G., Viseux, V., Ramelet, et al. 
 
Abbade, L. P. F., Lastória, S., & Rollo, H. d. A. 
 
O'Meara, S., Tierney, J., Cullum, N., et al. 
 
Taylor, R. J., Taylor, A. D., & Smyth, J. V. 
 
2006 
 
2011 
 
2009 
 
2002 
III-2 
 
IV 
 
IV 
 
IV 
 
Mobility / fixed ankle 
joint / walking aid 
Meagher, H., Clarke-Moloney, M., O Laighin, G., et al. 
 
Chaby, G., Viseux, V., Ramelet, et al. 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al. 
 
Barwell, J. R., Taylor, M., Deacon, J., et al. 
 
Franks, P. J., Moffatt, C. J., Connolly, et al. 
 
2012 
 
2006 
 
2009 
 
2001 
 
1995 
 
II 
 
III-2 
 
IV 
 
IV 
 
IV 
Previous limb surgery Chaby, G., Senet, P., Ganry, et al. (Venous surgery) 
 
Margolis, D. J., Berlin, J. A., & Strom, B. L. (Venous 
surgery and other limb surgery) 
 
Sufian, S., Lakhanpal, S., & Marquez, J. (Venous surgery) 
 
2013 
 
 
1999 
 
2011 
III-3 
 
 
IV 
 
IV 
Increased age Labropoulos, N., Wang, E. D., Lanier, et al. 
 
2012 
 
III-3 
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Kulkarni, S. R., Gohel, M. S., & Wakely, C. 
 
Gohel, M. S., Taylor, M., Earnshaw, J. J., et al. 
 
Barwell, J. R., Ghauri, A. S. K., Taylor, et al. 
 
Taylor, R. J., Taylor, A. D., & Smyth, J. V. 
 
Skene, A. I., Smith, J. M., Dore, C. J., et al. 
 
2007 
 
2005 
 
2000 
 
2002 
 
1992 
 
IV 
 
IV 
 
IV 
 
IV 
 
IV 
Ulcer area percentage 
reduction 
Kantor, J., & Margolis, D. J. 
 
Arnold, T. E., Stanley, J. C., Fellows, et al. 
2000 
 
1994 
IV 
 
IV 
Nutrition (Obesity) Labropoulos, N., Wang, E. D., Lanier, et al. 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al. 
 
2012 
 
2009 
III-3 
 
IV 
Heavier exudate 
 
Taylor, R. J., Taylor, A. D., & Smyth, J. V. 
 
2002 IV 
Tissue type Margolis, D. J., Berlin, J. A., & Strom, B. L. 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al. 
 
1999 
 
2009 
IV 
 
IV 
Calf/ankle 
circumference 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al. 
 
 
2009 
 
IV 
Surgical wound 
debridement 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., et al. 
 
2009 IV 
Surrounding skin Abbade, L. P. F., Lastória, S., & Rollo, H. D. A. 
 
Cardinal, M., Eisenbud, D. E., & Armstrong, D. G. 
2011 
 
2009 
 
IV 
 
IV 
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Medications Layton, A. M., & Ibbotson, S. H. 
 
Sola, M. L., Antonio, J., Fajardo, G., & Puerta, C. V. 
1994 
 
2012 
II 
 
IV 
Race Jones, K. R. 2009 IV 
Economic 
Environment 
 
   
Low social class Franks, P. J., Moffatt, C. J., Connolly, et al. 
 
1995 IV 
Social 
 
   
Home care Franks, P. J., Moffatt, C. J., Connolly, et al. 
 
1995 IV 
Social care Edwards, H., Courtney, M., Finlayson, K., et al. 
 
2005 II 
Psychological 
 
   
Depressive Symptoms Finlayson, K. J., Courtney, M. D., Gibb, M. A., et al. 2012 II 
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Appendix Three: Flowchart of eligible participants (Study One) 
  
 
 
n 
 
 
 
 
Eligible patients fitting inclusion criteria 
Study One
1 
n=73 
 
Study Two
2
 
n=43 
Study Three
3
  
n=87 
Study Four
4
  
n=10 
Study Five
5
  
n=33 
Study Six
6
  
n=17 
Study Seven
7
  
n=103 
Lost to follow up 
n=17 
Lost to follow up 
n=9 
Lost to follow up 
n=5 
Lost to follow up 
n=2 
Lost to follow up 
n=3 
Lost to follow up 
n=2 
Lost to follow up 
n=10 
Final analysis 
n=56 
Final analysis 
n=34 
Final analysis 
n=82 
Final analysis 
n=8 
Final analysis 
n=30 
Final analysis 
n=15 
Final analysis 
n=93 
Final sample n= 318 
1 
A trial of two community nursing models of care for patients with venous leg ulcers (Edwards et al., 2009)  
2 
An investigation of biomarkers in venous leg ulcers  
3 
A randomised control trial of two types of compression therapy for patients with venous leg ulcers (Finlayson et al., 2012) 
4 
A randomised controlled trial investigating the effects of a progressive resistance exercise program for patients with venous leg ulcers (O’Brien et al., 2012) 
5 
A prospective observational study of pathways of care for patients with chronic leg ulcers (Edwards et al., 2013) 
6 
A prospective observational study to determine relationships between clinical outcomes and biochemical markers in patients with chronic wounds (Stupar et al., 2012) 
7 
An evaluation of the Queensland University of Technology’s Wound Healing Community Outreach Service (Gibb et al., 2012) 
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Appendix Four: Questionnaire Instruments 
Pressure Ulcer Scale for Healing (PUSH) 
An instrument to measure healing in pressure ulcers 
DIRECTIONS: 
Observe and measure the pressure ulcer. Categorize the ulcer with respect to surface area, 
exudate, and type of wound tissue. Record a sub-score for each of these ulcer characteristics. 
Add the sub-scores to obtain the total score.  
 
 
Length 
X 
Width 
 
0 
 
0 cm
2
 
 
1 
 
<0.3 cm
2
 
 
2 
 
0.3–0.6 cm2 
 
3 
 
0.7–1.0 cm2 
 
4 
 
1.1–2.0 cm2 
 
5 
 
2.1–3.0 cm2 
 
 
 
 
 
 
Sub 
Score 
  
6 
 
3.1–4.0 cm2 
 
7 
 
4.1–8 cm2 
 
8 
 
8.1–12 cm2 
 
9 
 
12.1–24.0 cm2 
 
10 
 
>24 cm
2
 
 
Exudate 
Amount 
 
0 
None 
 
1 
Light 
 
2 
Moderate 
 
3 
Heavy 
   
Sub 
Score 
 
Tissue 
Type 
 
0 
Closed 
 
1 
Epithelial 
Tissue 
 
2 
Granulation 
Tissue 
 
3 
Slough 
 
4 
Necrotic 
Tissue 
  
 
Sub 
Score 
Total Score  
(National Pressure Ulcer Advisory Panel, 2013; Stotts, et al., 2001) 
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Medical outcomes study pain measures 
The following questions are about the pain or pains you experienced in the past 4 weeks. 
 
If you had more than one pain, answer the questions by describing your feelings of pain in 
general 
1. How much bodily pain have you generally had during the past 4 weeks?                  (Indicate One) 
 None ……………………………….  1 
Very mild ...………………………..  2 
Mild …………………………………  3 
Moderate …………………………..  4 
Severe ………………………………  5 
Very severe …………………………  6 
If you had no pain at all in the past 4 weeks, please leave the following questions blank. 
2. During the past 4 weeks, how often have you had pain or discomfort?                        (Indicate One) 
 
Once or twice………………. ……..  1 
A few times.………………………..  2 
Fairly often.………………………..  3 
Very often…………………………..   4 
Every day or almost every day ……  5 
3. When you had pain during the past 4 weeks, how long did it usually last?                  (Indicate One) 
 
A few minutes……………………….  1 
Several minutes to an hour ………..  2 
Several hours………………………..  3 
A day or two………………………….   4 
More than two days ……………..….  5 
4. During the past 4 weeks, how much did pain interfere with the following things? 
(Circle One Number on Each Line) 
 Not At All A Little Bit Moderately Quite a Bit Extremely 
a.Your mood 1 2 3 4 5 
b.Your ability to walk or move 
about 
1 2 3 4 5 
c.Your sleep 1 2 3 4 5 
d.Your normal work (including 
both work outside the home 
and housework) 
1 2 3 4 5 
e.Your recreational activities 1 2 3 4 5 
f.Your enjoyment of life 1 2 3 4 5 
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(Stewart, et al., 1992) 
 
 
 
 
 
 
 
 
 
 
 
 
5. During the past 4 weeks, how many days did pain interfere with the things you usually do? 
    (Your answer may range from 0 to 28 days.) 
WRITE IN NUMBER OF DAYS:  __________ 
6. Please circle the one number that best describes your pain on the average over the past  
    4 weeks. 
No Pain                Pain as bad as you 
can imagine 
                     
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
 
7. Please circle the one number that best describes your pain at its worst over the past 4 weeks. 
No Pain                Pain as bad as you 
can imagine 
                     
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
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Index of Activities of Daily Living (ADL)
 
For each area of functioning listed below, tick the description that applies. (The word 
“assistance” means supervision, direction, or personal assistance.) 
(Katz et al., 1976) 
Bathing – either sponge bath; tub bath, or shower 
 
 
Receives no assistance (gets 
in and out of tub by self if 
tub is usual means of 
bathing) 
 
 
Receives assistance in 
bathing only one part of the 
body (such as back or a leg) 
 
 
Receives assistance in bathing 
more than one part of the body (or 
not bathed) 
Dressing – gets clothes from closets and drawers – including underclothes, outer garments and 
using fasteners 
 
 
Gets clothes and gets 
completely dressed without 
assistance 
 
 
Gets clothes and gets dressed 
without assistance except for 
assistance in tying shoes 
 
 
Receives assistance in getting 
clothes or in getting dressed, or 
stays partly or completely 
undressed. 
Toileting – going to the toilet for bowel and urine elimination; cleaning self after elimination, and 
arranging clothes 
 
 
Goes to “toilet room”, cleans 
self, arranges clothes without 
assistance (may use object for 
support such as cane, walker, 
or wheelchair; may manage 
night bedpan or commode, 
emptying in morning) 
 
 
Receives assistance in going 
to “toilet room” or in 
cleansing self or in arranging 
clothes after elimination or in 
use of night bedpan or 
commode 
 
 
Doesn’t go to room termed 
“toilet” for the elimination 
process 
Transfer -  
 
 
Moves in and out of bed as 
well as in and out of chair 
without assistance (may be 
using object for support such 
as cane or walker) 
 
 
Moves in  and out of bed or 
chair with assistance 
 
 
Doesn’t get out of bed 
Continence -  
 
 
Controls urination and bowel 
movement completely by self 
 
 
Has occasional “accidents” 
 
 
Supervision helps keep urine or 
bowel control; catheter is used, 
or is incontinent 
Feeding -  
 
Feeds self without assistance 
 
Feeds self except for getting 
assistance in cutting meat or 
buttering bread 
 
Receives assistance in feeding 
or is fed partly or completely by 
using tubes or intravenous 
fluids 
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Instrumental Activities of Daily Living (IADL) 
Please place a tick in the space next to the statement that most represents your current 
level of functioning. 
 
Activity Guidelines for level of function 
 
Using 
Telephone 
You are: 
(  )  - able to look up numbers, dial, receive and make calls without help 
(  )  - able to answer the phone or dial an operator in an emergency but     
         need a special phone or help in getting the number or dialling 
(  )  -  unable to use telephone 
Travelling (  )  - able to drive your own car or travel alone on buses or taxis 
(  )  - able to travel but need someone to travel with 
(  )  - unable to travel 
Shopping (  )  - able to take care of all food and clothes shopping 
(  )  - able to shop but need someone to shop with 
(  )  - unable to shop 
Preparing 
Meals 
(  )  - able to plan and cook full meals 
(  )  - able to prepare light foods but are unable to cook full meals alone 
(  )  - unable to prepare any meals 
Housework (  )  - able to do heavy housework, ie. Scrub floors 
(  )  - able to do light housework, but need help with heavy tasks 
(  )  - unable to do any housework 
Taking 
Medicine 
(  )  - able to prepare / take medications in the right dose at the right time 
(  )  - able to take medications, but needs reminding or someone to  
         prepare them 
(  )  - unable to take medications 
Managing 
Money 
(  )  - able to manage buying needs, i.e., write checks, pay bills 
(  )  - able to manage daily buying needs but you need help managing     
         your checkbook and paying bills 
(  )  - unable to handle money 
(Lawton, et al., 1969) 
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                  The Medical Outcomes Study Social Support Survey 
About how many close friends and close relatives do you have (people you feel at ease with 
and can talk to about what is on your mind)? 
Write in the number of close friends and close relatives: 
How often is each of the following kinds of support available to you if you need it? 
 (Circle one number on each line) 
 None 
of the 
time 
A 
little 
of the 
time 
Some 
of the 
time 
Most 
of the 
time 
All 
of 
the 
time 
Someone to help you if you were confined to bed. 1 2 3 4 5 
Someone you can count on to listen to you when  
you need to talk.      
1 2 3 4 5 
Someone to give you good advice about a crisis. 1 2 3 4 5 
Someone to take you to the doctor if you needed it. 1 2 3 4 5 
Someone who shows you love and affection. 1 2 3 4 5 
Someone to have a good time with. 1 2 3 4 5 
Someone to give you information to help you  
understand a situation. 
1 2 3 4 5 
Someone to confide in or talk to about yourself or      
your problems. 
1 2 3 4 5 
Someone who hugs you. 1 2 3 4 5 
Someone to get together with for relaxation. 1 2 3 4 5 
Someone to prepare your meals if you were unable 
to do it yourself.      
1 2 3 4 5 
Someone whose advice you really want. 1 2 3 4 5 
Someone to do things with to help you get your  
mind off things.     
1 2 3 4 5 
Someone to help with daily chores if you were sick 1 2 3 4 5 
Someone to share your most private worries and      
fears with. 
1 2 3 4 5 
Someone to turn to for suggestions about how to       
deal with a personal problem. 
1 2 3 4 5 
Someone to do something enjoyable with 1 2 3 4 5 
Someone who understands your problems. 1 2 3 4 5 
Someone to love and make you feel wanted. 1 2 3 4 5 
(Sherbourne, et at., 1991, p.713) 
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Geriatric Depression Scale (Shortened 15 item version) 
Choose the best answer for how you felt over the last week: 
(Please circle your response) 
Are you basically satisfied with your life? Yes  /  No 
Have you dropped many of your activities and interests? Yes  /  No 
Do you feel that your life is empty? Yes  /  No 
Do you often get bored? Yes  /  No 
Are you in good spirits most of the time? Yes  /  No 
Are you afraid that something bad is going to happen to you? Yes  /  No 
Do you feel happy most of the time? Yes  /  No 
Do you often feel helpless? Yes  /  No 
Do you prefer to stay at home, rather than go out and do new  
  things? 
Yes  /  No 
Do you feel that you have more problems with memory than most? Yes  /  No 
Do you think it is wonderful to be alive now? Yes  /  No 
Do you feel pretty worthless the way you are now? Yes  /  No 
Do you feel full of energy? Yes  /  No 
Do you feel that your situation is hopeless? Yes  /  No 
Do you think that most people are better off than you are? Yes  /  No 
(Brink et al., 1982) 
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SF-12® Health Survey 
This survey asks for your views about your health. This information will help you 
keep track of how you feel and how well you are able to do your usual activities. 
 
Answer every question by selecting the answer as indicated. If you are unsure about 
how to answer a question, please give the best answer you can.  
 
 
1. In general, would you say your health is: 
 Excellent Very good Good Fair Poor 
 
     
 
 
2. The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
 
 
Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
 
 
a Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf    
 
 b Climbing several flights of stairs 
   
 
 
3. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? 
 
 Yes No 
 
 
 a Accomplished less than you would like 
  
 
 b Were limited in the kind of work or other activities 
  
 
 
4. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such 
as feeling depressed or anxious)? 
 Yes No 
 
 a Accomplished less than you would like 
  
 
 b Did work or other activities less carefully than usual 
  
 
 
5. During thepast 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 
 Not at all A little bit Moderately Quite a bit Extremely 
 
     
 
 
6. These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest 
to the way you have been feeling. 
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How much of the time during the past 4 weeks... 
 
 
All 
of the 
time 
Most 
of the 
time 
A 
good 
bit of 
the 
time 
Some 
of the 
time 
A 
little 
of the 
time 
None 
of the 
time 
 
 a Have you felt calm and peaceful? 
      
 
 b Did you have a lot of energy? 
      
 
 c Have you felt downhearted and blue? 
      
 
 
7. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, 
relatives, etc.)? 
 
All of the 
time 
Most of the 
time 
Some of the 
time 
A little of the 
time 
None of the 
time 
 
     
 
 
(Ware, et al., 1996) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Spitzer’s quality of life 
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(Spitzer, et al., 1981) 
 
 
 
 
 
 
Cardiff Wound Impact Schedule (C.W.I.S.) 
Physical Symptoms and Daily Living 
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Have you experienced any of the following during the past week? 
(Please tick the appropriate column) 
 Not at all/ 
Not 
applicable 
Seldom Sometimes Frequently Always 
Disturbed sleep      
Difficulty in bathing      
Immobility around the   
Home 
     
Immobility outside the 
Home 
     
Leakage from the 
wound(s) 
     
Pain from the wound Site      
Discomfort from the 
bandaging/dressing 
     
Unpleasant odour or smell 
from the wound(s)   
     
Problems with Everyday 
tasks (eg. Shopping) 
     
Difficulty in finding 
appropriate footwear 
     
Problems with the  
amount of time needed to 
care for the wound site 
     
Financial difficulties as a 
result of the wound(s) 
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Physical Symptoms and Daily Living 
How stressful has this experience been for you? 
(Please tick the appropriate column) 
 Not at all/ 
Not 
applicable 
Slightly Moderately Quite a bit Very 
 
Disturbed sleep      
Difficulty in bathing      
Immobility around the Home      
Immobility outside the Home      
Leakage from the wound(s)      
Pain from the wound site      
Discomfort from the 
bandaging/dressing 
     
Unpleasant odour or smell 
from the wound(s) 
     
Problems with everyday tasks 
(eg shopping) 
     
Difficulty in finding 
appropriate footwear 
     
Problems with the amount of 
time needed to care for the 
wound site      
     
Financial difficulties as a     
result of the wound(s) 
 
     
(Price, et al., 2004, p.13) 
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Appendix Five: Human ethics approval certificates 
(Study One and Two) 
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(Study Three) 
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Appendix Six: Physiological / Economic / Social / Psychological 
characteristics of total ulcer sample (Study One) 
 
      Medical Conditions for retrospective total ulcer sample (n=318 ulcers / 247participants)  
  Healed 
n (%) 
Unhealed 
n (%) 
     Total 
n (%) 
  
                            Frequencies 2 p 
Diabetes Yes 
No 
33 (15.2%) 
184 (84.8%) 
19 (19.8%) 
77 (80.2%) 
52 (16.6%) 
261 (83.4%) 
 
1.01 
 
0.315 
Osteoarthritis Yes 
No 
69 (31.2%) 
146 (67.9%) 
26 (27.4%) 
69 (72.6%) 
95 (30.6%) 
215 (69.4%) 
 
0.69 
 
0.405 
Rheumatoid Arthritis Yes 
No 
12 (5.6%) 
203 (94.4%) 
12 (12.6%) 
83 (87.4%) 
24 (7.7%) 
286 (92.3%) 
 
4.59 
 
0.032 
Hypertension Yes 
No 
100 (46.5%) 
115 (53.5%) 
41 (42.7%) 
55 (57.3%) 
141 (45.3%) 
170 (54.7%) 
 
0.39 
 
0.534 
Heart Disease Yes 
No 
59 (27.4%) 
156 (72.6%) 
33 (34.4%) 
63 (65.6%) 
92 (29.6%) 
219 (70.4%) 
 
1.53 
 
0.216 
CVA Yes 
No 
23 (10.7%) 
192 (89.3%) 
16 (16.7%) 
80 (83.3%) 
39 (12.5%) 
272 (87.5%) 
 
2.16 
 
0.142 
Autoimmune Disease Yes 
No 
16 (7.7%) 
191 (92.3%) 
13 (14.6%) 
76 (85.4%) 
29 (9.8%) 
267 (90.2%) 
 
3.33 
 
0.068 
Respiratory Disease* Yes 
No 
18 (9.7%) 
189 (90.3%) 
4 (4.4%) 
86 (95.6%) 
22 (8.1%) 
275 (91.9%) 
 
 
 
0.166 
Gout Yes 
No 
5 (2.4%) 
202 (97.6%) 
7 (7.8%) 
83 (92.2%) 
12 (4.0%) 
285 (96.0%) 
 
4.65 
 
0.031 
Hypothyroidism Yes 
No 
19 (9.2%) 
188 (90.8%) 
7 (7.8%) 
83 (92.2%) 
26 (8.8%) 
271 (91.2%) 
 
0.15 
 
0.695 
Hypercholesterolaemia/ 
Hyperlipidaemia 
Yes 
No 
12 (5.9%) 
192 (94.1%) 
9 (10.3%) 
78 (89.7%) 
21 (7.2%) 
270 (92.8%) 
1
1.81 
 
0.178 
Cancer  Yes 
No 
 
25 (12.1%) 
182 (87.9%) 
8 (8.9%) 
82 (91.1%) 
33 (11.1%) 
264 (88.9%) 
0
0.65 
 
0.422 
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  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
                           Frequencies 2 p 
Other medical conditions Yes 
No 
101 (46.3%) 
113 (53.7%) 
39 (41.1%) 
56 (58.9%) 
140 (44.7%) 
169 (55.3%) 
1
1.00 
 
0.317 
More than three medical 
conditions 
Yes 
No 
51 (23.7%) 
164 (76.3%) 
30 (31.6%) 
65 (68.4%) 
81 (26.1%) 
229 (73.9%) 
2
2.11 
 
0.147 
*Fishers exact test used due to the value in at least one cell being < 5                      
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Medications for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
               Frequencies 2 p 
Anticoagulants  Yes 
No 
81 (39.1%) 
126 (60.9%) 
39 (45.9%) 
46 (54.1%) 
120 (41.1%) 
172 (58.9%) 
 
1.14 
 
0.287 
Antihypertensives Yes 
No 
98 (47.3%) 
109 (52.7%) 
37 (43.0%) 
49 (57.0%) 
135 (46.1%) 
158 (53.9%) 
 
0.46 
 
0.499 
Diuretic Yes 
No 
65 (30.7%) 
147 (69.3%) 
19 (21.8%) 
68 (78.2%) 
84 (28.1%) 
215 (71.9%) 
 
2.38 
 
0.123 
Thyroxine Yes 
No 
17 (8.2%) 
190 (91.8%) 
6 (7.1%) 
78 (92.9%) 
23 (7.9%) 
268 (92.1%) 
 
0.09 
 
0.759 
Steroids Yes 
No 
34 (16.4%) 
173 (83.6%) 
8 (9.5%) 
76 (90.5%) 
42 (14.4%) 
249 (85.6%) 
 
2.30 
 
0.129 
Analgesics Yes 
No 
103 (49.8%) 
104 (50.2%) 
45 (53.6%) 
39 (46.4%) 
148 (50.9%) 
143 (49.1%) 
 
0.35 
 
0.555 
Ventolin* Yes 
No 
21 (10.1%) 
186 (89.9%) 
2 (2.4%) 
82 (97.6%) 
23 (7.9%) 
268 (92.1%) 
 
 
 
0.029 
Antidepressants Yes 
No 
27 (13%) 
180 (87.0%) 
19 (22.9%) 
64 (77.1%) 
46 (15.9%) 
244 (84.1%) 
 
4.31 
 
0.038 
Non-Steroidal Anti-
inflammatories 
Yes 
No 
33 (17.6%) 
160 (82.4%) 
15 (19.5%) 
62 (80.5%) 
48 (18.1%) 
222 (81.9%) 
 
0.21 
 
0.644 
Zinc* Yes 
No 
11 (5.8%) 
179 (94.2%) 
1 (1.3%) 
74 (98.7%) 
12 (4.5%) 
253 (95.5%) 
 
 
 
0.188 
Allopurinol Yes 
No 
8 (4.2%) 
182 (95.8%) 
8 (10.7%) 
67 (89.3%) 
16 (6.0%) 
249 (94.0%) 
 
3.95 
 
0.047 
Statin  Yes 
No 
29 (15.3%) 
161 (84.7%) 
17 (22.7%) 
58 (77.3%) 
46 (17.4%) 
219 (82.6%) 
 
2.06 
 
0.152 
Antibiotics 
 
Yes 
No 
37 (19.5%) 
153 (80.5%) 
9 (12.0%) 
66 (88.0%) 
46 (17.4%) 
219 (82.6%) 
 
2.09 
 
0.148 
Immunosuppressive 
medications* 
Yes 
No 
1 (0.5%) 
189 (99.5%) 
 
2 (2.7%) 
73 (97.3%) 
3 (1.1%) 
262 (98.9%) 
 
 
 
0.194 
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  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
                Frequencies 2 p 
Diabetic 
medications  
Yes 
No 
16 (8.4%) 
174 (91.6%) 
10 (13.3%) 
65 (86.7%) 
26 (9.8%) 
239 (90.2%) 
 
1.47 
 
0.226 
Reflux medications  
 
Yes 
No 
32 (16.8%) 
158 (83.2%) 
19 (25.3%) 
56 (74.7%) 
51 (19.2%) 
214 (80.8%) 
 
2.50 
 
0.114 
Benzodiazepines  Yes 
No 
7 (3.7%) 
183 (96.3%) 
6 (8.0%) 
69 (92.0%) 
13 (4.9%) 
252 (95.1%) 
 
2.15 
 
0.143 
Nitrates*  Yes 
No 
5 (2.6%) 
185 (97.4%) 
2 (2.7%) 
73 (97.3%) 
7 (2.6%) 
258 (97.4%) 
 
 
 
1.000 
HRT* Yes 
No 
5 (2.6%) 
185 (97.4%) 
1 (1.4%) 
73 (98.6%) 
6 (2.3%) 
258 (97.7%) 
 
 
 
1.000 
Any other 
medications 
Yes 
No 
120 (60.2%) 
76 (39.8%) 
46 (61.3%) 
29 (38.7%) 
166 (60.5%) 
105 (39.5%) 
 
0.00 
 
0.987 
4 or more types of 
medications 
Yes 
No 
96 (48.5%) 
102 (51.5%) 
43 (55.1%) 
35 (44.9%) 
139 (50.4%) 
137 (49.6%) 
 
0.99 
 
0.320 
 
*Fishers exact test used due to the value in at least one cell being < 5                      
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Venous history for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
            Frequencies 2 p 
Varicose veins in study 
leg 
Yes 
No 
136 (63.6%) 
68 (72.3%) 
78 (36.4%) 
26 (27.7%) 
214 (62.6%) 
94 (33.8%) 
 
2.26 
 
0.133 
DVT in study leg Yes 
No 
27 (13.6%) 
185 (86.4%) 
22 (23.7%) 
71 (76.3%) 
49 (16.6%) 
256 (83.4%) 
 
5.72 
 
0.017 
Venous surgery in 
study leg 
Yes 
No 
37 (17.4%) 
176 (82.6%) 
27 (29.0%) 
66 (71.0%) 
64 (20.9%) 
242 (79.1%) 
 
5.32 
 
0.021 
Venous injections in 
study leg 
Yes 
No 
14 (10.7%) 
134 (89.3%) 
5 (10.2%) 
53 (89.8%) 
19 (10.5%) 
187 (89.5%) 
 
0.04 
 
0.852 
Any surgery/trauma in 
study leg 
Yes 
No 
47 (43.9%) 
60 (56.1%) 
16 (41.0%) 
23 (59.0%) 
63 (43.2%) 
83 (56.8%) 
 
0.18 
 
0.671 
Cramps /  
Claudication in study 
leg 
 
Yes 
No 
 
18 (9.9%) 
173 (90.1%) 
 
13 (16.3%) 
72 (83.7%) 
 
31 (11.9%) 
245 (88.1%) 
 
 
2.03 
 
 
0.154 
Aching in study leg Yes 
No 
41 (40.2%) 
61 (59.8%) 
34 (58.6%) 
24 (41.4%) 
75 (46.9%) 
85 (53.1%) 
 
6.27 
 
0.012 
Any history swollen leg 
in study leg 
Yes 
No 
111 (76.0%) 
35 (24.0%) 
57 (75.0%) 
19 (25.0%) 
168 (75.7%) 
54 (24.3%) 
 
0.08 
 
0.782 
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Clinical data for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
              Frequencies 2 p 
Fixed ankle joint Yes 
No 
14 (15.2%) 
79 (84.8%) 
17 (50.0%) 
17 (50.0%) 
31 (24.6%) 
96 (75.4%) 
 
16.48 
 
<0.001 
Smoker Yes 
No 
21 (9.8%) 
193 (90.2%) 
14 (14.7%) 
81 (85.3%) 
35 (11.3%) 
274 (88.7%) 
 
1.59 
 
0.208 
Walking aid 
 
Yes 
No 
59 (27.8%) 
153 (72.2%) 
41 (42.3%) 
55 (57.7%) 
100 (32.4%) 
208 (67.6%) 
 
6.67 
 
0.010 
Calf/ankle 
ratio<1.3* 
Yes 
No 
3 (1.8%) 
164 (98.2%) 
2 (4.8%) 
40 (95.2%) 
5 (2.4%) 
204 (97.6%) 
 
 
 
0.264 
Calf size 
reduced by ≥ 
2cm at  week 2* 
 
Yes 
No 
 
37 (37.0%) 
63 (63.0%) 
 
2 (12.5%) 
14 (87.5%) 
 
39 (33.6%) 
77 (66.4%) 
 
 
 
 
 
0.085 
            Median (Range) Mann 
Whitney 
U 
p 
BMI  31(15.9-65.8) 29 (16.6-60.6) 31(15.9-65.8) 3861.50 0.201 
Pain/10  2.5 (0-10) 4 (0-10) 3 (0-10) 3104.00 0.032 
Ankle 
circumference 
 
25 (18-39.5) 
 
23.5 (20-33) 
 
24.9(18-39.5) 
 
3277.50 
 
0.378 
Calf 
circumference 
 
39.5(27-69.5) 
 
38.8 (29-69) 
 
39 (27-69.5) 
 
3203.50 
 
0.386 
                        Mean (SD) t p 
ABPI Study Leg  1.09 (0.11) 1.09 (0.11) 1.09 (0.11) 0.107 0.915 
Calf/Ankle ratio  1.61 (0.18) 1.62 (0.20) 1.61 (0.18) 0.452 0.651 
PCS
1 
 
 36.7 (10.7) 28.30 (7.34) 34.40 (10.40) -2.51 0.016 
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  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
                        Mean (SD) t p 
MOS Pain 
Effects 
Subscale
2
 
 
 
37.47(26.3) 
 
 
42.07 (29.72) 
 
 
38.91 (27.77) 
 
 
1.17 
 
 
0.242 
MOS Pain 
Severity 
Subscale
3 
 
 
27.48(14.2) 
 
 
29.64  (16.75) 
 
 
27.85 (15.14) 
 
 
0.96 
 
 
0.339 
CWIS
4
  63.14(18.3) 49.31 (23.38) 59.81 (19.57) -2.14 0.037 
*Fishers exact test used due to the value in at least one cell being < 5                      
1 PCS: Physical Component Summary Scale of the SF-12 survey, a health related quality of life measure (Ware, 
et al., 1996).  This scale is designed to have a mean of 50 and SD 10 where 0 indicates the lowest level of health 
and 100 indicates the highest level of health 
2 MOS pain effects scale (Stewart, et al., 1992) with scores  ranging between 1 being no effect of pain and 5 
being extremely effected by pain and this scale was then transformed to a score ranging from 0 to 100. 
3 MOS pain severity scale (Stewart, et al., 1992) with scores ranging between 1 (no pain) and 72 (worst pain). 
4 CWIS with scores ranging from 24 to 120, a high score representing a good wound specific health related 
quality of life and a low score representing a poor wound specific health related quality of life (Price, et al., 
2004). 
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Wound characteristics for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
  Frequencies 2 p 
Site of wound Left 
Right 
110 (55.0%) 
90 (45.0%) 
54 (58.1%) 
39 (41.9%) 
164 (56.0%) 
129 (44.0%) 
 
0.242 
 
0.623 
Previous ulcers Yes 
No 
153 (74.8%) 
53 (25.2%) 
73 (76.8%) 
22 (23.2%) 
226 (75.4%) 
75 (24.6%) 
 
0.230 
 
0.632 
Previous ulcer 
same site 
Yes 
No 
26 (33.3%) 
52 (66.7%) 
10 (38.5%) 
16 (61.5%) 
36 (34.6%) 
68 (65.4%) 
 
0.23 
 
0.634 
Duration of 
wound 
>24weeks 
 
Yes 
No 
 
106 (49.5%) 
108 (50.5%) 
 
56 (60.9%) 
36 (39.1%) 
 
162 (52.9%) 
144 (47.1%) 
 
 
3.32 
 
 
0.068 
Area ≥10cm2  Yes 
No 
33 (15.3%) 
182 (84.7%) 
34 (37.0%) 
58 (63.0%) 
67 (21.8%) 
240 (78.2%) 
 
17.63 
 
<0.001 
Infection Yes 
No 
8 (3.6%) 
212 (96.4%) 
2 (2.1%) 
95 (97.9%) 
10 (3.2%) 
307 (96.8%) 
 
0.55 
 
0.460 
Ulcer location 
(grouped) 
Gaiter 
Malleolus 
Other 
96 (49.0%) 
85 (43.4%) 
15 (7.7%) 
28 (35.0%) 
44 (55.0%) 
8 (10.0%) 
124 (44.9%) 
129 (46.7%) 
23 (8.3%) 
 
 
4.49 
 
 
0.106 
Exudate None 
Light 
Moderate 
Heavy 
10 (4.7%) 
81 (37.9%) 
98 (45.8%) 
25 (11.7%) 
2 (2.1%) 
24 (25.5%) 
52 (55.3%) 
16 (17.0%) 
12 (3.9%) 
105 (34.1%) 
150 (48.7%) 
41 (13.3%) 
 
 
 
6.61 
 
 
 
0.085 
Tissue type Epithelial 
Granulation 
Slough 
Necrotic 
9 (4.2%) 
105 (48.6%) 
99 (45.8%) 
3 (1.4%) 
3 (3.1%) 
31 (32.0%) 
60 (61.9%) 
3 (3.1%) 
12 (3.8%) 
136 (43.5%) 
159 (50.8%) 
6 (1.9%) 
 
 
 
8.87 
 
 
 
0.031 
Wound size 
>40% at 4 
weeks 
 
Yes 
No 
 
110 (75.2%) 
36 (24.8%) 
 
11 (26.2%) 
31 (73.8%) 
 
121 (64.2%) 
67 (35.8%) 
 
 
34.35 
 
 
<0.001 
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  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
  Frequencies 2 p 
Wound percent 
area reduction 
>25% at 4 
weeks 
 
 
Yes 
No 
 
 
117 (80.0%) 
29 (20.0%) 
 
 
14 (33.3%) 
28 (66.7%) 
 
 
131 (69.5%) 
57 (30.5%) 
 
 
 
33.82 
 
 
 
<0.001 
Wound percent 
area reduction 
>25% at 2 
weeks 
 
 
Yes 
No 
 
 
87 (65.9%) 
45 (34.1%) 
 
 
9 (25.0%) 
27 (75.0%) 
 
 
96 (57.1%) 
72 (42.9%) 
 
 
 
19.33 
 
 
 
<0.001 
Wound percent 
area reduction 
>40% at 2 
weeks 
 
 
Yes 
No 
 
 
59 (44.7%) 
73 (55.3%) 
 
 
5 (13.9%) 
31 (86.1%) 
 
 
64 (38.1%) 
104 (61.9%) 
 
 
 
11.38 
 
 
 
0.001 
Treated with ≥ 
30mmHg 
Compression 
 
Yes 
No 
 
164 (74.9%) 
55 (25.1%) 
 
50 (51.5%) 
47 (48.5%) 
 
214 (67.7%) 
102 (32.3%) 
 
 
16.75 
 
 
<0.001 
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Surrounding tissue characteristics for retrospective total ulcer sample (n=318 ulcers / 247 
participants) 
 Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
 Frequencies 2 p 
Healthy* Yes 
No 
4 (4.3%) 
90 (95.7%) 
2 (5.9%) 
32 (94.1%) 
6 (4.7%) 
122 (95.3%) 
 
 
 
0.656 
Dry/scaly Yes 
No 
67 (71.3%) 
27 (28.7%) 
22 (62.9%) 
13 (37.1%) 
89 (69.9%) 
40 (31.0%) 
 
0.845 
 
0.358 
Maceration Yes 
No 
29 (30.9%) 
65 (69.1%) 
13 (38.2%) 
21 (61.8%) 
42 (32.8%) 
86 (67.2%) 
 
0.618 
 
0.432 
Blistered* Yes 
No 
2 (2.2%) 
91 (97.8%) 
1 (2.9%) 
33 (97.1%) 
3 (2.4%) 
124 (97.6%) 
  
1.000 
Erythema Yes 
No 
40 (40.4%) 
59 (59.6%) 
18 (50.0%) 
18 (50.0%) 
58 (43.0%) 
77 (57.0%) 
 
0.99 
 
0.319 
Induration Yes 
No 
13 (12.3%) 
93 (87.7%) 
8 (18.6%) 
35 (81.4%) 
21 (14.1%) 
128 (85.9%) 
 
1.02 
 
0.314 
Lymphoedema* Yes 
No 
0 (0%) 
92 (100.0%) 
4 (11.4%) 
31 (88.6%) 
4 (3.1%) 
123 (96.9%) 
 
 
 
0.005 
Haemosiderosis Yes 
No 
60 (56.1%) 
47 (43.9%) 
14 (32.6%) 
29 (67.4%) 
74 (49.3%) 
76 (50.7%) 
 
6.79 
 
0.009 
Bruised* Yes 
No 
2 (2.2%) 
91 (97.8%) 
0 (0%) 
34 (100%) 
2 (1.6%) 
125 (98.4%) 
 
 
 
1.000 
Hyperkeratosis Yes 
No 
30 (32.3%) 
63 (67.7%) 
11 (32.4%) 
23 (67.6%) 
41 (32.3%) 
86 (67.7%) 
 
0.00 
 
0.992 
Eczema Yes 
No 
42 (20.5%) 
163 (79.5%) 
16 (23.9%) 
51 (76.1%) 
58 (21.3%) 
214 (78.7%) 
 
0.35 
 
0.556 
Excoriated* Yes 
No 
4 (4.3%) 
90 (95.7%) 
3 (8.8%) 
31 (91.2%) 
7 (5.5%) 
121 (94.5%) 
 
 
 
0.381 
Cellulitis* Yes 
No 
0 (0%) 
93 (100.0%) 
1 (2.9%) 
33 (97.1%) 
1 (0.8%) 
126 (99.2%) 
 
 
 
0.268 
Oedema 
 
Yes 
No 
149 (73.4%) 
54 (26.6%) 
42 (60.0%) 
28 (40.0%) 
191 (70.0%) 
82 (30.0%) 
 
4.45 
 
0.035 
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  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
  Frequencies 2 p 
Atrophie 
Blanche 
Yes 
No 
49 (46.2%) 
57 (53.8%) 
17 (40.5%) 
25 (59.5%) 
66 (44.6%) 
82 (55.4%) 
 
0.40 
 
0.526 
*Fishers exact test used due to the value in at least one cell being < 5                      
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Economical characteristic profile for retrospective total ulcer sample (n=318 ulcers / 247 
participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
        Frequencies 2 p 
Source 
of 
income  
Pension (DVA) 
Pension 
(Aged/Disability) 
Self funded 
retiree/employed 
Other 
8 (4.2%) 
 
149 (78.0%) 
 
27 (14.1%) 
7 (3.7%) 
5 (5.6%) 
 
73 (81.1%) 
 
8 (8.9%) 
4 (4.4%) 
13 (4.6%) 
 
222 (79.0%) 
 
35 (12.5%) 
11 (3.9%) 
 
 
 
 
 
1.77 
 
 
 
 
 
0.622 
Health 
care card 
Yes 
No 
149 (67.4%) 
34 (18.6%) 
75 (87.2%) 
11 (12.8%) 
224 (83.3%) 
45 (16.7%) 
 
1.41 
 
0.236 
  Mean (SD) t p 
SEIFA 
code1
 
 1011.07 
(79.1) 
1019.88 
(78.8) 
1013.76 
(79) 
 
0.90 
 
0.368 
 
1SEIFA code: Index of Relative Socio-economic Advantage and Disadvantage –standardised against a mean of 
1000 with a standard deviation of 100.  The average SEIFA score will be 1000 and the middle two-thirds of 
SEIFA scores will fall between 900 and 1100 with a range from 500 to 1300.  A lower value indicating greater 
disadvantage and a lack of advantage and a higher score indicating a relative lack of disadvantage and greater 
advantage (Australian Bureau of Statistics, 2006). 
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Social characteristics for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
      Frequencies 2 p 
Carer Yes 
No 
12 (5.6%) 
202 (94.4%) 
8 (8.5%) 
86 (91.5%) 
20 (6.5%) 
288 (93.5%) 
 
0.91 
 
0.341 
Lives 
alone 
Yes 
No 
85 (39.7%) 
129 (60.3%) 
59 (61.5%) 
37 (38.5%) 
144 (46.5%) 
166 (53.5%) 
 
12.60 
 
<0.001 
Marital 
status 
Married/Defacto 
Divorced 
Single 
Separated 
Widowed 
93 (46.7%) 
2 (1.0%) 
48 (24.1%) 
5 (2.5%) 
51 (25.6%) 
31 (33.3%) 
1 (1.1%) 
27 (29.0%) 
2 (2.2%) 
32 (34.4%) 
124 (42.5%) 
3 (1.0%) 
75 (25.7%) 
7 (2.4%) 
83 (28.4%) 
 
 
 
 
5.03 
 
 
 
 
0.284 
  Median (Range) Mann 
Whitney 
U 
p 
MOSSSS 
Total1
 
 81.6 
(1.3-100) 
64.5 
(11.8-100) 
72.4 
(1.3-100) 
 
817.50 
 
0.320 
  Mean (SD) t p 
ADL2
 
 17.74 (1.02) 17.21 (1.29) 17.46 (1.19) -1.706 0.094 
IADL3
 
 19 (1.76) 18.40 (2.19) 18.89 (1.89) -0.683 0.499 
       
 
 
1 Medical Outcomes Study Social Support Survey (MOSSSS): totals are calculated and transformed with scores 
ranging from 19 to 95 with higher scores indicating more support (McDowell, et al., 1996) 
2 ADL: Katz Activities of Daily Living (ADL) Survey: with scores ranging from 6 to 18, with lower scores 
indicating that a large amount of help with ADLs is necessary and higher scores indicating total independence. 
3 IADL: Instrumental Activities of Daily Living (IADL) survey: (Lawton, et al., 1969).  The sum of the eight 
responses ranging from scores of 7 to 21 with a higher score indicating a patient’s greater independence with 
functional behaviours. 
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Psychological profile for retrospective total ulcer sample (n=318 ulcers / 247 participants) 
  Healed 
n (%) 
Unhealed 
n (%) 
Total 
n (%) 
  
    Frequencies 2 p 
GDS>41
 
Yes 
No 
48 (31.8%) 
103 (68.2%) 
33 (45.8%) 
39 (54.2%) 
81 (36.3%) 
142 (63.7%) 
 
4.16 
 
0.041 
Diagnosed 
Clinical 
Depression 
 
Yes 
No 
 
29 (13.7%) 
179 (86.3%) 
 
18 (19.8%) 
72 (80.2%) 
 
47 (15.5%) 
251 (84.5%) 
 
 
1.74 
 
 
0.188 
  Mean (SD) t p 
MCS2
 
 49.55 (10.37) 48.04 (12.14) 48.32 (10.73) -0.42 0.635 
 
1 GDS with scores ranging between 0 and 15.  Scores between 0 and 4 are considered normal; 5 to 9 indicate 
mild depression; and 10 to 15 indicate moderate to severe depression (Brink, et al., 1982; McDowell, et al., 
1996). 
2MCS: Medical Component Summary Scale of the Short Form 12 item health survey (SF-12) (Ware, et al., 
1996).  This scale is designed to have a mean of 50 and SD 10 where 0 indicates the lowest level of mental 
health and 100 indicates the highest level of mental health.
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Appendix Seven: Expert wound advisory group 
Title First Name Surname Position 
Prof Helen Edwards Head, School of Nursing, Queensland University of Technology (QUT) 
QUT Program Leader, Wound Management Innovation Cooperative Research Centre 
Dr Stephen  Yelland General Practitioner specialising in Chronic Wound Management and Medical Representative for  
the Australian Wound Management Association (Queensland) 
Ms Lenora  Steele State Manager clinical review (Ozcare) 
Ms Donna  Hickling Senior Clinical Dietician, The Prince Charles Hospital 
Ms Michelle Gibb Nurse Practitioner (Wound Management), QUT Wound Healing Community Outreach Service (WHCOS), School 
of Nursing (SON) 
Ms Kerrie Coleman Nurse Practitioner (Wound Management), Royal Brisbane & Women’s Hospital chronic wound clinic  
Mr Paul Burrows Podiatrist, Blue Care Redcliffe Community Care 
Dr Kathleen Finlayson Research Fellow, SON, Institute of Health and Biomedical Innovation (IHBI) 
Ms  Christina  Parker Higher Degree Research student, SON, IHBI 
A/Prof William  McGuiness Head of School at Alfred  Faculty of Health Sciences School of Nursing and Midwifery /  
President Australian Wound Management Association / Chair Australian Pressure Ulcer  
Advisory Research Committee / Australian Venous Leg Ulcer Guideline Development committee 
Ms Suzanne Kapp Clinical Nurse Consultant Wound Management & Research, Royal District Nursing Service (RDNS) Institute 
Ms Charne Miller Research Fellow, RDNS Institute 
Dr Lisa Donohue General Manager, RDNS Institute 
A/Prof Michael  Woodward Head of Aged and Residential Care, Austin Health / Royal Australasian College of Physicians,  
Fellow / Former president Australian Wound Management Association 
Ms Kerrie Storey Community Care Advisor (Ozcare) 
Prof Graham Kerr Faculty of Health, School - Exercise and Nutrition Sciences 
Prof Kerlyn Carville University Associate Professor, Health Sciences, School of Nursing and Midwifery, Curtin University and 
Domiciliary Nursing Western Australia 
Mr Troy Edwards Clinical Nurse (Wound Management) RB&WH 
Em Prof Nancy Stotts Emeritus Professor, Department of Physiological Nursing at the University of California San Francisco.  
Dr Dianne  Smith General Practitioner / Previous President Queensland Wound Care Association /  Clinical Lecturer for the  
University of Queensland's Medical School, RB&WH chronic wound clinic 
Dr Rajna Ogrin Podiatrist and Research fellow, RDNS Institute 
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Appendix Eight: Wound advisory group terms of reference 
 
 
 
 
 
 
WOUND  ADVISORY GROUP  
TERMS OF REFERENCE 
 
Project Background 
At present, there are no screening tools available to assist clinicians to rapidly detect 
leg ulcers at-risk of delayed healing or recurrence in order to guide timely and appropriate 
wound management and prevention decisions. Assessment of wounds traditionally relies on 
sequential classical clinical assessments over a period of weeks or months to determine 
whether the current treatments are effective (Abbade & Lastoria, 2005). The lack of such 
tools contributes to the current high level of health service use and poor rates of wound 
healing. Around 70% of chronic leg ulcers are caused by venous disease and studies have 
shown that up to 50% of leg ulcers do not heal within six months, many remain unhealed for 
years or decades; and after healing, up to 70% recur (Abbade & Lastoria, 2005; Cullum et al., 
2001).  
This project aims to determine predictors of delayed wound healing and recurrence of 
venous leg ulcers; and develop and validate risk assessment tools for non-healing venous leg 
ulcers and for recurrence of venous leg ulcers. Expected outcomes include the development 
and validation of innovative multidisciplinary risk assessment tools for early detection of 
those at risk of non-healing and recurrence of venous leg ulcers and potential for improved 
healing and recurrence rates for patients with venous leg ulcers, leading to cost savings for 
consumers and the health care system. 
 
Purpose 
The purpose of the Wound Advisory Group is to enable health care providers and consumers 
with experience and expertise in management of venous leg ulcers to contribute expert advice 
and stakeholder perspectives on the process and outcomes of the project ‘Risk Assessment 
Tools for Management and Prevention of Venous Leg Ulcers’.  The Group will act as a 
guidance and reference forum for the research team in the conduct of this project.   
 
Goals  
The goals of the Reference Group are to: 
1. Provide a reference forum for the research team and advise on directions and/or strategies 
for the development and validation of the Risk Assessment Tools.  
2. Foster and maintain a collaborative, productive working relationship between Reference 
Group members and the project research team. 
3. Review project material and provide timely feedback to the research team in relation to 
project goals and milestones.   
4. Represent the interests of the particular stakeholder groups or organisations.   
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Desired Outcomes 
 Annual and final reports on the progress and findings of the research project team that 
have benefited from the scrutiny and perspectives of stakeholder groups and 
organisations.  
 Facilitation of wound healing and prevention of recurrence through development, 
validation and dissemination of a tool for health professionals to enable early detection 
and intervention to prevent complications  
 Decreased costs to health service providers and patients through improved healing rates 
and preventative strategies.  
 
Membership  
Through formal invitation.  
Members will be appointed for the duration of the project.  An individual may withdraw from 
the Reference Group at any time with written notification to the Chair. 
 
Timeframe  
The project commenced in 2011 and is due for completion by the end of 2014. 
 
Meetings  
Meetings will be conducted via teleconference three times each year and will be of 
approximately one hour’s duration. 
 Meetings will be chaired by the research project team.  
 The minutes will be recorded by the Queensland University of Technology (QUT) 
research team (or nominated proxy).  Draft minutes will be circulated to members after 
each meeting subject to confirmation at the following meeting.  The minutes will be kept 
to the minimum detail required to effectively summarise the proceedings i.e. issues, 
decision, actions.  The minutes will be presented by the Chair for acceptance at the 
following meeting.  
 A call for agenda items will be made by the QUT research team at least five days before 
the meeting to enable distribution of the agenda. 
 All documents distributed to members are of a confidential nature and it is expected that 
circulation will be limited to members of their specific stakeholder group.  
 All members must protect and maintain information discussed within the scope of their 
Group membership as confidential until such time as this information has been officially 
released for public distribution. 
 
Resources 
 Basic secretariat support e.g. agendas, minutes, meeting coordination will be provided by 
the QUT project research staff.  
 The preferred method of correspondence for distribution of agenda, minutes and 
associated documentation is via electronic mail   
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Appendix Nine: Sensitivity and Specificity 
Retrospective validation database (n=119) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coordinates of the Curve 
Total Risk Assessment Score 
Risk assessment 
score greater than or 
equal To 
Sensitivity 1-Specificity 
-1.00 1.000 1.000 
.50 1.000 .990 
1.50 .944 .950 
2.50 .944 .911 
3.50 .944 .901 
4.50 .944 .832 
5.50 .944 .723 
6.50 .889 .644 
7.50 .889 .475 
8.50 .889 .396 
9.50 .889 .366 
10.50 .778 .307 
11.50 .667 .248 
12.50 .556 .198 
13.50 .556 .129 
14.50 .500 .040 
15.50 .389 .040 
16.50 .333 .020 
17.50 .222 .010 
18.50 .111 .010 
19.50 .056 .000 
21.00 .000 .000 
 
Optimal cut-off score to least misclassify non-healed 
and healed venous leg ulcers: 13 
 Page | 230  
 
 
Prospective validation database (n=141) 
Coordinates of the Curve 
Total Risk Assessment Score   
Risk 
assessment 
score greater 
than or equal 
To 
Sensitivity 1 - Specificity 
-1.0000 1.000 1.000 
1.0000 1.000 .990 
2.5000 1.000 .980 
3.5000 1.000 .971 
4.5000 1.000 .912 
5.5000 .974 .863 
6.5000 .949 .765 
7.5000 .949 .735 
8.5000 .923 .676 
9.5000 .872 .608 
10.5000 .872 .520 
11.5000 .821 .451 
12.5000 .769 .363 
13.5000 .667 .294 
14.5000 .667 .196 
15.5000 .564 .147 
16.5000 .487 .127 
17.5000 .385 .069 
18.5000 .359 .029 
19.5000 .205 .010 
20.5000 .154 .010 
21.5000 .103 .010 
22.5000 .051 .000 
23.5000 .026 .000 
25.0000 .000 .000 
Optimal cut-off score to least misclassify non-healed 
and healed venous leg ulcers: 16 
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Appendix Ten: Participant information and consents 
(Study Three – Prospective Validation) 
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(Study Three – Health Professionals’ Feedback) 
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Appendix Eleven: Health professionals’ feedback Sheet 
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Appendix Twelve: PhD Study connection with WMI-CRC Project 3-05
WMI-CRC Project 3.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highlighted areas indicated PhD contribution to the larger WMI-CRC Project 3.05 
*This involved the validation of a pilot sample of data  
 
 
 
 
Phase 1 
Analysis of existing datasets to 
identify risk factors for non-
healing venous leg ulcers 
(VLUs) 
Literature review to identify 
known risk factors for non-
healing venous leg ulcers 
Development of Risk 
Assessment Tool (RAT) for 
non-healing venous leg ulcers 
Analysis of existing datasets to 
identify risk factors for 
recurrence of venous leg ulcers 
Literature review to identify 
known risk factors for 
recurrence of venous leg ulcers 
Development of RAT for 
recurrence of venous leg ulcers 
 
Phase 2 
Testing the inter-rater reliability 
of the RAT for non-healing 
VLUs 
Commencement of a multisite, 
prospective longitudinal study to 
test the validity of the RAT for 
non-healing VLUs 
Data collection on a wider range 
of potential predictors in this 
prospective study. 
Testing the inter-rater reliability 
of the RAT for recurrence of 
VLUs 
Commencement of a multisite, 
prospective longitudinal study to 
test the validity of the RAT for 
recurrence of VLUs 
Data collection on a wider range 
of potential predictors of 
recurrence in this prospective 
study. 
 
Phase 3 
Analysis of data from multisite, 
prospective study. 
Validation of the RAT for non-
healing VLUs in this sample.* 
Identification of additional 
predictors of non-healing VLUs 
Adaptation and modification of 
the RAT for non-healing VLUs 
based on this analysis. 
Validation of the RAT for 
recurrence of VLUs in this 
sample. 
Identification of additional 
predictors of recurrence of 
VLUs 
Adaptation and modification of 
the RAT for recurrence of VLUs 
based on this analysis. 
 
Concurrent WMI-CRC 
Projects 
These may contribute possible 
biomarkers that could be 
incorporated into future 
versions of the risk assessment 
tools (eg. Biochemical and 
Microbiological information) 
 
 
 
 Page | 237  
 
References 
Abbade, L. P. F., & Lastória, S. (2005). Venous ulcer: epidemiology, physiopathology, 
diagnosis and treatment. International Journal of Dermatology, 44(6), 449-456. 
  
Abbade, L. P. F., Lastória, S., & Rollo, H. d. A. (2011). Venous ulcer: clinical characteristics 
and risk factors. International Journal of Dermatology, 50(4), 405-411. 
  
Acquadro, C., Price, P., & Wollina, U. (2005). Linguistic validation of the Cardiff Wound 
Impact Schedule into French, German and US English. J Wound Care, 14(1), 14-17. 
  
Allen, J. (2008). Venous leg ulcers: an overview. Canadian Nursing Home, 19(4), 16-18. 
  
Altman, D. G., & Bland, J. M. (1994). Diagnostic tests 3: receiver operating characteristic 
plots. BMJ, 309(6948), 188.  
 
Anand, S. C., Dean, C., Nettleton, R., & Praburaj, D. V. (2003). Health-related quality of life 
tools for venous-ulcerated patients. British Journal of Nursing 12(1), 48. 
  
Anthony, M. (2013). Nursing Assesment of Deep Vein Thrombosis. MedSurg Nursing, 22(2), 
95-123. 
  
Arnold, T. E., Stanley, J. C., Fellows, E. P., Moncada, G. A., Allen, R., Hutchinson, J. J., . . . 
Kerstein, M. D. (1994). Prospective, Multicenter Study of Managing Lower Extremity 
Venous Ulcers. Annals of Vascular Surgery, 8(4), 356-362. doi: 
http://dx.doi.org/10.1007/BF02132997 
 
Australian Bureau of Statistics. (2006). Socio-economic indexes for areas (SEIFA)  Retrieved 
17.2.12, from http://www.abs.gov.au/ausstats/abs@.nsf/mf/2039.0/ 
 
Australian Institute of Health and Welfare. (2012). Health expenditure Australia 2010-11 
   Retrieved 29/6/13, from http://www.aihw.gov.au/publication-
detail/?id=10737423009&tab=3 
 
Baker, S. R., & Stacey, M. C. (1994). Epidemiology of chronic leg ulcers in Australia. The 
Australian And New Zealand Journal Of Surgery, 64(4), 258-261.  
 
Baker, S. R., Stacey, M. C., Jopp-McKay, A. G., Hoskin, S. E., & Thompson, P. J. (1991). 
Epidemiology of chronic venous ulcers. The British Journal Of Surgery, 78(7), 864-
867. doi: 10.1002/bjs.1800780729 
 
Barwell, J. R., Davies, C. E., Deacon, J., Harvey, K., Minor, J., Sassano, A., . . . Poskitt, K. 
R. (2004). Comparison of surgery and compression with compression alone in chronic 
venous ulceration (ESCHAR study): randomised controlled trial. Lancet, 363(9424), 
1854-1859.  
Barwell, J. R., Ghauri, A. S. K., Taylor, M., Deacon, J., Wakely, C., Poskitt, K. R., & 
Whyman, M. R. (2000). Risk factors for healing and recurrence of chronic venous leg 
ulcers. Phlebology, 15(2), 49-52. doi: 10.1007/s005230070021 
 Page | 238  
 
 
Barwell, J. R., Taylor, M., Deacon, J., Davies, C., Whyman, M. R., & Poskitt, K. R. (2001). 
Ankle motility is a risk factor for healing of chronic venous leg ulcers. Phlebology, 
16(1), 38-40. doi: 10.1007/s005230170018 
 
Barwell, J. R., Taylor, M., Ghauri, A. S. K., Bronder, C., Phillips, L., Poskitt, K. R., & 
Whyman, M. R. (2000). Risk factors for delayed healing and long-term recurrence in 
chronic venous leg ulcers. British Journal of Surgery, 87(4), 501. 
  
Beers, M. H., Porter, R. S., Jones, T. V., Kaplan, J. L., & Berkwits, M. (Eds.). (2006). The 
merck manual of diagnosis and therapy (Eighteenth ed.). New Jersey: Merck 
Research Laboratories. 
 
Bergan, J. J., Schmid-Schönbein, G. W., & Takase, S. (2001). Therapeutic approach to 
chronic venous insufficiency and its complications: place of Daflon 500 mg. 
Angiology, 52 Suppl 1(1 suppl), S43-S47. doi: 10.1177/000331970105200106 
 
Bergqvist, D., Lindholm, C., & Nelzén, O. (1999). Chronic leg ulcers: the impact of venous 
disease. Journal Of Vascular Surgery, 29(4), 752-755.  
 
Black, S. B. (1995). Venous stasis ulcers: a review. Ostomy Wound Management, 41(8), 20.  
 
Bouza, C., Muñoz, A., & Amate, J. M. (2005). Efficacy of modern dressings in the treatment 
of leg ulcers: A systematic review. Wound Repair & Regeneration, 13(3), 218-229. 
doi: 10.1111/j.1067-1927.2005.130302.x 
 
Bower, V. M., & Hobbs, M. (2009). Validation of the basic foot screening checklist: a 
population screening tool for identifying foot ulcer risk in people with diabetes 
mellitus. J Am Podiatr Med Assoc, 99(4), 339-347. doi: 99/4/339 
 
Briggs M, Nelson EA, & Martyn-St James, M. (2012). Topical agents or dressings for pain in 
venous leg ulcers. Cochrane Database of Systematic Reviews doi: 
10.1002/14651858.CD001177.pub3 
 
Briggs, M., & Closs, S. (2003). The prevalence of leg ulceration: a review of the literature. 
EWMA Journal, 3(2), 14-20. 
  
Brink, T., Yesavage, J., Lum, O., Heersema, P., Adey, M., & Rose, T. (1982). Screening tests 
for geriatric depression. Clinical Gerontologist: The Journal of Aging and Mental 
Health, 1(1), 37-43. doi: 10.1300/J018v01n01_06 
 
Browse, N. L., & Burnand, K. G. (1982). The cause of venous ulceration. Lancet, 2(8292), 
243-245. doi: S0140-6736(82)90325-7  
 
 
 
Brummett, B. H., Barefoot, J. C., Siegler, I. C., Clapp-Channing, N. E., Lytle, B. L., 
Bosworth, H. B., . . . Mark, D. B. (2001). Characteristics of Socially Isolated Patients 
With Coronary Artery Disease Who Are at Elevated Risk for Mortality. 
Psychosomatic Medicine, 63(2), 267-272.  
 Page | 239  
 
 
Buchanan, M. (2010). The impact of clinical factors and sociodemographic variables on 
health-related quality of life in venous leg ulceration. M.Sc. MR65021, Queen's 
University (Canada), Canada. Retrieved from 
http://gateway.library.qut.edu.au/login?url=http://search.proquest.com/docview/76094
5581?accountid=13380  
  
Callam, M. J., Harper, D. R., Dale, J. J., & Ruckley, C. V. (1987). Chronic ulcer of the leg: 
clinical history. British Medical Journal (Clin Res Ed), 294(6584), 1389-1391.  
 
Callam, M. J., Ruckley, C. V., Harper, D. R., & Dale, J. J. (1985). Chronic ulceration of the 
leg: extent of the problem and provision of care.  British Medical Journal, 290(6485), 
1855-1856.  
 
Campbell, H., Hotchkiss, R., Bradshaw, N., & Porteous, M. (1998). Integrated Care 
Pathways. BMJ: British Medical Journal, 316(7125), 133-137.  
 
Cardinal, M., Eisenbud, D. E., & Armstrong, D. G. (2009). Wound shape geometry 
measurements correlate to eventual wound healing. Wound Repair & Regeneration, 
17(2), 173-178. doi: 10.1111/j.1524-475X.2009.00464.x 
 
Casey, G. (2011). Chronic wound healing: Leg ulcers. Kai Tiaki Nursing New Zealand, 
17(11), 24-29.  
 
Centers for Medicare & Medicaid Services. (2005). CMS examines the usual care of chronic 
wounds. Adv Skin Wound Care, 18(5 Pt 1), 248-256. doi: 00129334-200506000-
00011  
 
Chaby, G., Senet, P., Ganry, O., Caudron, A., Thuillier, D., Debure, C., . . . Lok, C. (2013). 
Prognostic factors associated with healing of venous leg ulcers: a multicentre, 
prospective, cohort study. The British Journal Of Dermatology, 169(5), 1106-1113. 
doi: 10.1111/bjd.12570 
 
Chaby, G., Viseux, V., Ramelet, A. A., Ganry, O., Billet, A., & Lok, C. (2006). Refractory 
venous leg ulcers: A study of risk factors. Dermatologic Surgery, 32(4), 512-519. doi: 
10.1111/j.1524-4725.2006.32104.x 
 
Charles, H. (2004). Does leg ulcer treatment improve patients' quality of life? J Wound Care, 
13(6), 209-213.  
 
Charles, H. (2010). The influence of social support on leg ulcer healing. British Journal of 
Community Nursing, 15, S14-21.  
 
 
 
Chase, S. K., Whittemore, R., Crosby, N., Freney, D., Howes, P., & Phillips, T. J. (2000). 
Living with chronic venous leg ulcers: a descriptive study of knowledge and 
functional health status. J Community Health Nurs, 17(1), 1-13. doi: 
10.1207/S15327655JCHN1701_01 
 
 Page | 240  
 
Chong, T. W., Bott, M. J., Kern, J. A., Peeler, B. B., Tribble, C. G., & Harthun, N. L. (2005). 
Subfascial endoscopic perforating vein surgery (SEPS) for the treatment of venous 
ulcers. Ostomy/wound management, 51(9), 26.  
 
Clark, J. J. (2002). Wound repair and factors influencing healing. Critical Care Nursing 
Quarterly, 25(1), 1-12. 
  
Clarke-Moloney, M., Godfrey, A., O'Connor, V., Meagher, H., Burke, P. E., Kavanagh, E. 
G., . . . Lyons, G. M. (2007). Mobility in patients with venous leg ulceration. 
European Journal Of Vascular And Endovascular Surgery, 33(4), 488-493. 
  
Claudy, A. L., Mirshahi, M., Soria, C., & Soria, J. (1991). Detection of undegraded fibrin and 
tumor necrosis factor-α in venous leg ulcers. Journal Of The American Academy Of 
Dermatology, 25(4), 623-627. doi: http://dx.doi.org/10.1016/0190-9622(91)70242-T 
 
Coghlan, D. (2004). Chronic venous insufficiency. ASUM Ultrasound Bulletin, 7(4), 14-21.  
 
Coleridge Smith, P. D., Thomas, P., Scurr, J. H., & Dormandy, J. A. (1988). Causes of  
venous ulceration - a new hypothesis. British Medical Journal, 296(6638), 1726-
1727.  
 
Coull, A., Tolson, D., & McIntosh, J. (2006). Class-3c compression bandaging for venous 
ulcers: comparison of spiral and figure-of-eight techniques. Journal of Advanced 
Nursing, 54(3), 274-283.  
 
Coyer, F., Edwards, H., & Finlayson, K. (2005). Best Practice Community Care for Clients 
with Chronic Venous Leg Ulcers: National Institute for Clinical Studies (NICS) 
Report for Phase 1 Evidence Uptake Network. Brisbane: Queensland University of 
Technology. 
 
Cromwell, T. J. (2002). Evaluation of outpatient leg ulcer care. Ph.D., Saint Louis 
University. Retrieved from 
http://gateway.library.qut.edu.au/login?url=http://search.ebscohost.com/login.aspx?dir
ect=true&db=c8h&AN=2005043413&site=ehost-live  
  
Cullum, N., Nelson, E. A., Fletcher, A. W., & Sheldon, T. A. (2001). Compression for 
venous leg ulcers. Cochrane Database of Systematic Reviews, 2, CD000265.  
 
Defloor, T., & Grypdonck, M. F. H. (2005). Pressure ulcers: validation of two risk 
assessment scales. Journal of Clinical Nursing, 14(3), 373-382. doi: 10.1111/j.1365-
2702.2004.01058.x 
 
Dormandy, J. A. (1995). Pharmacologic Treatment of Venous Leg Ulcers. Journal of 
Cardiovascular Pharmacology, 25, S61-S65.  
Ebbeskog, B., Lindholm, C., Grauers, M., & Ohman, S. (1999). A follow-up study of leg 
ulcer patients in South Stockholm. Journal of Wound Care, 8(4), 170-174.  
 
Edwards, H., Courtney, M., Finlayson, K., Lindsay, E., Lewis, C., Shuter, P., & Chang, A. 
(2005). Chronic venous leg ulcers: effect of a community nursing intervention on pain 
and healing. Nursing Standard, 19(52), 47-54.  
 Page | 241  
 
 
Edwards, H., Courtney, M., Finlayson, K., Shuter, P., & Lindsay, E. (2009). A randomised 
controlled trial of a community nursing intervention: improved quality of life and 
healing for clients with chronic leg ulcers. Journal of Clinical Nursing, 18(11), 1541-
1549. doi: 10.1111/j.1365-2702.2008.02648.x 
 
Edwards, H., Finlayson, K., Courtney, M., Graves, N., Gibb, M., & Parker, C. (2013). Health 
service pathways for patients with chronic leg ulcers: identifying effective pathways 
for facilitation of evidence based wound care. BMC Health Services Research, 13(1), 
86.  
 
El Miedany, Y., El Gaafary, M., Toth, M., Palmer, D., & Ahmed, I. (2011). Falls risk 
assessment score (FRAS): Time to rethink. Journal of Clinical Gerontology and 
Geriatrics, 2(1), 21-26. doi: http://dx.doi.org/10.1016/j.jcgg.2011.01.002 
 
Ettridge, L. (2011). Post-thrombotic syndrome: a case study. Nurs Standard, 25(33), 60-68. 
  
Etufugh, C. N., & Phillips, T. J. (2007). Venous ulcers. Clinics in dermatology, 25(1), 121-
130. doi: 10.1016/j.clindermatol.2006.09.004 
 
European Wound Management Association (Ed.). (2003). Position document: Understanding 
compression therapy. London: MEP Ltd. 
 
European Wound Management Association (Ed.). (2008). Position Document: Hard-to-heal 
wounds: a holistic approach. London: MEP Ltd. 
 
Falanga, V. (2000). Classifications for wound bed preparation and stimulation of chronic 
wounds. Wound Repair & Regeneration, 8(5), 347-352.  
 
Falanga, V., & Eaglstein, W. H. (1993). The "trap" hypothesis of venous ulceration. The 
Lancet, 341(8851), 1006-1008.  
 
Falanga, V., Kirsner, R., Katz, M. H., Gould, E., Eaglstein, W. H., & McFalls, S. (1992). 
Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during 
ulcer healing. The Journal Of Dermatologic Surgery And Oncology, 18(5), 409-414.  
 
Falanga, V., Margolis, D., Alvarez, O., Auletta, M., Maggiacomo, F., Altman, M., . . . 
Hardin-Young, J. (1998). Rapid healing of venous ulcers and lack of clinical rejection 
with an allogeneic cultured human skin equivalent. Human Skin Equivalent 
Investigators Group. Archives Of Dermatology, 134(3), 293-300.  
 
Falanga, V., Saap, L. J., & Ozonoff, A. (2006). Wound bed score and its correlation with 
healing of chronic wounds. Dermatologic Therapy, 19(6), 383-390. doi: 
10.1111/j.1529-8019.2006.00096.x 
Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27(8), 
861-874. doi: 10.1016/j.patrec.2005.10.010 
 
Ferreira, P., Migue´ns, C., Gouveia, J., & Furtado, K. (2007). Medic¸a˜o da qualidade de vida 
de docentes com feridas croˆ nicas: a Escala de cicatrizac¸a˜o da u´ lcera de Pressa˜o e 
o Esquema Cardiff de Impacto da Ferida. Nursing (221), 32–41.  
 Page | 242  
 
 
Ferrell, B. A., Artinian, B. M., & Sessing, D. (1995). The sessing scale for assessment of 
pressure ulcer healing. J AM Geriatr Soc, 43, 37-40.  
 
Fife, C. E., Carter, M. J., & Walker, D. (2010). Why is it so hard to do the right thing in 
wound care? Wound Repair & Regeneration, 18(2), 154-158. doi: 10.1111/j.1524-
475X.2010.00571.x 
 
Finlayson, K., Edwards, H., & Courtney, M. (2009). Factors associated with recurrence of 
venous leg ulcers: a survey and retrospective chart review. International Journal of 
Nursing Studies, 46(8), 1071-1078. doi: 10.1016/j.ijnurstu.2008.12.012 
 
Finlayson, K. J., Courtney, M. D., Gibb, M. A., O'Brien, J. A., Parker, C. N., & Edwards, H. 
E. (2012). The effectiveness of a four-layer compression bandage system in 
comparison to Class 3 compression hosiery on healing and quality of life for patients 
with venous leg ulcers: a randomised controlled trial. Int Wound J. doi: 
10.1111/j.1742-481X.2012.01033.x 
 
Flahr, D., Woodbury, G., & Gregaoire, D. (2005). Clinimetrics and wound science. Wound 
Care Canada, 3(2), 18-19.  
 
Flanagan, M. (1996). Wound care clinic. A practical framework for wound assessment 1: 
physiology. British Journal of Nursing, 5(22), 1391. 
  
Fowkes, F. G. R., Evans, C. J., & Lee, A. J. (2001). Prevalence and risk factors of chronic 
venous insufficiency. Angiology, 52, S5-S15.  
 
Franks, P. J., Bosanquet, N., Connolly, M., Oldroyd, M. I., Moffatt, C. J., Greenhalgh, R. M., 
& McCollum, C. N. (1995). Venous ulcer healing - effect of socioeconomic-factors in 
London. Journal of Epidemiology and Community Health, 49(4), 385-388. doi: 
10.1136/jech.49.4.385 
 
Franks, P. J., McCullagh, L., & Moffatt, C. J. (2003). Assessing quality of life in patients 
with chronic leg ulceration using the Medical Outcomes Short Form-36 
Questionnaire. Ostomy Wound Management, 49(2), 26.  
 
Franks, P. J., Moffatt, C. J., Connolly, M., Bosanquet, N., Oldroyd, M. I., Greenhalgh, R. M., 
& McCollum, C. N. (1995). Factors associated with healing leg ulceration with high 
compression. Age And Ageing, 24(5), 407-410.  
 
Gatt, J. (2011). Current perspectives in venous leg ulcer care. Nursing in Practice, 60.  
 
Gelfand, J. M., Hoffstad, O., & Margolis, D. J. (2002). Surrogate endpoints for the treatment 
of venous leg ulcers. Journal of Investigative Dermatology, 119(6), 1420-1425.  
Gibb, M. A., Edwards, H., & Finlayson, K. (2012). Innovative practice in the assessment, 
management and prevention of chronic wounds: introducing the wound management 
nurse practitioner model. Paper presented at the 4th Congress of the World Union of 
Wound Healing Societies, Yokohama, Japan. 
 
 Page | 243  
 
Gibson, J. (2007). A severity score comprising patient age, ulcer chronicity, and venous refill 
time predicted venous leg ulcer healing at 24 weeks. Evidence-Based Nursing, 10, 
122. doi: 10.1136/ebn.10.4.122 
 
Gilchrist, B., & Reed, C. (1989). The bacteriology of chronic venous ulcers treated with 
occlusive hydrocolloid dressings. Br J Dermatol, 121, 337-344.  
 
Gjødsbøl, K., Christensen, J. J., Karlsmark, T., Jørgensen, B., Klein, B. M., & Krogfelt, K. A. 
(2006). Multiple bacterial species reside in chronic wounds: a longitudinal study. 
International Wound Journal, 3(3), 225-231. 
  
Glaser, R., Kiecolt-Glaser, J. K., Marucha, P. T., MacCallum, R. C., Laskowski, B. S., & 
Malarkey, W. B. (1999). Stress-related changes in proinflammatory cytokine 
production in wounds. [Journal]. Arch Gen Psychiatry, 56, 450-456.  
 
Glinski, W., Chodynicka, B., Roszkiewicz, J., Bogdanowski, T., Lecewicz-Torun, B., 
Kaszuba, A., . . . Pachocki, R. (2000). The beneficial augmentative effect of 
micronised purified flavonoid fraction on the healing of leg ulcers: an open, 
multicentre, controlled, randomised study. Phlebology, 14(4), 151-157. doi: 
10.1177/026835559901400405  
 
Gohel, M. S., Barwell, J. R., Earnshaw, J. J., Heather, B. P., Mitchell, D. C., Whyman, M. R., 
& Poskitt, K. R. (2005). Randomized clinical trial of compression plus surgery versus 
compression alone in chronic venous ulceration (ESCHAR study) — haemodynamic 
and anatomical changes. British Journal of Surgery, 92(3), 291-297. doi: 
10.1002/bjs.4837 
 
Gohel, M. S., Taylor, M., Earnshaw, J. J., Heather, B. P., Poskitt, K. R., & Whyman, M. R. 
(2005). Risk factors for delayed healing and recurrence of chronic venous leg ulcers--
An analysis of 1324 legs. European Journal of Vascular and Endovascular Surgery, 
29(1), 74-77. doi: DOI: 10.1016/j.ejvs.2004.10.002 
 
Golinko, M. S., Clark, S., Rennert, R., Flattau, A., Boulton, A. J. M., & Brem, H. (2009). 
Wound emergencies: the importance of assessment, documentation, and early 
treatment using a wound electronic medical record. Ostomy Wound Management, 
55(5), 54-61.  
 
Gonzalez-Consuegra, R. V., & Verdu, J. (2011). Quality of life in people with venous leg 
ulcers: an integrative review. Journal of Advanced Nursing, 67(5), 926-944. doi: 
10.1111/j.1365-2648.2010.05568.x 
 
Gorecki, C., Lamping, D. L., Brown, J. M., Madill, A., Firth, J., & Nixon, J. (2010). 
Development of a conceptual framework of health-related quality of life in pressure 
ulcers A patient-focused approach. International Journal of Nursing Studies, 47(12), 
1525-1534. doi: 10.1016/j.ijnurstu.2010.05.014 
Graf, C. (2008). The Lawton Instrumental Activities of Daily Living Scale. [Article]. 
American Journal of Nursing, 108(4), 52-62.  
 
 Page | 244  
 
Graham, I. D., Harrison, M. B., Friedberg, E., Lorimer, K., & Vandevelde-Coke, S. (2001). 
Assessing the population with leg and foot ulcers: regional planning study. The 
Canadian Nurse, 97(2), 18.  
 
Graham, I. D., Harrison, M. B., Moffat, C., & Franks, P. (2001). Leg ulcer care: nursing 
attitudes and knowledge. The Canadian Nurse, 97(3), 19-24.  
 
Graham, I. D., Harrison, M. B., Nelson, E. A., Lorimer, K., & Fisher, A. (2003). Prevalence 
of lower-limb ulceration: a systematic review of prevalence studies. Advances in Skin 
& Wound Care, 16(6), 305-316.  
 
Green, J., & Jester, R. (2009). Health-related quality of life and chronic venous leg 
ulceration: part 1. British Journal of Community Nursing, 14(12), S12.  
 
Green, J., & Jester, R. (2010). Health-related quality of life and chronic venous leg 
ulceration: part 2. British Journal of Community Nursing, 15(3), S4.  
 
Grey, J. E. (2006). Venous and arterial leg ulcers. BMJ (British Medical Journal), 332(7537), 
347-350.  
 
Gross, E. A., Wood, C. R., Lazarus, G. S., & Margolis, D. J. (1993). Venous leg ulcers: an 
analysis of underlying venous disease. The British Journal Of Dermatology, 129(3), 
270-274.  
 
Guest, M., Smith, J. J., Sira, M. S., Madden, P., Greenhalgh, R. M., & Davies, A. H. (1999). 
Venous ulcer healing by four-layer compression bandaging is not influenced by the 
pattern of venous incompetence. Br J Surg, 86(11), 1437-1440. doi: bjs1288  
10.1046/j.1365-2168.1999.01288.x 
 
Guilhou, J. J., Fevrier, F., Debure, C., Dubeaux, D., Gillet-Terver, M. N., Guillot, B., . . . 
Nicolaides, A. N. (1997). Benefit of a 2-month treatment with a micronized, purified 
flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled 
versus placebo trial. Int J Microcirc Clin Exp, 17 Suppl 1, 21-26.  
 
Haghpanah, S., Bogie, K., Wang, X., Banks, P. G., & Ho, C. H. (2006). Reliability of 
electronic versus manual wound measurement techniques. Archives of Physical 
Medicine & Rehabilitation, 87(10), 1396-1402.  
 
Hampton, S. (2012). The art-and science-of wound healing Practice Nurse, 42(12).  
 
Hansson, C., Hoborn, J., & Moller, A. (1995). The microbial flora in venous leg ulcers 
without clinical signs of infection.  Repeated culture using a validated standardised 
microbiological technique. Acta Derm Venereol, 75(1), 24-30.  
 
Hansson, C., Holm, J., Lillieborg, S., & Syren, A. (1993). Repeated treatment with lidocaine 
prilocaine cream (EMLA) as a topical anaesthetic for the cleansing of venous leg 
ulcers -  A controlled study. Acta Dermato-Venereologica, 73(3), 231-233.  
Harding, K. G., Morris, H. L., & Patel, G. K. (2002). Science, medicine and the future: 
healing chronic wounds. BMJ, 324(7330), 160-163.  
 
 Page | 245  
 
Hareendran, A., Bradbury, A., Budd, J., Geroulakos, G., Hobbs, R., Kenkre, J., & Symonds, 
T. (2005). Measuring the impact of venous leg ulcers on quality of life. Journal of 
Wound Care, 14(2), 53-57.  
 
Harris, C., Bates-Jensen, B., Parslow, N., Raizman, R., Singh, M., & Ketchen, R. (2010). 
Bates-Jensen Wound Assessment Tool Pictorial Guide Validation Project. [Article]. 
Journal of Wound Ostomy and Continence Nursing, 37(3), 253-259. doi: 
10.1097/WON.0b013e3181d73aab 
 
Harvey, D. (2006). New, improved Kerraboot: a tool for leg ulcer healing. Br J Community 
Nurs, 11(6), S26, S28-30.  
 
Heinen, M. M., van Achterberg, T., Reimer, W. S. O., van de Kerkhof, P. C. M., & de Laat, 
E. (2004). Venous leg ulcer patients: a review of the literature on lifestyle and pain-
related interventions. Journal of Clinical Nursing, 13(3), 355-366. doi: 
10.1046/j.1365-2702.2003.00887.x 
 
Heit, J. A., Rooke, T. W., Silverstein, M. D., Mohr, D. N., Lohse, C. M., Petterson, T. M., . . . 
Melton, L. J. (2001). Trends in the incidence of venous stasis syndrome and venous 
ulcer: A 25-year population-based study. Journal of Vascular Surgery, 33(5), 1022-
1027. doi: DOI: 10.1067/mva.2001.113308 
 
Herber, O. R., Schnepp, W., & Rieger, M. A. (2007). A systematic review on the impact of 
leg ulceration on patients' quality of life. Health and quality of life outcomes, 5, 44. 
doi: 10.1186/1477-7525-5-44 
 
Herberger, K., Rustenbach, S. J., Haartje, O., Blome, C., Franzke, N., SchÃ¤fer, I., . . . 
Augustin, M. (2011). Quality of life and satisfaction of patients with leg ulcers--
results of a community-based study. VASA. Zeitschrift FÃ¼r GefÃ¤sskrankheiten. 
Journal For Vascular Diseases, 40(2), 131-138.  
 
Hess, C. T. (2005). The art of skin and wound care documentation. Advances in Skin & 
Wound Care, 23(8), 502-513.  
 
Hill, D. P., Poore, S., Wilson, J., Robson, M. C., & Cherry, G. W. (2004). Initial healing rates 
of venous ulcers: are they useful as predictors of healing? The American Journal of 
Surgery, 188(1, Number 1 Supplement 1), 22-25.  
 
Hjerppe, A., Saarinen, J. P., Venermo, M. A., Huhtala, H. S., & Vaalasti, A. (2010). 
Prolonged healing of venous leg ulcers: the role of venous reflux, ulcer characteristics 
and mobility. Journal of Wound Care, 19(11), 474.  
 
Hon, J., Lagden, K., McLaren, A. M., O'Sullivan, D., Orr, L., Houghton, P. E., & Woodbury, 
M. G. (2010). A prospective, multicenter study to validate use of the PUSH in patients 
with diabetic, venous, and pressure ulcers. Ostomy Wound Management, 56(2), 26-36.  
Houghton, P. E., Kincaid, C. B., Campbell, K. E., Woodbury, M. G., & Keast, D. H. (2000). 
Photographic assessment of the appearance of chronic pressure and leg ulcers. Ostomy 
Wound Manage, 46(4), 20-26, 28-30.  
 
 Page | 246  
 
Iglesias, C. P., Birks, Y., Nelson, E. A., Scanlon, E., & Cullum, N. A. (2005). Quality of life 
of people with venous leg ulcers: A comparison of the discriminative and responsive 
characteristics of two generic and a disease specific instruments. Quality of Life 
Research, 14(7), 1705-1718. doi: 10.1007/s11136-005-2751-9 
 
Jones, J., Barr, W., Robinson, J., & Carlisle, C. (2006). Depression in patients with chronic 
venous ulceration. [Article]. British Journal of Nursing (BJN), 15(11), S17-S23.  
 
Jones, J. E., Robinson, J., Barr, W., & Carlisle, C. (2008). Impact of exudate and odour from 
chronic venous leg ulceration. Nursing Standard, 22(45), 53-54, 56, 58 passim.  
 
Jones, K. R. (2009). Why do chronic venous leg ulcers not heal? Journal of Nursing Care 
Quality, 24(2), 116-124.  
 
Jull, A., Waters, J., & Arroll, B. (2002). Pentoxifylline for treatment of venous leg ulcers: a 
systematic review. Lancet, 359(9317), 1550.  
 
Justice, A. C., & Covinsky, K. E. (1999). Assessing the generalizability of prognostic 
information. Annals of Internal Medicine, 130(6), 515.  
 
Kantor, J., & Margolis, D. J. (2000). A multicentre study of percentage change in venous leg 
ulcer area as a prognostic index of healing at 24 weeks. British Journal of 
Dermatology, 142(5), 960-964. 
  
Katz, M. H. (Ed.). (2011). Multivariable analysis: A practical guide for clinicians and public 
health researchers (Third ed.): Cambridge University Press. 
 
Katz, S., & Akpom, C. (1976). 1976 Index of ADL. Medical Care, 14, 116-118.  
 
Kelechi, T. J., & Johnson, J. J. (2012). Guideline for the Management of Wounds in Patients 
With Lower-Extremity Venous Disease. Journal of Wound Ostomy and Continence 
Nursing, 39(6), 598-606. doi: 10.1097/WON.0b013e31827179e9 
 
Kerstein, M. D. (1996). The non-healing leg ulcer: peripheral vascular disease, chronic 
venous insufficiency, and ischemic vasculitis. Ostomy/Wound Management, 42(10A 
Suppl), 19S-35S.  
 
Kerstein, M. D., Gemmen, E., van Rijswijk, L., Lyder, C. H., Phillips, T., Xakellis, G., . . . 
Harrington, C. (2001). Cost and cost effectiveness of venous and pressure ulcer 
protocols of care. Disease Management & Health Outcomes, 9(11), 651-663.  
 
Kiecolt-Glaser, J. K., & Marucha, P. T. (1995). Slowing of wound healing by psychological 
stress. Lancet, 346(8984), 1194.  
 
Koopman, R. J., & Mainous, r. A. G. (2008). Evaluating multivariate risk scores for clinical 
decision making. Family Medicine, 40(6), 412-416.  
Kottner, J., Dassen, T., & Tannen, A. (2009). Inter- and intrarater reliability of the Waterlow 
pressure sore risk scale: A systematic review. International Journal of Nursing 
Studies, 46(3), 369-379. doi: http://dx.doi.org/10.1016/j.ijnurstu.2008.09.010 
 
 Page | 247  
 
Krasner, D. (1997). Wound healing scale, version 1.0: a proposal. Adv Wound Care, 10(5), 
82-85.  
 
Kroenke, K., Spitzer, R. L., Williams, J. B., Linzer, M., Hahn, S. R., deGruy, r. F. V., & 
Brody, D. (1994). Physical symptoms in primary care. Predictors of psychiatric 
disorders and functional impairment. Archives of family medicine, 3(9), 774-779. doi: 
10.1001/archfami.3.9.774 
 
Kulkarni, S. R., Gohel, M. S., & Wakely, C. (2007). A severity score comprising patient age, 
ulcer chronicity, and venous refill time predicted venous leg ulcer healing at 24 
weeks. Evidence-Based Nursing, 10(4), 122.  
 
Kunimoto, B. T. (2001). Assessment of venous leg ulcers: an in-depth discussion of a 
literature-guided approach. Ostomy Wound Management, 47(5), 38.  
 
Kyrle, P. A., & Eichinger, S. (2005). Deep vein thrombosis. The Lancet, 365(9465), 1163-
1174. doi: http://dx.doi.org/10.1016/S0140-6736(05)71880-8 
 
Labropoulos, N., Wang, E. D., Lanier, S. T., & Khan, S. U. (2012). Factors associated with 
poor healing and recurrence of venous ulceration. Plastic and Reconstructive Surgery, 
129(1), 179-186. doi: 10.1097/PRS.0b013e3182362a53 
 
Lantis, J. C., Marston, W. A., Farber, A., Kirsner, R. S., Zhang, Y., Lee, T. D., . . . Slade, H. 
B. (2013). The influence of patient and wound variables on healing of venous leg 
ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and 
fibroblasts. Journal of Vascular Surgery, 58(2), 433-439.  
 
Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: self-maintaining and 
instrumental activities of daily living. The Gerontologist, 9(3), 179-186.  
 
Layton, A. M., & Ibbotson, S. H. (1994). Randomised trial of oral aspirin for chronic venous 
leg ulcers. Lancet, 344(8916), 164.  
 
Lazarus, G. S., Cooper, D. M., Knighton, D. R., Margolis, D. J., Percoraro, R. E., 
Rodeheaver, G., & Robson, M. C. (1994). Definitions and guidelines for assessment 
of wounds and evaluation of healing. Wound Repair & Regeneration, 2(3), 165-170.  
 
LeBlond, R. F., DeGowin, R. L., & Brown, D. D. (2009). CHAPTER 06 - The Diagnostic 
Examination - The Skin and Nails. New York, United States, New York: The 
McGraw-Hill Companies, Inc., The Professional Book Group. 
 
Lindsay, E. (2004). The Lindsay Leg Club® Model: a model for evidence- based leg ulcer 
management. [Article]. British Journal of Community Nursing, 9, 17-22.  
 
Lindström, J., & Tuomilehto, J. (2003). The diabetes risk score: a practical tool to predict 
type 2 diabetes risk. Diabetes Care, 26(3), 725-731. doi: 10.2337/diacare.26.3.725 
Lopez, P., & Dachs, R. (2007). Cochrane briefs. Effectiveness of dressings for healing 
venous leg ulcers. American Family Physician, 75(5), 649-650.  
 
 Page | 248  
 
Maddox, D. (2012). Effects of venous leg ulceration on patients' quality of life. Nursing 
Standard, 26(38), 42+.  
 
Majeske, C. (1992). Reliability of wound surface area measurements. Physical Therapy, 
72(2), 138-141.  
 
Margolis, D. J., Allen-Taylor, L., Hoffstad, O., & Berlin, J. A. (2004). The accuracy of 
venous leg ulcer prognostic models in a wound care system. Wound Repair & 
Regeneration, 12(2), 163-168. 
  
Margolis, D. J., Berlin, J. A., & Strom, B. L. (1996). Interobserver agreement, sensitivity, and 
specificity of a "healed" chronic wound. Wound Repair & Regeneration, 4(3), 335-
338.  
 
Margolis, D. J., Berlin, J. A., & Strom, B. L. (1999). Risk factors associated with the failure 
of a venous leg ulcer to heal. Archives Of Dermatology, 135(8), 920-926.  
 
Margolis, D. J., Berlin, J. A., & Strom, B. L. (2000). Which venous leg ulcers will heal with 
limb compression bandages? The American Journal of Medicine, 109, 15-19.  
 
Margolis, D. J., Bilker, W., Santanna, J., & Baumgarten, M. (2002). Venous leg ulcer: 
incidence and prevalence in the elderly. Journal Of The American Academy Of 
Dermatology, 46(3), 381-386.  
 
Margolis, D. J., Knauss, J., & Bilker, W. (2002). Hormone replacement therapy and 
prevention of pressure ulcers and venous leg ulcers. Lancet, 359(9307), 675-677.  
 
Marucha, P. T., Kiecolt-Glaser, J. K., & Favagehi, M. (1998). Mucosal wound healing is 
impaired by examination stress. Psychosomatic Medicine, 60(3), 362-365.  
 
McDowell, I., & Newell, C. (1996). Measuring Health - A guide to rating scales and 
questionnaires (Second Edition ed.). Oxford: Oxford University Press. 
 
McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation 
coefficients. Psychological Methods, 1(1), 30-46. doi: 10.1037/1082-989x.1.1.30 
 
Meagher, H., Clarke-Moloney, M., O Laighin, G., & Grace, P. A. (2012). An experimental 
study of prescribed walking in the management of venous leg ulcers. Journal of 
Wound Care, 21(9), 421-430.  
 
Meaume, S., Couilliet, D., & Vin, F. (2005). Prognostic factors for venous ulcer healing in a 
non-selected population of ambulatory patients. Journal of Wound Care, 14(1), 31-34. 
  
Meetoo, D. (2013). Understanding and managing deep vein thrombosis. Nurse Prescribing, 
11(8), 390-395.  
Mekkes, J. R., Loots, M. A. M., Van Der Wal, A. C., & Bos, J. D. (2003). Causes, 
investigation and treatment of leg ulceration. British Journal of Dermatology, 148(3), 
388-401. doi: 10.1046/j.1365-2133.2003.05222.x 
 
 Page | 249  
 
Meleis, A. I. (2005). Theoretical nursing: development and progress. Philadelphia: 
Lippincott Williams & Wilkins. 
 
Merkle, D. (2011). Pain, depression, and quality of life: a description of factors related to 
venous leg wounds. Journal of Wound, Ostomy & Continence Nursing, 38(3S), S78-
S78.  
 
Metz, C. E. (1978). Basic principles of ROC analysis. Seminars in Nuclear Medicine, 8(4), 
283-298. doi: 10.1016/s0001-2998(78)80014-2 
 
Michel, C. C. (1990). Etiology of venous ulceration. British Journal of Surgery, 77(9), 1071-
1071. doi: 10.1002/bjs.1800770938 
 
Milic, D. J., Zivic, S. S., Bogdanovic, D. C., Karanovic, N. D., & Golubovic, Z. V. (2009). 
Risk factors related to the failure of venous leg ulcers to heal with compression 
treatment. J Vasc Surg, 49(5), 1242-1247. doi: S0741-5214(08)02007-7 
10.1016/j.jvs.2008.11.069 
 
Miller, G., Chen, E., & Cole, S. W. (2009). Health psychology: developing biologically 
plausible models linking the social world and physical health. Annual review of 
psychology, 60(1), 501-524. doi: 10.1146/annurev.psych.60.110707.163551 
 
Min, D. I., & Monaco, A. P. (1991). Complications associated with immunosuppressive 
therapy and their management. Pharmacotherapy, 11(5), 119S-125S. 
  
Moffatt, C. J., Doherty, D. C., Smithdale, R., & Franks, P. J. (2010). Clinical predictors of leg 
ulcer healing. The British Journal Of Dermatology, 162(1), 51-58.  
 
Moffatt, C. J., & Dorman, M. C. (1995). Recurrence of leg ulcers within a community ulcer 
service. Journal of Wound Care, 4(2), 57-61.  
 
Moffatt, C. J., Franks, P. J., Doherty, D. C., Smithdale, R., & Martin, R. (2006). 
Sociodemographic factors in chronic leg ulceration. British Journal of Dermatology, 
155, 307-312. doi: 10.1111/j.1365-2133.2006.07265.x 
 
Moore, K. (2005). Using wound area measurement to predict and monitor response to 
treatment of chronic wounds. Journal of Wound Care, 14(5), 229-232.  
 
Moore, K., Hall, V., Paull, A., Morris, T., Brown, S., McCulloch, D., . . . Harding, K. G. 
(2010). Surface bacteriology of venous leg ulcers and healing outcome. Journal Of 
Clinical Pathology, 63(9), 830-834.  
 
Moore, K., Huddleston, E., Stacey, M. C., & Harding, K. G. (2007). Venous leg ulcers - the 
search for a prognostic indicator. International Wound Journal, 4(2), 163-172.  
 
Morison, M. J., Moffatt, C. J., & Franks, P. J. (2007). Leg ulcers  A problem-based learning 
approach. Edinburgh: Mosby Elsevier. 
 
Mullins, M., Thomason, S. S., & Legro, M. (2005). Monitoring Pressure Ulcer Healing in 
Persons with Disabilities. Rehabilitation Nursing, 30(3), 92-99.  
 Page | 250  
 
 
National Health and Medical Research Council. (2007). NHMRC additional levels of 
evidence and grades for recommendation for developers of guidelines  Retrieved 
12/6/13, from 
http://www.nhmrc.gov.au/_files_nhmrc/file/guidelines/levels_grades05.pdf 
 
National Pressure Ulcer Advisory Panel. (2013). Educational and Clinical Resources - PUSH 
Tool  Retrieved 5th June, 2013, 2013, from http://wwwnpuaporg/wp-
content/uploads/2012/03/push3pdf 
 
Nogueira, G. S., Zanin, C. R., Miyazaki, M., & de Godoy, J. M. P. (2009). Venous Leg 
Ulcers and Emotional Consequences. International Journal of Lower Extremity 
Wounds, 8(4), 194-196. doi: 10.1177/1534734609350548 
 
Nogueira, G. S., Zanin, C. R., Miyazaki, M., & de Godoy, J. M. P. (2012). Quality of Life of 
Patients with Chronic Venous Ulcers and Socio-Demographic Factors. Wounds-a 
Compendium of Clinical Research and Practice, 24(10), 289-292. 
  
O'Meara S, Cullum N, Nelson EA, & Dumville, J. C. (2012). Compression for venous leg 
ulcers. Cochrane Database of Systematic Reviews (11). doi: 
10.1002/14651858.CD000265.pub3 
 
O'Meara, S., Cullum, N. A., & Nelson, E. A. (2009). Compression for venous leg ulcers. 
Cochrane Database of Systematic Reviews doi: 10.1002/14651858.CD000265.pub2 
 
O'Meara, S., Tierney, J., Cullum, N., Bland, J. M., Franks, P. J., Mole, T., & Scriven, M. 
(2009). Four layer bandage compared with short stretch bandage for venous leg 
ulcers: systematic review and meta-analysis of randomised controlled trials with data 
from individual patients. BMJ, 338, b1344. doi: 
10.1136/bmj.b1344338/apr17_1/b1344  
 
O'Meara, S. M., Bland, J. M., Dumville, J. C., & Cullum, N. A. (2012). A systematic review 
of the performance of instruments designed to measure the dimensions of pressure 
ulcers. Wound Repair and Regeneration, 20(3), 263-276.  
 
O’Brien, J., Edwards, H., Stewart, I., & Gibbs, H. (2012). A home-based progressive 
resistance exercise programme for patients with venous leg ulcers: a feasibility study. 
International Wound Journal, no-no. doi: 10.1111/j.1742-481X.2012.00995.x 
 
Ogrin, R., Woodward, M., Sussman, G., & Khalil, Z. (2011). Oxygen tension assessment: an 
overlooked tool for prediction of delayed healing in a clinical setting. International 
Wound Journal, 8(5), 437-445. doi: 10.1111/j.1742-481X.2011.00784.x 
 
Olin, J. W., Beusterien, K. M., Childs, M. B., Seavey, C., McHugh, L., & Griffiths, R. I. 
(1999). Medical costs of treating venous stasis ulcers: evidence from a retrospective 
cohort study. Vasc Med, 4(1), 1-7.  
 
Ongenae, K. C., & Phillips, T. J. (1993). Leg ulcer management. Emergency Medicine 25(9), 
44-53.  
 
 Page | 251  
 
Palfreyman. (2007). Dressings for venous leg ulcers: systematic review and meta-analysis 
(vol 335, pg 244, 2007). British Medical Journal, 335(7628), 1045-1045.  
 
Palfreyman, S. J., Tod, A. M., Brazier, J. E., & Michaels, J. A. (2010). A systematic review 
of health-related quality of life instruments used for people with venous ulcers: an 
assessment of their suitability and psychometric properties. Journal of Clinical 
Nursing, 19(19/20), 2673-2703.  
 
Pallant, J. (2011). SPSS Survival Manual (4th ed.). New South Wales: Allen & Unwin. 
 
Papaioannou, A., Parkinson, W., Cook, R., Ferko, N., Coker, E., & Adachi, J. D. (2004). 
Prediction of falls using a risk assessment tool in the acute care setting. BMC 
medicine, 2(1), 1-1. doi: 10.1186/1741-7015-2-1 
 
Paul, P., Pennell, M. L., & Lemeshow, S. (2013). Standardizing the power of the Hosmer–
Lemeshow goodness of fit test in large data sets. Statistics in Medicine, 32(1), 67-80. 
doi: 10.1002/sim.5525 
 
Persoon, A., Heinen, M. M., van der Vleuten, C. J. M., de Rooij, M. J., van de Kerkhof, P. C. 
M., & van Achterberg, T. (2004). Leg ulcers: a review of their impact on daily life. 
Journal of Clinical Nursing, 13(3), 341-354.  
 
Phillips, T., Stanton, B., Provan, A., & Lew, R. (1994). A study of the impact of leg ulcers on 
quality of life: financial, social, and psychologic implications. Journal Of The 
American Academy Of Dermatology, 31(1), 49-53.  
 
Phillips, T. J., Machado, F., Trout, R., Porter, J., Olin, J., & Falanga, V. (2000). Prognostic 
indicators in venous ulcers. J Am Acad Dermatol, 43(4), 627-630. doi: S0190-
9622(00)86781-X  
 
Popoola, M. M. (2000). Paradign shift: A clarion call for a holistic approach to chronic 
wound management. Advances in Skin & Wound Care, 13(1), 47-48.  
 
Popoola, M. M. (2003). A holistic approach to therapy for venous stasis leg ulcers. The 
American Journal for Nurse Practitioners, 7(7), 9-18.  
 
Posnett, J., & Franks, P. J. (2008). The burden of chronic wounds in the UK. Nurs Times, 
104(3), 44-45.  
 
Powell, C. C., Rohrer, M. J., Barnard, M. R., Peyton, B. D., Furman, M. I., & Michelson, A. 
D. (1999). Chronic venous insufficiency is associated with increased platelet and 
monocyte activation and aggregation. Journal of Vascular Surgery, 30(5), 844-853. 
doi: http://dx.doi.org/10.1016/S0741-5214(99)70009-1 
Price, P., & Harding, K. (2004). Cardiff wound impact schedule: the development of a 
condition-specific questionnaire to assess health-related quality of life in patients with 
chronic wounds of the lower limb. International Wound Journal, 1(1), 10-17. 
  
Ratliff, C. R., & Rodeheaver, G. T. (2005). Use of the PUSH tool to measure venous ulcer 
healing. Ostomy Wound Management, 51(5), 58. 
  
 Page | 252  
 
RCN Institute Centre for Evidence Based Nursing (Ed.). (2006). Clinical practice guidelines: 
The nursing management of patients with venous leg ulcers (2nd ed.). York: Royal 
College of Nursing. 
 
Robson, M. C., Cooper, D. M., Aslam, R., Gould, L. J., Harding, K. G., Margolis, D. J., . . . 
Wiersma-Bryant, L. (2006). Guidelines for the treatment of venous ulcers. Wound 
Repair and Regeneration, 14(6), 649-662. doi: 10.1111/j.1524-475X.2006.00174.x 
 
Rojas, A. I., & Phillips, T. J. (1999). Patients with chronic leg ulcers show diminished levels 
of vitamins A and E, carotenes, and zinc. Dermatologic Surgery, 25(8), 601-604. doi: 
10.1046/j.1524-4725.1999.99074.x 
 
Ruckley, C. V. (1997). Socioeconomic Impact of Chronic Venous Insufficiency and Leg 
Ulcers. Angiology, 48(1), 67-69.  
 
Rudolph, D. (2001). Standards of care for venous leg ulcers: compression therapy and moist 
wound healing. Journal Of Vascular Nursing: Official Publication Of The Society For 
Peripheral Vascular Nursing, 19(1), 20-27.  
 
Ryan, S., Eager, C., & Sibbald, R. G. (2003). Venous leg ulcer pain. Ostomy Wound 
Management, 49(4A), 16-23.  
 
Salaman, R. A., & Harding, K. G. (1995). The aetiology and healing rates of chronic leg 
ulcers. Journal of Wound Care, 4(7), 320-323.  
 
Santos, V. L. C., Sellmer, D., & Massulo, M. M. E. (2007). Inter rater reliability of Pressure 
Ulcer Scale for Healing (PUSH) in patients with chronic leg ulcers. Revista Latino-
Americana de Enfermagem 15(3), 391-396.  
 
Sbidian, E., Wolkenstein, P., Valeyrie-Allanore, L., Rodriguez, D., Hadj-Rabia, S., Ferkal, S., 
. . . Bastuji-Garin, S. (2010). NF-1Score: a prediction score for internal neurofibromas 
in neurofibromatosis-1. The Journal Of Investigative Dermatology, 130(9), 2173-
2178. doi: 10.1038/jid.2010.100 
 
Schultz, G. S., Sibbald, R. G., Falanga, V., Ayello, E. A., Dowsett, C., Harding, K., . . . 
Vanscheidt, W. (2003). Wound bed preparation: a systematic approach to wound 
management. Wound Repair and Regeneration, 11(Supplement 1), S1-S28.  
 
Scott, T. E., LaMorte, W. W., Gorin, D. R., & Menzoian, J. O. (1995). Risk factors for 
chronic venous insufficiency: a dual case-control study. J Vasc Surg, 22(5), 622-628. 
doi: S0741-5214(95)70050-1  
 
Scottish Intercollegiated Guidelines Network. (2010). Management of chronic venous leg 
ulcers - A national clinical guideline. Edinburgh. 
 
Seiler, W. O., & Stahelin, H. B. (1994). Identification of factors that impair wound of factors 
that impair wound-healing - A possible approach to wound -healing research. 
Wounds-a Compendium of Clinical Research and Practice, 6(3), 101-106.  
 
 Page | 253  
 
Sherbourne, C., & Stewart, A. (1991). The MOS social support survey. Soc. Sci. Med., 32(6), 
705-714.  
 
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. 
Psychological Bulletin, 86(2), 420-428. doi: 10.1037/0033-2909.86.2.420 
 
Shu-Chuan, J. H., & Lo, S. K. (2004). Living alone, social support, and feeling lonely among 
the elderly. Social Behavior and Personality: an international journal, 32(2), 129-
129. doi: 10.2224/sbp.2004.32.2.129 
 
Sieggreen, M. Y., & Kline, R. A. (2004). Recognizing and managing venous leg ulcers. 
Advances in Skin & Wound Care, 17(6), 302-311.  
 
Simka, M. (2007). Calf muscle pump impairment and delayed healing of venous leg ulcers: 
Air plethysmographic findings. The Journal of Dermatology, 34(8), 537-544.  
 
Simon, D. A., Dix, F. P., & McCollum, C. N. (2004). Management of venous leg ulcers. BMJ 
(Clinical Research Ed.), 328(7452), 1358-1362.  
 
Sipos, P., Gyory, H., Hagymasi, K., Ondrejka, P., & Blazovics, A. (2004). Special wound 
healing methods used in ancient Egypt and the mythological background. World 
Journal Of Surgery, 28(2), 211-216. doi: 10.1007/s00268-003-7073-x 
 
Skene, A. I., Smith, J. M., Dore, C. J., Charlett, A., & Lewis, J. D. (1992). Venous leg ulcers: 
a prognostic index to predict time to healing. British Medical Journal, 305(6862), 
1119-1121.  
 
Smith, E., & McGuiness, W. (2010). Managing venous leg ulcers in the community: personal 
financial cost to sufferers. Wound Practice & Research, 18(3), 134-139.  
 
Smith, P. D. (1999). Neutrophil activation and mediators of inflammation in chronic venous 
insufficiency. J Vasc Res, 36 Suppl 1, 24-36. doi: 54071 
 
Sola, M. L., Antonio, J., Fajardo, G., & Puerta, C. V. (2012). Influence of Aspirin Therapy in 
the Ulcer Associated With Chronic Venous Insufficiency. Annals of Vascular 
Surgery, 26(5), 620-629. doi: 10.1016/j.avsg.2011.02.051 
 
Solnek, B. L., & Seiter, T. (2002). How to diagnose and treat depression. The Nurse 
practitioner, 27(10), 12-23. doi: 10.1097/00006205-200210000-00005 
 
Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., . . . Catchlove, 
B. R. (1981). Measuring the quality of life of cancer patients: A concise QL-Index for 
use by physicians. Journal of Chronic Diseases, 34(12), 585-597. doi: 10.1016/0021-
9681(81)90058-8 
 
Stacey, M. C., Jopp Mckay, A. G., Rashid, P., Hoskin, S. E., & Thompson, P. J. (1997). The 
influence of dressings on venous ulcer healing - A randomised trial. European 
Journal of Vascular and Endovascular Surgery, 13(2), 174-179. doi: 10.1016/s1078-
5884(97)80015-9 
 
 Page | 254  
 
Steptoe, A., Shankar, A., Demakakos, P., & Wardle, J. (2013). Social isolation, loneliness, 
and all-cause mortality in older men and women. Proceedings of the National 
Academy of Sciences of the United States of America, 110(15), 5797-5801. doi: 
10.1073/pnas.1219686110 
 
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988). The MOS short-form general health 
survey: Reliability and validity in a patient population. Medical Care, 26(7), 724-735. 
doi: 10.1097/00005650-198807000-00007 
 
Stewart, A. L., & Ware, J., Jr. (1992). Measuring functioning and well-being: the medical 
outcomes study approach. Durham, North Carolina: Duke University Press. 
 
Stotts, N., Rodeheaver, G., Thomas, D., Frantz, R., Bartolucci, A., Sussman, C., . . . 
Maklebust, J. (2001). An Instrument to Measure Healing in Pressure Ulcers: 
Development and Validation of the Pressure Ulcer Scale for Healing (PUSH). J 
Gerontol A Biol Sci Med Sci, 56, M795 - 799.  
 
Stupar, D., Upton, Z., Gupta, R., & Shooter, G. (2012). Biochemical profiling of chronic leg 
ulcers. Paper presented at the 4th Congress of the World Union of Wound Healing 
Societies, Yokohama, Japan. 
 
Sud, H., & Gorman, J. (2008). Developing a risk assessment tool to improve patient safety. 
Nursing Times, 104(36), 26-27.  
 
Sufian, S., Lakhanpal, S., & Marquez, J. (2011). Superficial vein ablation for the treatment of 
primary chronic venous ulcers. Phlebology, 26(7), 301-306. doi: 
10.1258/phleb.2010.010058 
 
Sussman, C., & Swanson, G. (1997). Utility of the Sussman wound healing tool in predicting 
wound healing outcomes in physical therapy. Adv Wound Care, 10(5), 74-77.  
 
Szewczyk, M. T., Jawien, A., Migdalski, A., Piotrowicz, R., Grzela, T., & Brazis, P. (2009). 
Predicting time to healing by anatomical assessment of venous pathology. Medical 
Science Monitor, 15(2), CR74-CR81.  
 
Tabachnick, B. G., & Fidell, L. S. (2007). Using multivariate statistics (5th ed.). Needham 
Heights, MA: Allyn & Bacon. 
 
Takase, S., Schmid-Schonbein, G., & Bergan, J. J. (1999). Leukocyte activation in patients 
with venous insufficiency. Journal of Vascular Surgery, 30(1), 148-156. doi: 
10.1016/s0741-5214(99)70187-4 
Taylor, R. J., Taylor, A. D., & Smyth, J. V. (2002). Using an artificial neural network to 
predict healing times and risk factors for venous leg ulcers. Journal of Wound Care, 
11(3), 101-105.  
 
Tennvall, G. R., & Hjelmgren, J. (2005). Annual costs of treatment for venous leg ulcers in 
Sweden and the United Kingdom. Wound Repair & Regeneration, 13(1), 13-18. doi: 
10.1111/j.1067-1927.2005.130103.x 
 
 Page | 255  
 
The Australian Wound Management Association Inc and the New Zealand Wound Care 
Society Inc (Ed.). (2011). Australian and New Zealand Clinical Practice Guideline 
for Prevention and Management of Venous Leg Ulcers: Cambridge Publishing. 
 
Thomas, D. R., Rodeheaver, G. T., Bartolucci, A. A., Franz, R. A., Sussman, C., Ferrell, B. 
A., . . . Maklebust, J. (1997). Pressure ulcer scale for healing: derivation and 
validation of the PUSH tool. The PUSH Task Force. Adv Wound Care, 10(5), 96-101. 
  
Thompson, G., & Stephen-Haynes, J. (2007). An overview of wound healing and exudate 
management. British Journal of Community Nursing, 12(12), S22-S30.  
 
Tobón, J., Whitney, J. D., & Jarrett, M. (2008). Nutritional status and wound severity of 
overweight and obese patients with venous leg ulcers: a pilot study. Journal Of 
Vascular Nursing: Official Publication Of The Society For Peripheral Vascular 
Nursing, 26(2), 43-52.  
 
Tomaka, J., Thompson, S., & Palacios, J. (2006). The Relation of Social Isolation, 
Loneliness, and Social Support to Disease Outcomes Among the Elderly. Journal of 
Aging and Health, 18(3), 359-384. doi: 10.1177/0898264305280993 
 
Tortora, G. J., & Derrickson, B. (2012). Principles of anatomy & physiology (13th ed.). 
Hoboken: John Wiley & Sons, Inc. 
 
Van de Scheur, M., & Falanga, V. (1997). Pericapillary fibrin cuffs in venous disease. A 
reappraisal. Dermatol Surg, 23(10), 955-959. doi: S1076051297002811 
 
Van den Oever, R., Hepp, B., Debbaut, B., & Simon, I. (1998). Socio-economic impact of 
chronic venous insufficiency. An underestimated public health problem. International 
Angiology, 17(3), 161-167.  
 
Van Rijswijk, L., & Polansky, M. (1994). Predictors of time to healing deep pressure ulcers. 
Wounds-a Compendium of Clinical Research and Practice, 6(5), 159-165.  
 
Victor, C., Scambler, S., Bond, J., & Bowling, A. (2000). Being alone in later life: loneliness, 
social isolation and living alone. Reviews in Clinical Gerontology, 10(4), 407-417. 
doi: 10.1017/s0959259800104101 
 
Walker, N., Rodgers, A., Birchall, N., Norton, R., & MacMahon, S. (2002). Leg ulcers in 
New Zealand: age at onset, recurrence and provision of care in an urban population. 
The New Zealand Medical Journal, 115(1156), 286-289.  
 
Walshe, C. (1995). Living with a venous leg ulcer: a descriptive study of patients’ 
experiences. Journal of Advanced Nursing, 22(6), 1092-1100.  
 
Walters, S. J., Morrell, C. J., & Dixon, S. (1999). Measuring health-related quality of life in 
patients with venous leg ulcers. Quality of Life Research, 8(4), 327-336.  
 
Wand, H. (2011). Developing and validating a risk scoring tool for chlamydia infection 
among sexual health clinic attendees in Australia: A simple algorithm to identify 
 Page | 256  
 
those at high risk of chlamydia infection. Sexually Transmitted Infections, 87, A216-
A216. doi: 10.1136/sextrans-2011-050108.273 
 
Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: 
construction of scales and preliminary tests of reliability and validity. Medical Care, 
34(3), 220-233.  
 
Ware, J. E., Jr., Kosinski, M. A., Turner-Bowker, D. M., & Gandek, B. (2002). How to score 
Version 2 of the SF-12
R
 Health Survey (With a supplement documenting version 1): 
Lincoln, RI: QualityMetric Incorporated. 
 
Weiss, R. A., Heagle, C. R., & Raymond-Martimbeau, P. (1992). The bulletin of the north 
american society of phlebology. Insurance advisory committee report. The Journal Of 
Dermatologic Surgery And Oncology, 18(7), 609-616.  
 
West, B. T. (2009). Analyzing Longitudinal Data With the Linear Mixed Models Procedure 
in SPSS. Evaluation & the Health Professions, 32(3), 207-228. doi: 
10.1177/0163278709338554 
 
Whitney, J. D. (1999). Thoughts on theory. Journal of wound, ostomy, and continence 
nursing : official publication of The Wound, Ostomy and Continence Nurses Society / 
WOCN, 26(5), 228-229. doi: 10.1016/s1071-5754(99)90051-7 
 
Wilkinson, E. (2012). Oral zinc for arterial and venous leg ulcers. Cochrane Database of 
Systematic Reviews(8). doi: 10.1002/146518558.CD001273.pub2 
 
Williams, C. (2000). Leg ulcer after care: the role of compression hosiery. British Journal Of 
Nursing (Mark Allen Publishing), 9(13), 822.  
 
Wipke-Tevis, D. D., & Stotts, N. A. (1996). Nutritional risk, status, and intake of individuals 
with venous ulcers: a pilot study. Journal Of Vascular Nursing: Official Publication 
Of The Society For Peripheral Vascular Nursing, 14(2), 27-33.  
 
Woodbury, M. G., Houghton, P. E., Campbell, K. E., & Keast, D. H. (2004). Development, 
validity, reliability, and responsiveness of a new leg ulcer measurement tool. 
Advances in Skin & Wound Care, 17(4), 187-196.  
 
Woodward, M. (2002). Wound Management by Aged Care Specialists. Primary Intention: 
The Australian Journal of Wound Management, 10(2), 70-71, 73-76.  
 
Word, R. (2010). Medical and surgical therapy for advanced chronic venous insufficiency. 
Surgical Clinics of North America, 90(6), 1195-1214. doi: 10.1016/j.suc.2010.08.008 
World Health Organization. (2014). BMI Classification  Retrieved 23.3.14, 2014, from 
http://apps.who.int/bmi/index.jsp?introPage=intro_3.html 
 
WUWHS. (2008). Wound infection in clinical practice. An international consensus. 
International Wound Journal, 5 Suppl 3, iii-11.  
 
Wyatt, J. C., & Altman, D. G. (1995). Commentary--Prognostic models: Clinically useful or 
quickly forgotten? British Medical Journal, 311(7019), 1539-1539.  
 Page | 257  
 
 
Wyffels, J. T., & Edsberg, L. E. (2011). Granulation tissue of chronic pressure ulcers as a 
predictive indicator of wound closure. Advances in Skin & Wound Care, 24(10), 464-
473.  
 
Young, A., & McNaught, C.-E. (2011). The physiology of wound healing. Surgery (Oxford), 
29(10), 475-479. doi: http://dx.doi.org/10.1016/j.mpsur.2011.06.011 
 
Zenilman, J., Valle, M. F., Malas, M. B., Maruthur, N., Qazi, U., Suh, Y., . . . Lazarus, G. 
(2013) Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment 
Modalities. Rockville (MD). 
 
Zuidersma, M., Conradi, H. J., van Melle, J. P., Ormel, J., & de Jonge, P. (2013). Self-
reported depressive symptoms, diagnosed clinical depression and cardiac morbidity 
and mortality after myocardial infarction. International journal of cardiology, 167(6), 
2775-2780. doi: 10.1016/j.ijcard.2012.07.002 
 
 Page | 258  
 
 Page | 259  
 
 
